1	Lung	NN	O	lung	nn	2	SENT_1	[p1l879t82r940b108],
2	Cancer	NN	O	cancer	_	0	SENT_1	[p1l948t82r1034b103],
3	66	CD	NUMBER	66	number	4	SENT_1	[p1l1042t82r1071b103],
4	(	CD	NUMBER	(	dep	2	SENT_1	[p1l1080t81r1163b108],
5	2009	CD	DATE	2009	dep	4	SENT_1	[p1l1080t81r1163b108],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l1080t81r1163b108],
7	114-119	CD	NUMBER	114-119	dep	2	SENT_1	[p1l1173t82r1281b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l779t188r915b214],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l928t189r986b213],
3	available	JJ	O	available	amod	2	SENT_2	[p1l998t189r1133b214],
4	at	IN	O	at	_	0	SENT_2	[p1l1145t192r1172b214],
5	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1184t188r1392b214],

1	Lung	NN	O	lung	nn	2	SENT_3	[p1l926t289r1057b344],
2	Cancer	NN	O	cancer	_	0	SENT_3	[p1l1075t289r1260b333],

1	‘	NN	O	‘	_	0	SENT_4	[p1l36t375r126b400],
2	;	:	O	;	_	0	SENT_4	[p1l36t375r126b400],
3	,	,	O	,	_	0	SENT_4	[p1l36t375r126b400],
4	:	:	O	:	_	0	SENT_4	[p1l36t375r126b400],
5	'	''	O	'	_	0	SENT_4	[p1l36t375r126b400],
6	rv	NN	O	rv	dep	3	SENT_4	[p1l36t375r126b400],
7	.	.	O	.	_	0	SENT_4	[p1l36t375r126b400],

1	-	:	O	-	_	0	SENT_5	[p1l36t375r126b400],
2	.	.	O	.	_	0	SENT_5	[p1l248t394r252b397],

1	ELSEVIER	NNP	O	ELSEVIER	nn	3	SENT_6	[p1l12t421r248b456],
2	journal	NN	O	journal	nn	3	SENT_6	[p1l576t418r708b449],
3	homepage	NN	O	homepage	_	0	SENT_6	[p1l730t418r933b449],
4	:	:	O	:	_	0	SENT_6	[p1l730t418r933b449],
5	www.elsevier.com/Iocate/lungcan	NN	O	www.elsevier.com/iocate/lungcan	dep	3	SENT_6	[p1l949t418r1593b449],

1	Polymorphisms	NNS	O	polymorphism	nsubj	4	SENT_7	[p1l6t565r419b622],
2	of	IN	O	of	_	0	SENT_7	[p1l439t565r494b611],
3	EGFR	NN	ORGANIZATION	egfr	prep_of	1	SENT_7	[p1l504t568r635b611],
4	predict	VBP	O	predict	_	0	SENT_7	[p1l653t565r841b622],
5	clinical	JJ	O	clinical	amod	6	SENT_7	[p1l858t565r1045b611],
6	outcome	NN	O	outcome	dobj	4	SENT_7	[p1l1064t572r1295b611],
7	in	IN	O	in	_	0	SENT_7	[p1l1314t566r1363b610],
8	advanced	JJ	O	advanced	amod	12	SENT_7	[p1l1381t565r1631b611],
9	non-small-cell	JJ	O	non-small-cell	amod	12	SENT_7	[p1l6t637r391b682],
10	lung	NN	O	lung	nn	12	SENT_7	[p1l411t637r527b693],
11	cancer	NN	O	cancer	nn	12	SENT_7	[p1l544t650r718b682],
12	patients	NNS	O	patient	prep_in	4	SENT_7	[p1l735t638r947b693],
13	treated	VBN	O	treat	partmod	12	SENT_7	[p1l966t637r1155b682],
14	with	IN	O	with	_	0	SENT_7	[p1l1173t637r1295b682],
15	Geﬁtinib	NN	O	geﬁtinib	prep_with	13	SENT_7	[p1l1314t637r1543b682],

1	Fei	NNP	PERSON	Fei	nn	3	SENT_8	[p1l6t740r62b775],
2	Ma	NNP	PERSON	Ma	nn	3	SENT_8	[p1l78t736r206b781],
3	“	NNP	O	“	nsubj	34	SENT_8	[p1l78t736r206b781],
4	,	,	O	,	_	0	SENT_8	[p1l78t736r206b781],
5	Tong	NNP	PERSON	Tong	nn	6	SENT_8	[p1l220t742r321b784],
6	Sun	NNP	PERSON	Sun	appos	3	SENT_8	[p1l334t742r410b775],
7	'	POS	DATE	'	_	0	SENT_8	[p1l418t734r478b781],
8	33	CD	DATE	33	dep	6	SENT_8	[p1l418t734r478b781],
9	,	,	O	,	_	0	SENT_8	[p1l418t734r478b781],
10	Yuankai	NNP	ORGANIZATION	Yuankai	appos	8	SENT_8	[p1l491t740r657b775],
11	Shia	JJ	ORGANIZATION	shia	amod	14	SENT_8	[p1l673t740r770b781],
12	,	,	O	,	_	0	SENT_8	[p1l673t740r770b781],
13	Dianke	JJ	PERSON	dianke	amod	14	SENT_8	[p1l785t740r928b775],
14	Yub	NN	PERSON	yub	dep	10	SENT_8	[p1l942t734r1031b781],
15	,	,	O	,	_	0	SENT_8	[p1l942t734r1031b781],
16	Wen	NNP	O	Wen	nn	18	SENT_8	[p1l1044t742r1140b775],
17	Tan	NNP	O	Tan	nn	18	SENT_8	[p1l1153t734r1263b781],
18	”	NNP	O	”	appos	14	SENT_8	[p1l1153t734r1263b781],
19	,	,	O	,	_	0	SENT_8	[p1l1153t734r1263b781],
20	Ming	NNP	PERSON	Ming	nn	21	SENT_8	[p1l1278t740r1385b784],
21	Yangb	NNP	PERSON	Yangb	appos	14	SENT_8	[p1l1397t734r1533b784],
22	,	,	O	,	_	0	SENT_8	[p1l1397t734r1533b784],
23	Chen	NNP	PERSON	Chen	nn	24	SENT_8	[p1l1548t740r1652b775],
24	Wub	NNP	PERSON	Wub	appos	14	SENT_8	[p1l1665t734r1775b781],
25	,	,	O	,	_	0	SENT_8	[p1l1665t734r1775b781],
26	Datong	NNP	PERSON	Datong	nn	27	SENT_8	[p1l6t795r155b837],
27	Chua	NNP	PERSON	Chua	appos	14	SENT_8	[p1l169t793r283b833],
28	,	,	O	,	_	0	SENT_8	[p1l169t793r283b833],
29	Yan	NNP	ORGANIZATION	Yan	nn	30	SENT_8	[p1l296t795r372b828],
30	Suna	NNP	ORGANIZATION	Suna	appos	14	SENT_8	[p1l386t794r497b833],
31	,	,	O	,	_	0	SENT_8	[p1l386t794r497b833],
32	Binghe	NNP	PERSON	Binghe	nn	33	SENT_8	[p1l512t793r654b837],
33	Xu	NNP	PERSON	Xu	appos	14	SENT_8	[p1l668t794r786b833],
34	‘	VBD	O	‘	_	0	SENT_8	[p1l668t794r786b833],
35	*	CD	NUMBER	*	number	36	SENT_8	[p1l668t794r786b833],
36	’	CD	NUMBER	’	dobj	34	SENT_8	[p1l668t794r786b833],
37	*	NN	O	*	dep	36	SENT_8	[p1l668t794r786b833],
38	,	,	O	,	_	0	SENT_8	[p1l668t794r786b833],
39	Dongxin	NN	O	dongxin	nn	40	SENT_8	[p1l801t793r976b837],
40	Linb	NN	O	linb	dobj	34	SENT_8	[p1l991t787r1119b828],
41	’	CD	NUMBER	’	dep	40	SENT_8	[p1l991t787r1119b828],
42	**	NN	O	**	nn	44	SENT_8	[p1l991t787r1119b828],
43	3	CD	NUMBER	3	num	44	SENT_8	[p1l6t870r15b881],
44	Department	NNP	ORGANIZATION	Department	dep	40	SENT_8	[p1l22t870r169b896],
45	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l176t869r202b896],
46	Medical	NNP	ORGANIZATION	Medical	nn	47	SENT_8	[p1l205t869r300b891],
47	Oncology	NNP	ORGANIZATION	Oncology	prep_of	44	SENT_8	[p1l309t869r423b896],
48	,	,	O	,	_	0	SENT_8	[p1l309t869r423b896],
49	Cancer	NNP	ORGANIZATION	Cancer	nn	50	SENT_8	[p1l433t870r516b891],
50	Hospital	NNP	ORGANIZATION	Hospital	conj_and	47	SENT_8	[p1l523t869r623b896],
51	and	CC	ORGANIZATION	and	_	0	SENT_8	[p1l631t869r676b891],
52	Institute	NNP	ORGANIZATION	Institute	conj_and	47	SENT_8	[p1l683t869r789b894],
53	,	,	O	,	_	0	SENT_8	[p1l683t869r789b894],
54	Chinese	NNP	ORGANIZATION	Chinese	nn	55	SENT_8	[p1l799t869r891b891],
55	Academy	NNP	ORGANIZATION	Academy	dobj	34	SENT_8	[p1l897t869r1008b896],
56	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l1017t869r1043b896],
57	Medical	NNP	ORGANIZATION	Medical	nn	58	SENT_8	[p1l1046t869r1141b891],
58	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	55	SENT_8	[p1l1148t869r1248b891],
59	and	CC	O	and	_	0	SENT_8	[p1l1256t869r1301b891],
60	Peking	NNP	ORGANIZATION	Peking	nn	63	SENT_8	[p1l1308t869r1389b896],
61	Union	NNP	ORGANIZATION	Union	nn	63	SENT_8	[p1l1397t869r1467b891],
62	Medical	NNP	ORGANIZATION	Medical	nn	63	SENT_8	[p1l1476t869r1571b891],
63	College	NNP	ORGANIZATION	College	prep_of	55	SENT_8	[p1l1579t869r1669b896],
64	,	,	O	,	_	0	SENT_8	[p1l1579t869r1669b896],
65	Beijing	NNP	LOCATION	Beijing	prep_of	55	SENT_8	[p1l1678t869r1765b896],
66	,	,	O	,	_	0	SENT_8	[p1l1678t869r1765b896],
67	China	NNP	LOCATION	China	nn	71	SENT_8	[p1l1775t869r1843b891],
68	"	``	O	"	punct	71	SENT_8	[p1l6t901r16b916],
69	Department	NNP	O	Department	nn	71	SENT_8	[p1l23t906r170b931],
70	of	IN	O	of	amod	71	SENT_8	[p1l177t904r203b931],
71	Etiology	NNP	O	Etiology	prep_of	55	SENT_8	[p1l206t904r304b931],
72	and	CC	O	and	_	0	SENT_8	[p1l312t904r357b926],
73	Carcinogenesis	NNP	O	Carcinogenesis	nn	76	SENT_8	[p1l365t905r548b931],
74	,	,	O	,	_	0	SENT_8	[p1l365t905r548b931],
75	Cancer	NNP	ORGANIZATION	Cancer	conj_and	58	SENT_8	[p1l558t905r641b926],
76	Hospital	NNP	ORGANIZATION	Hospital	conj_and	58	SENT_8	[p1l647t904r747b931],
77	and	CC	ORGANIZATION	and	_	0	SENT_8	[p1l755t904r800b926],
78	Institute	NNP	ORGANIZATION	Institute	conj_and	58	SENT_8	[p1l808t905r914b929],
79	,	,	O	,	_	0	SENT_8	[p1l808t905r914b929],
80	Chinese	NNP	ORGANIZATION	Chinese	nn	81	SENT_8	[p1l924t904r1015b926],
81	Academy	NNP	ORGANIZATION	Academy	dobj	34	SENT_8	[p1l1021t904r1132b931],
82	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l1141t904r1167b931],
83	Medical	NNP	ORGANIZATION	Medical	nn	84	SENT_8	[p1l1170t904r1265b926],
84	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	81	SENT_8	[p1l1272t905r1372b926],
85	and	CC	O	and	_	0	SENT_8	[p1l1380t904r1425b926],
86	Peking	NNP	ORGANIZATION	Peking	nn	89	SENT_8	[p1l1433t904r1513b931],
87	Union	NNP	ORGANIZATION	Union	nn	89	SENT_8	[p1l1521t905r1592b926],
88	Medical	NNP	ORGANIZATION	Medical	nn	89	SENT_8	[p1l1600t904r1695b926],
89	College	NNP	ORGANIZATION	College	dobj	34	SENT_8	[p1l1704t904r1793b931],
90	,	,	O	,	_	0	SENT_8	[p1l1704t904r1793b931],
91	Beijing	NNP	LOCATION	Beijing	nn	93	SENT_8	[p1l1802t905r1889b931],
92	,	,	O	,	_	0	SENT_8	[p1l1802t905r1889b931],
93	China	NNP	LOCATION	China	appos	89	SENT_8	[p1l1899t904r1967b926],

1	ARTICLE	NN	O	article	_	0	SENT_9	[p1l6t1040r232b1062],
2	INFO	NN	O	info	nn	3	SENT_9	[p1l277t1040r401b1062],
3	ABSTRACT	NN	O	abstract	dep	1	SENT_9	[p1l701t1040r972b1062],

1	Article	NNP	O	Article	nn	2	SENT_10	[p1l6t1113r85b1135],
2	history	NN	O	history	nn	5	SENT_10	[p1l100t1113r190b1140],
3	-	:	O	-	_	0	SENT_10	[p1l100t1113r190b1140],
4	'	''	O	'	_	0	SENT_10	[p1l100t1113r190b1140],
5	Purpose	NN	O	purpose	_	0	SENT_10	[p1l716t1116r832b1145],
6	:	:	O	:	_	0	SENT_10	[p1l716t1116r832b1145],
7	Genetic	JJ	O	genetic	amod	8	SENT_10	[p1l854t1115r961b1139],
8	variations	NNS	O	variation	nsubj	12	SENT_10	[p1l980t1115r1120b1139],
9	in	IN	O	in	_	0	SENT_10	[p1l1142t1115r1168b1139],
10	EGFR	NN	ORGANIZATION	egfr	prep_in	8	SENT_10	[p1l1187t1116r1257b1139],
11	may	MD	O	may	aux	12	SENT_10	[p1l1278t1121r1338b1145],
12	alter	VB	O	alter	dep	5	SENT_10	[p1l1357t1115r1422b1139],
13	protein	NN	O	protein	nn	14	SENT_10	[p1l1442t1115r1543b1145],
14	function	NN	O	function	dobj	12	SENT_10	[p1l1564t1114r1682b1139],
15	and	CC	O	and	_	0	SENT_10	[p1l1703t1114r1754b1139],
16	therefore	RB	O	therefore	advmod	14	SENT_10	[p1l1775t1114r1905b1139],
17	the	DT	O	the	det	19	SENT_10	[p1l1925t1114r1970b1139],
18	therapeutic	JJ	O	therapeutic	amod	19	SENT_10	[p1l1991t1114r2154b1145],
19	efﬁcacy	NN	O	efﬁcacy	dobj	12	SENT_10	[p1l6t1154r114b1184],
20	Received	VBN	O	receive	partmod	19	SENT_10	[p1l7t1188r117b1210],
21	30	CD	DATE	30	num	22	SENT_10	[p1l126t1189r156b1210],
22	September	NNP	DATE	September	dobj	20	SENT_10	[p1l165t1188r302b1215],
23	2008	CD	DATE	2008	num	22	SENT_10	[p1l310t1189r372b1210],
24	Received	VBN	O	receive	partmod	22	SENT_10	[p1l7t1224r117b1245],
25	in	IN	O	in	_	0	SENT_10	[p1l126t1224r150b1245],
26	revised	JJ	O	revised	amod	27	SENT_10	[p1l158t1224r248b1245],
27	form	NN	O	form	prep_in	24	SENT_10	[p1l257t1224r317b1245],
28	2	CD	DATE	2	num	27	SENT_10	[p1l326t1225r339b1245],
29	December	NNP	DATE	December	tmod	27	SENT_10	[p1l349t1224r478b1245],
30	2008	CD	DATE	2008	num	29	SENT_10	[p1l486t1225r548b1245],
31	Accepted	JJ	O	accepted	amod	32	SENT_10	[p1l6t1259r121b1286],
32	25	CD	DATE	25	tmod	24	SENT_10	[p1l130t1261r159b1281],
33	December	NNP	DATE	December	dep	32	SENT_10	[p1l169t1259r298b1281],
34	2008	CD	DATE	2008	num	33	SENT_10	[p1l306t1261r368b1281],

1	of	IN	O	of	_	0	SENT_11	[p1l6t1334r35b1358],
2	epidermal	JJ	O	epidermal	amod	6	SENT_11	[p1l45t1334r189b1364],
3	growth	NN	O	growth	nn	6	SENT_11	[p1l202t1334r304b1364],
4	factor	NN	O	factor	nn	6	SENT_11	[p1l317t1334r398b1358],
5	receptor	NN	O	receptor	nn	6	SENT_11	[p1l411t1338r529b1364],
6	inhibitors	NNS	O	inhibitor	pobj	1	SENT_11	[p1l542t1334r685b1359],
7	.	.	O	.	_	0	SENT_11	[p1l542t1334r685b1359],

1	This	DT	O	this	det	2	SENT_12	[p1l698t1334r756b1358],
2	study	NN	O	study	nsubj	3	SENT_12	[p1l770t1334r847b1364],
3	investigated	VBD	O	investigate	_	0	SENT_12	[p1l860t1334r1031b1364],
4	the	DT	O	the	det	5	SENT_12	[p1l1045t1334r1090b1358],
5	association	NN	O	association	nsubj	22	SENT_12	[p1l1103t1335r1260b1358],
6	between	IN	O	between	_	0	SENT_12	[p1l1273t1334r1395b1358],
7	polymorphisms	NNS	O	polymorphism	prep_between	5	SENT_12	[p1l1408t1334r1480b1364, p1l6t1374r166b1404],
8	in	IN	O	in	_	0	SENT_12	[p1l177t1374r203b1398],
9	EGFR	NN	ORGANIZATION	egfr	prep_in	7	SENT_12	[p1l212t1375r282b1398],
10	and	CC	O	and	_	0	SENT_12	[p1l292t1374r343b1398],
11	clinical	JJ	O	clinical	amod	12	SENT_12	[p1l354t1374r453b1398],
12	outcome	NN	O	outcome	prep_between	5	SENT_12	[p1l464t1378r587b1398],
13	in	IN	O	in	_	0	SENT_12	[p1l598t1374r624b1398],
14	patients	NNS	O	patient	prep_in	12	SENT_12	[p1l634t1374r748b1404],
15	with	IN	O	with	_	0	SENT_12	[p1l758t1374r823b1398],
16	advanced	JJ	O	advanced	amod	18	SENT_12	[p1l833t1374r967b1398],
17	non-small-cell	JJ	O	non-small-cell	amod	18	SENT_12	[p1l977t1374r1183b1398],
18	lung	NN	O	lung	prep_with	14	SENT_12	[p1l1193t1374r1256b1404],
19	cancer	NN	O	cancer	nn	22	SENT_12	[p1l1265t1381r1358b1398],
20	(	CD	NUMBER	(	num	22	SENT_12	[p1l1367t1374r1480b1404],
21	NSCLC	NN	O	nsclc	nn	22	SENT_12	[p1l1367t1374r1480b1404],
22	)	NN	O	)	xcomp	3	SENT_12	[p1l1367t1374r1480b1404],
23	treated	VBN	O	treat	partmod	22	SENT_12	[p1l6t1414r107b1438],
24	with	IN	O	with	_	0	SENT_12	[p1l116t1414r181b1438],
25	Geﬁtinib	NN	PERSON	geﬁtinib	prep_with	23	SENT_12	[p1l191t1414r320b1438],
26	.	.	O	.	_	0	SENT_12	[p1l191t1414r320b1438],

1	Keywords	NNPS	O	Keywords	_	0	SENT_13	[p1l6t1470r131b1497],
2	:	:	O	:	_	0	SENT_13	[p1l6t1470r131b1497],
3	EGFR	NN	O	egfr	nn	8	SENT_13	[p1l6t1506r68b1527],
4	Polymorphism	NN	O	polymorphism	nn	8	SENT_13	[p1l7t1541r191b1568],
5	Lung	NN	O	lung	nn	8	SENT_13	[p1l7t1578r68b1604],
6	cancer	NN	O	cancer	nn	8	SENT_13	[p1l76t1583r158b1598],
7	Geﬁtinib	NN	O	geﬁtinib	nn	8	SENT_13	[p1l7t1612r116b1634],
8	therapy	NN	O	therapy	dep	1	SENT_13	[p1l124t1613r221b1639],

1	Methods	NNS	O	method	_	0	SENT_14	[p1l6t1714r132b1738],
2	:	:	O	:	_	0	SENT_14	[p1l6t1714r132b1738],
3	A	DT	O	a	det	7	SENT_14	[p1l145t1715r166b1738],
4	whole	JJ	O	whole	amod	7	SENT_14	[p1l178t1714r265b1738],
5	gene-based	JJ	O	gene-based	amod	7	SENT_14	[p1l279t1714r441b1744],
6	tag-SNP	NN	O	tag-snp	nn	7	SENT_14	[p1l454t1715r567b1744],
7	approach	NN	O	approach	nsubjpass	9	SENT_14	[p1l581t1714r712b1744],
8	was	VBD	O	be	auxpass	9	SENT_14	[p1l725t1721r779b1738],
9	used	VBN	O	use	dep	1	SENT_14	[p1l793t1714r859b1738],
10	to	TO	O	to	aux	11	SENT_14	[p1l872t1717r899b1738],
11	determine	VB	O	determine	xcomp	9	SENT_14	[p1l913t1714r1059b1738],
12	the	DT	O	the	det	14	SENT_14	[p1l1073t1714r1118b1738],
13	candidate	NN	O	candidate	nn	14	SENT_14	[p1l1132t1714r1270b1738],
14	SNPs	NNS	O	snp	dobj	11	SENT_14	[p1l1284t1715r1352b1738],
15	in	IN	O	in	_	0	SENT_14	[p1l1366t1714r1392b1738],
16	EGFR	NN	ORGANIZATION	egfr	prep_in	11	SENT_14	[p1l1405t1715r1481b1738],
17	.	.	O	.	_	0	SENT_14	[p1l1405t1715r1481b1738],

1	Four	CD	NUMBER	four	num	3	SENT_15	[p1l7t1755r70b1778],
2	tag	NN	O	tag	nn	3	SENT_15	[p1l79t1757r123b1784],
3	SNPs	NNS	O	snp	nsubj	51	SENT_15	[p1l133t1755r208b1782],
4	,	,	O	,	_	0	SENT_15	[p1l133t1755r208b1782],
5	one	CD	NUMBER	one	num	6	SENT_15	[p1l219t1761r269b1778],
6	CA	NNP	O	CA	appos	3	SENT_15	[p1l280t1755r318b1778],
7	simple	JJ	O	simple	amod	12	SENT_15	[p1l327t1754r421b1784],
8	sequence	NN	O	sequence	nn	12	SENT_15	[p1l431t1761r562b1784],
9	repeat	NN	O	repeat	nn	12	SENT_15	[p1l572t1757r662b1784],
10	(	CD	NUMBER	(	num	12	SENT_15	[p1l672t1754r796b1784],
11	CA-SSR	NN	O	ca-ssr	nn	12	SENT_15	[p1l672t1754r796b1784],
12	)	NN	O	)	nsubjpass	39	SENT_15	[p1l672t1754r796b1784],
13	in	IN	O	in	_	0	SENT_15	[p1l807t1754r833b1778],
14	intron	NN	O	intron	prep_in	12	SENT_15	[p1l843t1754r929b1778],
15	1	CD	NUMBER	1	num	14	SENT_15	[p1l941t1755r960b1782],
16	,	,	O	,	_	0	SENT_15	[p1l941t1755r960b1782],
17	one	CD	NUMBER	one	appos	14	SENT_15	[p1l970t1761r1021b1778],
18	coding	VBG	O	code	partmod	17	SENT_15	[p1l1031t1754r1126b1784],
19	region	NN	O	region	nn	20	SENT_15	[p1l1136t1754r1225b1784],
20	SNP	NN	O	snp	dobj	18	SENT_15	[p1l1235t1755r1290b1778],
21	(	CD	NUMBER	(	num	22	SENT_15	[p1l1300t1754r1420b1784],
22	R521I	NN	O	r521us	tmod	18	SENT_15	[p1l1300t1754r1420b1784],
23	(	CD	NUMBER	(	num	24	SENT_15	[p1l1300t1754r1420b1784],
24	)	NN	O	)	dep	22	SENT_15	[p1l1300t1754r1420b1784],
25	,	,	O	,	_	0	SENT_15	[p1l1300t1754r1420b1784],
26	and	CC	O	and	_	0	SENT_15	[p1l1431t1754r1482b1778],
27	SNPs	NNS	O	snp	appos	14	SENT_15	[p1l7t1795r75b1818],
28	identiﬁed	VBN	O	identiﬁed	partmod	27	SENT_15	[p1l88t1794r224b1818],
29	by	IN	O	by	_	0	SENT_15	[p1l237t1794r270b1824],
30	resequencing	VBG	O	resequence	agent	28	SENT_15	[p1l282t1794r471b1824],
31	in	IN	O	in	_	0	SENT_15	[p1l483t1794r509b1818],
32	the	DT	O	the	det	35	SENT_15	[p1l521t1794r566b1818],
33	tyrosine	NN	O	tyrosine	nn	35	SENT_15	[p1l578t1794r693b1824],
34	kinase	NN	O	kinase	nn	35	SENT_15	[p1l706t1794r796b1818],
35	domain	NN	O	domain	prep_in	30	SENT_15	[p1l808t1794r915b1818],
36	of	IN	O	of	_	0	SENT_15	[p1l928t1794r957b1818],
37	EGFR	NN	ORGANIZATION	egfr	prep_of	35	SENT_15	[p1l966t1795r1035b1818],
38	were	VBD	O	be	auxpass	39	SENT_15	[p1l1047t1801r1116b1818],
39	selected	VBN	O	select	rcmod	6	SENT_15	[p1l1129t1794r1244b1818],
40	to	TO	O	to	aux	41	SENT_15	[p1l1256t1797r1283b1818],
41	analyze	VB	O	analyze	xcomp	39	SENT_15	[p1l1296t1794r1402b1824],
42	their	PRP$	O	they	poss	43	SENT_15	[p1l1415t1794r1483b1818],
43	association	NN	O	association	dobj	41	SENT_15	[p1l7t1834r164b1858],
44	with	IN	O	with	_	0	SENT_15	[p1l172t1834r237b1858],
45	therapeutic	JJ	O	therapeutic	amod	46	SENT_15	[p1l246t1834r409b1864],
46	outcome	NN	O	outcome	prep_with	41	SENT_15	[p1l417t1837r540b1858],
47	and	CC	O	and	_	0	SENT_15	[p1l549t1834r600b1858],
48	survival	NN	O	survival	conj_and	46	SENT_15	[p1l609t1834r719b1858],
49	in	IN	O	in	_	0	SENT_15	[p1l729t1834r754b1858],
50	84	CD	NUMBER	84	prep_in	41	SENT_15	[p1l763t1835r797b1858],
51	advanced	VBD	O	advance	_	0	SENT_15	[p1l805t1834r939b1858],
52	NSCLC	NN	O	nsclc	nn	53	SENT_15	[p1l948t1835r1038b1858],
53	patients	NNS	O	patient	dobj	51	SENT_15	[p1l1047t1834r1161b1864],
54	treated	VBN	O	treat	partmod	53	SENT_15	[p1l1169t1834r1270b1858],
55	with	IN	O	with	_	0	SENT_15	[p1l1278t1834r1343b1858],
56	Geﬁtinib	NN	PERSON	geﬁtinib	prep_with	54	SENT_15	[p1l1352t1834r1481b1858],
57	.	.	O	.	_	0	SENT_15	[p1l1352t1834r1481b1858],

1	Progression-free	JJ	O	progression-free	amod	4	SENT_16	[p1l7t1874r240b1904],
2	and	CC	O	and	_	0	SENT_16	[p1l249t1874r301b1898],
3	overall	JJ	O	overall	conj_and	1	SENT_16	[p1l311t1874r405b1898],
4	survivals	NNS	O	survival	nsubjpass	6	SENT_16	[p1l416t1874r539b1898],
5	were	VBD	O	be	auxpass	6	SENT_16	[p1l549t1881r619b1898],
6	computed	VBN	O	compute	_	0	SENT_16	[p1l629t1874r771b1904],
7	by	IN	O	by	_	0	SENT_16	[p1l781t1874r815b1904],
8	Cox	NN	ORGANIZATION	cox	nn	9	SENT_16	[p1l824t1875r875b1898],
9	model	NN	O	model	agent	6	SENT_16	[p1l884t1874r972b1898],
10	adjusted	VBN	O	adjust	partmod	9	SENT_16	[p1l982t1874r1103b1904],
11	for	IN	O	for	_	0	SENT_16	[p1l1113t1874r1153b1898],
12	clinical	JJ	O	clinical	amod	13	SENT_16	[p1l1162t1874r1261b1898],
13	factors	NNS	O	factor	prep_for	10	SENT_16	[p1l1271t1874r1373b1898],
14	.	.	O	.	_	0	SENT_16	[p1l1271t1874r1373b1898],

1	clinical	JJ	O	clinical	amod	3	SENT_17	[p1l6t1913r98b1934],
2	outcome	NN	O	outcome	nn	3	SENT_17	[p1l116t1916r226b1934],
3	Results	NNS	O	result	_	0	SENT_17	[p1l719t1905r822b1929],
4	:	:	O	:	_	0	SENT_17	[p1l719t1905r822b1929],
5	We	PRP	O	we	nsubj	6	SENT_17	[p1l842t1906r889b1929],
6	identiﬁed	VBD	O	identiﬁed	dep	3	SENT_17	[p1l909t1905r1045b1929],
7	two	CD	NUMBER	two	num	9	SENT_17	[p1l1066t1909r1119b1929],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_17	[p1l1138t1906r1208b1929],
9	polymorphisms	NNS	O	polymorphism	dobj	6	SENT_17	[p1l1229t1905r1458b1935],
10	,	,	O	,	_	0	SENT_17	[p1l1229t1905r1458b1935],
11	rs2293347	NN	O	rs2293347	nn	14	SENT_17	[p1l1479t1906r1626b1929],
12	(	CD	NUMBER	(	num	14	SENT_17	[p1l1647t1905r1767b1935],
13	D994D	NN	O	d994d	nn	14	SENT_17	[p1l1647t1905r1767b1935],
14	)	NN	O	)	conj_and	9	SENT_17	[p1l1647t1905r1767b1935],
15	and	CC	O	and	_	0	SENT_17	[p1l1787t1905r1839b1929],
16	CA-SSR	NN	O	ca-ssr	dobj	6	SENT_17	[p1l1859t1906r1962b1929],
17	in	IN	O	in	_	0	SENT_17	[p1l1981t1905r2007b1929],
18	intron	NN	O	intron	prep_in	6	SENT_17	[p1l2027t1905r2114b1929],
19	1	CD	NUMBER	1	num	18	SENT_17	[p1l2136t1906r2154b1933],
20	,	,	O	,	_	0	SENT_17	[p1l2136t1906r2154b1933],
21	associated	VBN	O	associate	partmod	18	SENT_17	[p1l6t1944r152b1968],
22	with	IN	O	with	_	0	SENT_17	[p1l6t1983r71b2008],
23	clinical	JJ	O	clinical	amod	24	SENT_17	[p1l83t1983r182b2008],
24	outcome	NN	O	outcome	prep_with	21	SENT_17	[p1l195t1987r318b2008],
25	of	IN	O	of	_	0	SENT_17	[p1l331t1983r360b2008],
26	Geﬁtinib	JJ	O	geﬁtinib	amod	27	SENT_17	[p1l369t1983r491b2008],
27	therapy	NN	O	therapy	prep_of	24	SENT_17	[p1l503t1983r617b2014],
28	.	.	O	.	_	0	SENT_17	[p1l503t1983r617b2014],

1	The	DT	O	the	det	11	SENT_18	[p1l628t1983r680b2008],
2	response	NN	O	response	nn	10	SENT_18	[p1l692t1990r818b2014],
3	rate	NN	O	rate	amod	10	SENT_18	[p1l830t1987r884b2008],
4	for	IN	O	for	_	0	SENT_18	[p1l896t1983r936b2008],
5	the	DT	O	the	det	6	SENT_18	[p1l947t1984r991b2008],
6	rs2293347GG	NN	O	rs2293347gg	prep_for	3	SENT_18	[p1l1004t1985r1196b2008],
7	or	CC	O	or	_	0	SENT_18	[p1l1209t1990r1238b2008],
8	shorter	JJR	O	shorter	conj_or	3	SENT_18	[p1l1249t1983r1351b2008],
9	CA	NNP	O	CA	nn	10	SENT_18	[p1l1362t1984r1400b2008],
10	repeat	NN	O	repeat	nn	11	SENT_18	[p1l1412t1987r1502b2014],
11	genotype	NN	O	genotype	nsubj	14	SENT_18	[p1l1515t1987r1645b2014],
12	was	VBD	O	be	cop	14	SENT_18	[p1l1659t1990r1713b2008],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_18	[p1l1728t1983r1902b2014],
14	higher	JJR	O	higher	_	0	SENT_18	[p1l1915t1983r2006b2014],
15	than	IN	O	than	_	0	SENT_18	[p1l2020t1983r2083b2008],
16	that	DT	O	that	prep_than	14	SENT_18	[p1l2097t1983r2154b2008],
17	for	IN	O	for	_	0	SENT_18	[p1l6t2023r45b2048],
18	the	DT	O	the	det	19	SENT_18	[p1l62t2023r106b2048],
19	rs2293347GA	NN	O	rs2293347ga	prep_for	16	SENT_18	[p1l124t2024r315b2048],
20	or	CC	O	or	_	0	SENT_18	[p1l331t2030r361b2048],
21	AA	NN	O	aa	prep_for	16	SENT_18	[p1l376t2024r417b2048],
22	or	CC	O	or	_	0	SENT_18	[p1l434t2030r463b2048],
23	longer	JJR	O	longer	advmod	26	SENT_18	[p1l480t2023r570b2054],
24	CA	NNP	O	CA	nn	26	SENT_18	[p1l586t2024r624b2048],
25	repeat	NN	O	repeat	nn	26	SENT_18	[p1l641t2027r731b2054],
26	genotype	NN	O	genotype	prep_for	16	SENT_18	[p1l747t2027r877b2054],
27	(	CD	PERCENT	(	number	28	SENT_18	[p1l893t2023r979b2054],
28	71.2	CD	PERCENT	71.2	num	29	SENT_18	[p1l893t2023r979b2054],
29	%	NN	PERCENT	%	dep	26	SENT_18	[p1l893t2023r979b2054],
30	versus	CC	O	versus	_	0	SENT_18	[p1l993t2030r1083b2048],
31	37.5	CD	PERCENT	37.5	num	32	SENT_18	[p1l1097t2024r1179b2051],
32	%	NN	PERCENT	%	conj_or	19	SENT_18	[p1l1097t2024r1179b2051],
33	,	,	O	,	_	0	SENT_18	[p1l1097t2024r1179b2051],
34	P	NN	O	p	appos	32	SENT_18	[p1l1193t2025r1231b2048],
35	=	JJ	O	=	amod	16	SENT_18	[p1l1193t2025r1231b2048],
36	0.0043	CD	NUMBER	0.0043	tmod	35	SENT_18	[p1l1243t2024r1338b2048],
37	and	CC	O	and	_	0	SENT_18	[p1l1354t2023r1405b2048],
38	88.5	CD	PERCENT	88.5	num	39	SENT_18	[p1l1420t2024r1498b2048],
39	%	NN	PERCENT	%	conj_and	35	SENT_18	[p1l1420t2024r1498b2048],
40	versus	CC	O	versus	prep	39	SENT_18	[p1l1512t2030r1602b2048],
41	48.3	CD	PERCENT	48.3	num	42	SENT_18	[p1l1616t2024r1703b2051],
42	%	NN	PERCENT	%	dep	40	SENT_18	[p1l1616t2024r1703b2051],
43	,	,	O	,	_	0	SENT_18	[p1l1616t2024r1703b2051],
44	P	NN	O	p	appos	42	SENT_18	[p1l1717t2025r1755b2047],
45	=	JJ	O	=	amod	47	SENT_18	[p1l1717t2025r1755b2047],
46	0.0005	CD	NUMBER	0.0005	tmod	45	SENT_18	[p1l1766t2023r1882b2054],
47	)	NN	O	)	dep	35	SENT_18	[p1l1766t2023r1882b2054],
48	.	.	O	.	_	0	SENT_18	[p1l1766t2023r1882b2054],

1	The	DT	O	the	det	2	SENT_19	[p1l1895t2023r1947b2048],
2	rs2293347GC	NN	O	rs2293347gc	_	0	SENT_19	[p1l1962t2024r2154b2048],
3	.	.	O	.	_	0	SENT_19	[p1l1962t2024r2154b2048],

1	genotype	NN	O	genotype	nsubjpass	4	SENT_20	[p1l6t2067r136b2094],
2	was	VBD	O	be	auxpass	4	SENT_20	[p1l147t2070r201b2088],
3	also	RB	O	also	advmod	4	SENT_20	[p1l214t2063r268b2088],
4	associated	VBN	O	associate	_	0	SENT_20	[p1l281t2063r426b2088],
5	with	IN	O	with	_	0	SENT_20	[p1l440t2063r506b2088],
6	longer	JJR	O	longer	amod	8	SENT_20	[p1l520t2063r610b2094],
7	progression-free	JJ	O	progression-free	amod	8	SENT_20	[p1l623t2063r857b2094],
8	survival	NN	O	survival	prep_with	4	SENT_20	[p1l872t2063r981b2088],
9	compared	VBN	O	compare	_	0	SENT_20	[p1l996t2063r1137b2094],
10	with	IN	O	with	prepc_compared_with	8	SENT_20	[p1l1151t2063r1216b2088],
11	the	DT	O	the	det	12	SENT_20	[p1l1230t2063r1275b2088],
12	rs2293347GA	NN	O	rs2293347ga	pobj	8	SENT_20	[p1l1289t2065r1481b2088],
13	or	CC	O	or	_	0	SENT_20	[p1l1494t2070r1523b2088],
14	AA	NN	O	aa	nn	15	SENT_20	[p1l1535t2064r1576b2088],
15	genotype	NN	O	genotype	conj_or	12	SENT_20	[p1l1589t2067r1720b2094],
16	(	CD	NUMBER	(	number	17	SENT_20	[p1l1734t2064r1773b2094],
17	11	CD	DURATION	11	num	18	SENT_20	[p1l1734t2064r1773b2094],
18	months	NNS	NUMBER	month	tmod	15	SENT_20	[p1l1786t2063r1893b2088],
19	versus	CC	O	versus	_	0	SENT_20	[p1l1906t2070r1996b2088],
20	3	CD	DURATION	3	num	21	SENT_20	[p1l2009t2065r2024b2088],
21	months	NNS	NUMBER	month	conj_or	12	SENT_20	[p1l2040t2063r2154b2092],
22	,	,	O	,	_	0	SENT_20	[p1l2040t2063r2154b2092],
23	P	NN	O	p	appos	21	SENT_20	[p1l1054t2103r1210b2133],
24	=	JJ	O	=	amod	26	SENT_20	[p1l1054t2103r1210b2133],
25	0.0018	CD	NUMBER	0.0018	tmod	24	SENT_20	[p1l1054t2103r1210b2133],
26	)	NN	O	)	dep	23	SENT_20	[p1l1054t2103r1210b2133],
27	.	.	O	.	_	0	SENT_20	[p1l1054t2103r1210b2133],

1	A	DT	O	a	det	2	SENT_21	[p1l1221t2104r1242b2127],
2	combination	NN	O	combination	nsubj	10	SENT_21	[p1l1252t2103r1431b2127],
3	of	IN	O	of	_	0	SENT_21	[p1l1443t2103r1472b2127],
4	rs2293347GG	NN	O	rs2293347gg	prep_of	2	SENT_21	[p1l1481t2104r1673b2127],
5	and	CC	O	and	_	0	SENT_21	[p1l1684t2103r1736b2127],
6	shorter	JJR	O	shorter	amod	9	SENT_21	[p1l1748t2103r1850b2127],
7	CA	NNP	O	CA	nn	9	SENT_21	[p1l1861t2104r1899b2127],
8	repeat	NN	O	repeat	nn	9	SENT_21	[p1l1909t2106r1999b2133],
9	genotypes	NNS	O	genotype	prep_of	2	SENT_21	[p1l2010t2106r2154b2133],
10	had	VBD	O	have	_	0	SENT_21	[p1l810t2142r861b2166],
11	more	RBR	O	more	advmod	12	SENT_21	[p1l871t2149r944b2166],
12	pronounced	JJ	O	pronounced	amod	14	SENT_21	[p1l954t2142r1124b2172],
13	clinical	JJ	O	clinical	amod	14	SENT_21	[p1l1134t2142r1234b2166],
14	beneﬁt	NN	O	beneﬁt	dobj	10	SENT_21	[p1l1243t2142r1349b2167],
15	.	.	O	.	_	0	SENT_21	[p1l1243t2142r1349b2167],

1	Conclusion	NN	O	conclusion	_	0	SENT_22	[p1l680t2181r836b2205],
2	:	:	O	:	_	0	SENT_22	[p1l680t2181r836b2205],
3	The	DT	O	the	det	7	SENT_22	[p1l845t2181r896b2205],
4	D994D	NN	O	d994d	nn	7	SENT_22	[p1l906t2182r1003b2205],
5	and	CC	O	and	_	0	SENT_22	[p1l1013t2181r1064b2205],
6	CA-SSR	NN	O	ca-ssr	nn	7	SENT_22	[p1l1074t2182r1177b2205],
7	polymorphisms	NNS	O	polymorphism	nsubj	12	SENT_22	[p1l1185t2181r1407b2211],
8	in	IN	O	in	_	0	SENT_22	[p1l1418t2181r1444b2205],
9	EGFR	NN	ORGANIZATION	egfr	prep_in	7	SENT_22	[p1l1452t2182r1522b2205],
10	are	VBP	O	be	cop	12	SENT_22	[p1l1531t2188r1574b2205],
11	potential	JJ	O	potential	amod	12	SENT_22	[p1l1584t2181r1710b2211],
12	predictors	NNS	O	predictor	dep	1	SENT_22	[p1l1720t2181r1863b2211],
13	for	IN	O	for	_	0	SENT_22	[p1l1873t2181r1913b2205],
14	clinical	JJ	O	clinical	amod	15	SENT_22	[p1l1921t2181r2021b2205],
15	outcome	NN	O	outcome	prep_for	12	SENT_22	[p1l2031t2185r2154b2205],
16	in	IN	O	in	_	0	SENT_22	[p1l721t2220r747b2244],
17	advanced	JJ	O	advanced	amod	19	SENT_22	[p1l756t2220r890b2244],
18	NSCLC	NN	O	nsclc	nn	19	SENT_22	[p1l900t2221r991b2244],
19	patients	NNS	O	patient	prep_in	15	SENT_22	[p1l1000t2220r1114b2250],
20	treated	VBN	O	treat	partmod	19	SENT_22	[p1l1124t2220r1225b2244],
21	with	IN	O	with	_	0	SENT_22	[p1l1234t2220r1299b2244],
22	Geﬁtinib	NN	PERSON	geﬁtinib	prep_with	20	SENT_22	[p1l1309t2220r1438b2244],
23	.	.	O	.	_	0	SENT_22	[p1l1309t2220r1438b2244],

1	1	LS	NUMBER	1	_	0	SENT_23	[p1l9t2528r57b2577],
2	.	.	O	.	_	0	SENT_23	[p1l9t2528r57b2577],

1	Introduction	NN	O	introduction	_	0	SENT_24	[p1l100t2525r515b2577],

1	Lung	NN	O	lung	nn	2	SENT_25	[p1l106t2697r254b2758],
2	cancer	NN	O	cancer	nsubj	6	SENT_25	[p1l276t2709r477b2746],
3	is	VBZ	O	be	cop	6	SENT_25	[p1l500t2695r544b2746],
4	the	DT	O	the	det	6	SENT_25	[p1l568t2694r665b2746],
5	leading	VBG	O	lead	amod	6	SENT_25	[p1l690t2694r915b2758],
6	cause	NN	O	cause	_	0	SENT_25	[p1l938t2709r1105b2746],
7	of	IN	O	of	_	0	SENT_25	[p1l1130t2694r1193b2746],
8	cancer	NN	O	cancer	nn	11	SENT_25	[p1l1210t2694r1649b2746],
9	—	NN	O	—	nn	11	SENT_25	[p1l1210t2694r1649b2746],
10	related	JJ	O	related	amod	11	SENT_25	[p1l1210t2694r1649b2746],
11	death	NN	O	death	prep_of	6	SENT_25	[p1l1674t2694r1846b2746],
12	in	IN	O	in	_	0	SENT_25	[p1l1871t2695r1927b2745],
13	the	DT	O	the	det	17	SENT_25	[p1l1950t2694r2047b2746],
14	world	NN	O	world	nn	17	SENT_25	[p1l7t2776r185b2828],
15	[	NN	O	[	nn	17	SENT_25	[p1l215t2776r310b2841],
16	1	CD	NUMBER	1	num	17	SENT_25	[p1l215t2776r310b2841],
17	]	NN	O	]	prep_in	6	SENT_25	[p1l215t2776r310b2841],
18	.	.	O	.	_	0	SENT_25	[p1l215t2776r310b2841],

1	Non	JJ	O	non	amod	7	SENT_26	[p1l338t2776r791b2828],
2	—	CD	NUMBER	—	tmod	1	SENT_26	[p1l338t2776r791b2828],
3	small	JJ	O	small	amod	7	SENT_26	[p1l338t2776r791b2828],
4	—	JJ	O	—	amod	7	SENT_26	[p1l338t2776r791b2828],
5	cell	NN	O	cell	nn	7	SENT_26	[p1l338t2776r791b2828],
6	lung	NN	O	lung	nn	7	SENT_26	[p1l819t2776r953b2841],
7	cancer	NN	O	cancer	_	0	SENT_26	[p1l979t2791r1179b2828],
8	(	CD	NUMBER	(	num	9	SENT_26	[p1l1204t2776r1448b2840],
9	NSCLC	NN	O	nsclc	dep	7	SENT_26	[p1l1204t2776r1448b2840],
10	)	CD	NUMBER	)	num	11	SENT_26	[p1l1204t2776r1448b2840],
11	accounts	NNS	O	account	nsubj	23	SENT_26	[p1l1476t2784r1744b2828],
12	for	IN	O	for	_	0	SENT_26	[p1l1773t2776r1857b2828],
13	~	NN	O	~	prep_for	11	SENT_26	[p1l1883t2779r2048b2828],
14	80	CD	PERCENT	80	num	15	SENT_26	[p1l1883t2779r2048b2828],
15	%	NN	PERCENT	%	rcmod	9	SENT_26	[p1l1883t2779r2048b2828],
16	of	IN	O	of	_	0	SENT_26	[p1l8t2859r72b2911],
17	all	DT	O	all	det	18	SENT_26	[p1l95t2859r165b2911],
18	types	NNS	O	type	prep_of	15	SENT_26	[p1l195t2867r358b2924],
19	of	IN	O	of	_	0	SENT_26	[p1l390t2859r453b2911],
20	lung	NN	O	lung	nn	21	SENT_26	[p1l477t2859r611b2924],
21	cancer	NN	O	cancer	prep_of	18	SENT_26	[p1l641t2874r841b2911],
22	and	CC	O	and	_	0	SENT_26	[p1l870t2859r980b2911],
23	has	VBZ	O	have	rcmod	9	SENT_26	[p1l1012t2859r1111b2911],
24	only	RB	O	only	advmod	23	SENT_26	[p1l1143t2859r1275b2924],
25	~	RB	O	~	advmod	27	SENT_26	[p1l1305t2862r1466b2911],
26	14	CD	PERCENT	14	num	27	SENT_26	[p1l1305t2862r1466b2911],
27	%	NN	PERCENT	%	pobj	24	SENT_26	[p1l1305t2862r1466b2911],
28	of	IN	O	of	_	0	SENT_26	[p1l1496t2859r1559b2911],
29	5-year	JJ	DURATION	5-year	amod	32	SENT_26	[p1l1583t2863r1780b2924],
30	survival	NN	O	survival	nn	32	SENT_26	[p1l1809t2859r2047b2911],
31	rate	NN	O	rate	nn	32	SENT_26	[p1l9t2950r124b2994],
32	[	NN	O	[	prep_of	27	SENT_26	[p1l161t2942r256b3007],
33	2	CD	NUMBER	2	num	34	SENT_26	[p1l161t2942r256b3007],
34	]	NN	O	]	dobj	23	SENT_26	[p1l161t2942r256b3007],
35	.	.	O	.	_	0	SENT_26	[p1l161t2942r256b3007],

1	Although	IN	O	although	mark	7	SENT_27	[p1l287t2942r572b3007],
2	majority	NN	O	majority	nsubj	7	SENT_27	[p1l605t2943r865b3007],
3	of	IN	O	of	_	0	SENT_27	[p1l896t2942r960b2994],
4	NSCLC	NN	ORGANIZATION	nsclc	nn	5	SENT_27	[p1l986t2945r1182b2994],
5	patients	NNS	O	patient	prep_of	2	SENT_27	[p1l1214t2943r1460b3007],
6	may	MD	O	may	aux	7	SENT_27	[p1l1495t2957r1624b3007],
7	beneﬁt	VB	O	beneﬁt	advcl	17	SENT_27	[p1l1655t2942r1871b2994],
8	from	IN	O	from	_	0	SENT_27	[p1l1903t2942r2048b2994],
9	chemotherapy	NN	O	chemotherapy	prep_from	7	SENT_27	[p1l8t3026r461b3090],
10	,	,	O	,	_	0	SENT_27	[p1l8t3026r461b3090],
11	the	DT	O	the	det	13	SENT_27	[p1l507t3026r604b3077],
12	platinum	NN	O	platinum	nn	13	SENT_27	[p1l649t3026r1135b3090],
13	—	NN	O	—	nsubj	17	SENT_27	[p1l649t3026r1135b3090],
14	based	VBN	O	base	partmod	13	SENT_27	[p1l649t3026r1135b3090],
15	ﬁrst-line	JJ	O	ﬁrst-line	amod	16	SENT_27	[p1l1182t3025r1444b3077],
16	therapy	NN	O	therapy	dobj	14	SENT_27	[p1l1489t3026r1725b3090],
17	produces	VBZ	O	produce	_	0	SENT_27	[p1l1769t3026r2047b3090],
18	median	JJ	O	median	amod	20	SENT_27	[p1l9t3109r238b3161],
19	survival	NN	O	survival	nn	20	SENT_27	[p1l264t3109r501b3161],
20	times	NNS	O	time	dobj	17	SENT_27	[p1l526t3110r695b3161],
21	of	IN	O	of	_	0	SENT_27	[p1l721t3109r784b3161],
22	8-11	CD	NUMBER	8-11	num	23	SENT_27	[p1l802t3112r938b3161],
23	months	NNS	NUMBER	month	prep_of	20	SENT_27	[p1l971t3109r1203b3161],
24	and	CC	O	and	_	0	SENT_27	[p1l1228t3109r1339b3161],
25	1	LS	NUMBER	1	amod	30	SENT_27	[p1l1368t3112r1426b3160],
26	-	:	O	-	_	0	SENT_27	[p1l1368t3112r1426b3160],
27	and	CC	O	and	_	0	SENT_27	[p1l1452t3109r1562b3161],
28	2-year	JJ	DURATION	2-year	conj_and	25	SENT_27	[p1l1588t3112r1786b3173],
29	survival	NN	O	survival	nn	30	SENT_27	[p1l1809t3109r2047b3161],
30	rates	NNS	O	rate	conj_and	20	SENT_27	[p1l9t3200r154b3245],
31	of	IN	O	of	_	0	SENT_27	[p1l176t3192r240b3244],
32	35-40	CD	PERCENT	35-40	num	33	SENT_27	[p1l253t3195r485b3245],
33	%	NN	PERCENT	%	prep_of	30	SENT_27	[p1l253t3195r485b3245],
34	and	CC	O	and	_	0	SENT_27	[p1l506t3193r617b3244],
35	10-20	CD	PERCENT	10-20	num	36	SENT_27	[p1l642t3195r882b3252],
36	%	NN	PERCENT	%	prep_of	30	SENT_27	[p1l642t3195r882b3252],
37	,	,	O	,	_	0	SENT_27	[p1l642t3195r882b3252],
38	respectively	RB	O	respectively	advmod	41	SENT_27	[p1l905t3193r1273b3257],
39	[	CD	NUMBER	[	number	40	SENT_27	[p1l1296t3192r1444b3257],
40	3,4	CD	NUMBER	3,4	num	41	SENT_27	[p1l1296t3192r1444b3257],
41	]	NN	O	]	rcmod	30	SENT_27	[p1l1296t3192r1444b3257],
42	.	.	O	.	_	0	SENT_27	[p1l1296t3192r1444b3257],

1	Geﬁtinib	JJ	O	geﬁtinib	amod	3	SENT_28	[p1l1467t3192r1732b3245],
2	(	NN	O	(	nn	3	SENT_28	[p1l1754t3184r2047b3257],
3	lressaTM	NN	O	lressatm	nsubj	9	SENT_28	[p1l1754t3184r2047b3257],
4	,	,	O	,	_	0	SENT_28	[p1l1754t3184r2047b3257],
5	ZD1839	NN	O	zd1839	nn	6	SENT_28	[p1l7t3275r265b3339],
6	)	NN	O	)	appos	3	SENT_28	[p1l7t3275r265b3339],
7	is	VBZ	O	be	cop	9	SENT_28	[p1l290t3276r334b3327],
8	a	DT	O	a	det	9	SENT_28	[p1l359t3290r390b3327],
9	ﬁrst	JJ	O	ﬁrst	_	0	SENT_28	[p1l413t3275r534b3327],
10	molecularly	RB	O	molecularly	advmod	11	SENT_28	[p1l557t3275r921b3340],
11	targeting	VBG	O	target	dep	9	SENT_28	[p1l943t3276r1220b3340],
12	agent	NN	O	agent	dobj	11	SENT_28	[p1l1242t3283r1411b3340],
13	for	IN	O	for	_	0	SENT_28	[p1l1434t3275r1519b3327],
14	the	DT	O	the	det	15	SENT_28	[p1l1540t3275r1637b3327],
15	treatment	NN	O	treatment	prep_for	11	SENT_28	[p1l1661t3283r1969b3327],
16	of	IN	O	of	_	0	SENT_28	[p1l1992t3275r2055b3327],
17	patients	NNS	O	patient	prep_of	15	SENT_28	[p1l9t3359r254b3423],
18	with	IN	O	with	_	0	SENT_28	[p1l276t3358r417b3410],
19	advanced	JJ	O	advanced	amod	20	SENT_28	[p1l439t3358r728b3410],
20	NSCLC	NNP	O	NSCLC	prep_with	17	SENT_28	[p1l751t3361r946b3410],
21	refractory	JJ	O	refractory	amod	9	SENT_28	[p1l968t3358r1270b3423],
22	to	TO	O	to	_	0	SENT_28	[p1l1290t3366r1348b3410],
23	chemotherapy	NN	O	chemotherapy	prep_to	9	SENT_28	[p1l1370t3358r1823b3423],
24	.	.	O	.	_	0	SENT_28	[p1l1370t3358r1823b3423],

1	It	PRP	O	it	nsubj	9	SENT_29	[p1l1846t3361r1889b3410],
2	is	VBZ	O	be	cop	9	SENT_29	[p1l1910t3359r1953b3410],
3	an	DT	O	a	det	9	SENT_29	[p1l1976t3373r2048b3410],
4	orally	RB	O	orally	advmod	7	SENT_29	[p1l8t3441r181b3506],
5	active	JJ	O	active	amod	7	SENT_29	[p1l207t3442r399b3501],
6	,	,	O	,	_	0	SENT_29	[p1l207t3442r399b3501],
7	low	JJ	O	low	amod	9	SENT_29	[p1l428t3441r539b3493],
8	molecular	JJ	O	molecular	amod	9	SENT_29	[p1l565t3441r873b3493],
9	weight	NN	O	weight	_	0	SENT_29	[p1l897t3441r1123b3506],
10	,	,	O	,	_	0	SENT_29	[p1l897t3441r1123b3506],
11	synthetic	JJ	O	synthetic	amod	12	SENT_29	[p1l1152t3441r1434b3506],
12	quinazoline	NN	O	quinazoline	appos	9	SENT_29	[p1l1460t3441r1833b3506],
13	,	,	O	,	_	0	SENT_29	[p1l1460t3441r1833b3506],
14	which	WDT	O	which	nsubj	16	SENT_29	[p1l1859t3441r2048b3493],
15	selectively	RB	O	selectively	advmod	16	SENT_29	[p1l9t3525r330b3589],
16	targets	VBZ	O	target	rcmod	9	SENT_29	[p1l345t3532r552b3589],
17	the	DT	O	the	det	20	SENT_29	[p1l570t3525r666b3576],
18	epidermal	JJ	O	epidermal	amod	20	SENT_29	[p1l684t3525r995b3589],
19	growth	NN	O	growth	nn	20	SENT_29	[p1l1012t3525r1233b3589],
20	factor	NN	O	factor	dobj	16	SENT_29	[p1l1250t3524r1426b3576],
21	receptor	NN	O	receptor	nn	24	SENT_29	[p1l1442t3532r1698b3589],
22	(	CD	NUMBER	(	num	24	SENT_29	[p1l1713t3525r1919b3589],
23	EGFR	NN	ORGANIZATION	egfr	nn	24	SENT_29	[p1l1713t3525r1919b3589],
24	)	NN	O	)	tmod	16	SENT_29	[p1l1713t3525r1919b3589],
25	and	CC	O	and	advmod	24	SENT_29	[p1l1936t3525r2047b3576],

1	*	NN	O	*	_	0	SENT_30	[p2l55t32r76b56],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_30	[p2l119t31r480b84],
3	author	NN	O	author	dobj	2	SENT_30	[p2l496t31r667b73],
4	.	.	O	.	_	0	SENT_30	[p2l496t31r667b73],

1	Tel.	NNP	O	Tel.	_	0	SENT_31	[p2l682t31r780b73],
2	:	:	O	:	_	0	SENT_31	[p2l682t31r780b73],
3	+86 10 87788826	CD	NUMBER	+86 10 87788826	dep	1	SENT_31	[p2l979t33r1239b79],[p2l801t33r889b73],
4	;	:	O	;	_	0	SENT_31	[p2l979t33r1239b79],
5	fax	NN	O	fax	dep	1	SENT_31	[p2l1260t31r1347b73],
6	:	:	O	:	_	0	SENT_31	[p2l1260t31r1347b73],
7	+86 10 87715711	CD	NUMBER	+86 10 87715711	dep	5	SENT_31	[p2l1546t33r1782b73],[p2l1368t33r1456b73],
8	.	.	O	.	_	0	SENT_31	[p2l1546t33r1782b73],

1	**	NN	O	**	_	0	SENT_32	[p2l27t101r76b125],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_32	[p2l119t100r480b153],
3	author	NN	O	author	dobj	2	SENT_32	[p2l496t101r667b143],
4	.	.	O	.	_	0	SENT_32	[p2l496t101r667b143],

1	Tel.	NNP	O	Tel.	_	0	SENT_33	[p2l682t100r780b143],
2	:	:	O	:	_	0	SENT_33	[p2l682t100r780b143],
3	+86 10 87788491	CD	NUMBER	+86 10 87788491	dep	1	SENT_33	[p2l979t103r1238b149],[p2l801t103r889b142],
4	;	:	O	;	_	0	SENT_33	[p2l979t103r1238b149],
5	fax	NN	O	fax	dep	1	SENT_33	[p2l1259t100r1346b143],
6	:	:	O	:	_	0	SENT_33	[p2l1259t100r1346b143],
7	+86 10 67722460	CD	NUMBER	+86 10 67722460	dep	5	SENT_33	[p2l1545t103r1799b143],[p2l1367t103r1455b142],
8	.	.	O	.	_	0	SENT_33	[p2l1545t103r1799b143],

1	E-mail	NN	O	e-mail	nn	2	SENT_34	[p2l105t171r261b212],
2	addresses	NNS	O	address	_	0	SENT_34	[p2l277t171r516b213],
3	:	:	O	:	_	0	SENT_34	[p2l277t171r516b213],
4	xubinghe@medmai1.com.cn	NN	O	xubinghe@medmai1.com.cn	nn	8	SENT_34	[p2l533t171r1217b223],
5	(	CD	NUMBER	(	num	8	SENT_34	[p2l1234t171r1294b223],
6	B.	NNP	NUMBER	B.	nn	8	SENT_34	[p2l1234t171r1294b223],
7	Xu	NNP	PERSON	Xu	nn	8	SENT_34	[p2l1311t171r1407b223],
8	)	NNP	O	)	dep	2	SENT_34	[p2l1311t171r1407b223],
9	,	,	O	,	_	0	SENT_34	[p2l1311t171r1407b223],
10	lindx72@cicams.ac.cn	NN	O	lindx72@cicams.ac.cn	appos	8	SENT_34	[p2l1425t171r1959b213],

1	(	NN	O	(	_	0	SENT_35	[p2l8t241r74b293],
2	D.	NNP	PERSON	D.	nn	4	SENT_35	[p2l8t241r74b293],
3	Lin	NNP	PERSON	Lin	nn	4	SENT_35	[p2l93t241r196b293],
4	)	NNP	O	)	dep	1	SENT_35	[p2l93t241r196b293],
5	.	.	O	.	_	0	SENT_35	[p2l93t241r196b293],

1	1	CD	NUMBER	1	nsubj	4	SENT_36	[p2l64t306r77b334],
2	These	DT	O	these	det	3	SENT_36	[p2l102t311r244b353],
3	authors	NNS	O	author	dep	1	SENT_36	[p2l261t311r446b353],
4	contributed	VBD	O	contribute	_	0	SENT_36	[p2l464t311r752b353],
5	equally	RB	O	equally	advmod	4	SENT_36	[p2l769t311r947b364],
6	to	TO	O	to	_	0	SENT_36	[p2l962t318r1009b353],
7	this	DT	O	this	det	8	SENT_36	[p2l1026t311r1115b353],
8	work	NN	O	work	prep_to	4	SENT_36	[p2l1131t311r1269b353],
9	.	.	O	.	_	0	SENT_36	[p2l1131t311r1269b353],

1	0169-5002	CD	DURATION	0169-5002	_	0	SENT_37	[p2l8t457r318b510],
2	/	:	O	/	punct	1	SENT_37	[p2l8t457r318b510],
3	$	$	MONEY	$	nsubj	5	SENT_37	[p2l8t457r318b510],
4	—	CD	MONEY	—	num	3	SENT_37	[p2l336t483r362b487],
5	see	VBP	O	see	dep	1	SENT_37	[p2l381t470r458b499],
6	front	JJ	O	front	amod	7	SENT_37	[p2l475t458r595b499],
7	matter	NN	O	matter	dobj	5	SENT_37	[p2l611t464r777b499],
8	©	CD	NUMBER	©	num	12	SENT_37	[p2l792t461r831b499],
9	2009	CD	DATE	2009	num	12	SENT_37	[p2l848t460r969b499],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	12	SENT_37	[p2l987t458r1179b499],
11	Ireland	NNP	ORGANIZATION	Ireland	nn	12	SENT_37	[p2l1195t458r1366b499],
12	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_37	[p2l1384t458r1471b500],
13	.	.	O	.	_	0	SENT_37	[p2l1384t458r1471b500],

1	All	DT	O	all	det	2	SENT_38	[p2l1487t458r1553b499],
2	rights	NNS	O	rights	nsubj	3	SENT_38	[p2l1571t458r1710b510],
3	reserved	VBN	O	reserve	_	0	SENT_38	[p2l1729t458r1950b500],
4	.	.	O	.	_	0	SENT_38	[p2l1729t458r1950b500],

1	doi	FW	O	doi	_	0	SENT_39	[p2l8t527r842b579],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_39	[p2l8t527r842b579],
3	/	:	O	/	punct	5	SENT_39	[p2l8t527r842b579],
4	j.	NN	O	j.	nn	5	SENT_39	[p2l8t527r842b579],
5	lungcan	NN	O	lungcan	dep	2	SENT_39	[p2l8t527r842b579],
6	.2008.12.025	CD	NUMBER	.2008.12.025	dep	2	SENT_39	[p2l8t527r842b579],

1	©	RB	O	©	advmod	2	SENT_40	[p2l807t611r852b655],
2	2009	CD	DATE	2009	_	0	SENT_40	[p2l872t610r1010b656],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	5	SENT_40	[p2l1032t608r1254b656],
4	Ireland	NNP	ORGANIZATION	Ireland	nn	5	SENT_40	[p2l1272t608r1469b656],
5	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_40	[p2l1490t608r1590b656],
6	.	.	O	.	_	0	SENT_40	[p2l1490t608r1590b656],

1	All	DT	O	all	det	2	SENT_41	[p2l1609t608r1685b655],
2	rights	NNS	O	rights	nsubj	3	SENT_41	[p2l1705t608r1866b668],
3	reserved	VBN	O	reserve	_	0	SENT_41	[p2l1887t608r2144b656],
4	.	.	O	.	_	0	SENT_41	[p2l1887t608r2144b656],

1	blocks	VBZ	O	block	_	0	SENT_42	[p2l52t872r249b925],
2	the	DT	O	the	det	5	SENT_42	[p2l275t872r374b925],
3	tyrosine	NN	O	tyrosine	nn	5	SENT_42	[p2l400t872r655b938],
4	kinase	NN	O	kinase	nn	5	SENT_42	[p2l682t872r880b925],
5	activity	NN	O	activity	nsubj	8	SENT_42	[p2l906t872r1139b938],
6	[	CD	NUMBER	[	number	7	SENT_42	[p2l1166t871r1263b938],
7	5	CD	NUMBER	5	num	8	SENT_42	[p2l1166t871r1263b938],
8	]	NN	O	]	xcomp	1	SENT_42	[p2l1166t871r1263b938],
9	.	.	O	.	_	0	SENT_42	[p2l1166t871r1263b938],

1	The	DT	O	the	det	3	SENT_43	[p2l1287t872r1401b925],
2	response	NN	O	response	nn	3	SENT_43	[p2l1428t887r1706b938],
3	rates	NNS	O	rate	nsubj	10	SENT_43	[p2l1733t880r1881b925],
4	to	TO	O	to	_	0	SENT_43	[p2l1908t880r1967b925],
5	Geﬁtinib	NNP	O	Geﬁtinib	prep_to	3	SENT_43	[p2l1993t871r2144b925, p2l53t958r197b1011],
6	among	IN	O	among	_	0	SENT_43	[p2l222t973r437b1024],
7	advanced	JJ	O	advanced	amod	9	SENT_43	[p2l461t958r757b1011],
8	NSCLC	NN	O	nsclc	nn	9	SENT_43	[p2l783t960r984b1011],
9	patients	NNS	O	patient	prep_among	5	SENT_43	[p2l1009t958r1261b1024],
10	vary	VBP	O	vary	_	0	SENT_43	[p2l1285t973r1422b1024],
11	from	IN	O	from	_	0	SENT_43	[p2l1446t957r1595b1011],
12	8.9	CD	NUMBER	8.9	number	14	SENT_43	[p2l1620t960r1710b1011],
13	to	TO	O	to	dep	14	SENT_43	[p2l1735t966r1795b1011],
14	69	CD	PERCENT	69	num	15	SENT_43	[p2l1821t960r1939b1011],
15	%	NN	PERCENT	%	prep_from	10	SENT_43	[p2l1821t960r1939b1011],
16	[	CD	NUMBER	[	number	17	SENT_43	[p2l1967t957r2143b1024],
17	6	CD	NUMBER	6	num	18	SENT_43	[p2l1967t957r2143b1024],
18	—	NN	O	—	dep	15	SENT_43	[p2l1967t957r2143b1024],
19	8	CD	NUMBER	8	num	20	SENT_43	[p2l1967t957r2143b1024],
20	]	NN	O	]	dep	18	SENT_43	[p2l1967t957r2143b1024],
21	.	.	O	.	_	0	SENT_43	[p2l1967t957r2143b1024],

1	Studies	NNS	O	study	nsubj	3	SENT_44	[p2l53t1044r278b1097],
2	have	VBP	O	have	aux	3	SENT_44	[p2l301t1044r444b1097],
3	shown	VBN	O	show	_	0	SENT_44	[p2l467t1044r673b1097],
4	ethnic	JJ	O	ethnic	amod	5	SENT_44	[p2l695t1044r889b1097],
5	differences	NNS	O	difference	dobj	3	SENT_44	[p2l910t1044r1254b1097],
6	in	IN	O	in	_	0	SENT_44	[p2l1277t1045r1335b1096],
7	response	NN	O	response	prep_in	5	SENT_44	[p2l1356t1059r1634b1110],
8	to	TO	O	to	_	0	SENT_44	[p2l1656t1052r1715b1097],
9	Geﬁtinib	NNP	O	Geﬁtinib	prep_to	3	SENT_44	[p2l1737t1044r2009b1097],
10	and	CC	O	and	_	0	SENT_44	[p2l2031t1044r2144b1097],
11	Asian	JJ	MISC	asian	amod	12	SENT_44	[p2l50t1130r223b1182],
12	patients	NNS	O	patient	nsubj	13	SENT_44	[p2l247t1130r499b1196],
13	appeared	VBD	O	appear	conj_and	3	SENT_44	[p2l523t1129r813b1196],
14	to	TO	O	to	aux	15	SENT_44	[p2l837t1137r896b1182],
15	have	VB	O	have	xcomp	13	SENT_44	[p2l921t1129r1063b1182],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_44	[p2l1088t1129r1473b1196],
17	higher	JJR	O	higher	amod	18	SENT_44	[p2l1495t1129r1698b1196],
18	probability	NN	O	probability	dobj	15	SENT_44	[p2l1720t1129r2066b1196],
19	of	IN	O	of	_	0	SENT_44	[p2l2087t1129r2152b1182],
20	response	NN	O	response	prep_of	18	SENT_44	[p2l54t1231r347b1282],
21	.	.	O	.	_	0	SENT_44	[p2l54t1231r347b1282],

1	Although	IN	O	although	mark	20	SENT_45	[p2l376t1215r668b1282],
2	other	JJ	O	other	amod	3	SENT_45	[p2l698t1215r866b1268],
3	factors	NNS	O	factor	nsubj	20	SENT_45	[p2l894t1215r1118b1277],
4	,	,	O	,	_	0	SENT_45	[p2l894t1215r1118b1277],
5	such	JJ	O	such	_	0	SENT_45	[p2l1151t1215r1292b1268],
6	as	IN	O	as	_	0	SENT_45	[p2l1322t1231r1382b1268],
7	patient	NN	O	patient	poss	9	SENT_45	[p2l1414t1216r1682b1282],
8	’s	POS	O	’s	_	0	SENT_45	[p2l1414t1216r1682b1282],
9	age	NN	O	age	prep_such_as	3	SENT_45	[p2l1714t1231r1833b1282],
10	,	,	O	,	_	0	SENT_45	[p2l1714t1231r1833b1282],
11	sex	NN	O	sex	conj_and	9	SENT_45	[p2l1865t1231r1978b1277],
12	,	,	O	,	_	0	SENT_45	[p2l1865t1231r1978b1277],
13	diet	NN	O	diet	appos	11	SENT_45	[p2l2010t1215r2143b1277],
14	,	,	O	,	_	0	SENT_45	[p2l2010t1215r2143b1277],
15	and	CC	O	and	_	0	SENT_45	[p2l53t1301r166b1355],
16	performance	NN	O	performance	nn	17	SENT_45	[p2l201t1301r603b1368],
17	status	NN	O	status	conj_and	9	SENT_45	[p2l638t1309r837b1363],
18	,	,	O	,	_	0	SENT_45	[p2l638t1309r837b1363],
19	might	MD	O	might	aux	20	SENT_45	[p2l872t1301r1058b1368],
20	contribute	VB	O	contribute	advcl	32	SENT_45	[p2l1091t1301r1417b1355],
21	to	TO	O	to	_	0	SENT_45	[p2l1451t1309r1510b1355],
22	the	DT	O	the	det	24	SENT_45	[p2l1544t1301r1643b1355],
23	interindividual	JJ	O	interindividual	amod	24	SENT_45	[p2l1678t1301r2144b1355],
24	variability	NN	O	variability	prep_to	20	SENT_45	[p2l51t1388r372b1454],
25	[	CD	NUMBER	[	number	26	SENT_45	[p2l406t1387r503b1454],
26	9	CD	NUMBER	9	num	27	SENT_45	[p2l406t1387r503b1454],
27	]	NN	O	]	dep	24	SENT_45	[p2l406t1387r503b1454],
28	,	,	O	,	_	0	SENT_45	[p2l406t1387r503b1454],
29	it	PRP	O	it	nsubjpass	32	SENT_45	[p2l537t1388r580b1441],
30	is	VBZ	O	be	auxpass	32	SENT_45	[p2l612t1388r657b1441],
31	widely	RB	O	widely	advmod	32	SENT_45	[p2l689t1388r903b1454],
32	accepted	VBN	O	accept	dep	45	SENT_45	[p2l934t1388r1210b1454],
33	that	IN	O	that	complm	41	SENT_45	[p2l1243t1388r1369b1441],
34	a	DT	O	a	det	36	SENT_45	[p2l1400t1403r1432b1441],
35	signiﬁcant	JJ	O	signiﬁcant	amod	36	SENT_45	[p2l1465t1387r1792b1454],
36	portion	NN	O	portion	nsubj	41	SENT_45	[p2l1823t1388r2055b1454],
37	of	IN	O	of	_	0	SENT_45	[p2l2087t1387r2152b1441],
38	interindividual	JJ	O	interindividual	amod	39	SENT_45	[p2l54t1474r520b1527],
39	variability	NN	O	variability	prep_of	36	SENT_45	[p2l541t1474r862b1540],
40	is	VBZ	O	be	cop	41	SENT_45	[p2l883t1475r928b1527],
41	due	JJ	O	due	ccomp	32	SENT_45	[p2l951t1474r1065b1527],
42	to	TO	O	to	_	0	SENT_45	[p2l1087t1482r1146b1527],
43	genetic	JJ	O	genetic	amod	44	SENT_45	[p2l1168t1475r1395b1540],
44	variations	NNS	O	variation	prep_to	41	SENT_45	[p2l1414t1475r1725b1527],
45	[	VBP	O	[	_	0	SENT_45	[p2l1751t1474r2000b1540],
46	10	CD	NUMBER	10	num	47	SENT_45	[p2l1751t1474r2000b1540],
47	—	CD	NUMBER	—	dobj	45	SENT_45	[p2l1751t1474r2000b1540],
48	12	CD	NUMBER	12	num	49	SENT_45	[p2l1751t1474r2000b1540],
49	]	NN	O	]	nsubj	45	SENT_45	[p2l1751t1474r2000b1540],
50	.	.	O	.	_	0	SENT_45	[p2l1751t1474r2000b1540],

1	A	DT	O	a	det	3	SENT_46	[p2l150t1562r196b1612],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_46	[p2l214t1560r541b1626],
3	difference	NN	O	difference	nsubjpass	10	SENT_46	[p2l560t1560r874b1613],
4	in	IN	O	in	_	0	SENT_46	[p2l895t1561r953b1612],
5	response	NN	O	response	prep_in	3	SENT_46	[p2l973t1575r1251b1626],
6	to	TO	O	to	_	0	SENT_46	[p2l1271t1568r1330b1613],
7	Geﬁtinib	NNP	LOCATION	Geﬁtinib	prep_to	5	SENT_46	[p2l1351t1560r1623b1613],
8	has	VBZ	O	have	aux	10	SENT_46	[p2l1644t1560r1746b1613],
9	been	VBN	O	be	auxpass	10	SENT_46	[p2l1767t1560r1918b1613],
10	shown	VBN	O	show	_	0	SENT_46	[p2l1939t1560r2145b1613],
11	to	TO	O	to	aux	12	SENT_46	[p2l53t1653r112b1698],
12	depend	VB	O	depend	xcomp	10	SENT_46	[p2l136t1645r368b1712],
13	on	IN	O	on	_	0	SENT_46	[p2l393t1661r469b1698],
14	mutation	NN	O	mutation	nn	15	SENT_46	[p2l493t1646r783b1698],
15	status	NN	O	status	prep_on	12	SENT_46	[p2l807t1653r990b1698],
16	of	IN	O	of	_	0	SENT_46	[p2l1015t1645r1080b1698],
17	EGFR	NN	ORGANIZATION	egfr	prep_of	15	SENT_46	[p2l1093t1648r1262b1707],
18	,	,	O	,	_	0	SENT_46	[p2l1093t1648r1262b1707],
19	with	IN	O	with	_	0	SENT_46	[p2l1286t1645r1430b1698],
20	the	DT	O	the	det	22	SENT_46	[p2l1453t1645r1552b1698],
21	mutation	NN	O	mutation	nn	22	SENT_46	[p2l1577t1646r2144b1712],
22	—	NN	O	—	prep_with	15	SENT_46	[p2l1577t1646r2144b1712],
23	positive	JJ	O	positive	amod	24	SENT_46	[p2l1577t1646r2144b1712],
24	patients	NNS	O	patient	dobj	12	SENT_46	[p2l53t1732r305b1798],
25	showing	VBG	O	show	partmod	24	SENT_46	[p2l327t1731r593b1798],
26	a	DT	O	a	det	29	SENT_46	[p2l611t1747r643b1784],
27	much	JJ	O	much	amod	29	SENT_46	[p2l663t1731r837b1784],
28	greater	JJR	O	greater	dep	27	SENT_46	[p2l856t1739r1081b1798],
29	response	NN	O	response	dobj	25	SENT_46	[p2l1099t1747r1377b1798],
30	than	IN	O	than	_	0	SENT_46	[p2l1397t1731r1538b1784],
31	mutation	NN	O	mutation	npadvmod	33	SENT_46	[p2l1558t1732r2144b1798],
32	—	CD	NUMBER	—	num	31	SENT_46	[p2l1558t1732r2144b1798],
33	negative	JJ	O	negative	amod	34	SENT_46	[p2l1558t1732r2144b1798],
34	patients	NNS	O	patient	prep_than	29	SENT_46	[p2l53t1818r305b1884],
35	[	IN	O	[	_	0	SENT_46	[p2l328t1817r576b1884],
36	13	CD	NUMBER	13	number	37	SENT_46	[p2l328t1817r576b1884],
37	—	CD	NUMBER	—	prep_[	25	SENT_46	[p2l328t1817r576b1884],
38	15	CD	NUMBER	15	num	39	SENT_46	[p2l328t1817r576b1884],
39	]	NN	O	]	dep	37	SENT_46	[p2l328t1817r576b1884],
40	.	.	O	.	_	0	SENT_46	[p2l328t1817r576b1884],

1	Compared	VBN	O	compare	_	0	SENT_47	[p2l596t1817r917b1884],
2	with	IN	O	with	prepc_compared_with	11	SENT_47	[p2l935t1817r1080b1871],
3	the	DT	O	the	det	7	SENT_47	[p2l1097t1817r1196b1871],
4	wild	JJ	O	wild	amod	7	SENT_47	[p2l1214t1817r1521b1884],
5	—	NN	O	—	nn	7	SENT_47	[p2l1214t1817r1521b1884],
6	type	NN	O	type	nn	7	SENT_47	[p2l1214t1817r1521b1884],
7	EGFR	NN	ORGANIZATION	egfr	pobj	11	SENT_47	[p2l1541t1820r1716b1879],
8	,	,	O	,	_	0	SENT_47	[p2l1541t1820r1716b1879],
9	mutant	JJ	O	mutant	amod	10	SENT_47	[p2l1736t1825r1967b1871],
10	EGFR	NN	ORGANIZATION	egfr	nsubj	11	SENT_47	[p2l1985t1820r2147b1871],
11	exhibits	VBZ	O	exhibit	_	0	SENT_47	[p2l53t1904r300b1957],
12	increased	VBN	O	increase	amod	13	SENT_47	[p2l339t1904r637b1957],
13	activation	NN	O	activation	dobj	11	SENT_47	[p2l675t1904r983b1957],
14	following	VBG	O	follow	_	0	SENT_47	[p2l1021t1903r1317b1970],
15	ligand	NN	O	ligand	nn	16	SENT_47	[p2l1354t1904r1545b1970],
16	binding	NN	O	binding	prep_following	13	SENT_47	[p2l1582t1904r1823b1970],
17	and	CC	O	and	_	0	SENT_47	[p2l1858t1904r1972b1957],
18	thus	RB	O	thus	advmod	21	SENT_47	[p2l2009t1904r2143b1957],
19	enhanced	VBN	O	enhance	amod	21	SENT_47	[p2l53t1990r356b2043],
20	inhibitory	JJ	O	inhibitory	amod	21	SENT_47	[p2l398t1990r711b2056],
21	effect	NN	O	effect	prep_following	13	SENT_47	[p2l749t1990r923b2043],
22	of	IN	O	of	_	0	SENT_47	[p2l962t1990r1027b2043],
23	Geﬁtinib	NNP	O	Geﬁtinib	prep_of	21	SENT_47	[p2l1060t1990r1332b2043],
24	[	CD	NUMBER	[	num	23	SENT_47	[p2l1376t1990r1594b2056],
25	13,16	CD	NUMBER	13,16	num	26	SENT_47	[p2l1376t1990r1594b2056],
26	]	NN	O	]	dep	23	SENT_47	[p2l1376t1990r1594b2056],
27	.	.	O	.	_	0	SENT_47	[p2l1376t1990r1594b2056],

1	Although	IN	O	although	mark	8	SENT_48	[p2l1633t1990r1925b2056],
2	direct	JJ	O	direct	amod	3	SENT_48	[p2l1965t1990r2146b2043],
3	examination	NN	O	examination	nsubj	8	SENT_48	[p2l53t2076r447b2128],
4	of	IN	O	of	_	0	SENT_48	[p2l473t2075r538b2128],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_48	[p2l554t2078r709b2128],
6	mutations	NNS	O	mutation	prep_of	3	SENT_48	[p2l735t2076r1054b2128],
7	is	VBZ	O	be	cop	8	SENT_48	[p2l1081t2076r1126b2128],
8	possible	JJ	O	possible	advcl	15	SENT_48	[p2l1154t2075r1423b2142],
9	,	,	O	,	_	0	SENT_48	[p2l1154t2075r1423b2142],
10	the	DT	O	the	det	12	SENT_48	[p2l1450t2075r1549b2128],
11	clinical	JJ	O	clinical	amod	12	SENT_48	[p2l1576t2075r1797b2128],
12	practice	NN	O	practice	nsubj	15	SENT_48	[p2l1824t2076r2071b2142],
13	is	VBZ	O	be	cop	15	SENT_48	[p2l2098t2076r2143b2128],
14	somewhat	RB	O	somewhat	advmod	15	SENT_48	[p2l54t2161r382b2214],
15	difﬁcult	JJ	O	difﬁcult	_	0	SENT_48	[p2l396t2161r642b2214],
16	because	IN	O	because	mark	22	SENT_48	[p2l655t2161r905b2214],
17	somatic	JJ	O	somatic	amod	18	SENT_48	[p2l922t2162r1166b2214],
18	mutations	NNS	O	mutation	nsubjpass	22	SENT_48	[p2l1181t2162r1500b2214],
19	can	MD	O	can	aux	22	SENT_48	[p2l1517t2177r1623b2214],
20	only	RB	O	only	advmod	22	SENT_48	[p2l1638t2161r1774b2228],
21	be	VB	O	be	auxpass	22	SENT_48	[p2l1787t2161r1859b2214],
22	detected	VBN	O	detect	advcl	15	SENT_48	[p2l1875t2161r2144b2214],
23	in	IN	O	in	_	0	SENT_48	[p2l54t2248r111b2300],
24	target	NN	O	target	nn	25	SENT_48	[p2l133t2255r318b2314],
25	tissues	NNS	O	tissue	prep_in	22	SENT_48	[p2l339t2248r550b2300],
26	[	VBP	O	[	dep	25	SENT_48	[p2l578t2247r711b2314],
27	13	CD	NUMBER	13	num	28	SENT_48	[p2l578t2247r711b2314],
28	]	CD	NUMBER	]	dobj	26	SENT_48	[p2l578t2247r711b2314],
29	.	.	O	.	_	0	SENT_48	[p2l578t2247r711b2314],

1	It	PRP	O	it	nsubj	3	SENT_49	[p2l736t2251r779b2300],
2	is	VBZ	O	be	cop	3	SENT_49	[p2l801t2248r846b2300],
3	necessary	JJ	O	necessary	_	0	SENT_49	[p2l871t2263r1179b2314],
4	to	TO	O	to	aux	5	SENT_49	[p2l1200t2255r1259b2300],
5	obtain	VB	O	obtain	xcomp	3	SENT_49	[p2l1283t2247r1482b2300],
6	cancer	NN	O	cancer	nn	7	SENT_49	[p2l1505t2263r1711b2300],
7	specimens	NNS	O	specimen	dobj	5	SENT_49	[p2l1733t2248r2061b2314],
8	to	TO	O	to	aux	9	SENT_49	[p2l2085t2255r2144b2300],
9	get	VB	O	get	xcomp	5	SENT_49	[p2l52t2341r148b2400],
10	reliable	JJ	O	reliable	amod	11	SENT_49	[p2l172t2333r404b2387],
11	results	NNS	O	result	dobj	9	SENT_49	[p2l431t2333r654b2387],
12	.	.	O	.	_	0	SENT_49	[p2l431t2333r654b2387],

1	If	IN	O	if	mark	6	SENT_50	[p2l681t2333r727b2386],
2	blood	NN	O	blood	nn	3	SENT_50	[p2l745t2333r920b2387],
3	samples	NNS	O	sample	nsubjpass	6	SENT_50	[p2l947t2333r1199b2400],
4	can	MD	O	can	aux	6	SENT_50	[p2l1226t2349r1332b2387],
5	be	VB	O	be	auxpass	6	SENT_50	[p2l1357t2333r1429b2387],
6	used	VBN	O	use	advcl	17	SENT_50	[p2l1455t2333r1600b2387],
7	for	IN	O	for	_	0	SENT_50	[p2l1626t2333r1713b2387],
8	prediction	NN	O	prediction	prep_for	6	SENT_50	[p2l1737t2333r2060b2400],
9	to	TO	O	to	_	0	SENT_50	[p2l2085t2341r2144b2387],
10	Geﬁtinib	NN	LOCATION	geﬁtinib	nn	11	SENT_50	[p2l53t2419r325b2473],
11	response	NN	O	response	prep_to	6	SENT_50	[p2l352t2435r645b2486],
12	,	,	O	,	_	0	SENT_50	[p2l352t2435r645b2486],
13	it	PRP	O	it	nsubj	17	SENT_50	[p2l672t2420r715b2473],
14	would	MD	O	would	aux	17	SENT_50	[p2l738t2420r934b2473],
15	be	VB	O	be	cop	17	SENT_50	[p2l960t2420r1032b2473],
16	more	RBR	O	more	advmod	17	SENT_50	[p2l1059t2435r1220b2473],
17	helpful	JJ	O	helpful	_	0	SENT_50	[p2l1247t2419r1466b2486],
18	in	IN	O	in	_	0	SENT_50	[p2l1493t2420r1550b2472],
19	clinic	NN	O	clinic	prep_in	17	SENT_50	[p2l1576t2420r1756b2473],
20	.	.	O	.	_	0	SENT_50	[p2l1576t2420r1756b2473],

1	In	IN	O	in	_	0	SENT_51	[p2l1783t2423r1842b2472],
2	addition	NN	O	addition	prep_in	15	SENT_51	[p2l1867t2420r2143b2481],
3	,	,	O	,	_	0	SENT_51	[p2l1867t2420r2143b2481],
4	about	IN	O	about	nsubj	15	SENT_51	[p2l53t2506r232b2559],
5	20	CD	PERCENT	20	num	6	SENT_51	[p2l259t2509r378b2559],
6	%	NN	PERCENT	%	pobj	4	SENT_51	[p2l259t2509r378b2559],
7	of	IN	O	of	_	0	SENT_51	[p2l406t2506r471b2559],
8	patients	NNS	O	patient	prep_of	4	SENT_51	[p2l493t2507r745b2572],
9	showing	VBG	O	show	partmod	8	SENT_51	[p2l776t2506r1041b2572],
10	response	NN	O	response	dobj	9	SENT_51	[p2l1070t2521r1348b2572],
11	to	TO	O	to	_	0	SENT_51	[p2l1377t2514r1436b2559],
12	Geﬁtinib	NNP	O	Geﬁtinib	prep_to	9	SENT_51	[p2l1466t2506r1737b2559],
13	do	VBP	O	do	aux	15	SENT_51	[p2l1766t2506r1841b2559],
14	not	RB	O	not	neg	15	SENT_51	[p2l1871t2514r1973b2559],
15	have	VB	O	have	_	0	SENT_51	[p2l2001t2506r2144b2559],

1	F.	NNP	O	F.	nn	2	SENT_52	[p2l401t2648r417b2669],
2	Ma	NNP	O	Ma	_	0	SENT_52	[p2l426t2648r464b2669],
3	et	FW	O	et	nn	4	SENT_52	[p2l473t2650r496b2669],
4	al.	FW	O	al.	dep	2	SENT_52	[p2l503t2647r528b2669],
5	/	:	O	/	punct	2	SENT_52	[p2l535t2647r547b2674],
6	Lung	NN	O	lung	nn	7	SENT_52	[p2l553t2648r613b2674],
7	Cancer	NN	O	cancer	dep	2	SENT_52	[p2l620t2648r703b2669],
8	66	CD	NUMBER	66	number	9	SENT_52	[p2l710t2648r739b2669],
9	(	CD	NUMBER	(	num	10	SENT_52	[p2l747t2647r827b2674],
10	2009	CD	DATE	2009	dep	7	SENT_52	[p2l747t2647r827b2674],
11	)	CD	NUMBER	)	number	12	SENT_52	[p2l747t2647r827b2674],
12	114-119 115	CD	NUMBER	114-119 115	num	10	SENT_52	[p2l1714t2648r1758b2669],[p2l839t2648r942b2669],

1	somatic	JJ	O	somatic	amod	2	SENT_53	[p2l12t2787r261b2841],
2	EGFR	NN	ORGANIZATION	egfr	nsubj	5	SENT_53	[p2l282t2789r441b2841],
3	mutation	NN	O	mutation	dep	2	SENT_53	[p2l464t2787r774b2849],
4	,	,	O	,	_	0	SENT_53	[p2l464t2787r774b2849],
5	indicating	VBG	O	indicate	_	0	SENT_53	[p2l800t2787r1122b2854],
6	that	IN	O	that	complm	12	SENT_53	[p2l1144t2787r1273b2841],
7	mutations	NNS	O	mutation	nsubj	12	SENT_53	[p2l1296t2787r1621b2841],
8	are	VBP	O	be	cop	12	SENT_53	[p2l1646t2802r1743b2841],
9	not	RB	O	not	neg	12	SENT_53	[p2l1768t2795r1872b2841],
10	the	DT	O	the	det	12	SENT_53	[p2l1894t2787r1995b2841],
11	sole	JJ	O	sole	amod	12	SENT_53	[p2l2021t2787r2144b2841],
12	determinant	NN	O	determinant	ccomp	5	SENT_53	[p2l11t2874r412b2928],
13	for	IN	O	for	_	0	SENT_53	[p2l443t2874r532b2928],
14	response	NN	O	response	prep_for	12	SENT_53	[p2l563t2889r847b2941],
15	to	TO	O	to	_	0	SENT_53	[p2l879t2882r940b2928],
16	the	DT	O	the	det	20	SENT_53	[p2l972t2874r1073b2928],
17	drug	NN	O	drug	nn	20	SENT_53	[p2l1106t2874r1254b2941],
18	[	NN	O	[	nn	20	SENT_53	[p2l1288t2874r1422b2941],
19	17	CD	NUMBER	17	num	20	SENT_53	[p2l1288t2874r1422b2941],
20	]	NN	O	]	prep_to	14	SENT_53	[p2l1288t2874r1422b2941],
21	.	.	O	.	_	0	SENT_53	[p2l1288t2874r1422b2941],

1	Other	JJ	O	other	amod	3	SENT_54	[p2l1455t2874r1638b2928],
2	genetic	JJ	O	genetic	amod	3	SENT_54	[p2l1667t2875r1898b2941],
3	factors	NNS	O	factor	nsubj	14	SENT_54	[p2l1931t2874r2143b2928],
4	contributing	VBG	O	contribute	partmod	3	SENT_54	[p2l11t2960r411b3028],
5	to	TO	O	to	_	0	SENT_54	[p2l429t2968r490b3014],
6	sensitivity	NN	O	sensitivity	prep_to	4	SENT_54	[p2l510t2961r840b3028],
7	of	IN	O	of	_	0	SENT_54	[p2l858t2960r924b3014],
8	Geﬁtinib	NNP	LOCATION	Geﬁtinib	prep_of	6	SENT_54	[p2l936t2960r1214b3014],
9	in	IN	O	in	_	0	SENT_54	[p2l1234t2961r1293b3014],
10	NSCLC	NNP	O	NSCLC	nn	11	SENT_54	[p2l1312t2963r1517b3014],
11	patients	NNS	O	patient	prep_in	4	SENT_54	[p2l1536t2961r1793b3028],
12	are	VBP	O	be	cop	14	SENT_54	[p2l1813t2976r1910b3014],
13	largely	RB	O	largely	advmod	14	SENT_54	[p2l1930t2960r2146b3028],
14	unknown	JJ	O	unknown	_	0	SENT_54	[p2l11t3047r315b3101],
15	yet	RB	O	yet	advmod	14	SENT_54	[p2l335t3055r434b3115],
16	and	CC	O	and	cc	14	SENT_54	[p2l455t3047r587b3110],
17	,	,	O	,	_	0	SENT_54	[p2l455t3047r587b3110],
18	thus	RB	O	thus	advmod	23	SENT_54	[p2l610t3047r764b3110],
19	,	,	O	,	_	0	SENT_54	[p2l610t3047r764b3110],
20	efforts	NNS	O	effort	nsubjpass	23	SENT_54	[p2l788t3047r993b3101],
21	have	VBP	O	have	aux	23	SENT_54	[p2l1017t3047r1163b3101],
22	been	VBN	O	be	auxpass	23	SENT_54	[p2l1186t3047r1340b3101],
23	made	VBN	O	make	ccomp	14	SENT_54	[p2l1363t3047r1538b3101],
24	to	TO	O	to	aux	25	SENT_54	[p2l1560t3055r1621b3101],
25	identify	VB	O	identify	xcomp	23	SENT_54	[p2l1645t3047r1894b3115],
26	genetic	JJ	O	genetic	amod	27	SENT_54	[p2l1913t3048r2145b3115],
27	polymorphisms	NNS	O	polymorphism	dobj	25	SENT_54	[p2l11t3134r514b3202],
28	in	IN	O	in	_	0	SENT_54	[p2l542t3135r601b3188],
29	EGFR	NN	ORGANIZATION	egfr	prep_in	25	SENT_54	[p2l625t3137r783b3188],
30	that	WDT	O	that	nsubj	31	SENT_54	[p2l808t3134r937b3188],
31	have	VBP	O	have	rcmod	29	SENT_54	[p2l963t3134r1109b3188],
32	impact	NN	O	impact	dobj	31	SENT_54	[p2l1136t3135r1357b3202],
33	in	IN	O	in	_	0	SENT_54	[p2l1383t3135r1442b3188],
34	response	NN	O	response	prep_in	32	SENT_54	[p2l1468t3150r1752b3202],
35	to	TO	O	to	_	0	SENT_54	[p2l1779t3142r1839b3188],
36	Geﬁtinib	JJ	O	geﬁtinib	amod	37	SENT_54	[p2l1867t3134r2144b3188],
37	treatment	NN	O	treatment	prep_to	31	SENT_54	[p2l10t3230r347b3277],
38	.	.	O	.	_	0	SENT_54	[p2l10t3230r347b3277],

1	A	DT	O	a	det	3	SENT_55	[p3l110t26r157b77],
2	few	JJ	O	few	amod	3	SENT_55	[p3l178t23r295b78],
3	studies	NNS	O	study	nsubjpass	19	SENT_55	[p3l317t24r542b78],
4	evaluating	VBG	O	evaluate	partmod	3	SENT_55	[p3l567t24r901b91],
5	the	DT	O	the	det	6	SENT_55	[p3l923t24r1024b78],
6	association	NN	O	association	dobj	4	SENT_55	[p3l1048t24r1404b78],
7	between	IN	O	between	_	0	SENT_55	[p3l1427t23r1703b78],
8	genetic	JJ	O	genetic	amod	9	SENT_55	[p3l1725t24r1957b91],
9	polymorphisms	NNS	O	polymorphism	prep_between	6	SENT_55	[p3l1980t24r2144b91, p3l11t111r373b178],
10	in	IN	O	in	_	0	SENT_55	[p3l401t112r460b164],
11	EGFR	NN	ORGANIZATION	egfr	prep_in	9	SENT_55	[p3l484t114r643b165],
12	and	CC	O	and	_	0	SENT_55	[p3l668t111r784b165],
13	efﬁcacy	NN	O	efﬁcacy	conj_and	11	SENT_55	[p3l811t111r1056b178],
14	of	IN	O	of	_	0	SENT_55	[p3l1081t111r1147b165],
15	Geﬁtinib	JJ	LOCATION	geﬁtinib	amod	16	SENT_55	[p3l1166t111r1443b165],
16	treatment	NN	O	treatment	prep_of	6	SENT_55	[p3l1469t119r1792b165],
17	have	VBP	O	have	aux	19	SENT_55	[p3l1817t111r1964b165],
18	been	VBN	O	be	auxpass	19	SENT_55	[p3l1990t111r2145b165],
19	published	VBN	O	publish	_	0	SENT_55	[p3l11t197r343b265],
20	.	.	O	.	_	0	SENT_55	[p3l11t197r343b265],

1	The	DT	O	the	det	4	SENT_56	[p3l357t197r474b251],
2	most	RBS	O	most	advmod	3	SENT_56	[p3l491t205r650b251],
3	studied	VBN	O	study	amod	4	SENT_56	[p3l665t197r901b251],
4	polymorphism	NN	O	polymorphism	nsubj	13	SENT_56	[p3l918t197r1391b265],
5	is	VBZ	O	be	cop	13	SENT_56	[p3l1408t198r1454b251],
6	a	DT	O	a	det	13	SENT_56	[p3l1471t213r1503b251],
7	CA	NNP	O	CA	nn	13	SENT_56	[p3l1519t199r1605b251],
8	simple	JJ	O	simple	amod	13	SENT_56	[p3l1619t197r1831b265],
9	sequence	NN	O	sequence	nn	13	SENT_56	[p3l1849t213r2144b265],
10	repeat	NN	O	repeat	nn	13	SENT_56	[p3l11t292r214b352],
11	(	CD	NUMBER	(	num	13	SENT_56	[p3l251t284r532b352],
12	CA-SSR	NN	O	ca-ssr	nn	13	SENT_56	[p3l251t284r532b352],
13	)	NN	O	)	_	0	SENT_56	[p3l251t284r532b352],
14	in	IN	O	in	_	0	SENT_56	[p3l571t285r630b338],
15	intron	NN	O	intron	prep_in	13	SENT_56	[p3l668t285r864b338],
16	1	CD	NUMBER	1	num	15	SENT_56	[p3l904t287r928b338],
17	of	IN	O	of	_	0	SENT_56	[p3l975t284r1041b338],
18	EGFR	NN	ORGANIZATION	egfr	prep_of	15	SENT_56	[p3l1068t287r1226b338],
19	[	CD	NUMBER	[	num	18	SENT_56	[p3l1267t284r1489b352],
20	18,19	CD	NUMBER	18,19	num	21	SENT_56	[p3l1267t284r1489b352],
21	]	NN	O	]	dep	18	SENT_56	[p3l1267t284r1489b352],
22	.	.	O	.	_	0	SENT_56	[p3l1267t284r1489b352],

1	It	PRP	O	it	nsubjpass	3	SENT_57	[p3l1529t288r1573b338],
2	was	VBD	O	be	auxpass	3	SENT_57	[p3l1607t300r1730b338],
3	shown	VBN	O	show	dep	29	SENT_57	[p3l1769t284r1980b338],
4	that	IN	O	that	complm	9	SENT_57	[p3l2016t284r2146b338],
5	transcription	NN	O	transcription	nn	6	SENT_57	[p3l10t372r426b439],
6	activity	NN	O	activity	nsubj	9	SENT_57	[p3l446t372r684b439],
7	of	IN	O	of	_	0	SENT_57	[p3l702t371r769b426],
8	EGFR	NN	ORGANIZATION	egfr	prep_of	6	SENT_57	[p3l779t374r937b426],
9	declines	VBZ	O	decline	ccomp	3	SENT_57	[p3l957t371r1217b426],
10	with	IN	O	with	mark	15	SENT_57	[p3l1237t371r1385b425],
11	the	DT	O	the	det	12	SENT_57	[p3l1404t371r1506b426],
12	numbers	NNS	O	number	nsubj	15	SENT_57	[p3l1527t371r1810b426],
13	of	IN	O	of	_	0	SENT_57	[p3l1832t371r1898b426],
14	CA	NNP	O	CA	prep_of	12	SENT_57	[p3l1910t374r1996b426],
15	dinucleotides	VBZ	O	dinucleotide	advcl	9	SENT_57	[p3l2014t371r2144b425, p3l11t458r336b513],
16	increasing	VBG	O	increase	xcomp	15	SENT_57	[p3l364t459r692b526],
17	and	CC	O	and	_	0	SENT_57	[p3l717t458r833b513],
18	this	DT	O	this	det	19	SENT_57	[p3l859t458r975b513],
19	polymorphism	NN	O	polymorphism	nsubjpass	22	SENT_57	[p3l1003t458r1476b526],
20	has	VBZ	O	have	aux	22	SENT_57	[p3l1502t458r1606b513],
21	been	VBN	O	be	auxpass	22	SENT_57	[p3l1633t458r1787b513],
22	associated	VBN	O	associate	dep	29	SENT_57	[p3l1813t458r2144b513],
23	with	IN	O	with	_	0	SENT_57	[p3l9t546r157b600],
24	the	DT	O	the	det	25	SENT_57	[p3l184t546r286b600],
25	efﬁcacy	NN	O	efﬁcacy	prep_with	22	SENT_57	[p3l315t545r559b613],
26	of	IN	O	of	_	0	SENT_57	[p3l586t545r652b600],
27	EGFR	NN	ORGANIZATION	egfr	nn	28	SENT_57	[p3l673t548r839b600],
28	inhibitors	NNS	O	inhibitor	prep_of	25	SENT_57	[p3l865t546r1174b600],
29	[	VBP	O	[	_	0	SENT_57	[p3l1206t545r1561b613],
30	18,20	CD	NUMBER	18,20	num	31	SENT_57	[p3l1206t545r1561b613],
31	—	CD	NUMBER	—	dobj	29	SENT_57	[p3l1206t545r1561b613],
32	23	CD	NUMBER	23	num	33	SENT_57	[p3l1206t545r1561b613],
33	]	NN	O	]	nsubj	29	SENT_57	[p3l1206t545r1561b613],
34	.	.	O	.	_	0	SENT_57	[p3l1206t545r1561b613],

1	A	DT	O	a	det	2	SENT_58	[p3l1588t548r1634b599],
2	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_58	[p3l1658t548r1816b600],
3	promoter	NN	O	promoter	nn	5	SENT_58	[p3l1844t554r2146b613],
4	polymorphism	NN	O	polymorphism	nn	5	SENT_58	[p3l11t633r484b700],
5	(	NN	O	(	dep	2	SENT_58	[p3l504t633r742b700],
6	.	.	O	.	_	0	SENT_58	[p3l504t633r742b700],

1	—	NN	O	—	_	0	SENT_59	[p3l504t633r742b700],
2	.	.	O	.	_	0	SENT_59	[p3l504t633r742b700],

1	216G	CD	NUMBER	216g	nsubjpass	7	SENT_60	[p3l504t633r742b700],
2	>	JJR	O	>	amod	4	SENT_60	[p3l760t633r868b700],
3	T	NN	O	t	nn	4	SENT_60	[p3l760t633r868b700],
4	)	NN	O	)	dep	1	SENT_60	[p3l760t633r868b700],
5	was	VBD	O	be	auxpass	7	SENT_60	[p3l887t648r1010b687],
6	also	RB	O	also	advmod	7	SENT_60	[p3l1031t633r1155b687],
7	reported	VBN	O	report	dep	23	SENT_60	[p3l1176t633r1451b700],
8	to	TO	O	to	aux	10	SENT_60	[p3l1472t641r1532b687],
9	be	VB	O	be	auxpass	10	SENT_60	[p3l1552t633r1626b687],
10	associated	VBN	O	associate	xcomp	7	SENT_60	[p3l1647t633r1978b687],
11	with	IN	O	with	_	0	SENT_60	[p3l1997t633r2145b687],
12	altered	JJ	O	altered	amod	14	SENT_60	[p3l11t719r233b773],
13	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_60	[p3l258t722r424b773],
14	expression	NN	O	expression	prep_with	10	SENT_60	[p3l445t720r789b787],
15	and	CC	O	and	_	0	SENT_60	[p3l812t719r927b773],
16	differential	JJ	O	differential	amod	17	SENT_60	[p3l951t719r1306b773],
17	sensitivity	NN	O	sensitivity	prep_with	10	SENT_60	[p3l1331t720r1661b787],
18	and	CC	O	and	_	0	SENT_60	[p3l1682t719r1798b773],
19	toxicity	NN	O	toxicity	conj_and	17	SENT_60	[p3l1821t720r2062b787],
20	to	TO	O	to	_	0	SENT_60	[p3l2083t727r2144b773],
21	EGFR	NN	ORGANIZATION	egfr	nn	22	SENT_60	[p3l11t809r178b860],
22	inhibitors	NNS	O	inhibitor	prep_to	10	SENT_60	[p3l200t806r509b860],
23	[	VBP	O	[	_	0	SENT_60	[p3l538t806r799b874],
24	24	CD	NUMBER	24	num	25	SENT_60	[p3l538t806r799b874],
25	—	CD	NUMBER	—	dobj	23	SENT_60	[p3l538t806r799b874],
26	28	CD	NUMBER	28	num	27	SENT_60	[p3l538t806r799b874],
27	]	NN	O	]	nsubj	23	SENT_60	[p3l538t806r799b874],
28	.	.	O	.	_	0	SENT_60	[p3l538t806r799b874],

1	However	RB	O	however	advmod	5	SENT_61	[p3l826t810r1122b869],
2	,	,	O	,	_	0	SENT_61	[p3l826t810r1122b869],
3	these	DT	O	these	det	4	SENT_61	[p3l1147t806r1317b860],
4	studies	NNS	O	study	nsubj	5	SENT_61	[p3l1343t806r1567b860],
5	investigated	VBD	O	investigate	_	0	SENT_61	[p3l1594t806r1982b874],
6	only	RB	O	only	advmod	7	SENT_61	[p3l2008t806r2146b874],
7	one	CD	NUMBER	one	dobj	5	SENT_61	[p3l11t909r125b948],
8	or	CC	O	or	_	0	SENT_61	[p3l148t909r214b947],
9	two	CD	NUMBER	two	dobj	5	SENT_61	[p3l234t901r355b947],
10	but	CC	O	but	_	0	SENT_61	[p3l377t893r484b948],
11	not	RB	O	not	_	0	SENT_61	[p3l505t901r609b948],
12	all	DT	O	all	det	13	SENT_61	[p3l630t893r704b947],
13	polymorphisms	NNS	O	polymorphism	conj_negcc	7	SENT_61	[p3l727t893r1230b961],
14	in	IN	O	in	_	0	SENT_61	[p3l1254t894r1313b947],
15	the	DT	O	the	det	17	SENT_61	[p3l1334t893r1435b947],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_61	[p3l1456t896r1614b948],
17	gene	NN	O	gene	prep_in	5	SENT_61	[p3l1635t909r1800b961],
18	.	.	O	.	_	0	SENT_61	[p3l1635t909r1800b961],

1	Many	JJ	O	many	amod	2	SENT_62	[p3l113t984r291b1048],
2	polymorphisms	NNS	O	polymorphism	nsubjpass	5	SENT_62	[p3l386t981r889b1048],
3	have	VBP	O	have	aux	5	SENT_62	[p3l988t981r1133b1035],
4	been	VBN	O	be	auxpass	5	SENT_62	[p3l1230t981r1385b1035],
5	identiﬁed	VBN	O	identiﬁed	_	0	SENT_62	[p3l1482t980r1790b1035],
6	in	IN	O	in	_	0	SENT_62	[p3l1888t981r1947b1034],
7	the	DT	O	the	det	9	SENT_62	[p3l2043t981r2144b1035],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_62	[p3l9t1071r167b1122],
9	gene	NN	O	gene	prep_in	5	SENT_62	[p3l228t1083r378b1135],
10	according	VBG	O	accord	_	0	SENT_62	[p3l442t1068r755b1135],
11	to	TO	O	to	prepc_according_to	5	SENT_62	[p3l817t1076r877b1122],
12	the	DT	O	the	det	18	SENT_62	[p3l941t1068r1042b1122],
13	International	NNP	MISC	International	nn	18	SENT_62	[p3l1107t1068r1524b1122],
14	HapMap	NNP	MISC	HapMap	nn	18	SENT_62	[p3l1589t1071r1858b1135],
15	Project	NNP	MISC	Project	nn	18	SENT_62	[p3l1923t1069r2146b1135],
16	(	CD	NUMBER	(	num	18	SENT_62	[p3l11t1155r877b1222],
17	http://www.hapmap.org/	NN	O	http://www.hapmap.org/	nn	18	SENT_62	[p3l11t1155r877b1222],
18	)	NN	O	)	pobj	5	SENT_62	[p3l11t1155r877b1222],
19	and	CC	O	and	_	0	SENT_62	[p3l925t1155r1040b1209],
20	Environmental	JJ	O	environmental	amod	25	SENT_62	[p3l1088t1155r1562b1209],
21	Genome	NNP	O	Genome	nn	25	SENT_62	[p3l1609t1158r1876b1209],
22	Project	NNP	O	Project	nn	25	SENT_62	[p3l1923t1156r2146b1222],
23	(	CD	NUMBER	(	num	25	SENT_62	[p3l11t1241r1048b1309],
24	http://egp.gs.washington.edu/	NN	O	http://egp.gs.washington.edu/	nn	25	SENT_62	[p3l11t1241r1048b1309],
25	)	NN	O	)	conj_and	18	SENT_62	[p3l11t1241r1048b1309],
26	.	.	O	.	_	0	SENT_62	[p3l11t1241r1048b1309],

1	It	PRP	O	it	nsubjpass	4	SENT_63	[p3l1078t1244r1122b1295],
2	is	VBZ	O	be	auxpass	4	SENT_63	[p3l1148t1242r1194b1295],
3	highly	RB	O	highly	advmod	4	SENT_63	[p3l1224t1241r1424b1309],
4	warranted	VBN	O	warrant	_	0	SENT_63	[p3l1448t1241r1780b1295],
5	to	TO	O	to	aux	6	SENT_63	[p3l1808t1249r1868b1295],
6	identify	VB	O	identify	xcomp	4	SENT_63	[p3l1897t1241r2146b1309],
7	all	DT	O	all	det	8	SENT_63	[p3l11t1328r84b1382],
8	variants	NNS	O	variant	dobj	6	SENT_63	[p3l100t1329r356b1382],
9	that	WDT	O	that	nsubj	10	SENT_63	[p3l374t1328r503b1382],
10	inﬂuence	VBP	O	inﬂuence	rcmod	8	SENT_63	[p3l519t1328r813b1382],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_63	[p3l831t1331r998b1382],
12	expression	NN	O	expression	dobj	10	SENT_63	[p3l1012t1329r1356b1396],
13	or	CC	O	or	_	0	SENT_63	[p3l1373t1344r1439b1382],
14	function	NN	O	function	conj_or	12	SENT_63	[p3l1454t1328r1722b1382],
15	and	CC	O	and	_	0	SENT_63	[p3l1738t1328r1854b1382],
16	examine	VB	O	examine	conj_and	6	SENT_63	[p3l1872t1329r2144b1382],
17	their	PRP$	O	they	poss	18	SENT_63	[p3l10t1415r164b1469],
18	effects	NNS	O	effect	dobj	16	SENT_63	[p3l189t1415r396b1470],
19	on	IN	O	on	_	0	SENT_63	[p3l423t1431r502b1469],
20	sensitivity	NN	O	sensitivity	prep_on	16	SENT_63	[p3l529t1416r859b1483],
21	to	TO	O	to	_	0	SENT_63	[p3l883t1423r944b1469],
22	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_63	[p3l971t1418r1138b1470],
23	inhibitors	NNS	O	inhibitor	prep_to	16	SENT_63	[p3l1162t1415r1487b1470],
24	.	.	O	.	_	0	SENT_63	[p3l1162t1415r1487b1470],

1	Here	RB	O	here	advmod	3	SENT_64	[p3l1515t1419r1664b1470],
2	we	PRP	O	we	nsubj	3	SENT_64	[p3l1690t1431r1783b1469],
3	reported	VBD	O	report	_	0	SENT_64	[p3l1810t1415r2086b1483],
4	a	DT	O	a	det	6	SENT_64	[p3l2112t1431r2145b1469],
5	comprehensive	JJ	O	comprehensive	amod	6	SENT_64	[p3l11t1502r499b1570],
6	analysis	NN	O	analysis	dobj	3	SENT_64	[p3l532t1503r784b1570],
7	of	IN	O	of	_	0	SENT_64	[p3l818t1502r884b1557],
8	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_64	[p3l907t1505r1066b1557],
9	polymorphisms	NNS	O	polymorphism	prep_of	6	SENT_64	[p3l1097t1503r1600b1570],
10	and	CC	O	and	_	0	SENT_64	[p3l1635t1502r1750b1557],
11	their	PRP$	O	they	poss	12	SENT_64	[p3l1783t1503r1937b1557],
12	effect	NN	O	effect	conj_and	9	SENT_64	[p3l1968t1502r2146b1557],
13	on	IN	O	on	_	0	SENT_64	[p3l11t1606r89b1644],
14	outcome	NN	O	outcome	prep_on	3	SENT_64	[p3l111t1598r391b1644],
15	of	IN	O	of	_	0	SENT_64	[p3l414t1590r480b1644],
16	Geﬁtinib	JJ	O	geﬁtinib	amod	17	SENT_64	[p3l495t1590r772b1644],
17	therapy	NN	O	therapy	prep_of	14	SENT_64	[p3l794t1590r1052b1657],
18	.	.	O	.	_	0	SENT_64	[p3l794t1590r1052b1657],

1	2	LS	NUMBER	2	_	0	SENT_65	[p3l10t1766r65b1818],
2	.	.	O	.	_	0	SENT_65	[p3l10t1766r65b1818],

1	Materials	NNPS	O	Materials	_	0	SENT_66	[p3l111t1763r426b1817],
2	and	CC	O	and	_	0	SENT_66	[p3l447t1763r573b1817],
3	methods	NNS	O	method	conj_and	1	SENT_66	[p3l593t1763r889b1817],

1	2.1	CD	NUMBER	2.1	_	0	SENT_67	[p3l7t1943r103b1995],
2	.	.	O	.	_	0	SENT_67	[p3l7t1943r103b1995],

1	Patients	NNS	O	patient	_	0	SENT_68	[p3l151t1942r397b1995],
2	and	CC	O	and	_	0	SENT_68	[p3l418t1940r532b1995],
3	treatment	NN	O	treatment	conj_and	1	SENT_68	[p3l555t1948r861b1995],

1	This	DT	O	this	det	2	SENT_69	[p3l110t2118r241b2172],
2	study	NN	O	study	nsubj	3	SENT_69	[p3l286t2118r463b2185],
3	recruited	VBD	O	recruit	_	0	SENT_69	[p3l505t2118r795b2172],
4	84	CD	NUMBER	84	num	5	SENT_69	[p3l839t2121r916b2172],
5	patients	NNS	O	patient	dobj	3	SENT_69	[p3l959t2119r1216b2185],
6	with	IN	O	with	_	0	SENT_69	[p3l1259t2118r1407b2172],
7	advanced	JJ	O	advanced	amod	8	SENT_69	[p3l1450t2118r1752b2172],
8	NSCLC	NNP	O	NSCLC	prep_with	3	SENT_69	[p3l1797t2121r2016b2172],
9	.	.	O	.	_	0	SENT_69	[p3l1797t2121r2016b2172],

1	All	DT	O	all	det	2	SENT_70	[p3l2058t2118r2144b2171],
2	patients	NNS	O	patient	nsubj	5	SENT_70	[p3l11t2205r268b2272],
3	were	VBD	O	be	cop	5	SENT_70	[p3l291t2220r449b2258],
4	Han	NNP	MISC	Han	nn	5	SENT_70	[p3l473t2207r600b2258],
5	Chinese	NNP	MISC	Chinese	_	0	SENT_70	[p3l623t2204r887b2259],
6	.	.	O	.	_	0	SENT_70	[p3l623t2204r887b2259],

1	Eligible	JJ	O	eligible	amod	2	SENT_71	[p3l912t2204r1147b2272],
2	patients	NNS	O	patient	nsubj	3	SENT_71	[p3l1171t2205r1428b2272],
3	had	VBD	O	have	_	0	SENT_71	[p3l1453t2204r1568b2258],
4	at	IN	O	at	quantmod	6	SENT_71	[p3l1592t2212r1651b2258],
5	least	JJS	O	least	mwe	4	SENT_71	[p3l1673t2204r1822b2258],
6	one	CD	NUMBER	one	num	8	SENT_71	[p3l1844t2220r1958b2258],
7	measurable	JJ	O	measurable	amod	8	SENT_71	[p3l1982t2220r2144b2258, p3l12t2292r243b2346],
8	lesion	NN	O	lesion	dobj	3	SENT_71	[p3l277t2292r466b2346],
9	with	IN	O	with	_	0	SENT_71	[p3l497t2292r646b2346],
10	a	DT	O	a	det	12	SENT_71	[p3l679t2308r711b2346],
11	minimum	JJ	O	minimum	amod	12	SENT_71	[p3l745t2293r1063b2346],
12	size	NN	O	size	prep_with	3	SENT_71	[p3l1097t2293r1216b2346],
13	in	IN	O	in	_	0	SENT_71	[p3l1250t2293r1310b2346],
14	at	IN	O	at	quantmod	16	SENT_71	[p3l1343t2300r1402b2346],
15	least	JJS	O	least	mwe	14	SENT_71	[p3l1435t2292r1583b2346],
16	one	CD	NUMBER	one	num	17	SENT_71	[p3l1615t2308r1730b2346],
17	diameter	NN	O	diameter	prep_in	12	SENT_71	[p3l1764t2292r2054b2346],
18	of	IN	O	of	_	0	SENT_71	[p3l2086t2292r2152b2346],
19	310	CD	NUMBER	310	num	20	SENT_71	[p3l14t2382r134b2442],
20	mm	NN	O	mm	prep_of	17	SENT_71	[p3l151t2395r276b2433],
21	for	IN	O	for	_	0	SENT_71	[p3l298t2379r387b2433],
22	liver	NN	O	liver	nn	30	SENT_71	[p3l407t2379r557b2442],
23	,	,	O	,	_	0	SENT_71	[p3l407t2379r557b2442],
24	lung	NN	O	lung	nn	30	SENT_71	[p3l580t2379r735b2447],
25	,	,	O	,	_	0	SENT_71	[p3l580t2379r735b2447],
26	brain	NN	O	brain	nn	30	SENT_71	[p3l757t2379r922b2434],
27	or	CC	O	or	_	0	SENT_71	[p3l943t2395r1009b2433],
28	lymph	NN	O	lymph	nn	30	SENT_71	[p3l1029t2379r1233b2447],
29	node	NN	O	node	nn	30	SENT_71	[p3l1254t2379r1410b2434],
30	metastases	NNS	O	metastase	prep_for	20	SENT_71	[p3l1433t2387r1800b2442],
31	,	,	O	,	_	0	SENT_71	[p3l1433t2387r1800b2442],
32	WHO	WP	O	who	dep	34	SENT_71	[p3l1820t2382r1994b2433],
33	performance	NN	O	performance	nn	34	SENT_71	[p3l2017t2395r2144b2447, p3l11t2466r313b2521],
34	status	NN	O	status	rcmod	20	SENT_71	[p3l330t2475r517b2521],
35	of	IN	O	of	_	0	SENT_71	[p3l534t2466r601b2521],
36	0-1	CD	NUMBER	0-1	prep_of	34	SENT_71	[p3l609t2469r735b2529],
37	,	,	O	,	_	0	SENT_71	[p3l609t2469r735b2529],
38	and	CC	O	and	_	0	SENT_71	[p3l752t2467r868b2521],
39	life	NN	O	life	nn	40	SENT_71	[p3l885t2466r982b2521],
40	expectancy	NN	O	expectancy	conj_and	20	SENT_71	[p3l998t2475r1361b2534],
41	33	CD	DURATION	33	num	42	SENT_71	[p3l1377t2469r1458b2529],
42	months	NNS	NUMBER	month	tmod	40	SENT_71	[p3l1478t2467r1736b2521],
43	.	.	O	.	_	0	SENT_71	[p3l1478t2467r1736b2521],

1	Each	DT	O	each	det	2	SENT_72	[p3l1754t2467r1901b2521],
2	patient	NN	O	patient	nsubj	3	SENT_72	[p3l1917t2467r2145b2534],
3	received	VBD	O	receive	_	0	SENT_72	[p3l11t2554r278b2608],
4	orally	RB	O	orally	advmod	3	SENT_72	[p3l316t2554r497b2621],
5	Geﬁtinib	NNP	O	Geﬁtinib	dobj	3	SENT_72	[p3l532t2553r810b2608],
6	at	IN	O	at	_	0	SENT_72	[p3l846t2562r906b2608],
7	daily	JJ	SET	daily	amod	8	SENT_72	[p3l942t2554r1097b2621],
8	dose	NN	O	dose	prep_at	3	SENT_72	[p3l1132t2554r1277b2608],
9	of	IN	O	of	_	0	SENT_72	[p3l1315t2553r1381b2608],
10	250	CD	NUMBER	250	num	11	SENT_72	[p3l1410t2556r1528b2608],
11	mg	NN	O	mg	prep_of	8	SENT_72	[p3l1544t2569r1644b2621],
12	as	IN	O	as	_	0	SENT_72	[p3l1680t2569r1741b2608],
13	2nd	JJ	ORDINAL	2nd	prep_as	3	SENT_72	[p3l1780t2554r1900b2608],
14	or	CC	O	or	_	0	SENT_72	[p3l1938t2569r2003b2608],
15	3rd	JJ	ORDINAL	3rd	amod	17	SENT_72	[p3l2037t2554r2144b2608],
16	line	NN	O	line	nn	17	SENT_72	[p3l11t2641r127b2695],
17	monotherapy	NN	O	monotherapy	prep_as	3	SENT_72	[p3l158t2641r591b2708],
18	at	IN	O	at	_	0	SENT_72	[p3l619t2649r678b2695],
19	Cancer	NNP	LOCATION	Cancer	nn	20	SENT_72	[p3l707t2644r925b2695],
20	Hospital	NNP	LOCATION	Hospital	prep_at	3	SENT_72	[p3l953t2641r1234b2708],
21	,	,	O	,	_	0	SENT_72	[p3l953t2641r1234b2708],
22	Chinese	NNP	ORGANIZATION	Chinese	nn	23	SENT_72	[p3l1265t2641r1514b2695],
23	Academy	NNP	ORGANIZATION	Academy	appos	20	SENT_72	[p3l1542t2641r1838b2708],
24	of	IN	ORGANIZATION	of	_	0	SENT_72	[p3l1865t2641r1932b2695],
25	Medical	NNP	ORGANIZATION	Medical	nn	28	SENT_72	[p3l1954t2641r2144b2695, p3l11t2728r97b2782],
26	Sciences	NNPS	ORGANIZATION	Sciences	nn	28	SENT_72	[p3l117t2728r385b2782],
27	(	NNP	O	(	nn	28	SENT_72	[p3l406t2728r664b2795],
28	Beijing	NNP	LOCATION	Beijing	prep_of	23	SENT_72	[p3l406t2728r664b2795],
29	,	,	O	,	_	0	SENT_72	[p3l406t2728r664b2795],
30	China	NNP	LOCATION	China	appos	20	SENT_72	[p3l685t2728r891b2795],
31	)	CD	NUMBER	)	num	30	SENT_72	[p3l685t2728r891b2795],
32	between	IN	O	between	_	0	SENT_72	[p3l911t2727r1187b2782],
33	March	NNP	DATE	March	prep_between	30	SENT_72	[p3l1207t2728r1409b2782],
34	2004	CD	DATE	2004	num	33	SENT_72	[p3l1428t2730r1590b2782],
35	and	CC	O	and	_	0	SENT_72	[p3l1609t2728r1725b2782],
36	March	NNP	DATE	March	prep_between	30	SENT_72	[p3l1746t2728r1947b2782],
37	2006	CD	DATE	2006	num	36	SENT_72	[p3l1966t2730r2143b2782],
38	.	.	O	.	_	0	SENT_72	[p3l1966t2730r2143b2782],

1	The	DT	O	the	det	3	SENT_73	[p3l8t2815r124b2869],
2	blood	NN	O	blood	nn	3	SENT_73	[p3l153t2815r332b2869],
3	samples	NNS	O	sample	nsubjpass	5	SENT_73	[p3l362t2815r620b2882],
4	were	VBD	O	be	auxpass	5	SENT_73	[p3l648t2830r806b2869],
5	collected	VBN	O	collect	_	0	SENT_73	[p3l835t2815r1121b2869],
6	at	IN	O	at	_	0	SENT_73	[p3l1150t2823r1210b2869],
7	the	DT	O	the	det	8	SENT_73	[p3l1237t2815r1338b2869],
8	time	NN	O	time	prep_at	5	SENT_73	[p3l1367t2816r1512b2869],
9	of	IN	O	of	_	0	SENT_73	[p3l1541t2815r1607b2869],
10	enrollment	NN	O	enrollment	prep_of	8	SENT_73	[p3l1628t2815r2000b2870],
11	.	.	O	.	_	0	SENT_73	[p3l1628t2815r2000b2870],

1	The	DT	O	the	det	3	SENT_74	[p3l2027t2815r2144b2869],
2	primary	JJ	O	primary	amod	3	SENT_74	[p3l11t2902r269b2969],
3	outcome	NN	O	outcome	nsubj	12	SENT_74	[p3l299t2909r577b2955],
4	of	IN	O	of	_	0	SENT_74	[p3l609t2901r675b2955],
5	interest	NN	O	interest	prep_of	3	SENT_74	[p3l698t2902r943b2955],
6	in	IN	O	in	_	0	SENT_74	[p3l972t2902r1031b2955],
7	this	DT	O	this	det	8	SENT_74	[p3l1060t2901r1177b2955],
8	study	NN	O	study	prep_in	5	SENT_74	[p3l1209t2901r1385b2969],
9	was	VBD	O	be	cop	12	SENT_74	[p3l1412t2917r1535b2955],
10	the	DT	O	the	det	12	SENT_74	[p3l1565t2901r1667b2955],
11	best	JJS	O	best	amod	12	SENT_74	[p3l1697t2901r1830b2955],
12	response	NN	O	response	_	0	SENT_74	[p3l1859t2917r2144b2969],
13	achieved	VBN	O	achieve	partmod	12	SENT_74	[p3l11t2988r292b3042],
14	during	IN	O	during	_	0	SENT_74	[p3l324t2988r536b3056],
15	the	DT	O	the	det	16	SENT_74	[p3l566t2988r667b3042],
16	study	NN	O	study	prep_during	13	SENT_74	[p3l699t2988r876b3056],
17	until	IN	O	until	_	0	SENT_74	[p3l906t2988r1054b3042],
18	disease	NN	O	disease	nn	19	SENT_74	[p3l1086t2988r1317b3042],
19	progression	NN	O	progression	prep_until	13	SENT_74	[p3l1349t2989r1739b3056],
20	.	.	O	.	_	0	SENT_74	[p3l1349t2989r1739b3056],

1	The	DT	O	the	det	3	SENT_75	[p3l1769t2988r1886b3042],
2	clinical	JJ	O	clinical	amod	3	SENT_75	[p3l1918t2988r2143b3042],
3	response	NN	O	response	nsubjpass	8	SENT_75	[p3l11t3091r295b3143],
4	to	TO	O	to	_	0	SENT_75	[p3l324t3083r385b3129],
5	the	DT	O	the	det	6	SENT_75	[p3l415t3075r516b3129],
6	therapy	NN	O	therapy	prep_to	3	SENT_75	[p3l545t3075r792b3143],
7	was	VBD	O	be	auxpass	8	SENT_75	[p3l818t3091r941b3129],
8	evaluated	VBN	O	evaluate	_	0	SENT_75	[p3l972t3075r1281b3129],
9	every	DT	SET	every	det	11	SENT_75	[p3l1311t3091r1487b3143],
10	8	CD	SET	8	num	11	SENT_75	[p3l1515t3078r1548b3129],
11	weeks	NNS	NUMBER	week	tmod	8	SENT_75	[p3l1578t3075r1779b3129],
12	and	CC	O	and	_	0	SENT_75	[p3l1809t3075r1925b3129],
13	at	IN	O	at	conj_and	8	SENT_75	[p3l1955t3083r2015b3129],
14	the	DT	O	the	det	15	SENT_75	[p3l2042t3075r2144b3129],
15	end	NN	O	end	pobj	13	SENT_75	[p3l11t3162r127b3217],
16	of	IN	O	of	_	0	SENT_75	[p3l159t3162r225b3217],
17	Geﬁtinib	JJ	O	geﬁtinib	amod	18	SENT_75	[p3l249t3162r526b3217],
18	treatment	NN	O	treatment	prep_of	15	SENT_75	[p3l557t3170r879b3217],
19	according	VBG	O	accord	_	0	SENT_75	[p3l909t3162r1222b3230],
20	to	TO	O	to	prepc_according_to	13	SENT_75	[p3l1251t3170r1312b3217],
21	the	DT	O	the	det	22	SENT_75	[p3l1343t3162r1444b3217],
22	Response	NN	O	response	pobj	13	SENT_75	[p3l1476t3166r1774b3230],
23	Evaluation	NN	O	evaluation	nn	24	SENT_75	[p3l1806t3162r2144b3217],
24	Criteria	NNS	O	criterion	nsubj	28	SENT_75	[p3l11t3250r248b3304],
25	in	IN	O	in	_	0	SENT_75	[p3l284t3250r343b3303],
26	Solid	JJ	O	solid	amod	27	SENT_75	[p3l380t3249r535b3304],
27	Tumors	NNS	O	tumor	prep_in	24	SENT_75	[p3l570t3253r813b3304],
28	[	VBP	O	[	rcmod	22	SENT_75	[p3l853t3249r993b3317],
29	29	CD	NUMBER	29	num	30	SENT_75	[p3l853t3249r993b3317],
30	]	CD	NUMBER	]	dobj	28	SENT_75	[p3l853t3249r993b3317],
31	.	.	O	.	_	0	SENT_75	[p3l853t3249r993b3317],

1	Complete	JJ	O	complete	amod	2	SENT_76	[p3l1031t3249r1335b3317],
2	response	NN	O	response	nsubj	12	SENT_76	[p3l1373t3265r1656b3317],
3	(	CD	NUMBER	(	num	5	SENT_76	[p3l1694t3250r1826b3317],
4	CR	JJ	O	cr	amod	5	SENT_76	[p3l1694t3250r1826b3317],
5	)	NN	O	)	dep	2	SENT_76	[p3l1694t3250r1826b3317],
6	and	CC	O	and	_	0	SENT_76	[p3l1863t3250r1979b3304],
7	partial	JJ	O	partial	amod	8	SENT_76	[p3l2016t3265r2143b3317, p3l10t3337r110b3391],
8	response	NN	O	response	conj_and	2	SENT_76	[p3l143t3352r427b3404],
9	(	CD	NUMBER	(	num	11	SENT_76	[p3l460t3337r590b3404],
10	PR	NN	O	pr	nn	11	SENT_76	[p3l460t3337r590b3404],
11	)	NN	O	)	dep	8	SENT_76	[p3l460t3337r590b3404],
12	had	VBD	O	have	_	0	SENT_76	[p3l622t3337r738b3391],
13	a	DT	O	a	det	14	SENT_76	[p3l770t3353r802b3391],
14	conﬁrmation	NN	O	conﬁrmation	dobj	12	SENT_76	[p3l834t3337r1250b3391],
15	at	IN	O	at	_	0	SENT_76	[p3l1282t3345r1341b3391],
16	a	DT	O	a	det	17	SENT_76	[p3l1372t3352r1404b3391],
17	minimum	NN	O	minimum	prep_at	14	SENT_76	[p3l1436t3338r1754b3391],
18	of	IN	O	of	_	0	SENT_76	[p3l1786t3337r1852b3391],
19	4	CD	DURATION	4	num	20	SENT_76	[p3l1874t3340r1912b3390],
20	weeks	NNS	NUMBER	week	prep_of	17	SENT_76	[p3l1942t3337r2143b3391],
21	between	IN	O	between	_	0	SENT_76	[p3l10t3423r287b3477],
22	the	DT	O	the	det	23	SENT_76	[p3l302t3423r403b3477],
23	assessments	NNS	O	assessment	prep_between	20	SENT_76	[p3l419t3431r832b3486],
24	,	,	O	,	_	0	SENT_76	[p3l419t3431r832b3486],
25	and	CC	O	and	_	0	SENT_76	[p3l849t3423r965b3477],
26	stable	JJ	O	stable	amod	30	SENT_76	[p3l983t3423r1169b3477],
27	disease	NN	O	disease	nn	30	SENT_76	[p3l1185t3423r1416b3477],
28	(	CD	NUMBER	(	num	30	SENT_76	[p3l1433t3423r1567b3490],
29	SD	NN	O	sd	nn	30	SENT_76	[p3l1433t3423r1567b3490],
30	)	NN	O	)	nsubj	33	SENT_76	[p3l1433t3423r1567b3490],
31	should	MD	O	should	aux	33	SENT_76	[p3l1585t3423r1798b3477],
32	be	VB	O	be	cop	33	SENT_76	[p3l1814t3423r1888b3477],
33	present	JJ	DATE	present	conj_and	12	SENT_76	[p3l1905t3431r2146b3491],
34	for	IN	O	for	_	0	SENT_76	[p3l11t3510r100b3564],
35	a	DT	O	a	det	36	SENT_76	[p3l120t3526r152b3564],
36	minimum	NN	O	minimum	prep_for	33	SENT_76	[p3l174t3511r492b3564],
37	of	IN	O	of	_	0	SENT_76	[p3l514t3510r579b3564],
38	24	CD	DURATION	24	num	39	SENT_76	[p3l593t3513r670b3564],
39	weeks	NNS	NUMBER	week	prep_of	36	SENT_76	[p3l689t3510r890b3564],
40	from	IN	O	from	_	0	SENT_76	[p3l914t3510r1065b3564],
41	the	DT	O	the	det	43	SENT_76	[p3l1086t3510r1187b3564],
42	ﬁrst	NN	O	ﬁrst	nn	43	SENT_76	[p3l1210t3510r1336b3564],
43	dose	NN	O	dose	prep_from	33	SENT_76	[p3l1356t3510r1517b3565],
44	.	.	O	.	_	0	SENT_76	[p3l1356t3510r1517b3565],

1	Progression	NN	O	progression	nsubjpass	6	SENT_77	[p3l1541t3511r1913b3578],
2	within	IN	O	within	_	0	SENT_77	[p3l1933t3510r2145b3564],
3	24	CD	DURATION	24	num	4	SENT_77	[p3l11t3600r87b3651],
4	weeks	NNS	NUMBER	week	prep_within	1	SENT_77	[p3l116t3597r317b3652],
5	was	VBD	O	be	auxpass	6	SENT_77	[p3l348t3613r470b3652],
6	deﬁned	VBN	O	deﬁned	_	0	SENT_77	[p3l504t3597r743b3652],
7	as	IN	O	as	_	0	SENT_77	[p3l775t3613r837b3652],
8	progressive	JJ	O	progressive	amod	12	SENT_77	[p3l871t3598r1235b3665],
9	disease	NN	O	disease	nn	12	SENT_77	[p3l1267t3597r1498b3652],
10	(	NN	O	(	nn	12	SENT_77	[p3l1531t3597r1683b3665],
11	PD	NN	O	pd	nn	12	SENT_77	[p3l1531t3597r1683b3665],
12	)	NN	O	)	prep_as	6	SENT_77	[p3l1531t3597r1683b3665],
13	.	.	O	.	_	0	SENT_77	[p3l1531t3597r1683b3665],

1	In	IN	O	in	_	0	SENT_78	[p3l1716t3601r1776b3651],
2	this	DT	O	this	det	3	SENT_78	[p3l1807t3597r1923b3652],
3	study	NN	O	study	prep_in	19	SENT_78	[p3l1956t3597r2143b3665],
4	,	,	O	,	_	0	SENT_78	[p3l1956t3597r2143b3665],
5	patients	NNS	O	patient	nsubjpass	19	SENT_78	[p3l11t3685r268b3752],
6	achieving	VBG	O	achieve	partmod	5	SENT_78	[p3l299t3684r606b3752],
7	CR	NN	O	cr	dobj	6	SENT_78	[p3l634t3687r731b3747],
8	,	,	O	,	_	0	SENT_78	[p3l634t3687r731b3747],
9	PR	NN	O	pr	dobj	6	SENT_78	[p3l762t3688r856b3747],
10	,	,	O	,	_	0	SENT_78	[p3l762t3688r856b3747],
11	or	CC	O	or	_	0	SENT_78	[p3l887t3700r953b3739],
12	SD	NN	O	sd	dobj	6	SENT_78	[p3l981t3687r1063b3739],
13	for	IN	O	for	_	0	SENT_78	[p3l1093t3684r1183b3739],
14	at	IN	DURATION	at	quantmod	16	SENT_78	[p3l1210t3692r1270b3739],
15	least	JJS	DURATION	least	mwe	14	SENT_78	[p3l1299t3684r1446b3739],
16	24	CD	DURATION	24	num	17	SENT_78	[p3l1475t3687r1551b3738],
17	weeks	NNS	NUMBER	week	prep_for	6	SENT_78	[p3l1579t3684r1780b3739],
18	were	VBD	O	be	auxpass	19	SENT_78	[p3l1809t3700r1967b3739],
19	classiﬁed	VBN	O	classiﬁed	_	0	SENT_78	[p3l1998t3684r2143b3739, p4l12t16r182b71],

1	as	IN	O	as	_	0	SENT_79	[p4l208t32r270b71],
2	responders	NNS	O	responder	pobj	1	SENT_79	[p4l297t17r651b84],
3	whereas	IN	O	whereas	mark	11	SENT_79	[p4l676t17r945b71],
4	patients	NNS	O	patient	nsubjpass	11	SENT_79	[p4l973t17r1230b84],
5	having	VBG	O	have	partmod	4	SENT_79	[p4l1257t17r1471b84],
6	PD	NN	O	pd	dobj	5	SENT_79	[p4l1496t20r1580b70],
7	within	IN	O	within	_	0	SENT_79	[p4l1605t17r1817b71],
8	24	CD	DURATION	24	num	9	SENT_79	[p4l1842t19r1919b70],
9	weeks	NNS	NUMBER	week	prep_within	6	SENT_79	[p4l1942t17r2143b71],
10	were	VBD	O	be	auxpass	11	SENT_79	[p4l9t119r166b158],
11	classiﬁed	VBN	O	classiﬁed	dep	2	SENT_79	[p4l193t104r487b158],
12	as	IN	O	as	_	0	SENT_79	[p4l513t119r575b158],
13	non-responders	NNS	O	non-responder	prep_as	11	SENT_79	[p4l603t104r1128b171],
14	.	.	O	.	_	0	SENT_79	[p4l603t104r1128b171],

1	Progression-free	JJ	O	progression-free	amod	5	SENT_80	[p4l1155t104r1682b171],
2	survival	NN	O	survival	nn	5	SENT_80	[p4l1709t104r1957b158],
3	(	CD	NUMBER	(	num	5	SENT_80	[p4l1984t104r2144b171],
4	PFS	NN	O	pf	nn	5	SENT_80	[p4l1984t104r2144b171],
5	)	NN	O	)	nsubjpass	7	SENT_80	[p4l1984t104r2144b171],
6	was	VBD	O	be	auxpass	7	SENT_80	[p4l9t207r132b245],
7	deﬁned	VBN	O	deﬁned	_	0	SENT_80	[p4l159t191r399b245],
8	as	IN	O	as	_	0	SENT_80	[p4l426t207r488b245],
9	the	DT	O	the	det	10	SENT_80	[p4l516t191r617b245],
10	time	NN	O	time	prep_as	7	SENT_80	[p4l643t192r788b245],
11	from	IN	O	from	_	0	SENT_80	[p4l816t191r968b245],
12	ﬁrst	NN	O	ﬁrst	nn	13	SENT_80	[p4l994t191r1121b245],
13	dose	NN	O	dose	prep_from	7	SENT_80	[p4l1146t191r1291b245],
14	of	IN	O	of	_	0	SENT_80	[p4l1318t191r1384b245],
15	Geﬁtinib	NNP	O	Geﬁtinib	prep_of	13	SENT_80	[p4l1403t191r1681b245],
16	to	TO	O	to	_	0	SENT_80	[p4l1707t199r1768b245],
17	the	DT	O	the	det	18	SENT_80	[p4l1794t191r1895b245],
18	date	NN	O	date	prep_to	7	SENT_80	[p4l1922t191r2058b245],
19	of	IN	O	of	_	0	SENT_80	[p4l2085t191r2152b245],
20	disease	NN	O	disease	nn	21	SENT_80	[p4l11t278r242b332],
21	progression	NN	O	progression	prep_of	18	SENT_80	[p4l262t279r637b346],
22	or	CC	O	or	_	0	SENT_80	[p4l656t294r722b332],
23	death	NN	O	death	conj_or	21	SENT_80	[p4l739t278r919b332],
24	due	JJ	O	due	_	0	SENT_80	[p4l938t278r1054b332],
25	to	TO	O	to	_	0	SENT_80	[p4l1073t286r1133b332],
26	any	DT	O	any	det	27	SENT_80	[p4l1153t294r1266b346],
27	cause	NN	O	cause	prep_due_to	21	SENT_80	[p4l1283t294r1474b333],
28	.	.	O	.	_	0	SENT_80	[p4l1283t294r1474b333],

1	Overall	JJ	O	overall	amod	5	SENT_81	[p4l1495t278r1720b332],
2	survival	NN	O	survival	nn	5	SENT_81	[p4l1741t278r1989b332],
3	(	CD	NUMBER	(	num	5	SENT_81	[p4l2009t278r2144b345],
4	OS	NN	O	os	nn	5	SENT_81	[p4l2009t278r2144b345],
5	)	NN	O	)	nsubjpass	7	SENT_81	[p4l2009t278r2144b345],
6	was	VBD	O	be	auxpass	7	SENT_81	[p4l9t382r132b421],
7	deﬁned	VBN	O	deﬁned	_	0	SENT_81	[p4l151t366r391b421],
8	as	IN	O	as	_	0	SENT_81	[p4l409t382r471b421],
9	the	DT	O	the	det	10	SENT_81	[p4l490t366r592b421],
10	time	NN	O	time	prep_as	7	SENT_81	[p4l610t367r755b421],
11	between	IN	O	between	_	0	SENT_81	[p4l773t366r1050b421],
12	ﬁrst	CD	NUMBER	ﬁrst	num	13	SENT_81	[p4l1068t366r1194b421],
13	dose	NN	O	dose	prep_between	10	SENT_81	[p4l1211t366r1356b421],
14	of	IN	O	of	_	0	SENT_81	[p4l1375t366r1441b421],
15	Geﬁtinib	NNP	LOCATION	Geﬁtinib	prep_of	13	SENT_81	[p4l1452t366r1729b421],
16	and	CC	O	and	_	0	SENT_81	[p4l1747t366r1863b421],
17	death	NN	O	death	prep_between	10	SENT_81	[p4l1882t366r2062b421],
18	or	CC	O	or	_	0	SENT_81	[p4l2080t382r2146b421],
19	the	DT	O	the	det	21	SENT_81	[p4l10t454r111b508],
20	last	JJ	O	last	amod	21	SENT_81	[p4l134t454r245b508],
21	follow-up	NN	O	follow-up	conj_and	13	SENT_81	[p4l266t453r593b521],
22	.	.	O	.	_	0	SENT_81	[p4l266t453r593b521],

1	Dates	NNS	O	date	nsubjpass	5	SENT_82	[p4l616t457r790b508],
2	of	IN	O	of	_	0	SENT_82	[p4l813t453r879b508],
3	death	NN	O	death	prep_of	1	SENT_82	[p4l893t454r1073b508],
4	were	VBD	O	be	auxpass	5	SENT_82	[p4l1093t469r1250b508],
5	obtained	VBN	O	obtain	_	0	SENT_82	[p4l1273t454r1554b508],
6	from	IN	O	from	_	0	SENT_82	[p4l1577t453r1728b508],
7	(	CD	NUMBER	(	prep_from	5	SENT_82	[p4l1750t454r1833b521],
8	a	DT	O	a	det	10	SENT_82	[p4l1750t454r1833b521],
9	)	NN	O	)	nn	10	SENT_82	[p4l1750t454r1833b521],
10	inpatient	NN	O	inpatient	dobj	5	SENT_82	[p4l1855t454r2145b521],
11	and	CC	O	and	_	0	SENT_82	[p4l11t541r126b595],
12	outpatient	NN	O	outpatient	nn	13	SENT_82	[p4l146t542r484b608],
13	records	NNS	O	record	conj_and	10	SENT_82	[p4l502t541r752b603],
14	,	,	O	,	_	0	SENT_82	[p4l502t541r752b603],
15	(	NN	O	(	nn	16	SENT_82	[p4l772t541r860b608],
16	b	NN	O	b	conj_and	10	SENT_82	[p4l772t541r860b608],
17	)	CD	NUMBER	)	num	18	SENT_82	[p4l772t541r860b608],
18	patient	NN	O	patient	poss	20	SENT_82	[p4l880t542r1154b608],
19	’s	POS	O	’s	_	0	SENT_82	[p4l880t542r1154b608],
20	family	NN	O	family	dep	16	SENT_82	[p4l1175t541r1386b608],
21	,	,	O	,	_	0	SENT_82	[p4l1175t541r1386b608],
22	or	CC	O	or	_	0	SENT_82	[p4l1406t556r1472b595],
23	(	NN	O	(	nn	24	SENT_82	[p4l1490t541r1570b608],
24	c	NN	O	c	dobj	5	SENT_82	[p4l1490t541r1570b608],
25	)	CD	NUMBER	)	dep	24	SENT_82	[p4l1490t541r1570b608],
26	local	JJ	O	local	amod	31	SENT_82	[p4l1590t541r1737b595],
27	Public	NNP	O	Public	nn	31	SENT_82	[p4l1757t541r1951b595],
28	Security	NNP	O	Security	nn	31	SENT_82	[p4l1970t544r2143b595, p4l11t629r122b695],
29	Census	NNP	O	Census	nn	31	SENT_82	[p4l149t631r369b682],
30	Register	NNP	O	Register	nn	31	SENT_82	[p4l398t629r656b695],
31	Ofﬁce	NNP	O	Ofﬁce	dep	24	SENT_82	[p4l682t628r881b682],
32	.	.	O	.	_	0	SENT_82	[p4l682t628r881b682],

1	Patients	NNS	O	patient	nsubjpass	7	SENT_83	[p4l911t629r1164b682],
2	who	WP	O	who	nsubjpass	5	SENT_83	[p4l1191t628r1331b682],
3	were	VBD	O	be	auxpass	5	SENT_83	[p4l1357t643r1515b682],
4	not	RB	O	not	neg	5	SENT_83	[p4l1543t636r1647b682],
5	departed	VBN	O	depart	rcmod	1	SENT_83	[p4l1673t628r1959b695],
6	were	VBD	O	be	auxpass	7	SENT_83	[p4l1986t643r2143b682],
7	censored	VBN	O	censor	_	0	SENT_83	[p4l11t714r298b768],
8	at	IN	O	at	_	0	SENT_83	[p4l320t722r379b768],
9	the	DT	O	the	det	11	SENT_83	[p4l399t714r500b768],
10	last	JJ	O	last	amod	11	SENT_83	[p4l523t714r634b768],
11	date	NN	O	date	prep_at	7	SENT_83	[p4l654t714r790b768],
12	they	PRP	O	they	nsubjpass	14	SENT_83	[p4l812t714r953b782],
13	were	VBD	O	be	auxpass	14	SENT_83	[p4l971t730r1129b768],
14	known	VBN	O	know	rcmod	11	SENT_83	[p4l1151t714r1370b768],
15	to	TO	O	to	aux	17	SENT_83	[p4l1391t722r1451b768],
16	be	VB	O	be	cop	17	SENT_83	[p4l1473t714r1547b768],
17	alive	JJ	O	alive	xcomp	14	SENT_83	[p4l1569t714r1716b768],
18	based	VBN	O	base	_	0	SENT_83	[p4l1737t714r1921b768],
19	on	IN	O	on	prepc_based_on	17	SENT_83	[p4l1943t730r2022b768],
20	the	DT	O	the	det	21	SENT_83	[p4l2042t714r2143b768],
21	date	NN	O	date	pobj	17	SENT_83	[p4l11t801r146b855],
22	of	IN	O	of	_	0	SENT_83	[p4l175t801r242b855],
23	last	JJ	O	last	amod	24	SENT_83	[p4l262t801r373b855],
24	contact	NN	O	contact	prep_of	21	SENT_83	[p4l400t809r650b856],
25	.	.	O	.	_	0	SENT_83	[p4l400t809r650b856],

1	This	DT	O	this	det	2	SENT_84	[p4l676t801r808b855],
2	study	NN	O	study	nsubjpass	4	SENT_84	[p4l838t801r1014b869],
3	was	VBD	O	be	auxpass	4	SENT_84	[p4l1039t817r1161b855],
4	approved	VBN	O	approve	_	0	SENT_84	[p4l1191t801r1490b869],
5	by	IN	O	by	_	0	SENT_84	[p4l1518t801r1594b869],
6	the	DT	O	the	det	9	SENT_84	[p4l1620t801r1721b855],
7	Institutional	JJ	ORGANIZATION	institutional	amod	9	SENT_84	[p4l1750t801r2144b855],
8	Review	NNP	ORGANIZATION	Review	nn	9	SENT_84	[p4l11t889r242b943],
9	Board	NNP	ORGANIZATION	Board	agent	4	SENT_84	[p4l266t888r449b943],
10	of	IN	ORGANIZATION	of	_	0	SENT_84	[p4l474t888r540b942],
11	the	DT	ORGANIZATION	the	det	13	SENT_84	[p4l556t888r658b943],
12	Chinese	JJ	ORGANIZATION	chinese	amod	13	SENT_84	[p4l683t888r932b943],
13	Academy	NN	ORGANIZATION	academy	prep_of	9	SENT_84	[p4l954t888r1250b956],
14	of	IN	ORGANIZATION	of	_	0	SENT_84	[p4l1273t888r1339b943],
15	Medical	NNP	ORGANIZATION	Medical	nn	18	SENT_84	[p4l1356t888r1609b943],
16	Sciences	NNP	ORGANIZATION	Sciences	nn	18	SENT_84	[p4l1634t889r1902b943],
17	Cancer	NNP	ORGANIZATION	Cancer	nn	18	SENT_84	[p4l1928t891r2146b943],
18	Hospital	NNP	ORGANIZATION	Hospital	prep_of	13	SENT_84	[p4l11t976r292b1043],
19	.	.	O	.	_	0	SENT_84	[p4l11t976r292b1043],

1	2.2	CD	NUMBER	2.2	_	0	SENT_85	[p4l7t1152r113b1204],
2	.	.	O	.	_	0	SENT_85	[p4l7t1152r113b1204],

1	Polymorphism	NN	O	polymorphism	nn	2	SENT_86	[p4l161t1149r603b1217],
2	analysis	NN	O	analysis	_	0	SENT_86	[p4l627t1149r871b1217],

1	Tag-SNPs	NNS	O	tag-snp	nsubjpass	3	SENT_87	[p4l110t1329r406b1394],
2	were	VBD	O	be	auxpass	3	SENT_87	[p4l456t1342r613b1381],
3	selected	VBN	O	select	_	0	SENT_87	[p4l665t1326r924b1381],
4	according	VBG	O	accord	_	0	SENT_87	[p4l976t1326r1288b1394],
5	to	TO	O	to	prepc_according_to	3	SENT_87	[p4l1337t1334r1397b1381],
6	the	DT	O	the	pobj	3	SENT_87	[p4l1448t1326r1549b1381],
7	genotyped	VBN	O	genotype	partmod	6	SENT_87	[p4l1599t1326r1937b1394],
8	SNPs	NNS	O	snp	dep	7	SENT_87	[p4l1989t1329r2143b1381],
9	in	IN	O	in	_	0	SENT_87	[p4l11t1414r70b1467],
10	Asian	JJ	LOCATION	asian	amod	11	SENT_87	[p4l131t1414r308b1468],
11	populations	NNS	O	population	prep_in	8	SENT_87	[p4l372t1413r751b1481],
12	in	IN	O	in	_	0	SENT_87	[p4l817t1414r876b1467],
13	the	DT	O	the	det	16	SENT_87	[p4l939t1413r1040b1467],
14	International	NNP	MISC	International	nn	16	SENT_87	[p4l1106t1413r1523b1468],
15	HapMap	NNP	MISC	HapMap	nn	16	SENT_87	[p4l1588t1417r1858b1481],
16	Project	NNP	MISC	Project	prep_in	11	SENT_87	[p4l1923t1414r2145b1481],
17	(	CD	NUMBER	(	num	18	SENT_87	[p4l11t1501r189b1568],
18	http	NN	O	http	dep	8	SENT_87	[p4l11t1501r189b1568],
19	:	:	O	:	_	0	SENT_87	[p4l11t1501r189b1568],
20	/	:	O	/	punct	29	SENT_87	[p4l199t1500r851b1568],
21	/	:	O	/	punct	27	SENT_87	[p4l199t1500r851b1568],
22	www.hapmap.org	NN	O	www.hapmap.org	dep	27	SENT_87	[p4l199t1500r851b1568],
23	/	:	O	/	punct	24	SENT_87	[p4l199t1500r851b1568],
24	)	NN	O	)	dep	22	SENT_87	[p4l860t1501r877b1568],
25	and	CC	O	and	_	0	SENT_87	[p4l895t1501r1011b1555],
26	the	DT	O	the	dep	22	SENT_87	[p4l1028t1501r1129b1555],
27	Environmental	NNP	O	Environmental	dep	29	SENT_87	[p4l1147t1501r1621b1555],
28	Genome	NNP	O	Genome	nn	29	SENT_87	[p4l1639t1503r1905b1555],
29	Project	NNP	O	Project	dep	6	SENT_87	[p4l1923t1501r2145b1568],
30	(	CD	NUMBER	(	num	31	SENT_87	[p4l11t1588r1048b1655],
31	http://egp.gs.washington.edu/	NN	O	http://egp.gs.washington.edu/	dep	29	SENT_87	[p4l11t1588r1048b1655],
32	)	NN	O	)	dep	29	SENT_87	[p4l11t1588r1048b1655],
33	.	.	O	.	_	0	SENT_87	[p4l11t1588r1048b1655],

1	Genotypes	NNS	O	genotype	nsubj	10	SENT_88	[p4l1095t1591r1433b1655],
2	of	IN	O	of	_	0	SENT_88	[p4l1480t1588r1546b1642],
3	235	CD	NUMBER	235	num	4	SENT_88	[p4l1584t1591r1698b1642],
4	SNPs	NNS	O	snp	prep_of	1	SENT_88	[p4l1747t1591r1901b1642],
5	across	IN	O	across	_	0	SENT_88	[p4l1948t1603r2143b1642],
6	a	DT	O	a	det	8	SENT_88	[p4l11t1690r43b1728],
7	195.3-l	JJ	O	195.3-l	amod	8	SENT_88	[p4l89t1674r364b1729],
8	0.8	CD	NUMBER	0.8	prep_across	4	SENT_88	[p4l1304t1938r1395b1990],
9	as	IN	O	as	advmod	10	SENT_88	[p4l1419t1951r1481b1990],
10	described	VBN	O	describe	_	0	SENT_88	[p4l1504t1936r1814b1990],
11	[	NN	O	[	nn	13	SENT_88	[p4l1840t1935r1980b2003],
12	30	CD	NUMBER	30	num	13	SENT_88	[p4l1840t1935r1980b2003],
13	]	NN	O	]	dobj	10	SENT_88	[p4l1840t1935r1980b2003],
14	.	.	O	.	_	0	SENT_88	[p4l1840t1935r1980b2003],

1	Four	CD	NUMBER	four	num	3	SENT_89	[p4l2003t1939r2146b1990],
2	tag	NN	O	tag	nn	3	SENT_89	[p4l10t2031r108b2090],
3	SNPs	NNS	O	snp	nsubjpass	6	SENT_89	[p4l139t2026r293b2077],
4	were	VBD	O	be	auxpass	6	SENT_89	[p4l324t2038r481b2077],
5	thus	RB	O	thus	advmod	6	SENT_89	[p4l513t2023r651b2077],
6	chosen	VBN	O	choose	dep	14	SENT_89	[p4l683t2023r906b2077],
7	as	IN	O	as	_	0	SENT_89	[p4l937t2038r999b2077],
8	candidate	NN	O	candidate	nn	9	SENT_89	[p4l1032t2023r1344b2077],
9	SNPs	NNS	O	snp	prep_as	6	SENT_89	[p4l1376t2026r1530b2077],
10	and	CC	O	and	_	0	SENT_89	[p4l1563t2023r1679b2077],
11	each	DT	O	each	conj_and	9	SENT_89	[p4l1711t2023r1856b2077],
12	of	IN	O	of	_	0	SENT_89	[p4l1888t2023r1953b2077],
13	them	PRP	O	they	prep_of	11	SENT_89	[p4l1977t2023r2144b2077],
14	represents	VBZ	O	represent	_	0	SENT_89	[p4l11t2118r345b2177],
15	35	CD	NUMBER	35	num	16	SENT_89	[p4l372t2113r454b2172],
16	SNPs	NNS	O	snp	dobj	14	SENT_89	[p4l479t2113r633b2164],
17	(	CD	NUMBER	(	num	18	SENT_89	[p4l657t2110r788b2177],
18	Fig	NN	O	fig	nsubj	14	SENT_89	[p4l657t2110r788b2177],
19	.	.	O	.	_	0	SENT_89	[p4l657t2110r788b2177],

1	1	CD	NUMBER	1	_	0	SENT_90	[p4l815t2110r889b2177],
2	)	NN	O	)	dep	1	SENT_90	[p4l815t2110r889b2177],
3	.	.	O	.	_	0	SENT_90	[p4l815t2110r889b2177],

1	If	IN	O	if	mark	7	SENT_91	[p4l913t2110r961b2163],
2	one	CD	NUMBER	one	num	6	SENT_91	[p4l976t2125r1090b2164],
3	or	CC	O	or	_	0	SENT_91	[p4l1114t2125r1180b2164],
4	more	JJR	O	more	num	6	SENT_91	[p4l1201t2125r1365b2164],
5	tag	NN	O	tag	nn	6	SENT_91	[p4l1388t2118r1485b2177],
6	SNPs	NNS	O	snp	nsubj	7	SENT_91	[p4l1507t2113r1661b2164],
7	had	VBD	O	have	_	0	SENT_91	[p4l1685t2110r1800b2164],
8	impact	NN	O	impact	dobj	7	SENT_91	[p4l1824t2111r2045b2177],
9	on	IN	O	on	prep	7	SENT_91	[p4l2066t2126r2144b2164],

1	(	NN	O	(	nn	2	SENT_92	[p4l260t2244r302b2276],
2	A	NN	O	a	_	0	SENT_92	[p4l260t2244r302b2276],
3	)	CD	NUMBER	)	num	4	SENT_92	[p4l260t2244r302b2276],
4	(	NN	O	(	dep	2	SENT_92	[p4l711t2244r753b2276],
5	B	NN	O	b	nn	8	SENT_92	[p4l711t2244r753b2276],
6	)	CD	NUMBER	)	num	8	SENT_92	[p4l711t2244r753b2276],
7	(	NN	O	(	nn	8	SENT_92	[p4l1059t2244r1103b2276],
8	o	NN	O	o	dep	4	SENT_92	[p4l1059t2244r1103b2276],
9	)	CD	NUMBER	)	dep	2	SENT_92	[p4l1059t2244r1103b2276],

1	candidate	NN	O	candidate	nn	2	SENT_93	[p4l6t2289r167b2317],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_93	[p4l177t2290r414b2329],
3	or	CC	O	or	_	0	SENT_93	[p4l423t2296r456b2316],
4	regions	NNS	O	region	conj_or	2	SENT_93	[p4l464t2290r580b2323],

1	V	NN	O	v	dep	4	SENT_94	[p4l845t2329r867b2352],
2	-	:	O	-	_	0	SENT_94	[p4l815t2356r869b2379],
3	o	NN	O	o	dep	1	SENT_94	[p4l815t2356r869b2379],
4	rs	VBZ	O	r	_	0	SENT_94	[p4l884t2362r907b2379],
5	7809028	CD	NUMBER	7809028	num	6	SENT_94	[p4l915t2356r1024b2379],
6	rs	NNS	O	r	dobj	4	SENT_94	[p4l884t2413r906b2431],
7	2293347	CD	NUMBER	2293347	nsubj	4	SENT_94	[p4l914t2408r1024b2431],

1	rs2075102	NN	O	rs2075102	nn	4	SENT_95	[p4l884t2522r1024b2544],
2	P	NN	O	p	nn	4	SENT_95	[p4l1072t2503r1079b2547],
3	d	NN	O	d	nn	4	SENT_95	[p4l1072t2503r1079b2547],
4	*	NN	O	*	_	0	SENT_95	[p4l1072t2503r1079b2547],
5	'	''	O	'	_	0	SENT_95	[p4l1114t2513r1116b2515],
6	-	:	O	-	_	0	SENT_95	[p4l1140t2503r1177b2557],
7	'	''	DATE	'	_	0	SENT_95	[p4l1140t2503r1177b2557],
8	3	CD	DATE	3	dep	4	SENT_95	[p4l1140t2503r1177b2557],

1	rs	NNS	O	r	_	0	SENT_96	[p4l884t2668r907b2683],
2	11977388	CD	NUMBER	11977388	dep	1	SENT_96	[p4l916t2662r1039b2683],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_97	[p4l550t2600r585b2723],

1	In	IN	O	in	_	0	SENT_98	[p4l725t2665r740b2686],
2	.	.	O	.	_	0	SENT_98	[p4l755t2666r764b2686],

1	.	.	O	.	_	0	SENT_99	[p4l755t2666r764b2686],

1	.	.	O	.	_	0	SENT_100	[p4l1603t2603r1624b2755],

1	°	NN	O	°	_	0	SENT_101	[p4l1603t2603r1624b2755],
2	.	.	O	.	_	0	SENT_101	[p4l1603t2603r1624b2755],

1	°	NN	O	°	_	0	SENT_102	[p4l1603t2603r1624b2755],
2	.	.	O	.	_	0	SENT_102	[p4l1603t2603r1624b2755],

1	°	NN	O	°	_	0	SENT_103	[p4l1603t2603r1624b2755],
2	.	.	O	.	_	0	SENT_103	[p4l1603t2603r1624b2755],

1	°	NN	O	°	_	0	SENT_104	[p4l1603t2603r1624b2755],
2	.	.	O	.	_	0	SENT_104	[p4l1603t2603r1624b2755],

1	°	NN	O	°	_	0	SENT_105	[p4l1603t2603r1624b2755],
2	.	.	O	.	_	0	SENT_105	[p4l1603t2603r1624b2755],

1	°	NN	O	°	_	0	SENT_106	[p4l1603t2603r1624b2755],
2	99.99	CD	NUMBER	99.99	dobj	1	SENT_106	[p4l1577t2468r1624b2594],
3	.	.	O	.	_	0	SENT_106	[p4l1577t2468r1624b2594],
4	"	''	O	"	punct	1	SENT_106	[p4l1577t2468r1624b2594],

1	o-nouuor	NN	O	o-nouuor	nn	2	SENT_107	[p4l1632t2603r1647b2755],
2	m-taco	NN	O	m-taco	nsubj	3	SENT_107	[p4l1633t2467r1647b2594],
3	rs	VBZ	O	r	_	0	SENT_107	[p4l884t2909r907b2927],
4	4947492	CD	NUMBER	4947492	dobj	3	SENT_107	[p4l914t2905r1024b2927],

1	.	.	O	.	_	0	SENT_108	[p4l654t3002r728b3028],

1	—	NN	O	—	_	0	SENT_109	[p4l654t3002r728b3028],
2	.	.	O	.	_	0	SENT_109	[p4l654t3002r728b3028],

1	O	NN	O	o	nn	2	SENT_110	[p4l654t3002r728b3028],
2	MSNP	NN	O	msnp	_	0	SENT_110	[p4l752t3004r831b3026],
3	—	SYM	O	—	dep	6	SENT_110	[p4l653t3036r725b3062],
4	-	:	O	-	_	0	SENT_110	[p4l653t3036r725b3062],
5	I	PRP	O	I	nsubj	6	SENT_110	[p4l653t3036r725b3062],
6	CA-SSR	VBP	O	ca-ssr	dep	2	SENT_110	[p4l750t3039r853b3061],
7	—	CD	NUMBER	—	num	8	SENT_110	[p4l655t3072r725b3099],
8	|	CD	NUMBER	|	dobj	6	SENT_110	[p4l655t3072r725b3099],
9	:	:	O	:	_	0	SENT_110	[p4l655t3072r725b3099],
10	|	CD	NUMBER	|	num	13	SENT_110	[p4l655t3072r725b3099],
11	rs229334T	NN	O	rs229334t	nn	13	SENT_110	[p4l752t3074r893b3097],
12	j	NN	O	j	nn	13	SENT_110	[p4l652t3113r725b3135],
13	soqueced-region	NN	O	soqueced-region	dobj	6	SENT_110	[p4l751t3111r958b3137],

1	\	NN	O	\	nn	2	SENT_111	[p4l722t3160r848b3250],
2	J	NN	O	j	_	0	SENT_111	[p4l722t3160r848b3250],
3	_	IN	O	_	dep	2	SENT_111	[p4l722t3160r848b3250],

1	Fig	NN	O	fig	_	0	SENT_112	[p4l6t3294r51b3321],
2	.	.	O	.	_	0	SENT_112	[p4l6t3294r51b3321],

1	1	LS	NUMBER	1	_	0	SENT_113	[p4l59t3295r78b3316],
2	.	.	O	.	_	0	SENT_113	[p4l59t3295r78b3316],

1	The	DT	O	the	det	3	SENT_114	[p4l93t3294r138b3316],
2	genomic	JJ	O	genomic	amod	3	SENT_114	[p4l146t3295r253b3321],
3	organization	NN	O	organization	_	0	SENT_114	[p4l260t3294r417b3321],
4	and	CC	O	and	_	0	SENT_114	[p4l425t3294r470b3316],
5	candidate	NN	O	candidate	conj_and	3	SENT_114	[p4l478t3294r600b3316],
6	polymorphic	JJ	O	polymorphic	amod	7	SENT_114	[p4l608t3294r767b3321],
7	loci	NNS	O	locus	dep	3	SENT_114	[p4l775t3294r818b3316],
8	or	CC	O	or	_	0	SENT_114	[p4l826t3300r852b3316],
9	region	NN	O	region	dep	3	SENT_114	[p4l860t3295r938b3321],
10	of	IN	O	of	_	0	SENT_114	[p4l946t3294r972b3316],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_114	[p4l976t3295r1037b3316],
12	gene	NN	O	gene	prep_of	3	SENT_114	[p4l1045t3300r1109b3321],
13	.	.	O	.	_	0	SENT_114	[p4l1045t3300r1109b3321],

1	(	NN	O	(	nn	2	SENT_115	[p4l1118t3294r1154b3321],
2	A	NN	O	a	_	0	SENT_115	[p4l1118t3294r1154b3321],
3	)	CD	NUMBER	)	num	5	SENT_115	[p4l1118t3294r1154b3321],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_115	[p4l1161t3295r1223b3316],
5	gene	NN	O	gene	dep	2	SENT_115	[p4l1230t3300r1288b3321],
6	located	JJ	O	located	amod	5	SENT_115	[p4l1297t3294r1386b3316],
7	in	IN	O	in	_	0	SENT_115	[p4l1395t3295r1418b3315],
8	chromosome	NN	O	chromosome	nn	9	SENT_115	[p4l1426t3294r1588b3316],
9	7p12	NN	O	7p12	prep_in	6	SENT_115	[p4l1596t3295r1663b3321],
10	.	.	O	.	_	0	SENT_115	[p4l1596t3295r1663b3321],

1	(	NN	O	(	nn	2	SENT_116	[p4l1671t3294r1706b3321],
2	B	NN	O	b	nsubj	8	SENT_116	[p4l1671t3294r1706b3321],
3	)	CD	NUMBER	)	num	6	SENT_116	[p4l1671t3294r1706b3321],
4	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_116	[p4l1713t3295r1775b3316],
5	gene	NN	O	gene	nn	6	SENT_116	[p4l1782t3300r1840b3321],
6	structure	NN	O	structure	dep	2	SENT_116	[p4l1849t3297r1962b3316],
7	and	CC	O	and	cc	8	SENT_116	[p4l1970t3294r2015b3316],
8	genotyped	VBN	O	genotype	_	0	SENT_116	[p4l2022t3294r2154b3321],
9	polymorphic	JJ	O	polymorphic	amod	10	SENT_116	[p4l6t3330r166b3356],
10	loci	NNS	O	locus	dobj	8	SENT_116	[p4l176t3330r218b3351],
11	or	CC	O	or	_	0	SENT_116	[p4l229t3336r254b3351],
12	region	NN	O	region	conj_or	10	SENT_116	[p4l264t3330r348b3356],
13	.	.	O	.	_	0	SENT_116	[p4l264t3330r348b3356],

1	The	DT	O	the	det	2	SENT_117	[p4l357t3330r403b3351],
2	candidate	NN	O	candidate	nsubj	5	SENT_117	[p4l413t3330r534b3351],
3	polymorphic	JJ	O	polymorphic	amod	4	SENT_117	[p4l545t3330r704b3356],
4	loci	NNS	O	locus	dep	2	SENT_117	[p4l714t3330r756b3351],
5	included	VBD	O	include	_	0	SENT_117	[p4l767t3330r875b3351],
6	4	CD	NUMBER	4	num	9	SENT_117	[p4l884t3331r899b3351],
7	representative	JJ	O	representative	amod	9	SENT_117	[p4l909t3330r1088b3356],
8	tag	NN	O	tag	nn	9	SENT_117	[p4l1098t3333r1136b3356],
9	SNPs	NNS	O	snp	dobj	5	SENT_117	[p4l1146t3331r1206b3351],
10	and	CC	O	and	_	0	SENT_117	[p4l1216t3330r1261b3351],
11	one	CD	NUMBER	one	num	18	SENT_117	[p4l1272t3336r1316b3351],
12	well-known	JJ	O	well-known	amod	18	SENT_117	[p4l1326t3330r1476b3351],
13	CA	NNP	O	CA	nn	18	SENT_117	[p4l1486t3331r1520b3351],
14	simple	JJ	O	simple	amod	18	SENT_117	[p4l1529t3330r1612b3356],
15	sequence	NN	O	sequence	nn	18	SENT_117	[p4l1622t3336r1737b3356],
16	repeat	NN	O	repeat	nn	18	SENT_117	[p4l1747t3333r1826b3356],
17	(	CD	NUMBER	(	num	18	SENT_117	[p4l1835t3330r1900b3356],
18	SSR	NN	O	ssr	dep	20	SENT_117	[p4l1835t3330r1900b3356],
19	)	CD	NUMBER	)	num	20	SENT_117	[p4l1835t3330r1900b3356],
20	polymorphism	NN	O	polymorphism	conj_and	5	SENT_117	[p4l1910t3330r2099b3356],
21	.	.	O	.	_	0	SENT_117	[p4l1910t3330r2099b3356],

1	The	DT	O	the	det	2	SENT_118	[p4l2109t3330r2154b3351],
2	region	NN	O	region	nsubjpass	12	SENT_118	[p4l6t3365r85b3392],
3	encoding	VBG	O	encode	partmod	2	SENT_118	[p4l94t3365r208b3392],
4	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_118	[p4l217t3366r282b3386],
5	tyrosine	NN	O	tyrosine	nn	7	SENT_118	[p4l290t3365r391b3392],
6	kinase	NN	O	kinase	nn	7	SENT_118	[p4l401t3365r480b3386],
7	domain	NN	O	domain	dobj	3	SENT_118	[p4l489t3365r584b3386],
8	and	CC	O	and	_	0	SENT_118	[p4l593t3365r638b3386],
9	intron/exon	NN	O	intron/exon	nn	10	SENT_118	[p4l648t3365r794b3392],
10	border	NN	O	border	dobj	3	SENT_118	[p4l803t3365r886b3386],
11	were	VBD	O	be	auxpass	12	SENT_118	[p4l894t3371r956b3386],
12	chosen	VBN	O	choose	_	0	SENT_118	[p4l965t3365r1052b3386],
13	for	IN	O	for	_	0	SENT_118	[p4l1061t3365r1096b3386],
14	sequencing	NN	O	sequencing	prep_for	12	SENT_118	[p4l1105t3365r1251b3392],
15	.	.	O	.	_	0	SENT_118	[p4l1105t3365r1251b3392],

1	(	NN	O	(	nsubj	2	SENT_119	[p4l1261t3365r1295b3392],
2	C	NN	O	c	_	0	SENT_119	[p4l1261t3365r1295b3392],
3	)	CD	NUMBER	)	dobj	2	SENT_119	[p4l1261t3365r1295b3392],
4	The	DT	O	the	det	7	SENT_119	[p4l1304t3365r1349b3386],
5	linkage	NN	O	linkage	nn	7	SENT_119	[p4l1359t3365r1448b3392],
6	disequilibrium	NN	O	disequilibrium	nn	7	SENT_119	[p4l1458t3365r1641b3392],
7	plot	NN	O	plot	dep	3	SENT_119	[p4l1650t3365r1699b3392],
8	of	IN	O	of	_	0	SENT_119	[p4l1707t3365r1733b3386],
9	EGFR	NN	ORGANIZATION	egfr	prep_of	7	SENT_119	[p4l1739t3366r1800b3386],
10	for	IN	O	for	_	0	SENT_119	[p4l1810t3365r1844b3386],
11	l-Ian	JJ	MISC	l-ian	amod	13	SENT_119	[p4l1853t3366r1902b3386],
12	Chinese	JJ	MISC	chinese	amod	13	SENT_119	[p4l1912t3365r2009b3386],
13	population	NN	O	population	prep_for	9	SENT_119	[p4l2018t3365r2154b3392],
14	using	VBG	O	use	xcomp	2	SENT_119	[p4l6t3401r73b3427],
15	HapMap	NNP	O	HapMap	nn	18	SENT_119	[p4l81t3402r186b3427],
16	Phase	NN	O	phase	nn	18	SENT_119	[p4l195t3400r266b3422],
17	II	CD	NUMBER	ii	num	18	SENT_119	[p4l275t3402r289b3422],
18	data	NNS	O	datum	dobj	14	SENT_119	[p4l298t3400r357b3422],
19	.	.	O	.	_	0	SENT_119	[p4l298t3400r357b3422],

1	LD	NN	O	ld	nn	2	SENT_120	[p4l367t3402r398b3422],
2	plots	NNS	O	plot	nsubjpass	4	SENT_120	[p4l407t3401r466b3427],
3	were	VBD	O	be	auxpass	4	SENT_120	[p4l475t3407r536b3422],
4	identiﬁed	VBN	O	identiﬁed	_	0	SENT_120	[p4l545t3400r665b3422],
5	by	IN	O	by	_	0	SENT_120	[p4l673t3401r703b3427],
6	strong	JJ	O	strong	amod	7	SENT_120	[p4l711t3404r790b3427],
7	LD	NN	O	ld	agent	4	SENT_120	[p4l798t3402r835b3422],
8	.	.	O	.	_	0	SENT_120	[p4l798t3402r835b3422],

1	116	CD	NUMBER	116	num	3	SENT_121	[p4l6t3503r51b3524],
2	F.	NNP	O	F.	nn	3	SENT_121	[p4l819t3503r834b3524],
3	Ma	NNP	O	Ma	_	0	SENT_121	[p4l843t3503r881b3524],
4	et	FW	O	et	nn	5	SENT_121	[p4l890t3505r913b3524],
5	al.	FW	O	al.	dep	3	SENT_121	[p4l920t3502r1030b3529],
6	/	:	O	/	punct	3	SENT_121	[p4l920t3502r1030b3529],
7	Lung	NN	O	lung	nn	8	SENT_121	[p4l920t3502r1030b3529],
8	Cancer	NN	O	cancer	dep	3	SENT_121	[p4l1037t3503r1120b3524],
9	66	CD	NUMBER	66	number	10	SENT_121	[p4l1127t3503r1157b3524],
10	(	CD	NUMBER	(	num	11	SENT_121	[p4l1164t3502r1245b3529],
11	2009	CD	DATE	2009	dep	8	SENT_121	[p4l1164t3502r1245b3529],
12	)	CD	NUMBER	)	number	13	SENT_121	[p4l1164t3502r1245b3529],
13	114-119	CD	NUMBER	114-119	num	11	SENT_121	[p4l1256t3503r1359b3524],

1	Table	NNP	O	Table	_	0	SENT_122	[p4l6t3582r76b3603],
2	1	CD	NUMBER	1	num	1	SENT_122	[p4l85t3583r97b3603],
3	Information	NNP	O	Information	dep	1	SENT_122	[p4l6t3617r156b3639],
4	and	CC	O	and	_	0	SENT_122	[p4l165t3617r211b3639],
5	genotyping	VBG	O	genotype	amod	6	SENT_122	[p4l219t3617r362b3644],
6	approach	NN	O	approach	conj_and	1	SENT_122	[p4l370t3617r486b3644],
7	of	IN	O	of	_	0	SENT_122	[p4l495t3617r521b3639],
8	some	DT	O	some	det	9	SENT_122	[p4l527t3623r593b3639],
9	polymorphisms	NNS	O	polymorphism	prep_of	6	SENT_122	[p4l602t3617r799b3644],
10	in	IN	O	in	_	0	SENT_122	[p4l809t3617r831b3639],
11	the	DT	O	the	det	13	SENT_122	[p4l840t3617r880b3639],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_122	[p4l888t3618r950b3639],
13	gene	NN	O	gene	prep_in	9	SENT_122	[p4l958t3623r1023b3644],
14	.	.	O	.	_	0	SENT_122	[p4l958t3623r1023b3644],

1	No.	NN	O	no.	_	0	SENT_123	[p4l6t3677r46b3697],
2	.	.	O	.	_	0	SENT_123	[p4l6t3677r46b3697],

1	Identity	NN	O	identity	nn	5	SENT_124	[p4l82t3675r181b3702],
2	Base	NN	O	base	nn	5	SENT_124	[p4l264t3677r320b3697],
3	change	NN	O	change	nn	5	SENT_124	[p4l328t3675r416b3702],
4	Location	NNP	O	Location	nn	5	SENT_124	[p4l453t3676r569b3697],
5	‘	NNP	O	‘	nsubj	6	SENT_124	[p4l453t3676r569b3697],
6	Position	NN	O	position	_	0	SENT_124	[p4l694t3676r795b3697],
7	PCR	NN	O	pcr	nn	8	SENT_124	[p4l892t3676r940b3697],
8	primers	NNS	O	primer	nsubj	9	SENT_124	[p4l948t3672r1057b3702],
9	”	VBP	O	”	ccomp	6	SENT_124	[p4l948t3672r1057b3702],
10	Tm	NN	O	tm	nn	11	SENT_124	[p4l1904t3677r1934b3701],
11	Endonuclease	NN	O	endonuclease	dobj	9	SENT_124	[p4l6t3711r179b3733],

1	1	CD	NUMBER	1	num	2	SENT_125	[p5l6t39r16b59],
2	rs4947492	NN	O	rs4947492	_	0	SENT_125	[p5l81t39r212b60],
3	A	DT	O	a	det	5	SENT_125	[p5l262t39r280b59],
4	>	JJR	O	>	amod	5	SENT_125	[p5l286t43r299b56],
5	G	NN	O	g	dep	2	SENT_125	[p5l305t39r323b60],
6	101022	CD	NUMBER	101022	dep	5	SENT_125	[p5l453t39r540b60],
7	Intron	NNP	O	Intron	dep	2	SENT_125	[p5l693t39r770b60],
8	1	CD	NUMBER	1	number	9	SENT_125	[p5l780t39r790b59],
9	5	CD	NUMBER	5	num	10	SENT_125	[p5l891t39r1413b66],
10	’	NN	O	’	dep	7	SENT_125	[p5l891t39r1413b66],
11	.	.	O	.	_	0	SENT_125	[p5l891t39r1413b66],

1	—	NN	O	—	_	0	SENT_126	[p5l891t39r1413b66],
2	.	.	O	.	_	0	SENT_126	[p5l891t39r1413b66],

1	GAAGTGGAGATAGTCACATA'ITAG	NN	O	gaagtggagatagtcacata'itag	nn	2	SENT_127	[p5l891t39r1413b66],
2	§	NN	O	§	nsubj	3	SENT_127	[p5l891t39r1413b66],
3	C	NN	O	c	_	0	SENT_127	[p5l891t39r1413b66],
4	.	.	O	.	_	0	SENT_127	[p5l891t39r1413b66],

1	—	NN	O	—	_	0	SENT_128	[p5l891t39r1413b66],
2	.	.	O	.	_	0	SENT_128	[p5l891t39r1413b66],

1	3	CD	NUMBER	3	num	2	SENT_129	[p5l891t39r1413b66],
2	’	NN	O	’	_	0	SENT_129	[p5l891t39r1413b66],
3	;	:	O	;	_	0	SENT_129	[p5l891t39r1413b66],
4	5	CD	NUMBER	5	num	5	SENT_129	[p5l1424t39r1865b60],
5	’	NN	O	’	dep	2	SENT_129	[p5l1424t39r1865b60],
6	.	.	O	.	_	0	SENT_129	[p5l1424t39r1865b60],

1	—	NN	O	—	_	0	SENT_130	[p5l1424t39r1865b60],
2	.	.	O	.	_	0	SENT_130	[p5l1424t39r1865b60],

1	TGACCAAGAGCACTCTACACAG	NN	O	tgaccaagagcactctacacag	_	0	SENT_131	[p5l1424t39r1865b60],
2	.	.	O	.	_	0	SENT_131	[p5l1424t39r1865b60],

1	—	NN	O	—	_	0	SENT_132	[p5l1424t39r1865b60],
2	.	.	O	.	_	0	SENT_132	[p5l1424t39r1865b60],

1	3	CD	NUMBER	3	num	2	SENT_133	[p5l1424t39r1865b60],
2	’	NN	O	’	dep	10	SENT_133	[p5l1424t39r1865b60],
3	63	CD	NUMBER	63	num	6	SENT_133	[p5l1902t39r1931b60],
4	“	NN	O	“	nn	6	SENT_133	[p5l1939t39r1965b60],
5	C	NN	O	c	nn	6	SENT_133	[p5l1939t39r1965b60],
6	Bgl	NN	O	bgl	dep	2	SENT_133	[p5l2000t38r2038b65],
7	I	PRP	O	I	dep	10	SENT_133	[p5l2046t39r2052b59],
8	2	CD	NUMBER	2	num	10	SENT_133	[p5l2062t39r2075b59],
9	rs11977388	NN	O	rs11977388	nn	10	SENT_133	[p5l6t74r148b95],
10	T	NN	O	t	dep	16	SENT_133	[p5l186t75r220b95],
11	>	JJR	O	>	amod	12	SENT_133	[p5l186t75r220b95],
12	C	NN	O	c	dep	10	SENT_133	[p5l227t74r242b95],
13	145276	CD	NUMBER	145276	num	14	SENT_133	[p5l377t74r466b95],
14	Intron	NNP	O	Intron	dep	12	SENT_133	[p5l617t75r695b95],
15	14	CD	NUMBER	14	num	14	SENT_133	[p5l704t74r732b95],
16	5	CD	NUMBER	5	_	0	SENT_133	[p5l815t74r1122b95],
17	’	SYM	O	’	dep	19	SENT_133	[p5l815t74r1122b95],
18	-	:	O	-	_	0	SENT_133	[p5l815t74r1122b95],
19	TCAATATCGCCAATFAI	NN	O	tcaatatcgccaatfaus	dep	16	SENT_133	[p5l815t74r1122b95],
20	I	PRP	O	I	nsubj	30	SENT_133	[p5l1149t75r1153b95],
21	AATGQC-3	NN	O	aatgqc-3	nn	22	SENT_133	[p5l1173t74r1318b102],
22	’	NN	O	’	dep	20	SENT_133	[p5l1173t74r1318b102],
23	;	:	O	;	_	0	SENT_133	[p5l1173t74r1318b102],
24	5	CD	NUMBER	5	dep	22	SENT_133	[p5l1329t74r1438b95],
25	’	SYM	O	’	dep	22	SENT_133	[p5l1329t74r1438b95],
26	-	:	O	-	_	0	SENT_133	[p5l1329t74r1438b95],
27	TGTGI	NN	O	tgtgus	dep	29	SENT_133	[p5l1329t74r1438b95],
28	I	PRP	O	I	dep	27	SENT_133	[p5l1449t75r1454b95],
29	I	PRP	O	I	dep	20	SENT_133	[p5l1464t75r1469b95],
30	IGAGGGATAGGCTGG3	VBP	O	igagggataggctgg3	rcmod	19	SENT_133	[p5l1480t74r1771b95],
31	’	CD	NUMBER	’	number	32	SENT_133	[p5l1480t74r1771b95],
32	58	CD	NUMBER	58	num	33	SENT_133	[p5l1827t74r1856b95],
33	“	NN	O	“	dobj	30	SENT_133	[p5l1863t74r1889b95],
34	C	NN	O	c	nn	35	SENT_133	[p5l1863t74r1889b95],
35	Msp	NN	O	msp	dep	43	SENT_133	[p5l1924t75r1975b101],
36	I	PRP	O	I	dep	35	SENT_133	[p5l1984t74r1990b95],
37	3	CD	NUMBER	3	num	39	SENT_133	[p5l2000t74r2013b95],
38	rS2075102	NN	O	rs2075102	nn	39	SENT_133	[p5l6t110r134b131],
39	C	NN	O	c	npadvmod	40	SENT_133	[p5l187t110r202b131],
40	>	JJR	O	>	amod	36	SENT_133	[p5l209t114r221b128],
41	A	DT	O	a	det	42	SENT_133	[p5l227t110r245b131],
42	166335	CD	NUMBER	166335	dep	43	SENT_133	[p5l377t110r467b131],
43	Intron	NNP	O	Intron	dep	33	SENT_133	[p5l618t110r695b131],
44	20	CD	NUMBER	20	num	43	SENT_133	[p5l703t110r733b131],
45	5	CD	NUMBER	5	num	46	SENT_133	[p5l815t110r1333b134],
46	’	NN	O	’	dep	43	SENT_133	[p5l815t110r1333b134],
47	.	.	O	.	_	0	SENT_133	[p5l815t110r1333b134],

1	—	NN	O	—	_	0	SENT_134	[p5l815t110r1333b134],
2	.	.	O	.	_	0	SENT_134	[p5l815t110r1333b134],

1	AGACl	NN	O	agacl	_	0	SENT_135	[p5l815t110r1333b134],
2	'	''	O	'	_	0	SENT_135	[p5l815t110r1333b134],
3	GTAATCTGCAT1	NN	O	gtaatctgcat1	dep	1	SENT_135	[p5l815t110r1333b134],
4	'	''	O	'	_	0	SENT_135	[p5l815t110r1333b134],
5	AGGTGCl	NN	O	aggtgcl	nn	7	SENT_135	[p5l815t110r1333b134],
6	'	''	O	'	_	0	SENT_135	[p5l815t110r1333b134],
7	GA	NN	O	ga	dep	3	SENT_135	[p5l815t110r1333b134],
8	.	.	O	.	_	0	SENT_135	[p5l815t110r1333b134],

1	—	NN	O	—	_	0	SENT_136	[p5l815t110r1333b134],
2	.	.	O	.	_	0	SENT_136	[p5l815t110r1333b134],

1	3	CD	NUMBER	3	num	2	SENT_137	[p5l815t110r1333b134],
2	’	NN	O	’	_	0	SENT_137	[p5l815t110r1333b134],
3	;	:	O	;	_	0	SENT_137	[p5l815t110r1333b134],
4	5	CD	NUMBER	5	num	5	SENT_137	[p5l1344t110r1756b131],
5	’	NN	O	’	dep	2	SENT_137	[p5l1344t110r1756b131],
6	.	.	O	.	_	0	SENT_137	[p5l1344t110r1756b131],

1	—	NN	O	—	_	0	SENT_138	[p5l1344t110r1756b131],
2	.	.	O	.	_	0	SENT_138	[p5l1344t110r1756b131],

1	ATGCCCAGGACl	NN	O	atgcccaggacl	_	0	SENT_139	[p5l1344t110r1756b131],
2	'	''	O	'	_	0	SENT_139	[p5l1344t110r1756b131],
3	GCAGAGTC	NNP	O	GCAGAGTC	dep	1	SENT_139	[p5l1344t110r1756b131],
4	.	.	O	.	_	0	SENT_139	[p5l1344t110r1756b131],

1	—	NN	O	—	_	0	SENT_140	[p5l1344t110r1756b131],
2	.	.	O	.	_	0	SENT_140	[p5l1344t110r1756b131],

1	3	CD	NUMBER	3	num	2	SENT_141	[p5l1344t110r1756b131],
2	’	NN	O	’	_	0	SENT_141	[p5l1344t110r1756b131],
3	57	CD	NUMBER	57	num	6	SENT_141	[p5l1827t110r1855b131],
4	°	NN	O	°	nn	6	SENT_141	[p5l1862t110r1889b131],
5	C	NN	O	c	nn	6	SENT_141	[p5l1862t110r1889b131],
6	Dde	NN	O	dde	dep	2	SENT_141	[p5l1925t109r1972b131],
7	I	PRP	O	I	dep	6	SENT_141	[p5l1981t110r1987b131],
8	4	CD	NUMBER	4	dep	2	SENT_141	[p5l2001t110r2016b130],
9	rs7809028	CD	NUMBER	rs7809028	num	10	SENT_141	[p5l6t156r139b177],
10	G	NN	O	g	dep	8	SENT_141	[p5l187t156r205b177],
11	>	JJR	O	>	dep	2	SENT_141	[p5l211t160r224b173],
12	A	DT	O	a	det	16	SENT_141	[p5l229t156r248b176],
13	—	CD	NUMBER	—	num	16	SENT_141	[p5l376t168r390b170],
14	Downstream	JJ	O	downstream	amod	16	SENT_141	[p5l618t156r779b177],
15	5	CD	NUMBER	5	num	16	SENT_141	[p5l815t145r1240b180],
16	’	NN	O	’	dep	11	SENT_141	[p5l815t145r1240b180],
17	.	.	O	.	_	0	SENT_141	[p5l815t145r1240b180],

1	—	NN	O	—	_	0	SENT_142	[p5l815t145r1240b180],
2	.	.	O	.	_	0	SENT_142	[p5l815t145r1240b180],

1	CATCAGAGAGTGGACCAGCA	NNP	O	CATCAGAGAGTGGACCAGCA	_	0	SENT_143	[p5l815t145r1240b180],
2	.	.	O	.	_	0	SENT_143	[p5l815t145r1240b180],

1	—	NN	O	—	_	0	SENT_144	[p5l815t145r1240b180],
2	.	.	O	.	_	0	SENT_144	[p5l815t145r1240b180],

1	3	CD	NUMBER	3	number	2	SENT_145	[p5l815t145r1240b180],
2	’	CD	NUMBER	’	num	3	SENT_145	[p5l815t145r1240b180],
3	_	NN	O	_	_	0	SENT_145	[p5l815t145r1240b180],
4	;	:	O	;	_	0	SENT_145	[p5l815t145r1240b180],
5	5	CD	NUMBER	5	num	6	SENT_145	[p5l1250t156r1668b177],
6	’	NN	O	’	dep	3	SENT_145	[p5l1250t156r1668b177],
7	.	.	O	.	_	0	SENT_145	[p5l1250t156r1668b177],

1	—	NN	O	—	_	0	SENT_146	[p5l1250t156r1668b177],
2	.	.	O	.	_	0	SENT_146	[p5l1250t156r1668b177],

1	AGCA'I	NN	O	agca'us	_	0	SENT_147	[p5l1250t156r1668b177],
2	'	''	O	'	_	0	SENT_147	[p5l1250t156r1668b177],
3	l'AGGGGTGGTGTGAG	NN	O	l'aggggtggtgtgag	dep	1	SENT_147	[p5l1250t156r1668b177],
4	.	.	O	.	_	0	SENT_147	[p5l1250t156r1668b177],

1	—	NN	O	—	_	0	SENT_148	[p5l1250t156r1668b177],
2	.	.	O	.	_	0	SENT_148	[p5l1250t156r1668b177],

1	3	CD	NUMBER	3	num	2	SENT_149	[p5l1250t156r1668b177],
2	’	NN	O	’	_	0	SENT_149	[p5l1250t156r1668b177],
3	68	CD	NUMBER	68	num	4	SENT_149	[p5l1827t156r1857b177],
4	°	NN	O	°	dep	2	SENT_149	[p5l1864t156r1890b177],
5	C	NN	O	c	nn	6	SENT_149	[p5l1864t156r1890b177],
6	BsmA	NN	O	bsma	dep	4	SENT_149	[p5l1925t156r1992b177],
7	I	PRP	O	I	dep	2	SENT_149	[p5l2001t156r2007b176],
8	5	CD	NUMBER	5	num	10	SENT_149	[p5l2017t156r2030b177],
9	rS2293347	NN	O	rs2293347	nn	10	SENT_149	[p5l6t191r137b212],
10	G	NN	O	g	dep	7	SENT_149	[p5l187t191r205b212],
11	>	JJR	O	>	dep	2	SENT_149	[p5l211t195r224b209],
12	A	DT	O	a	det	15	SENT_149	[p5l230t191r248b212],
13	181946	CD	NUMBER	181946	number	14	SENT_149	[p5l377t191r466b212],
14	(	CD	NUMBER	(	num	15	SENT_149	[p5l475t190r581b217],
15	D994D	NN	O	d994d	dep	11	SENT_149	[p5l475t190r581b217],
16	)	CD	NUMBER	)	num	17	SENT_149	[p5l475t190r581b217],
17	Exon	NNP	O	Exon	dep	2	SENT_149	[p5l618t191r678b212],
18	25	CD	NUMBER	25	num	17	SENT_149	[p5l687t191r716b212],
19	5	CD	NUMBER	5	num	20	SENT_149	[p5l815t191r1223b212],
20	’	NN	O	’	dep	17	SENT_149	[p5l815t191r1223b212],
21	.	.	O	.	_	0	SENT_149	[p5l815t191r1223b212],

1	—	NN	O	—	_	0	SENT_150	[p5l815t191r1223b212],
2	.	.	O	.	_	0	SENT_150	[p5l815t191r1223b212],

1	ATGAGGTAC1	NN	O	atgaggtac1	_	0	SENT_151	[p5l815t191r1223b212],
2	'	''	O	'	_	0	SENT_151	[p5l815t191r1223b212],
3	CGTCGGCATC	NNP	O	CGTCGGCATC	dep	1	SENT_151	[p5l815t191r1223b212],
4	.	.	O	.	_	0	SENT_151	[p5l815t191r1223b212],

1	—	NN	O	—	_	0	SENT_152	[p5l815t191r1223b212],
2	.	.	O	.	_	0	SENT_152	[p5l815t191r1223b212],

1	3	CD	NUMBER	3	num	2	SENT_153	[p5l815t191r1223b212],
2	’	NN	O	’	_	0	SENT_153	[p5l815t191r1223b212],
3	;	:	O	;	_	0	SENT_153	[p5l1228t196r1232b215],
4	5	CD	NUMBER	5	num	5	SENT_153	[p5l1243t191r1654b212],
5	’	NN	O	’	dep	2	SENT_153	[p5l1243t191r1654b212],
6	.	.	O	.	_	0	SENT_153	[p5l1243t191r1654b212],

1	—	NN	O	—	_	0	SENT_154	[p5l1243t191r1654b212],
2	.	.	O	.	_	0	SENT_154	[p5l1243t191r1654b212],

1	GAACCAAGGGGGA'IT	NN	O	gaaccaaggggga'it	_	0	SENT_155	[p5l1243t191r1654b212],
2	1	CD	NUMBER	1	dep	1	SENT_155	[p5l1243t191r1654b212],
3	'	''	O	'	_	0	SENT_155	[p5l1243t191r1654b212],
4	CA'IT	NNP	O	CA'IT	dep	2	SENT_155	[p5l1243t191r1654b212],
5	.	.	O	.	_	0	SENT_155	[p5l1243t191r1654b212],

1	—	NN	O	—	_	0	SENT_156	[p5l1243t191r1654b212],
2	.	.	O	.	_	0	SENT_156	[p5l1243t191r1654b212],

1	3	CD	NUMBER	3	num	2	SENT_157	[p5l1243t191r1654b212],
2	’	NN	O	’	_	0	SENT_157	[p5l1243t191r1654b212],
3	60	CD	NUMBER	60	num	6	SENT_157	[p5l1827t191r1857b212],
4	°	NN	O	°	nn	6	SENT_157	[p5l1863t191r1890b212],
5	C	NN	O	c	nn	6	SENT_157	[p5l1863t191r1890b212],
6	Tﬁ	NN	O	tﬁ	dep	2	SENT_157	[p5l1926t190r1955b217],
7	I	PRP	O	I	dep	6	SENT_157	[p5l1963t191r1969b212],
8	6	CD	NUMBER	6	num	9	SENT_157	[p5l1979t191r1993b212],
9	rs11543848	NN	O	rs11543848	dep	2	SENT_157	[p5l6t226r150b247],
10	A	DT	O	a	det	15	SENT_157	[p5l186t226r204b246],
11	>	JJR	O	>	dep	12	SENT_157	[p5l210t230r223b243],
12	G	NN	O	g	amod	15	SENT_157	[p5l229t226r247b247],
13	142285	CD	NUMBER	142285	number	14	SENT_157	[p5l377t226r467b247],
14	(	CD	NUMBER	(	num	15	SENT_157	[p5l477t225r547b252],
15	K521	NN	O	k521	dep	9	SENT_157	[p5l477t225r547b252],
16	R	NN	O	r	nn	18	SENT_157	[p5l552t225r577b252],
17	)	CD	NUMBER	)	num	18	SENT_157	[p5l552t225r577b252],
18	Exon	NNP	O	Exon	dep	2	SENT_157	[p5l617t226r678b247],
19	13	CD	NUMBER	13	number	20	SENT_157	[p5l688t226r714b247],
20	5	CD	NUMBER	5	num	21	SENT_157	[p5l815t226r1114b247],
21	’	NN	O	’	dep	18	SENT_157	[p5l815t226r1114b247],
22	.	.	O	.	_	0	SENT_157	[p5l815t226r1114b247],

1	—	NN	O	—	_	0	SENT_158	[p5l815t226r1114b247],
2	.	.	O	.	_	0	SENT_158	[p5l815t226r1114b247],

1	TGCTGTGACCCACTCT	NNP	MISC	TGCTGTGACCCACTCT	nn	2	SENT_159	[p5l815t226r1114b247],
2	GTCl	NNP	MISC	GTCl	poss	5	SENT_159	[p5l1115t226r1180b247],
3	'	POS	O	'	_	0	SENT_159	[p5l1115t226r1180b247],
4	-3	CD	NUMBER	-3	num	5	SENT_159	[p5l1179t226r1210b247],
5	’	NN	O	’	_	0	SENT_159	[p5l1179t226r1210b247],
6	;	:	O	;	_	0	SENT_159	[p5l1215t231r1219b250],
7	5	CD	NUMBER	5	num	8	SENT_159	[p5l1230t226r1651b247],
8	’	NN	O	’	dep	5	SENT_159	[p5l1230t226r1651b247],
9	.	.	O	.	_	0	SENT_159	[p5l1230t226r1651b247],

1	—	NN	O	—	_	0	SENT_160	[p5l1230t226r1651b247],
2	.	.	O	.	_	0	SENT_160	[p5l1230t226r1651b247],

1	CAACGCAAGGGGA'ITAAAGA	NN	O	caacgcaagggga'itaaaga	_	0	SENT_161	[p5l1230t226r1651b247],
2	.	.	O	.	_	0	SENT_161	[p5l1230t226r1651b247],

1	—	NN	O	—	_	0	SENT_162	[p5l1230t226r1651b247],
2	.	.	O	.	_	0	SENT_162	[p5l1230t226r1651b247],

1	3	CD	NUMBER	3	num	2	SENT_163	[p5l1230t226r1651b247],
2	’	NN	O	’	_	0	SENT_163	[p5l1230t226r1651b247],
3	63	CD	NUMBER	63	num	6	SENT_163	[p5l1827t226r1855b247],
4	“	NN	O	“	nn	6	SENT_163	[p5l1863t226r1889b247],
5	C	NN	O	c	nn	6	SENT_163	[p5l1863t226r1889b247],
6	Sty	NN	O	sty	dep	2	SENT_163	[p5l1924t226r1961b252],
7	I	PRP	O	I	dep	2	SENT_163	[p5l1970t226r1976b246],
8	3	CD	NUMBER	3	num	10	SENT_163	[p5l32t295r41b306],
9	Nucleotide	NN	MISC	nucleotide	nn	10	SENT_163	[p5l57t294r192b316],
10	location	NN	O	location	dep	7	SENT_163	[p5l201t294r302b316],
11	counting	VBG	O	count	partmod	2	SENT_163	[p5l311t294r422b321],
12	from	IN	O	from	_	0	SENT_163	[p5l430t294r490b316],
13	the	DT	O	the	det	15	SENT_163	[p5l498t294r538b316],
14	ATG	NN	ORGANIZATION	atg	nn	15	SENT_163	[p5l546t295r597b316],
15	codon	NN	O	codon	prep_from	11	SENT_163	[p5l606t294r682b316],
16	of	IN	O	of	_	0	SENT_163	[p5l691t294r717b316],
17	the	DT	O	the	det	19	SENT_163	[p5l722t294r762b316],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_163	[p5l770t295r832b316],
19	gene	NN	O	gene	prep_of	15	SENT_163	[p5l840t300r905b321],
20	.	.	O	.	_	0	SENT_163	[p5l840t300r905b321],

1	‘’	NN	O	‘’	nsubj	9	SENT_164	[p5l31t329r41b344],
2	The	DT	O	the	det	5	SENT_164	[p5l56t332r102b354],
3	underlined	VBN	O	underline	amod	5	SENT_164	[p5l111t332r406b354],
4	—	NN	O	—	nn	5	SENT_164	[p5l111t332r406b354],
5	nucleotides	NNS	O	nucleotide	nsubj	8	SENT_164	[p5l111t332r406b354],
6	were	VBD	O	be	cop	8	SENT_164	[p5l415t338r477b354],
7	mismatch	NN	O	mismatch	nn	8	SENT_164	[p5l486t332r610b354],
8	nucleotides	NNS	O	nucleotide	rcmod	1	SENT_164	[p5l619t332r763b354],
9	introduced	VBN	O	introduce	_	0	SENT_164	[p5l772t332r909b354],
10	to	TO	O	to	aux	11	SENT_164	[p5l918t335r942b354],
11	create	VB	O	create	xcomp	9	SENT_164	[p5l951t335r1027b354],
12	a	DT	O	a	det	14	SENT_164	[p5l1035t338r1048b354],
13	restriction	NN	O	restriction	nn	14	SENT_164	[p5l1057t332r1187b354],
14	enzyme	NN	O	enzyme	dobj	11	SENT_164	[p5l1195t338r1294b359],
15	recognizing	VBG	O	recognize	xcomp	11	SENT_164	[p5l1303t332r1450b359],
16	site	NN	O	site	dobj	15	SENT_164	[p5l1458t332r1507b354],
17	.	.	O	.	_	0	SENT_164	[p5l1458t332r1507b354],

1	response	NN	O	response	nsubjpass	8	SENT_165	[p5l12t514r296b566],
2	to	TO	O	to	_	0	SENT_165	[p5l318t506r378b552],
3	Geﬁtinib	NNP	PERSON	Geﬁtinib	prep_to	1	SENT_165	[p5l402t498r695b561],
4	,	,	O	,	_	0	SENT_165	[p5l402t498r695b561],
5	functional	JJ	O	functional	amod	6	SENT_165	[p5l718t498r1042b552],
6	SNPs	NNS	O	snp	appos	3	SENT_165	[p5l1065t501r1219b553],
7	was	VBD	O	be	auxpass	8	SENT_165	[p5l1241t514r1363b552],
8	addressed	VBN	O	address	_	0	SENT_165	[p5l1387t498r1709b552],
9	among	IN	O	among	_	0	SENT_165	[p5l1732t514r1951b566],
10	those	DT	O	those	det	11	SENT_165	[p5l1971t498r2144b553],
11	SNPs	NNS	O	snp	prep_among	8	SENT_165	[p5l12t588r165b640],
12	the	DT	O	the	det	14	SENT_165	[p5l191t586r292b640],
13	tag	NN	O	tag	nn	14	SENT_165	[p5l317t594r415b653],
14	SNPs	NNS	O	snp	nsubj	15	SENT_165	[p5l438t588r592b640],
15	represent	VBP	O	represent	rcmod	11	SENT_165	[p5l619t594r938b653],
16	.	.	O	.	_	0	SENT_165	[p5l619t594r938b653],

1	SNPs	NNS	O	snp	nsubjpass	43	SENT_166	[p5l965t588r1118b640],
2	in	IN	O	in	_	0	SENT_166	[p5l1144t587r1204b639],
3	the	DT	O	the	det	8	SENT_166	[p5l1228t586r1329b640],
4	most	RBS	O	most	advmod	5	SENT_166	[p5l1354t594r1513b640],
5	important	JJ	O	important	amod	8	SENT_166	[p5l1537t586r1861b653],
6	tyrosine	NN	O	tyrosine	nn	8	SENT_166	[p5l1884t586r2144b653],
7	kinase	NN	O	kinase	nn	8	SENT_166	[p5l12t673r214b727],
8	domain	NN	O	domain	prep_in	1	SENT_166	[p5l237t673r480b727],
9	of	IN	O	of	_	0	SENT_166	[p5l502t672r568b727],
10	EGFR	NN	ORGANIZATION	egfr	prep_of	8	SENT_166	[p5l580t675r738b727],
11	(	CD	NUMBER	(	num	12	SENT_166	[p5l760t673r966b740],
12	exons	NNS	O	exon	dep	10	SENT_166	[p5l760t673r966b740],
13	18-21	CD	NUMBER	18-21	dep	10	SENT_166	[p5l993t675r1172b727],
14	and	CC	O	and	_	0	SENT_166	[p5l1203t673r1319b727],
15	their	PRP$	O	they	poss	17	SENT_166	[p5l1341t673r1495b727],
16	exon/intron	JJ	O	exon/intron	amod	17	SENT_166	[p5l1515t672r1891b740],
17	boundaries	NNS	O	boundary	conj_and	10	SENT_166	[p5l1912t673r2144b727, p5l11t760r187b827],
18	)	CD	NUMBER	)	num	22	SENT_166	[p5l1912t673r2144b727, p5l11t760r187b827],
19	and	CC	O	and	_	0	SENT_166	[p5l222t760r338b814],
20	two	CD	NUMBER	two	conj_and	18	SENT_166	[p5l372t768r492b814],
21	well-studied	JJ	O	well-studied	amod	22	SENT_166	[p5l526t760r931b814],
22	polymorphisms	NNS	O	polymorphism	dep	17	SENT_166	[p5l967t760r1486b827],
23	,	,	O	,	_	0	SENT_166	[p5l967t760r1486b827],
24	CA-SSR	NN	O	ca-ssr	conj_and	8	SENT_166	[p5l1521t762r1754b814],
25	in	IN	O	in	_	0	SENT_166	[p5l1786t761r1845b813],
26	intron	NN	O	intron	prep_in	24	SENT_166	[p5l1879t761r2075b814],
27	1	CD	NUMBER	1	num	26	SENT_166	[p5l2112t763r2136b813],
28	and	CC	O	and	_	0	SENT_166	[p5l11t846r127b900],
29	rs11543848	CD	NUMBER	rs11543848	conj_and	8	SENT_166	[p5l171t849r540b900],
30	(	CD	NUMBER	(	num	32	SENT_166	[p5l585t846r830b913],
31	R521l	NN	O	r521l	nn	32	SENT_166	[p5l585t846r830b913],
32	(	NN	O	(	dep	29	SENT_166	[p5l585t846r830b913],
33	,	,	O	,	_	0	SENT_166	[p5l585t846r830b913],
34	also	RB	O	also	advmod	29	SENT_166	[p5l875t846r999b900],
35	assigned	VBN	O	assign	partmod	1	SENT_166	[p5l1042t846r1318b914],
36	as	IN	O	as	_	0	SENT_166	[p5l1362t862r1424b900],
37	R497K	NN	O	r497k	prep_as	35	SENT_166	[p5l1469t849r1677b900],
38	in	IN	O	in	_	0	SENT_166	[p5l1719t847r1778b900],
39	literature	NN	O	literature	nn	40	SENT_166	[p5l1821t846r2144b913],
40	)	NN	O	)	prep_in	37	SENT_166	[p5l1821t846r2144b913],
41	were	VBD	O	be	auxpass	43	SENT_166	[p5l10t949r167b987],
42	also	RB	O	also	advmod	43	SENT_166	[p5l199t933r323b987],
43	included	VBN	O	include	_	0	SENT_166	[p5l355t933r632b987],
44	(	CD	NUMBER	(	num	45	SENT_166	[p5l664t933r796b1001],
45	Fig	NN	O	fig	dobj	43	SENT_166	[p5l664t933r796b1001],
46	.	.	O	.	_	0	SENT_166	[p5l664t933r796b1001],

1	1	CD	NUMBER	1	_	0	SENT_167	[p5l831t933r905b1001],
2	)	NN	O	)	dep	1	SENT_167	[p5l831t933r905b1001],
3	.	.	O	.	_	0	SENT_167	[p5l831t933r905b1001],

1	The	DT	O	the	det	2	SENT_168	[p5l935t933r1052b987],
2	genotypes	NNS	O	genotype	nsubjpass	12	SENT_168	[p5l1082t941r1409b1001],
3	of	IN	O	of	_	0	SENT_168	[p5l1442t933r1508b987],
4	SNPs	NNS	O	snp	prep_of	2	SENT_168	[p5l1532t936r1686b987],
5	in	IN	O	in	_	0	SENT_168	[p5l1719t934r1778b987],
6	the	DT	O	the	det	8	SENT_168	[p5l1808t933r1909b987],
7	kinase	NN	O	kinase	nn	8	SENT_168	[p5l1942t933r2144b987],
8	domain	NN	O	domain	prep_in	4	SENT_168	[p5l11t1020r254b1074],
9	and	CC	O	and	_	0	SENT_168	[p5l288t1020r404b1074],
10	CA-SSR	NN	O	ca-ssr	prep_in	4	SENT_168	[p5l438t1023r671b1075],
11	were	VBD	O	be	auxpass	12	SENT_168	[p5l700t1036r858b1074],
12	determined	VBN	O	determine	_	0	SENT_168	[p5l892t1020r1265b1074],
13	by	IN	O	by	_	0	SENT_168	[p5l1299t1020r1375b1088],
14	DNA-sequencing	NN	O	dna-sequencing	agent	12	SENT_168	[p5l1407t1021r1945b1088],
15	in	IN	O	in	_	0	SENT_168	[p5l1978t1021r2037b1074],
16	an	DT	O	a	det	19	SENT_168	[p5l2070t1036r2145b1074],
17	ABI	NNP	O	ABI	nn	19	SENT_168	[p5l9t1110r116b1161],
18	3730	CD	NUMBER	3730	num	19	SENT_168	[p5l146t1110r300b1162],
19	system	NN	O	system	prep_in	14	SENT_168	[p5l331t1116r568b1175],
20	.	.	O	.	_	0	SENT_168	[p5l331t1116r568b1175],

1	Polymerase	NN	MISC	polymerase	nn	10	SENT_169	[p5l599t1108r967b1175],
2	chain	NN	O	chain	nn	10	SENT_169	[p5l997t1108r1168b1162],
3	reaction	NN	O	reaction	nn	10	SENT_169	[p5l1198t1108r1823b1162],
4	—	NN	O	—	nn	10	SENT_169	[p5l1198t1108r1823b1162],
5	restriction	NN	O	restriction	nn	10	SENT_169	[p5l1198t1108r1823b1162],
6	fragment	NN	O	fragment	nn	10	SENT_169	[p5l1853t1107r2146b1175],
7	length	NN	O	length	nn	10	SENT_169	[p5l12t1195r215b1262],
8	polymorphism	NN	O	polymorphism	nn	10	SENT_169	[p5l230t1195r703b1262],
9	(	NN	O	(	nn	10	SENT_169	[p5l718t1195r1070b1262],
10	PCR-RFLP	NN	O	pcr-rflp	nsubjpass	14	SENT_169	[p5l718t1195r1070b1262],
11	)	CD	NUMBER	)	num	12	SENT_169	[p5l718t1195r1070b1262],
12	methods	NNS	O	method	dep	10	SENT_169	[p5l1087t1195r1364b1249],
13	were	VBD	O	be	auxpass	14	SENT_169	[p5l1379t1211r1536b1249],
14	established	VBN	O	establish	_	0	SENT_169	[p5l1552t1195r1914b1249],
15	to	TO	O	to	aux	16	SENT_169	[p5l1929t1203r1989b1249],
16	analyze	VB	O	analyze	xcomp	14	SENT_169	[p5l2005t1211r2144b1249, p5l12t1281r137b1349],
17	other	JJ	O	other	amod	19	SENT_169	[p5l160t1281r331b1335],
18	candidate	NN	O	candidate	nn	19	SENT_169	[p5l352t1281r663b1335],
19	SNPS	NN	O	snp	dobj	16	SENT_169	[p5l686t1284r840b1335],
20	(	CD	NUMBER	(	num	21	SENT_169	[p5l864t1281r1056b1348],
21	Table	NNP	O	Table	dep	19	SENT_169	[p5l864t1281r1056b1348],
22	1	CD	NUMBER	1	num	21	SENT_169	[p5l1082t1284r1134b1344],
23	;	:	O	;	_	0	SENT_169	[p5l1082t1284r1134b1344],
24	Supplementary	NNP	O	Supplementary	nn	25	SENT_169	[p5l1162t1281r1656b1349],
25	Table	NNP	O	Table	dep	19	SENT_169	[p5l1674t1281r1842b1335],
26	1	CD	NUMBER	1	number	27	SENT_169	[p5l1868t1284r1893b1335],
27	)	CD	NUMBER	)	dep	25	SENT_169	[p5l1909t1281r1942b1348],
28	.	.	O	.	_	0	SENT_169	[p5l1909t1281r1942b1348],

1	2.3	CD	NUMBER	2.3	_	0	SENT_170	[p5l7t1463r113b1515],
2	.	.	O	.	_	0	SENT_170	[p5l7t1463r113b1515],

1	Statistical	JJ	O	statistical	amod	2	SENT_171	[p5l161t1460r463b1515],
2	analysis	NN	O	analysis	_	0	SENT_171	[p5l484t1460r729b1528],

1	X2-Test	NN	O	x2-test	nsubjpass	3	SENT_172	[p5l114t1628r347b1706],
2	was	VBD	O	be	auxpass	3	SENT_172	[p5l398t1653r521b1692],
3	used	VBN	O	use	_	0	SENT_172	[p5l578t1637r725b1692],
4	to	TO	O	to	aux	5	SENT_172	[p5l781t1645r841b1692],
5	compare	VB	O	compare	xcomp	3	SENT_172	[p5l897t1653r1174b1705],
6	clinical	JJ	O	clinical	amod	7	SENT_172	[p5l1230t1637r1456b1692],
7	characteristics	NNS	O	characteristic	dobj	5	SENT_172	[p5l1511t1637r1972b1692],
8	and	CC	O	and	_	0	SENT_172	[p5l2028t1637r2144b1692],
9	response	NN	O	response	dobj	5	SENT_172	[p5l12t1740r296b1792],
10	according	VBG	O	accord	_	0	SENT_172	[p5l329t1725r642b1792],
11	to	TO	O	to	prepc_according_to	5	SENT_172	[p5l672t1733r732b1779],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_172	[p5l764t1728r922b1779],
13	genotypes	NNS	O	genotype	pobj	5	SENT_172	[p5l952t1733r1295b1792],
14	.	.	O	.	_	0	SENT_172	[p5l952t1733r1295b1792],

1	A	DT	O	a	det	2	SENT_173	[p5l1327t1727r1374b1778],
2	Fisher	NNP	O	Fisher	poss	5	SENT_173	[p5l1404t1725r1642b1779],
3	's	POS	O	's	_	0	SENT_173	[p5l1404t1725r1642b1779],
4	exact	JJ	O	exact	amod	5	SENT_173	[p5l1676t1733r1844b1779],
5	test	NN	O	test	nsubjpass	7	SENT_173	[p5l1874t1733r1991b1779],
6	was	VBD	O	be	auxpass	7	SENT_173	[p5l2021t1740r2143b1779],
7	used	VBN	O	use	_	0	SENT_173	[p5l11t1811r159b1865],
8	when	WRB	O	when	advmod	9	SENT_173	[p5l182t1811r362b1865],
9	necessary	JJ	O	necessary	advcl	7	SENT_173	[p5l386t1827r711b1879],
10	.	.	O	.	_	0	SENT_173	[p5l386t1827r711b1879],

1	Progression	NN	O	progression	nsubjpass	9	SENT_174	[p5l736t1811r1262b1879],
2	—	CD	NUMBER	—	number	3	SENT_174	[p5l736t1811r1262b1879],
3	free	JJ	O	free	dep	1	SENT_174	[p5l736t1811r1262b1879],
4	and	CC	O	and	_	0	SENT_174	[p5l1286t1811r1402b1865],
5	overall	JJ	O	overall	amod	7	SENT_174	[p5l1427t1811r1641b1865],
6	survival	NN	O	survival	nn	7	SENT_174	[p5l1666t1811r1915b1865],
7	curves	NNS	O	curve	conj_and	3	SENT_174	[p5l1939t1827r2144b1865],
8	were	VBD	O	be	auxpass	9	SENT_174	[p5l10t1914r167b1952],
9	drawn	VBN	O	draw	_	0	SENT_174	[p5l211t1898r413b1952],
10	with	IN	O	with	_	0	SENT_174	[p5l454t1898r602b1952],
11	the	DT	O	the	det	12	SENT_174	[p5l644t1898r745b1952],
12	Kaplan	NNP	PERSON	Kaplan	prep_with	9	SENT_174	[p5l789t1898r1241b1966],
13	.	.	O	.	_	0	SENT_174	[p5l789t1898r1241b1966],

1	—	NN	O	—	_	0	SENT_175	[p5l789t1898r1241b1966],
2	.	.	O	.	_	0	SENT_175	[p5l789t1898r1241b1966],

1	Meier	NNP	PERSON	Meier	nn	4	SENT_176	[p5l789t1898r1241b1966],
2	product	NN	O	product	nn	4	SENT_176	[p5l1282t1898r1532b1966],
3	limit	NN	O	limit	nn	4	SENT_176	[p5l1574t1898r1726b1952],
4	method	NN	O	method	_	0	SENT_176	[p5l1767t1898r2014b1952],
5	for	IN	O	for	_	0	SENT_176	[p5l2058t1898r2147b1952],
6	each	DT	O	each	prep_for	4	SENT_176	[p5l11t1985r156b2039],
7	of	IN	O	of	_	0	SENT_176	[p5l180t1985r246b2039],
8	the	DT	O	the	det	10	SENT_176	[p5l261t1985r362b2039],
9	different	JJ	O	different	amod	10	SENT_176	[p5l387t1985r664b2039],
10	genotypes	NNS	O	genotype	prep_of	6	SENT_176	[p5l686t1993r1029b2053],
11	.	.	O	.	_	0	SENT_176	[p5l686t1993r1029b2053],

1	Comparisons	NNS	MISC	comparison	nsubjpass	3	SENT_177	[p5l1054t1986r1469b2053],
2	were	VBD	O	be	auxpass	3	SENT_177	[p5l1492t2001r1650b2039],
3	made	VBN	O	make	_	0	SENT_177	[p5l1675t1985r1850b2039],
4	with	IN	O	with	_	0	SENT_177	[p5l1872t1985r2020b2039],
5	the	DT	O	the	det	6	SENT_177	[p5l2043t1985r2144b2039],
6	log	NN	O	log	prep_with	3	SENT_177	[p5l12t2073r283b2140],
7	—	CD	NUMBER	—	num	9	SENT_177	[p5l12t2073r283b2140],
8	rank	NN	O	rank	nn	9	SENT_177	[p5l12t2073r283b2140],
9	test	NN	O	test	dep	6	SENT_177	[p5l315t2081r446b2127],
10	.	.	O	.	_	0	SENT_177	[p5l315t2081r446b2127],

1	Hazard	NN	O	hazard	nn	2	SENT_178	[p5l481t2073r706b2127],
2	ratios	NNS	O	ratio	nsubjpass	14	SENT_178	[p5l742t2073r918b2127],
3	of	IN	O	of	_	0	SENT_178	[p5l954t2072r1020b2127],
4	both	DT	O	both	preconj	5	SENT_178	[p5l1046t2073r1191b2127],
5	progression	NN	O	progression	prep_of	2	SENT_178	[p5l1226t2074r1600b2140],
6	and	CC	O	and	_	0	SENT_178	[p5l1634t2073r1750b2127],
7	death	NN	O	death	conj_and	5	SENT_178	[p5l1785t2073r1965b2127],
8	with	IN	O	with	_	0	SENT_178	[p5l1997t2073r2145b2127],
9	95	CD	PERCENT	95	number	10	SENT_178	[p5l11t2162r132b2214],
10	%	NN	PERCENT	%	amod	12	SENT_178	[p5l11t2162r132b2214],
11	conﬁdence	NN	O	conﬁdence	nn	12	SENT_178	[p5l159t2159r506b2214],
12	intervals	NNS	O	interval	prep_with	5	SENT_178	[p5l533t2160r808b2214],
13	were	VBD	O	be	auxpass	14	SENT_178	[p5l833t2175r991b2214],
14	estimated	VBN	O	estimate	_	0	SENT_178	[p5l1018t2160r1335b2214],
15	by	IN	O	by	_	0	SENT_178	[p5l1361t2160r1437b2227],
16	using	VBG	O	use	agent	14	SENT_178	[p5l1462t2160r1634b2227],
17	the	DT	O	the	det	19	SENT_178	[p5l1658t2160r1760b2214],
18	Cox	NN	ORGANIZATION	cox	nn	19	SENT_178	[p5l1787t2162r1903b2214],
19	model	NN	O	model	dobj	16	SENT_178	[p5l1928t2160r2144b2222],
20	,	,	O	,	_	0	SENT_178	[p5l1928t2160r2144b2222],
21	with	IN	O	with	_	0	SENT_178	[p5l10t2247r157b2301],
22	genotype	NN	O	genotype	prep_with	19	SENT_178	[p5l193t2255r505b2314],
23	,	,	O	,	_	0	SENT_178	[p5l193t2255r505b2314],
24	sex	NN	O	sex	prep_with	19	SENT_178	[p5l544t2263r660b2309],
25	,	,	O	,	_	0	SENT_178	[p5l544t2263r660b2309],
26	smoking	NN	O	smoking	nn	27	SENT_178	[p5l698t2247r972b2314],
27	status	NN	O	status	prep_with	19	SENT_178	[p5l1009t2255r1195b2301],
28	and	CC	O	and	_	0	SENT_178	[p5l1233t2247r1349b2301],
29	histological	JJ	O	histological	amod	30	SENT_178	[p5l1387t2247r1753b2314],
30	subtype	NN	O	subtype	conj_and	22	SENT_178	[p5l1792t2247r2044b2314],
31	as	IN	O	as	_	0	SENT_178	[p5l2081t2262r2144b2301],
32	covariates	NNS	O	covariate	prep_as	16	SENT_178	[p5l11t2335r348b2389],
33	.	.	O	.	_	0	SENT_178	[p5l11t2335r348b2389],

1	All	DT	O	all	det	3	SENT_179	[p5l371t2334r457b2388],
2	statistical	JJ	O	statistical	amod	3	SENT_179	[p5l483t2334r787b2388],
3	tests	NNS	O	test	nsubj	4	SENT_179	[p5l812t2342r957b2388],
4	are	VBP	O	be	_	0	SENT_179	[p5l983t2350r1079b2388],
5	two-sided	JJ	O	two-sided	amod	6	SENT_179	[p5l1104t2334r1428b2388],
6	tests	NNS	O	test	nsubjpass	12	SENT_179	[p5l1452t2342r1598b2388],
7	and	CC	O	and	_	0	SENT_179	[p5l1624t2334r1739b2388],
8	P	NN	O	p	nsubjpass	12	SENT_179	[p5l1762t2337r1846b2388],
9	<	JJR	O	<	dep	12	SENT_179	[p5l1762t2337r1846b2388],
10	0.05	CD	NUMBER	0.05	nsubjpass	12	SENT_179	[p5l1864t2337r1995b2389],
11	was	VBD	O	be	auxpass	12	SENT_179	[p5l2021t2350r2143b2388],
12	considered	VBN	O	consider	xcomp	4	SENT_179	[p5l11t2421r361b2475],
13	significance	NN	O	significance	dobj	12	SENT_179	[p5l400t2421r792b2489],
14	.	.	O	.	_	0	SENT_179	[p5l400t2421r792b2489],

1	The	DT	O	the	det	2	SENT_180	[p5l828t2421r945b2475],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_180	[p5l982t2421r1250b2489],
3	were	VBD	O	be	auxpass	4	SENT_180	[p5l1287t2437r1444b2475],
4	performed	VBN	O	perform	_	0	SENT_180	[p5l1483t2421r1822b2489],
5	with	IN	O	with	_	0	SENT_180	[p5l1859t2421r2006b2475],
6	the	DT	O	the	det	9	SENT_180	[p5l2043t2421r2144b2475],
7	SPSS	NNP	ORGANIZATION	SPSS	nn	9	SENT_180	[p5l12t2511r157b2562],
8	software	NN	O	software	nn	9	SENT_180	[p5l181t2508r457b2562],
9	package	NN	O	package	prep_with	4	SENT_180	[p5l480t2508r736b2576],
10	(	CD	NUMBER	(	num	11	SENT_180	[p5l759t2508r1028b2576],
11	Version	NNP	O	Version	dep	4	SENT_180	[p5l759t2508r1028b2576],
12	12.0	CD	NUMBER	12.0	num	11	SENT_180	[p5l1053t2511r1196b2571],
13	,	,	O	,	_	0	SENT_180	[p5l1053t2511r1196b2571],
14	SPSS	NNP	ORGANIZATION	SPSS	nn	15	SENT_180	[p5l1220t2511r1365b2562],
15	Inc.	NNP	ORGANIZATION	Inc.	appos	11	SENT_180	[p5l1389t2512r1514b2571],
16	,	,	O	,	_	0	SENT_180	[p5l1389t2512r1514b2571],
17	Chicago	NNP	LOCATION	Chicago	appos	11	SENT_180	[p5l1537t2508r1801b2576],
18	,	,	O	,	_	0	SENT_180	[p5l1537t2508r1801b2576],
19	IL	NN	LOCATION	il	nn	20	SENT_180	[p5l1825t2509r1918b2576],
20	)	NN	O	)	appos	11	SENT_180	[p5l1825t2509r1918b2576],
21	.	.	O	.	_	0	SENT_180	[p5l1825t2509r1918b2576],

1	3	LS	NUMBER	3	_	0	SENT_181	[p5l9t2695r66b2747],
2	.	.	O	.	_	0	SENT_181	[p5l9t2695r66b2747],

1	Results	NNS	O	result	_	0	SENT_182	[p5l112t2692r352b2746],

1	3.1	CD	NUMBER	3.1	_	0	SENT_183	[p5l8t2872r103b2924],
2	.	.	O	.	_	0	SENT_183	[p5l8t2872r103b2924],

1	Patient	NN	O	patient	nn	2	SENT_184	[p5l151t2870r372b2923],
2	characteristics	NNS	O	characteristic	_	0	SENT_184	[p5l390t2869r830b2923],
3	and	CC	O	and	_	0	SENT_184	[p5l852t2869r965b2923],
4	response	NN	O	response	conj_and	2	SENT_184	[p5l987t2885r1252b2937],
5	to	TO	O	to	_	0	SENT_184	[p5l1276t2877r1330b2923],
6	Geﬁtinib	JJ	O	geﬁtinib	amod	7	SENT_184	[p5l1354t2869r1612b2937],
7	treatment	NN	O	treatment	prep_to	2	SENT_184	[p5l1637t2877r1943b2923],

1	Patients	NNS	O	patient	nsubjpass	10	SENT_185	[p5l113t3047r384b3101],
2	’	CD	NUMBER	’	num	4	SENT_185	[p5l113t3047r384b3101],
3	baseline	NN	O	baseline	nn	4	SENT_185	[p5l413t3047r676b3101],
4	characteristics	NNS	O	characteristic	dep	1	SENT_185	[p5l705t3047r1165b3101],
5	and	CC	O	and	_	0	SENT_185	[p5l1195t3047r1311b3101],
6	response	NN	O	response	conj_and	1	SENT_185	[p5l1340t3062r1624b3114],
7	to	TO	O	to	_	0	SENT_185	[p5l1652t3055r1713b3101],
8	Geﬁtinib	NNP	O	Geﬁtinib	prep_to	6	SENT_185	[p5l1742t3046r2020b3101],
9	are	VBP	O	be	auxpass	10	SENT_185	[p5l2048t3062r2144b3101],
10	shown	VBN	O	show	_	0	SENT_185	[p5l12t3134r223b3188],
11	in	IN	O	in	_	0	SENT_185	[p5l248t3135r307b3187],
12	Table	NNP	O	Table	prep_in	10	SENT_185	[p5l328t3134r496b3188],
13	2	CD	NUMBER	2	num	12	SENT_185	[p5l522t3137r573b3188],
14	.	.	O	.	_	0	SENT_185	[p5l522t3137r573b3188],

1	Median	JJ	O	median	amod	2	SENT_186	[p5l599t3134r840b3188],
2	age	NN	O	age	nsubj	8	SENT_186	[p5l864t3150r970b3201],
3	of	IN	O	of	_	0	SENT_186	[p5l995t3134r1061b3188],
4	the	DT	O	the	det	5	SENT_186	[p5l1078t3134r1179b3188],
5	patients	NNS	O	patient	prep_of	2	SENT_186	[p5l1204t3135r1461b3201],
6	was	VBD	O	be	cop	8	SENT_186	[p5l1486t3150r1608b3188],
7	56	CD	DURATION	56	num	8	SENT_186	[p5l1635t3137r1710b3188],
8	years	NNS	NUMBER	year	_	0	SENT_186	[p5l1733t3150r1900b3201],
9	(	JJ	O	(	amod	10	SENT_186	[p5l1926t3134r2144b3201],
10	range	NN	O	range	attr	8	SENT_186	[p5l1926t3134r2144b3201],
11	,	,	O	,	_	0	SENT_186	[p5l1926t3134r2144b3201],
12	34-76	CD	NUMBER	34-76	num	13	SENT_186	[p5l10t3223r207b3274],
13	years	NNS	NUMBER	year	tmod	14	SENT_186	[p5l228t3220r438b3288],
14	)	RB	O	)	amod	10	SENT_186	[p5l228t3220r438b3288],
15	.	.	O	.	_	0	SENT_186	[p5l228t3220r438b3288],

1	Among	IN	O	among	_	0	SENT_187	[p5l458t3222r690b3288],
2	patients	NNS	O	patient	prep_among	10	SENT_187	[p5l712t3221r985b3288],
3	,	,	O	,	_	0	SENT_187	[p5l712t3221r985b3288],
4	female	JJ	O	female	nsubj	10	SENT_187	[p5l1009t3220r1239b3283],
5	,	,	O	,	_	0	SENT_187	[p5l1009t3220r1239b3283],
6	non-smoker	JJ	O	non-smoker	nsubj	10	SENT_187	[p5l1263t3220r1665b3283],
7	,	,	O	,	_	0	SENT_187	[p5l1263t3220r1665b3283],
8	and	CC	O	and	_	0	SENT_187	[p5l1689t3220r1804b3274],
9	adenocarcinoma	NN	O	adenocarcinoma	conj_and	4	SENT_187	[p5l1827t3220r2144b3274, p5l11t3308r246b3361],
10	accounted	VBD	O	account	_	0	SENT_187	[p5l266t3307r595b3361],
11	for	IN	O	for	_	0	SENT_187	[p5l617t3307r706b3361],
12	57.1	CD	PERCENT	57.1	num	13	SENT_187	[p5l725t3310r904b3370],
13	%	NN	PERCENT	%	prep_for	10	SENT_187	[p5l725t3310r904b3370],
14	,	,	O	,	_	0	SENT_187	[p5l725t3310r904b3370],
15	82.1	CD	PERCENT	82.1	num	16	SENT_187	[p5l926t3310r1113b3370],
16	%	NN	PERCENT	%	prep_for	10	SENT_187	[p5l926t3310r1113b3370],
17	,	,	O	,	_	0	SENT_187	[p5l926t3310r1113b3370],
18	and	CC	O	and	_	0	SENT_187	[p5l1135t3307r1251b3361],
19	79.8	CD	PERCENT	79.8	num	20	SENT_187	[p5l1273t3310r1465b3370],
20	%	NN	PERCENT	%	prep_for	10	SENT_187	[p5l1273t3310r1465b3370],
21	,	,	O	,	_	0	SENT_187	[p5l1273t3310r1465b3370],
22	respectively	RB	O	respectively	advmod	10	SENT_187	[p5l1487t3307r1882b3375],
23	.	.	O	.	_	0	SENT_187	[p5l1487t3307r1882b3375],

1	Median	JJ	O	median	amod	3	SENT_188	[p5l1904t3307r2145b3361],
2	follow-up	JJ	O	follow-up	amod	3	SENT_188	[p5l12t3394r323b3462],
3	period	NN	O	period	nsubj	6	SENT_188	[p5l363t3394r568b3462],
4	was	VBD	O	be	cop	6	SENT_188	[p5l606t3410r728b3448],
5	21	CD	DURATION	21	num	6	SENT_188	[p5l768t3397r833b3448],
6	months	NNS	NUMBER	month	_	0	SENT_188	[p5l881t3394r1123b3448],
7	(	JJ	O	(	amod	8	SENT_188	[p5l1163t3394r1381b3462],
8	range	NN	O	range	attr	6	SENT_188	[p5l1163t3394r1381b3462],
9	,	,	O	,	_	0	SENT_188	[p5l1163t3394r1381b3462],
10	14-51	CD	NUMBER	14-51	num	11	SENT_188	[p5l1425t3397r1602b3448],
11	months	NNS	NUMBER	month	tmod	12	SENT_188	[p5l1650t3394r1935b3462],
12	)	RB	O	)	amod	8	SENT_188	[p5l1650t3394r1935b3462],
13	.	.	O	.	_	0	SENT_188	[p5l1650t3394r1935b3462],

1	As	IN	O	as	mark	12	SENT_189	[p5l1971t3397r2046b3448],
2	of	IN	O	of	_	0	SENT_189	[p5l2086t3394r2152b3448],
3	December	NNP	DATE	December	prep_of	12	SENT_189	[p5l12t3481r340b3535],
4	2007	CD	DATE	2007	num	3	SENT_189	[p5l370t3484r538b3544],
5	,	,	O	,	_	0	SENT_189	[p5l370t3484r538b3544],
6	73	CD	NUMBER	73	num	7	SENT_189	[p5l573t3484r643b3535],
7	patients	NNS	O	patient	nsubj	12	SENT_189	[p5l679t3482r936b3549],
8	(	IN	O	(	_	0	SENT_189	[p5l970t3481r1199b3549],
9	86.9	CD	PERCENT	86.9	num	10	SENT_189	[p5l970t3481r1199b3549],
10	%	NN	PERCENT	%	prep_(	7	SENT_189	[p5l970t3481r1199b3549],
11	)	CD	NUMBER	)	dep	10	SENT_189	[p5l970t3481r1199b3549],
12	had	VBD	O	have	advcl	23	SENT_189	[p5l1232t3481r1347b3535],
13	disease	NN	O	disease	nn	14	SENT_189	[p5l1381t3481r1612b3535],
14	progression	NN	O	progression	dobj	12	SENT_189	[p5l1645t3482r2035b3549],
15	,	,	O	,	_	0	SENT_189	[p5l1645t3482r2035b3549],
16	46	CD	NUMBER	46	num	17	SENT_189	[p5l2066t3484r2144b3535],
17	patients	NNS	O	patient	nsubjpass	23	SENT_189	[p5l12t3569r269b3636],
18	(	IN	O	(	_	0	SENT_189	[p5l300t3569r529b3636],
19	54.8	CD	PERCENT	54.8	number	20	SENT_189	[p5l300t3569r529b3636],
20	%	NN	PERCENT	%	num	21	SENT_189	[p5l300t3569r529b3636],
21	)	CD	NUMBER	)	prep_(	17	SENT_189	[p5l300t3569r529b3636],
22	were	VBD	O	be	auxpass	23	SENT_189	[p5l558t3584r716b3623],
23	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_189	[p5l747t3568r1075b3623],
24	as	IN	O	as	_	0	SENT_189	[p5l1106t3584r1168b3623],
25	dead	JJ	O	dead	prep_as	23	SENT_189	[p5l1199t3569r1367b3631],
26	,	,	O	,	_	0	SENT_189	[p5l1199t3569r1367b3631],
27	and	CC	O	and	_	0	SENT_189	[p5l1398t3569r1514b3623],
28	the	DT	O	the	det	30	SENT_189	[p5l1544t3569r1645b3623],
29	survival	NN	O	survival	nn	30	SENT_189	[p5l1677t3569r1925b3623],
30	status	NN	O	status	nsubj	39	SENT_189	[p5l1957t3577r2144b3623],
31	of	IN	O	of	_	0	SENT_189	[p5l11t3656r78b3710],
32	5	CD	NUMBER	5	num	33	SENT_189	[p5l92t3659r125b3710],
33	patients	NNS	O	patient	prep_of	30	SENT_189	[p5l149t3657r406b3723],
34	(	IN	O	(	_	0	SENT_189	[p5l429t3656r618b3723],
35	6.0	CD	PERCENT	6.0	num	36	SENT_189	[p5l429t3656r618b3723],
36	%	NN	PERCENT	%	prep_(	33	SENT_189	[p5l429t3656r618b3723],
37	)	NN	O	)	dep	36	SENT_189	[p5l429t3656r618b3723],
38	was	VBD	O	be	cop	39	SENT_189	[p5l638t3672r760b3710],
39	unknown	JJ	O	unknown	conj_and	23	SENT_189	[p5l783t3656r1102b3710],
40	.	.	O	.	_	0	SENT_189	[p5l783t3656r1102b3710],

1	Among	IN	O	among	_	0	SENT_190	[p5l1122t3658r1354b3723],
2	all	DT	O	all	det	3	SENT_190	[p5l1374t3656r1447b3710],
3	patients	NNS	O	patient	prep_among	9	SENT_190	[p5l1469t3657r1727b3723],
4	treated	VBN	O	treat	partmod	3	SENT_190	[p5l1749t3656r1977b3710],
5	with	IN	O	with	_	0	SENT_190	[p5l1997t3656r2145b3710],
6	Geﬁtinib	NN	PERSON	geﬁtinib	prep_with	4	SENT_190	[p5l12t3742r305b3804],
7	,	,	O	,	_	0	SENT_190	[p5l12t3742r305b3804],
8	there	EX	O	there	expl	9	SENT_190	[p5l326t3742r492b3796],
9	was	VBD	O	be	_	0	SENT_190	[p5l512t3758r634b3796],
10	no	DT	O	no	det	15	SENT_190	[p5l657t3758r733b3796],
11	complete	JJ	O	complete	amod	15	SENT_190	[p5l755t3742r1050b3810],
12	response	NN	O	response	nn	15	SENT_190	[p5l1072t3758r1356b3810],
13	(	CD	NUMBER	(	num	15	SENT_190	[p5l1378t3742r1510b3809],
14	CR	JJ	O	cr	amod	15	SENT_190	[p5l1378t3742r1510b3809],
15	)	NN	O	)	nsubj	9	SENT_190	[p5l1378t3742r1510b3809],
16	whereas	IN	O	whereas	mark	17	SENT_190	[p5l1530t3742r1798b3796],
17	31	CD	PERCENT	31	dep	15	SENT_190	[p5l1819t3745r1886b3796],
18	(	CD	PERCENT	(	number	19	SENT_190	[p5l1914t3742r2144b3809],
19	36.9	CD	PERCENT	36.9	dep	20	SENT_190	[p5l1914t3742r2144b3809],
20	%	NN	PERCENT	%	dep	17	SENT_190	[p5l1914t3742r2144b3809],
21	)	CD	NUMBER	)	tmod	9	SENT_190	[p5l1914t3742r2144b3809],

1	had	VBD	O	have	_	0	SENT_191	[p6l12t16r127b70],
2	partial	JJ	O	partial	amod	3	SENT_191	[p6l151t16r357b84],
3	response	NN	O	response	dobj	1	SENT_191	[p6l381t32r665b84],
4	(	CD	NUMBER	(	num	6	SENT_191	[p6l688t16r834b83],
5	PR	NN	O	pr	nn	6	SENT_191	[p6l688t16r834b83],
6	)	NN	O	)	nsubj	1	SENT_191	[p6l688t16r834b83],
7	,	,	O	,	_	0	SENT_191	[p6l688t16r834b83],
8	20	CD	PERCENT	20	number	9	SENT_191	[p6l858t19r934b70],
9	(	CD	PERCENT	(	nsubj	30	SENT_191	[p6l957t16r1187b84],
10	23.8	CD	PERCENT	23.8	num	11	SENT_191	[p6l957t16r1187b84],
11	%	NN	PERCENT	%	nsubj	13	SENT_191	[p6l957t16r1187b84],
12	)	CD	NUMBER	)	dep	11	SENT_191	[p6l957t16r1187b84],
13	had	VBD	O	have	rcmod	9	SENT_191	[p6l1210t16r1326b70],
14	stable	JJ	O	stable	amod	15	SENT_191	[p6l1350t16r1536b70],
15	disease	NN	O	disease	dobj	13	SENT_191	[p6l1559t16r1790b70],
16	more	RBR	DURATION	more	advmod	17	SENT_191	[p6l1814t32r1978b70],
17	than	IN	DURATION	than	quantmod	18	SENT_191	[p6l2001t16r2145b70],
18	24	CD	DURATION	24	num	19	SENT_191	[p6l11t106r88b157],
19	weeks	NNS	NUMBER	week	tmod	15	SENT_191	[p6l110t103r310b157],
20	(	CD	NUMBER	(	num	22	SENT_191	[p6l336t104r486b171],
21	SD	NN	O	sd	nn	22	SENT_191	[p6l336t104r486b171],
22	)	NN	O	)	dep	15	SENT_191	[p6l336t104r486b171],
23	,	,	O	,	_	0	SENT_191	[p6l336t104r486b171],
24	and	CC	O	and	_	0	SENT_191	[p6l512t103r627b157],
25	33	CD	PERCENT	33	number	26	SENT_191	[p6l651t106r724b157],
26	(	CD	PERCENT	(	conj_and	15	SENT_191	[p6l752t104r981b171],
27	39.3	CD	PERCENT	39.3	num	28	SENT_191	[p6l752t104r981b171],
28	%	NN	PERCENT	%	dep	26	SENT_191	[p6l752t104r981b171],
29	)	CD	NUMBER	)	tmod	13	SENT_191	[p6l752t104r981b171],
30	had	VBD	O	have	ccomp	1	SENT_191	[p6l1007t103r1122b157],
31	progressive	JJ	O	progressive	amod	35	SENT_191	[p6l1147t104r1512b171],
32	disease	NN	O	disease	nn	35	SENT_191	[p6l1537t103r1768b157],
33	(	NN	O	(	nn	35	SENT_191	[p6l1793t104r1945b171],
34	PD	NN	O	pd	nn	35	SENT_191	[p6l1793t104r1945b171],
35	)	NN	O	)	dobj	30	SENT_191	[p6l1793t104r1945b171],
36	.	.	O	.	_	0	SENT_191	[p6l1793t104r1945b171],

1	Overall	RB	O	overall	advmod	10	SENT_192	[p6l1971t106r2144b157, p6l11t191r101b253],
2	,	,	O	,	_	0	SENT_192	[p6l1971t106r2144b157, p6l11t191r101b253],
3	51	CD	PERCENT	51	nsubj	10	SENT_192	[p6l121t194r185b245],
4	(	CD	PERCENT	(	number	5	SENT_192	[p6l212t191r441b258],
5	60.7	CD	PERCENT	60.7	num	6	SENT_192	[p6l212t191r441b258],
6	%	NN	PERCENT	%	dep	3	SENT_192	[p6l212t191r441b258],
7	)	CD	NUMBER	)	num	8	SENT_192	[p6l212t191r441b258],
8	patients	NNS	O	patient	dep	3	SENT_192	[p6l461t191r718b258],
9	were	VBD	O	be	cop	10	SENT_192	[p6l736t206r894b245],
10	responder	NN	O	responder	_	0	SENT_192	[p6l914t191r1239b258],
11	whereas	IN	O	whereas	mark	19	SENT_192	[p6l1254t191r1523b245],
12	33	CD	PERCENT	33	number	13	SENT_192	[p6l1542t193r1616b245],
13	(	CD	PERCENT	(	nsubj	19	SENT_192	[p6l1638t191r1867b258],
14	39.3	CD	PERCENT	39.3	num	15	SENT_192	[p6l1638t191r1867b258],
15	%	NN	PERCENT	%	dep	13	SENT_192	[p6l1638t191r1867b258],
16	)	CD	NUMBER	)	num	17	SENT_192	[p6l1638t191r1867b258],
17	patients	NNS	O	patient	dep	13	SENT_192	[p6l1887t191r2144b258],
18	were	VBD	O	be	cop	19	SENT_192	[p6l10t294r167b332],
19	non-responder	JJ	O	non-responder	advcl	10	SENT_192	[p6l191t278r680b345],
20	.	.	O	.	_	0	SENT_192	[p6l191t278r680b345],

1	3.2	CD	NUMBER	3.2	_	0	SENT_193	[p6l8t460r113b512],
2	.	.	O	.	_	0	SENT_193	[p6l8t460r113b512],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_194	[p6l162t460r319b511],
2	tag-SNPs	NNS	O	tag-snp	_	0	SENT_194	[p6l343t460r615b525],
3	and	CC	O	and	_	0	SENT_194	[p6l637t457r750b511],
4	response	NN	O	response	conj_and	2	SENT_194	[p6l772t473r1037b525],
5	to	TO	O	to	_	0	SENT_194	[p6l1060t465r1115b511],
6	Geﬁtinib	NN	O	geﬁtinib	nn	7	SENT_194	[p6l1139t457r1397b525],
7	therapy	NN	O	therapy	prep_to	2	SENT_194	[p6l1422t457r1654b525],

1	Four	CD	NUMBER	four	num	2	SENT_195	[p6l113t638r256b688],
2	tag-SNPs	NNS	O	tag-snp	nsubjpass	29	SENT_195	[p6l332t637r633b702],
3	,	,	O	,	_	0	SENT_195	[p6l332t637r633b702],
4	rs4947492	NN	O	rs4947492	nn	8	SENT_195	[p6l714t637r1064b697],
5	,	,	O	,	_	0	SENT_195	[p6l714t637r1064b697],
6	rs11977388	NN	O	rs11977388	dep	8	SENT_195	[p6l1144t637r1524b697],
7	,	,	O	,	_	0	SENT_195	[p6l1144t637r1524b697],
8	rs2075102	NN	O	rs2075102	appos	2	SENT_195	[p6l1604t637r1949b697],
9	,	,	O	,	_	0	SENT_195	[p6l1604t637r1949b697],
10	and	CC	O	and	_	0	SENT_195	[p6l2028t634r2144b688],
11	rs7809028	NN	O	rs7809028	appos	2	SENT_195	[p6l12t724r367b784],
12	,	,	O	,	_	0	SENT_195	[p6l12t724r367b784],
13	which	WDT	O	which	nsubj	14	SENT_195	[p6l388t722r586b776],
14	represent	VBP	O	represent	rcmod	8	SENT_195	[p6l607t730r913b789],
15	6	CD	NUMBER	6	dobj	14	SENT_195	[p6l933t724r984b784],
16	,	,	O	,	_	0	SENT_195	[p6l933t724r984b784],
17	17	CD	NUMBER	17	appos	15	SENT_195	[p6l1010t725r1086b784],
18	,	,	O	,	_	0	SENT_195	[p6l1010t725r1086b784],
19	16	CD	NUMBER	16	num	17	SENT_195	[p6l1112t724r1196b784],
20	,	,	O	,	_	0	SENT_195	[p6l1112t724r1196b784],
21	and	CC	NUMBER	and	_	0	SENT_195	[p6l1219t722r1334b776],
22	5	CD	NUMBER	5	appos	15	SENT_195	[p6l1358t725r1390b776],
23	common	JJ	O	common	amod	24	SENT_195	[p6l1414t737r1697b776],
24	SNPs	NNS	O	snp	dep	17	SENT_195	[p6l1718t724r1889b784],
25	,	,	O	,	_	0	SENT_195	[p6l1718t724r1889b784],
26	respectively	RB	O	respectively	advmod	17	SENT_195	[p6l1912t737r2144b789, p6l11t809r198b876],
27	,	,	O	,	_	0	SENT_195	[p6l1912t737r2144b789, p6l11t809r198b876],
28	were	VBD	O	be	auxpass	29	SENT_195	[p6l215t825r372b863],
29	genotyped	VBN	O	genotype	_	0	SENT_195	[p6l390t809r745b876],
30	.	.	O	.	_	0	SENT_195	[p6l390t809r745b876],

1	The	DT	O	the	det	3	SENT_196	[p6l761t809r877b863],
2	genotype	NN	O	genotype	nn	3	SENT_196	[p6l894t817r1190b876],
3	frequencies	NNS	O	frequency	nsubjpass	20	SENT_196	[p6l1209t809r1576b876],
4	of	IN	O	of	_	0	SENT_196	[p6l1596t809r1662b863],
5	these	DT	O	these	det	6	SENT_196	[p6l1671t809r1841b863],
6	tag-SNPs	NNS	O	tag-snp	prep_of	3	SENT_196	[p6l1859t812r2144b876],
7	and	CC	O	and	_	0	SENT_196	[p6l11t895r127b949],
8	their	PRP$	O	they	poss	9	SENT_196	[p6l155t895r309b949],
9	distributions	NNS	O	distribution	nsubjpass	20	SENT_196	[p6l335t895r744b949],
10	among	IN	O	among	_	0	SENT_196	[p6l774t911r993b963],
11	responders	NNS	O	responder	prep_among	9	SENT_196	[p6l1020t895r1374b963],
12	and	CC	O	and	_	0	SENT_196	[p6l1403t895r1519b949],
13	non	JJ	O	non	amod	15	SENT_196	[p6l1548t895r2056b963],
14	—	NN	O	—	nn	15	SENT_196	[p6l1548t895r2056b963],
15	responders	NNS	O	responder	conj_and	3	SENT_196	[p6l1548t895r2056b963],
16	of	IN	O	of	_	0	SENT_196	[p6l2086t895r2152b949],
17	Geﬁtinib	JJ	O	geﬁtinib	amod	18	SENT_196	[p6l12t982r289b1036],
18	treatment	NN	O	treatment	prep_of	15	SENT_196	[p6l324t990r646b1036],
19	were	VBD	O	be	auxpass	20	SENT_196	[p6l678t998r836b1036],
20	summarized	VBN	O	summarize	_	0	SENT_196	[p6l873t982r1272b1036],
21	in	IN	O	in	_	0	SENT_196	[p6l1308t983r1367b1036],
22	Table	NNP	O	Table	prep_in	20	SENT_196	[p6l1399t982r1567b1036],
23	3	CD	NUMBER	3	num	22	SENT_196	[p6l1601t985r1654b1037],
24	.	.	O	.	_	0	SENT_196	[p6l1601t985r1654b1037],

1	No	DT	O	no	det	3	SENT_197	[p6l1691t986r1776b1036],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_197	[p6l1813t982r2146b1050],
3	difference	NN	O	difference	nsubjpass	10	SENT_197	[p6l11t1069r332b1123],
4	in	IN	O	in	_	0	SENT_197	[p6l365t1070r423b1123],
5	response	NN	O	response	prep_in	3	SENT_197	[p6l456t1085r739b1137],
6	to	TO	O	to	_	0	SENT_197	[p6l772t1077r832b1123],
7	Geﬁtinib	NN	O	geﬁtinib	nn	8	SENT_197	[p6l865t1069r1142b1123],
8	therapy	NN	O	therapy	prep_to	5	SENT_197	[p6l1174t1069r1421b1137],
9	was	VBD	O	be	auxpass	10	SENT_197	[p6l1449t1085r1572b1123],
10	observed	VBN	O	observe	_	0	SENT_197	[p6l1605t1069r1894b1123],
11	among	IN	O	among	_	0	SENT_197	[p6l1926t1085r2146b1137],
12	different	JJ	O	different	amod	13	SENT_197	[p6l11t1156r289b1210],
13	genotypes	NNS	O	genotype	prep_among	10	SENT_197	[p6l329t1164r656b1224],
14	of	IN	O	of	_	0	SENT_197	[p6l700t1156r766b1210],
15	3	CD	NUMBER	3	num	16	SENT_197	[p6l799t1159r833b1210],
16	tag-SNPs	NN	O	tag-snp	prep_of	13	SENT_197	[p6l879t1159r1179b1224],
17	,	,	O	,	_	0	SENT_197	[p6l879t1159r1179b1224],
18	i.e.	FW	O	i.e.	prep_of	13	SENT_197	[p6l1224t1157r1325b1219],
19	,	,	O	,	_	0	SENT_197	[p6l1224t1157r1325b1219],
20	rs4947492	NN	O	rs4947492	prep_of	13	SENT_197	[p6l1369t1159r1720b1219],
21	,	,	O	,	_	0	SENT_197	[p6l1369t1159r1720b1219],
22	rs11977388	NN	O	rs11977388	prep_of	13	SENT_197	[p6l1764t1159r2144b1219],
23	,	,	O	,	_	0	SENT_197	[p6l1764t1159r2144b1219],
24	and	CC	O	and	_	0	SENT_197	[p6l11t1244r127b1298],
25	rs2075102	NN	O	rs2075102	prep_of	13	SENT_197	[p6l155t1246r501b1298],
26	.	.	O	.	_	0	SENT_197	[p6l155t1246r501b1298],

1	However	RB	O	however	advmod	8	SENT_198	[p6l529t1247r825b1306],
2	,	,	O	,	_	0	SENT_198	[p6l529t1247r825b1306],
3	patients	NNS	O	patient	nsubj	8	SENT_198	[p6l854t1244r1111b1311],
4	carrying	VBG	O	carry	partmod	3	SENT_198	[p6l1139t1244r1405b1311],
5	the	DT	O	the	det	7	SENT_198	[p6l1430t1244r1531b1298],
6	rs7809028G	NN	O	rs7809028g	nn	7	SENT_198	[p6l1559t1246r1948b1298],
7	allele	NN	O	allele	dobj	4	SENT_198	[p6l1975t1244r2144b1298],
8	tended	VBD	O	tend	_	0	SENT_198	[p6l11t1331r233b1385],
9	to	TO	O	to	aux	10	SENT_198	[p6l278t1339r339b1385],
10	have	VB	O	have	xcomp	8	SENT_198	[p6l385t1331r531b1385],
11	higher	JJR	O	higher	amod	13	SENT_198	[p6l578t1331r785b1398],
12	response	NN	O	response	nn	13	SENT_198	[p6l829t1347r1113b1398],
13	rate	NN	O	rate	dobj	10	SENT_198	[p6l1159t1339r1280b1385],
14	than	IN	O	than	_	0	SENT_198	[p6l1326t1331r1470b1385],
15	those	DT	O	those	nsubj	16	SENT_198	[p6l1515t1331r1687b1385],
16	carrying	VBG	O	carry	prepc_than	10	SENT_198	[p6l1734t1332r1999b1398],
17	the	DT	O	the	det	21	SENT_198	[p6l2043t1331r2144b1385],
18	Table	NNP	O	Table	nn	21	SENT_198	[p6l7t1413r150b1457],
19	2	CD	NUMBER	2	num	21	SENT_198	[p6l167t1416r197b1457],
20	Clinical	JJ	O	clinical	amod	21	SENT_198	[p6l10t1485r197b1528],
21	characteristics	NNS	O	characteristic	dobj	16	SENT_198	[p6l223t1485r593b1528],
22	of	IN	O	of	_	0	SENT_198	[p6l619t1485r672b1528],
23	patients	NNS	O	patient	prep_of	16	SENT_198	[p6l691t1486r898b1539],
24	with	IN	O	with	_	0	SENT_198	[p6l923t1485r1041b1528],
25	advanced	JJ	O	advanced	amod	26	SENT_198	[p6l1066t1485r1308b1528],
26	NSCLC	NN	O	nsclc	prep_with	23	SENT_198	[p6l1334t1487r1499b1528],
27	and	CC	O	and	_	0	SENT_198	[p6l1523t1485r1616b1528],
28	clinical	JJ	O	clinical	amod	29	SENT_198	[p6l1642t1485r1823b1528],
29	response	NN	O	response	conj_and	23	SENT_198	[p6l1849t1497r2077b1539],
30	to	TO	O	to	_	0	SENT_198	[p6l2102t1491r2150b1528],
31	Geﬁtinib	NN	O	geﬁtinib	nn	32	SENT_198	[p6l10t1556r232b1600],
32	therapy	NN	O	therapy	prep_to	29	SENT_198	[p6l250t1556r457b1611],
33	.	.	O	.	_	0	SENT_198	[p6l250t1556r457b1611],

1	Patients	NNS	O	patient	dep	2	SENT_199	[p6l1153t1681r1357b1724],
2	(	VBP	O	(	_	0	SENT_199	[p6l1376t1680r1425b1734],
3	n	NN	O	n	nsubj	4	SENT_199	[p6l1376t1680r1425b1734],
4	=	JJ	O	=	xcomp	2	SENT_199	[p6l1439t1698r1465b1712],
5	84	CD	NUMBER	84	num	6	SENT_199	[p6l1479t1680r1561b1734],
6	)	NN	O	)	nsubj	2	SENT_199	[p6l1479t1680r1561b1734],

1	No.	NN	PERCENT	no.	nn	2	SENT_200	[p6l1153t1793r1235b1834],
2	%	NN	PERCENT	%	_	0	SENT_200	[p6l1828t1792r1861b1834],

1	Age	NNP	O	Age	_	0	SENT_201	[p6l7t1905r102b1957],
2	(	CD	NUMBER	(	num	3	SENT_201	[p6l120t1903r296b1957],
3	years	NNS	NUMBER	year	dep	1	SENT_201	[p6l120t1903r296b1957],
4	)	IN	O	)	amod	3	SENT_201	[p6l120t1903r296b1957],

1	Sex	NN	O	sex	_	0	SENT_202	[p6l10t2164r97b2206],

1	Male	JJ	O	male	_	0	SENT_203	[p6l64t2235r188b2278],
2	36	CD	NUMBER	36	number	3	SENT_203	[p6l1152t2237r1215b2278],
3	42.9	CD	NUMBER	42.9	dep	1	SENT_203	[p6l1827t2237r1936b2279],
4	Female	JJ	O	female	dep	1	SENT_203	[p6l64t2307r246b2351],
5	48	CD	NUMBER	48	number	6	SENT_203	[p6l1150t2309r1213b2351],
6	57.1	CD	NUMBER	57.1	dep	4	SENT_203	[p6l1832t2309r1930b2351],

1	WHO	WP	O	who	dep	3	SENT_204	[p6l7t2424r147b2466],
2	performance	NN	O	performance	nn	3	SENT_204	[p6l165t2422r494b2476],
3	status	NN	O	status	_	0	SENT_204	[p6l513t2428r663b2466],

1	Smoking	NN	O	smoking	nn	2	SENT_205	[p6l10t2682r234b2736],
2	status	NN	O	status	_	0	SENT_205	[p6l252t2688r402b2725],

1	Non-smoker	NN	O	non-smoker	_	0	SENT_206	[p6l64t2754r386b2798],
2	69	CD	NUMBER	69	num	1	SENT_206	[p6l1153t2756r1214b2798],
3	82.1	CD	NUMBER	82.1	num	4	SENT_206	[p6l1829t2756r1930b2798],
4	Smoker	NN	O	smoker	dep	1	SENT_206	[p6l64t2827r260b2870],
5	15	CD	NUMBER	15	number	6	SENT_206	[p6l1159t2829r1213b2870],
6	17.9	CD	NUMBER	17.9	dep	4	SENT_206	[p6l1837t2829r1936b2871],

1	Histological	JJ	O	histological	amod	2	SENT_207	[p6l10t2941r311b2996],
2	subtype	NN	O	subtype	_	0	SENT_207	[p6l331t2941r533b2996],

1	Adenocarcinoma	NN	O	adenocarcinoma	_	0	SENT_208	[p6l62t3014r497b3058],
2	67	CD	NUMBER	67	number	3	SENT_208	[p6l1154t3016r1214b3057],
3	79.8	CD	NUMBER	79.8	dep	1	SENT_208	[p6l1830t3016r1935b3058],
4	Othera	NNP	O	Othera	dep	1	SENT_208	[p6l64t3086r230b3130],
5	17	CD	NUMBER	17	number	6	SENT_208	[p6l1161t3089r1214b3129],
6	20.2	CD	NUMBER	20.2	dep	4	SENT_208	[p6l1829t3088r1935b3130],

1	Geﬁtinib	JJ	O	geﬁtinib	amod	2	SENT_209	[p6l10t3201r232b3245],
2	therapy	NN	O	therapy	_	0	SENT_209	[p6l250t3201r448b3256],

1	2nd	JJ	ORDINAL	2nd	amod	2	SENT_210	[p6l64t3274r161b3317],
2	line	NN	O	line	_	0	SENT_210	[p6l179t3274r272b3317],
3	44	CD	NUMBER	44	number	4	SENT_210	[p6l1150t3276r1215b3317],
4	52.4	CD	NUMBER	52.4	dep	2	SENT_210	[p6l1830t3276r1937b3318],
5	3rd	JJ	ORDINAL	3rd	amod	6	SENT_210	[p6l63t3346r149b3390],
6	line	NN	O	line	dep	4	SENT_210	[p6l167t3346r261b3390],
7	40	CD	NUMBER	40	num	8	SENT_210	[p6l1151t3348r1214b3390],
8	47.6	CD	NUMBER	47.6	dep	2	SENT_210	[p6l1830t3348r1936b3390],

1	Clinical	JJ	O	clinical	amod	2	SENT_211	[p6l10t3461r198b3504],
2	response	NN	O	response	_	0	SENT_211	[p6l217t3473r444b3515],

1	Partial	JJ	O	partial	amod	2	SENT_212	[p6l64t3532r228b3576],
2	response	NN	O	response	_	0	SENT_212	[p6l246t3545r475b3587],
3	31	CD	NUMBER	31	number	4	SENT_212	[p6l1155t3534r1208b3576],
4	36.9	CD	NUMBER	36.9	num	6	SENT_212	[p6l1828t3534r1936b3576],
5	Stable	JJ	O	stable	amod	6	SENT_212	[p6l64t3605r218b3648],
6	disease	NN	O	disease	dep	2	SENT_212	[p6l236t3605r422b3648],
7	20	CD	NUMBER	20	number	8	SENT_212	[p6l1153t3607r1214b3648],
8	23.8	CD	NUMBER	23.8	num	10	SENT_212	[p6l1829t3607r1935b3649],
9	Progressive	JJ	O	progressive	amod	10	SENT_212	[p6l64t3677r355b3730],
10	disease	NN	O	disease	dep	6	SENT_212	[p6l373t3676r559b3720],
11	33	CD	NUMBER	33	num	12	SENT_212	[p6l1153t3678r1212b3720],
12	39.3	CD	NUMBER	39.3	dep	2	SENT_212	[p6l1828t3678r1934b3720],

1	3	CD	NUMBER	3	nsubj	2	SENT_213	[p7l60t24r79b45],
2	Includes	VBZ	O	include	_	0	SENT_213	[p7l112t22r325b65],
3	squamous	JJ	O	squamous	amod	10	SENT_213	[p7l345t34r604b76],
4	cell	NN	O	cell	nn	10	SENT_213	[p7l622t22r708b65],
5	carcinoma	NN	O	carcinoma	nn	10	SENT_213	[p7l727t22r995b65],
6	(	CD	NUMBER	(	num	10	SENT_213	[p7l1012t22r1061b76],
7	n	NN	O	n	nn	10	SENT_213	[p7l1012t22r1061b76],
8	=	JJ	O	=	amod	10	SENT_213	[p7l1075t40r1101b53],
9	12	CD	NUMBER	12	num	10	SENT_213	[p7l1117t22r1194b76],
10	)	NN	O	)	dobj	2	SENT_213	[p7l1117t22r1194b76],
11	and	CC	O	and	_	0	SENT_213	[p7l1212t22r1306b65],
12	large	JJ	O	large	amod	14	SENT_213	[p7l1324t22r1448b76],
13	cell	NN	O	cell	nn	14	SENT_213	[p7l1467t22r1553b65],
14	carcinoma	NN	O	carcinoma	dep	19	SENT_213	[p7l1572t22r1839b65],
15	(	CD	NUMBER	(	num	16	SENT_213	[p7l1856t22r1906b76],
16	n	NN	O	n	npadvmod	17	SENT_213	[p7l1856t22r1906b76],
17	=	JJ	O	=	amod	14	SENT_213	[p7l1919t40r1946b53],
18	5	CD	NUMBER	5	num	19	SENT_213	[p7l1960t22r2021b76],
19	)	NN	O	)	conj_and	2	SENT_213	[p7l1960t22r2021b76],
20	.	.	O	.	_	0	SENT_213	[p7l1960t22r2021b76],

1	Table	NNP	O	Table	dep	2	SENT_214	[p7l7t230r150b274],
2	3	CD	NUMBER	3	amod	4	SENT_214	[p7l166t232r196b274],
3	Genotype	NN	O	genotype	nn	4	SENT_214	[p7l10t304r256b356],
4	distribution	NN	O	distribution	nsubj	17	SENT_214	[p7l278t302r582b345],
5	of	IN	O	of	_	0	SENT_214	[p7l604t302r658b345],
6	4	CD	NUMBER	4	num	8	SENT_214	[p7l672t304r703b345],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_214	[p7l723t304r849b345],
8	tag-SNPs	NNS	O	tag-snp	prep_of	4	SENT_214	[p7l871t304r1099b356],
9	among	IN	O	among	_	0	SENT_214	[p7l1122t314r1298b356],
10	responders	NNS	O	responder	prep_among	8	SENT_214	[p7l1319t302r1604b356],
11	and	CC	O	and	_	0	SENT_214	[p7l1626t302r1719b345],
12	non-responders	NNS	O	non-responder	conj_and	10	SENT_214	[p7l1742t302r2150b356],
13	of	IN	O	of	_	0	SENT_214	[p7l10t373r63b417],
14	advanced	JJ	O	advanced	amod	16	SENT_214	[p7l74t373r317b417],
15	NSCLC	NN	O	nsclc	nn	16	SENT_214	[p7l336t375r500b417],
16	patients	NNS	O	patient	prep_of	10	SENT_214	[p7l518t374r725b427],
17	treated	VBN	O	treat	_	0	SENT_214	[p7l743t373r926b417],
18	with	IN	O	with	_	0	SENT_214	[p7l943t373r1062b417],
19	Geﬁtinib	NN	PERSON	geﬁtinib	prep_with	17	SENT_214	[p7l1080t373r1315b417],
20	.	.	O	.	_	0	SENT_214	[p7l1080t373r1315b417],

1	Genotype	NN	O	genotype	nn	2	SENT_215	[p7l10t514r256b566],
2	Respondera	NN	MISC	respondera	_	0	SENT_215	[p7l592t512r885b566],
3	Non-responderb	JJ	MISC	non-responderb	amod	4	SENT_215	[p7l1206t505r1620b566],
4	P	NN	O	p	dep	2	SENT_215	[p7l1939t515r1971b555],

1	No.	NN	PERCENT	no.	nn	4	SENT_216	[p7l592t655r673b697],
2	%	NN	PERCENT	%	nn	4	SENT_216	[p7l834t655r866b696],
3	No.	NN	PERCENT	no.	nn	4	SENT_216	[p7l1206t655r1287b697],
4	%	NN	PERCENT	%	_	0	SENT_216	[p7l1448t655r1480b696],

1	rs4947492	NN	O	rs4947492	nn	2	SENT_217	[p7l10t767r277b809],
2	A	NN	O	a	_	0	SENT_217	[p7l294t767r333b808],
3	>	JJR	O	>	amod	4	SENT_217	[p7l345t775r370b803],
4	G	NN	O	g	dep	2	SENT_217	[p7l384t767r420b809],
5	0.578	CD	NUMBER	0.578	dep	2	SENT_217	[p7l1941t767r2077b809],

1	AA	NN	O	aa	_	0	SENT_218	[p7l62t839r137b881],
2	22	CD	NUMBER	22	number	3	SENT_218	[p7l592t840r652b881],
3	56.4	CD	NUMBER	56.4	num	5	SENT_218	[p7l836t840r943b882],
4	17	CD	NUMBER	17	number	5	SENT_218	[p7l1213t840r1266b881],
5	43.6	CD	NUMBER	43.6	dep	1	SENT_218	[p7l1479t840r1588b882],
6	AG	NNP	O	AG	dep	1	SENT_218	[p7l62t912r135b954],
7	22	CD	NUMBER	22	num	6	SENT_218	[p7l592t912r652b953],
8	66.7	CD	NUMBER	66.7	num	11	SENT_218	[p7l834t912r941b954],
9	11	CD	NUMBER	11	num	11	SENT_218	[p7l1214t912r1261b953],
10	33.3	CD	NUMBER	33.3	num	11	SENT_218	[p7l1481t912r1586b954],
11	GG	NNS	O	gg	dep	6	SENT_218	[p7l64t984r140b1026],
12	7	CD	NUMBER	7	number	13	SENT_218	[p7l625t985r652b1025],
13	70.0	CD	NUMBER	70.0	num	15	SENT_218	[p7l837t984r942b1026],
14	3	CD	NUMBER	3	number	15	SENT_218	[p7l1237t984r1265b1026],
15	30.0	CD	NUMBER	30.0	dep	11	SENT_218	[p7l1480t984r1588b1026],

1	rs11977388	NN	O	rs11977388	nn	2	SENT_219	[p7l10t1099r301b1141],
2	T	NN	O	t	_	0	SENT_219	[p7l318t1100r350b1140],
3	>	JJR	O	>	amod	4	SENT_219	[p7l362t1107r388b1135],
4	C	NN	O	c	dep	2	SENT_219	[p7l401t1099r432b1141],
5	0.444	CD	NUMBER	0.444	dep	2	SENT_219	[p7l1941t1099r2084b1141],

1	T1	NN	O	t1	_	0	SENT_220	[p7l62t1172r125b1213],
2	"	''	O	"	punct	1	SENT_220	[p7l62t1172r125b1213],
3	17	CD	NUMBER	17	number	4	SENT_220	[p7l599t1172r652b1213],
4	58.6	CD	NUMBER	58.6	dep	1	SENT_220	[p7l836t1172r942b1214],
5	12	CD	NUMBER	12	number	6	SENT_220	[p7l1211t1172r1265b1213],
6	41.4	CD	NUMBER	41.4	num	7	SENT_220	[p7l1483t1172r1589b1214],
7	TC	NN	O	tc	dep	1	SENT_220	[p7l62t1244r126b1286],
8	29	CD	NUMBER	29	number	9	SENT_220	[p7l591t1244r653b1286],
9	65.9	CD	NUMBER	65.9	num	7	SENT_220	[p7l835t1244r942b1286],
10	15	CD	NUMBER	15	number	11	SENT_220	[p7l1211t1244r1265b1286],
11	34.1	CD	NUMBER	34.1	num	12	SENT_220	[p7l1480t1244r1582b1286],
12	CC	NN	O	cc	dep	7	SENT_220	[p7l64t1317r129b1358],
13	5	CD	NUMBER	5	number	14	SENT_220	[p7l625t1317r652b1358],
14	45.5	CD	NUMBER	45.5	num	12	SENT_220	[p7l833t1317r941b1359],
15	6	CD	NUMBER	6	number	16	SENT_220	[p7l1239t1317r1267b1358],
16	54.5	CD	NUMBER	54.5	amod	12	SENT_220	[p7l1481t1317r1587b1359],

1	rs2075102	NN	O	rs2075102	nn	2	SENT_221	[p7l10t1431r273b1473],
2	C	NN	O	c	_	0	SENT_221	[p7l293t1431r324b1473],
3	>	JJR	O	>	dep	2	SENT_221	[p7l337t1439r363b1467],
4	A	DT	O	a	det	5	SENT_221	[p7l374t1431r412b1472],
5	0.854	CD	NUMBER	0.854	dep	2	SENT_221	[p7l1941t1431r2081b1473],

1	CC	NN	O	cc	dep	6	SENT_222	[p7l64t1504r129b1545],
2	33	CD	NUMBER	33	num	1	SENT_222	[p7l591t1504r651b1545],
3	60.0	CD	NUMBER	60.0	num	4	SENT_222	[p7l835t1504r942b1546],
4	22	CD	NUMBER	22	dep	1	SENT_222	[p7l1205t1504r1265b1545],
5	40.0	CD	NUMBER	40.0	dep	6	SENT_222	[p7l1479t1504r1588b1546],
6	CA	NNP	O	CA	dep	15	SENT_222	[p7l64t1576r133b1618],
7	18	CD	NUMBER	18	num	6	SENT_222	[p7l599t1576r652b1618],
8	62.1	CD	NUMBER	62.1	number	9	SENT_222	[p7l835t1576r936b1618],
9	11	CD	NUMBER	11	dep	6	SENT_222	[p7l1214t1576r1261b1617],
10	37.9	CD	NUMBER	37.9	num	13	SENT_222	[p7l1482t1576r1588b1618],
11	AA	NN	O	aa	nn	13	SENT_222	[p7l62t1648r137b1690],
12	o	NN	O	o	nn	13	SENT_222	[p7l625t1649r653b1690],
13	o.o	NN	O	o.o	dep	9	SENT_222	[p7l868t1649r942b1691],
14	1	CD	NUMBER	1	num	15	SENT_222	[p7l1241t1649r1261b1690],
15	100.0	CD	NUMBER	100.0	_	0	SENT_222	[p7l1453t1649r1588b1691],

1	rs7809028	CD	NUMBER	rs7809028	num	2	SENT_223	[p7l10t1764r281b1805],
2	G	NN	O	g	_	0	SENT_223	[p7l301t1764r337b1805],
3	>	JJR	O	>	dep	2	SENT_223	[p7l351t1771r377b1799],
4	A	DT	O	a	det	6	SENT_223	[p7l388t1763r426b1805],
5	0.085	CD	NUMBER	0.085	num	6	SENT_223	[p7l1941t1763r2101b1806],
6	C	NN	O	c	dep	2	SENT_223	[p7l1941t1763r2101b1806],

1	GG	NNS	O	gg	dep	9	SENT_224	[p7l64t1836r140b1878],
2	24	CD	NUMBER	24	num	3	SENT_224	[p7l592t1836r654b1877],
3	66.7	CD	NUMBER	66.7	dep	1	SENT_224	[p7l834t1836r941b1878],
4	12	CD	NUMBER	12	number	5	SENT_224	[p7l1211t1836r1266b1877],
5	33.3	CD	NUMBER	33.3	dep	3	SENT_224	[p7l1481t1836r1586b1878],
6	GA	NN	O	ga	dep	9	SENT_224	[p7l64t1908r138b1950],
7	18	CD	NUMBER	18	num	6	SENT_224	[p7l599t1908r652b1950],
8	69.2	CD	NUMBER	69.2	num	9	SENT_224	[p7l835t1908r941b1950],
9	8	CD	NUMBER	8	dep	15	SENT_224	[p7l1238t1908r1266b1950],
10	30.8	CD	NUMBER	30.8	num	11	SENT_224	[p7l1480t1908r1587b1950],
11	AA	NN	O	aa	dep	9	SENT_224	[p7l62t1981r137b2022],
12	7	CD	NUMBER	7	number	13	SENT_224	[p7l625t1981r652b2022],
13	38.9	CD	NUMBER	38.9	dep	11	SENT_224	[p7l834t1981r942b2023],
14	11	CD	NUMBER	11	num	15	SENT_224	[p7l1214t1981r1260b2022],
15	61.1	CD	NUMBER	61.1	_	0	SENT_224	[p7l1483t1981r1582b2023],

1	3	CD	NUMBER	3	nsubj	2	SENT_225	[p7l61t2093r79b2115],
2	Includes	VBZ	O	include	_	0	SENT_225	[p7l112t2091r325b2135],
3	partial	JJ	O	partial	amod	4	SENT_225	[p7l344t2091r510b2145],
4	response	NN	O	response	dobj	2	SENT_225	[p7l529t2104r757b2145],
5	and	CC	O	and	_	0	SENT_225	[p7l775t2091r868b2135],
6	stable	JJ	O	stable	amod	7	SENT_225	[p7l887t2091r1037b2135],
7	disease	NN	O	disease	dobj	2	SENT_225	[p7l1056t2091r1254b2135],
8	.	.	O	.	_	0	SENT_225	[p7l1056t2091r1254b2135],

1	1	CD	NUMBER	1	num	2	SENT_226	[p7l58t2162r79b2193],
2	’	CD	NUMBER	’	nsubj	3	SENT_226	[p7l58t2162r79b2193],
3	Includes	VBZ	O	include	_	0	SENT_226	[p7l112t2169r325b2212],
4	progressive	JJ	O	progressive	amod	5	SENT_226	[p7l344t2169r637b2223],
5	disease	NN	O	disease	dobj	3	SENT_226	[p7l656t2169r854b2213],
6	.	.	O	.	_	0	SENT_226	[p7l656t2169r854b2213],

1	C	NN	O	c	nn	2	SENT_227	[p7l62t2248r79b2270],
2	P	NN	O	p	nsubj	3	SENT_227	[p7l109t2249r178b2289],
3	=	JJ	O	=	_	0	SENT_227	[p7l109t2249r178b2289],
4	0.027	CD	NUMBER	0.027	dobj	3	SENT_227	[p7l191t2249r328b2290],
5	when	WRB	O	when	advmod	4	SENT_227	[p7l349t2246r493b2290],
6	rs7809028	NN	O	rs7809028	nn	8	SENT_227	[p7l513t2249r785b2290],
7	AA	NN	O	aa	nn	8	SENT_227	[p7l804t2248r879b2289],
8	genotype	NN	O	genotype	nsubjpass	4	SENT_227	[p7l896t2253r1134b2301],
9	was	VBD	O	be	auxpass	4	SENT_227	[p7l1153t2259r1251b2290],
10	compared	VBN	O	compare	_	0	SENT_227	[p7l1272t2246r1529b2301],
11	with	IN	O	with	_	0	SENT_227	[p7l1548t2246r1666b2290],
12	combined	JJ	O	combined	amod	13	SENT_227	[p7l1686t2246r1941b2290],
13	GG	NNS	O	gg	prep_compared_with	4	SENT_227	[p7l1962t2248r2037b2290],
14	and	CC	O	and	advmod	4	SENT_227	[p7l2058t2246r2150b2290],

1	GA	NN	O	ga	_	0	SENT_228	[p7l10t2320r83b2361],
2	genotype	NN	O	genotype	dep	1	SENT_228	[p7l98t2324r349b2372],
3	.	.	O	.	_	0	SENT_228	[p7l98t2324r349b2372],

1	F.	NNP	O	F.	nn	2	SENT_229	[p7l401t2448r417b2469],
2	Ma	NNP	O	Ma	_	0	SENT_229	[p7l426t2448r464b2469],
3	et	FW	O	et	nn	4	SENT_229	[p7l473t2450r496b2469],
4	al.	FW	O	al.	dep	2	SENT_229	[p7l503t2447r528b2469],
5	/	:	O	/	punct	2	SENT_229	[p7l535t2447r547b2474],
6	Lung	NN	O	lung	nn	7	SENT_229	[p7l553t2448r613b2474],
7	Cancer	NN	O	cancer	dep	2	SENT_229	[p7l620t2448r703b2469],
8	66	CD	NUMBER	66	number	9	SENT_229	[p7l710t2448r739b2469],
9	(	CD	NUMBER	(	num	10	SENT_229	[p7l747t2447r827b2474],
10	2009	CD	DATE	2009	dep	7	SENT_229	[p7l747t2447r827b2474],
11	)	CD	NUMBER	)	number	12	SENT_229	[p7l747t2447r827b2474],
12	114-119 117	CD	NUMBER	114-119 117	num	10	SENT_229	[p7l1714t2448r1758b2469],[p7l839t2448r942b2469],

1	A	DT	O	a	det	2	SENT_230	[p7l6t2589r53b2640],
2	allele	NN	O	allele	_	0	SENT_230	[p7l91t2587r260b2641],
3	(	CD	PERCENT	(	number	4	SENT_230	[p7l301t2587r499b2654],
4	67.3	CD	PERCENT	67.3	num	5	SENT_230	[p7l301t2587r499b2654],
5	%	NN	PERCENT	%	dep	2	SENT_230	[p7l301t2587r499b2654],
6	versus	CC	O	versus	_	0	SENT_230	[p7l536t2602r741b2641],
7	51.6	CD	PERCENT	51.6	num	8	SENT_230	[p7l784t2587r976b2654],
8	%	NN	PERCENT	%	conj_versus	2	SENT_230	[p7l784t2587r976b2654],
9	)	CD	NUMBER	)	dep	21	SENT_230	[p7l784t2587r976b2654],
10	although	IN	O	although	dep	21	SENT_230	[p7l1017t2587r1303b2654],
11	the	DT	O	the	det	12	SENT_230	[p7l1342t2587r1444b2641],
12	difference	NN	O	difference	nsubj	21	SENT_230	[p7l1485t2586r1806b2641],
13	was	VBD	O	be	cop	21	SENT_230	[p7l1845t2602r1968b2641],
14	only	RB	O	only	advmod	15	SENT_230	[p7l2010t2587r2148b2654],
15	marginally	RB	O	marginally	advmod	21	SENT_230	[p7l9t2674r355b2741],
16	signiﬁcant	JJ	O	signiﬁcant	amod	21	SENT_230	[p7l393t2674r727b2741],
17	(	NN	O	(	nn	21	SENT_230	[p7l765t2674r1107b2741],
18	P	NN	O	p	nn	21	SENT_230	[p7l765t2674r1107b2741],
19	=	JJ	O	=	amod	21	SENT_230	[p7l765t2674r1107b2741],
20	0.067	CD	NUMBER	0.067	num	21	SENT_230	[p7l765t2674r1107b2741],
21	)	NN	O	)	dep	8	SENT_230	[p7l765t2674r1107b2741],
22	.	.	O	.	_	0	SENT_230	[p7l765t2674r1107b2741],

1	Speciﬁcally	RB	O	speciﬁcally	advmod	32	SENT_231	[p7l1147t2674r1520b2741],
2	,	,	O	,	_	0	SENT_231	[p7l1147t2674r1520b2741],
3	the	DT	O	the	det	5	SENT_231	[p7l1559t2674r1661b2728],
4	response	NN	O	response	nn	5	SENT_231	[p7l1700t2690r1985b2741],
5	rate	NN	O	rate	nsubj	32	SENT_231	[p7l2024t2682r2146b2728],
6	was	VBD	O	be	cop	32	SENT_231	[p7l7t2776r130b2814],
7	67.7	CD	PERCENT	67.7	num	8	SENT_231	[p7l160t2763r331b2815],
8	%	NN	PERCENT	%	nn	32	SENT_231	[p7l160t2763r331b2815],
9	among	IN	O	among	_	0	SENT_231	[p7l359t2776r579b2828],
10	62	CD	NUMBER	62	num	11	SENT_231	[p7l607t2763r681b2814],
11	patients	NNS	O	patient	prep_among	8	SENT_231	[p7l711t2761r969b2828],
12	with	IN	O	with	_	0	SENT_231	[p7l997t2760r1145b2814],
13	the	DT	O	the	det	14	SENT_231	[p7l1173t2760r1274b2814],
14	GG	NNS	O	gg	prep_with	11	SENT_231	[p7l1304t2763r1398b2814],
15	and	CC	O	and	_	0	SENT_231	[p7l1426t2760r1542b2814],
16	GA	NN	O	ga	nn	17	SENT_231	[p7l1571t2762r1663b2814],
17	genotype	NN	O	genotype	conj_and	14	SENT_231	[p7l1688t2768r2000b2828],
18	,	,	O	,	_	0	SENT_231	[p7l1688t2768r2000b2828],
19	and	CC	O	and	_	0	SENT_231	[p7l2030t2760r2146b2814],
20	38.9	CD	PERCENT	38.9	num	21	SENT_231	[p7l8t2850r187b2902],
21	%	NN	PERCENT	%	prep_among	8	SENT_231	[p7l8t2850r187b2902],
22	among	IN	O	among	_	0	SENT_231	[p7l224t2863r444b2915],
23	18	CD	NUMBER	18	num	24	SENT_231	[p7l484t2850r550b2901],
24	patients	NNS	O	patient	prep_among	21	SENT_231	[p7l590t2848r847b2915],
25	with	IN	O	with	_	0	SENT_231	[p7l885t2847r1033b2901],
26	the	DT	O	the	det	29	SENT_231	[p7l1069t2847r1171b2901],
27	AA	NN	O	aa	nn	29	SENT_231	[p7l1206t2850r1299b2901],
28	(	NN	O	(	nn	29	SENT_231	[p7l1334t2847r1674b2915],
29	P	NN	O	p	prep_with	24	SENT_231	[p7l1334t2847r1674b2915],
30	=	JJ	O	=	amod	32	SENT_231	[p7l1334t2847r1674b2915],
31	0.027	CD	NUMBER	0.027	tmod	30	SENT_231	[p7l1334t2847r1674b2915],
32	)	NN	O	)	_	0	SENT_231	[p7l1334t2847r1674b2915],
33	.	.	O	.	_	0	SENT_231	[p7l1334t2847r1674b2915],

1	These	DT	O	these	det	2	SENT_232	[p7l1710t2847r1895b2901],
2	results	NNS	O	result	nsubj	3	SENT_232	[p7l1934t2847r2145b2901],
3	imply	VBP	O	imply	_	0	SENT_232	[p7l9t2934r193b3002],
4	that	IN	O	that	complm	15	SENT_232	[p7l222t2934r351b2988],
5	one	CD	NUMBER	one	num	8	SENT_232	[p7l381t2950r496b2988],
6	or	CC	O	or	_	0	SENT_232	[p7l527t2950r594b2988],
7	more	JJR	O	more	num	8	SENT_232	[p7l623t2950r788b2988],
8	SNPs	NNS	O	snp	nsubj	15	SENT_232	[p7l819t2937r974b2988],
9	represented	VBN	O	represent	partmod	8	SENT_232	[p7l1006t2934r1390b3002],
10	by	IN	O	by	_	0	SENT_232	[p7l1421t2934r1497b3002],
11	this	DT	O	this	det	13	SENT_232	[p7l1526t2934r1642b2988],
12	tag	NN	O	tag	nn	13	SENT_232	[p7l1674t2942r1772b3002],
13	SNP	NN	O	snp	agent	9	SENT_232	[p7l1802t2937r1927b2988],
14	might	MD	O	might	aux	15	SENT_232	[p7l1958t2934r2148b3002],
15	have	VB	O	have	ccomp	3	SENT_232	[p7l9t3021r155b3075],
16	impact	NN	O	impact	dobj	15	SENT_232	[p7l197t3022r418b3089],
17	on	IN	O	on	_	0	SENT_232	[p7l457t3037r535b3075],
18	response	NN	O	response	prep_on	16	SENT_232	[p7l576t3037r860b3089],
19	to	TO	O	to	_	0	SENT_232	[p7l900t3029r961b3075],
20	Geﬁtinib	NNP	LOCATION	Geﬁtinib	prep_to	15	SENT_232	[p7l1002t3021r1296b3076],
21	.	.	O	.	_	0	SENT_232	[p7l1002t3021r1296b3076],

1	Among	IN	O	among	_	0	SENT_233	[p7l1334t3024r1566b3089],
2	the	DT	O	the	det	4	SENT_233	[p7l1605t3021r1706b3075],
3	5	CD	NUMBER	5	num	4	SENT_233	[p7l1748t3025r1780b3075],
4	SNPs	NNS	O	snp	prep_among	13	SENT_233	[p7l1824t3024r1977b3075],
5	that	WDT	O	that	nsubj	6	SENT_233	[p7l2019t3021r2148b3075],
6	rs7809028	VBP	O	rs7809028	rcmod	4	SENT_233	[p7l9t3111r348b3163],
7	represents	VBZ	O	represent	ccomp	6	SENT_233	[p7l383t3117r734b3176],
8	,	,	O	,	_	0	SENT_233	[p7l383t3117r734b3176],
9	rs2293347	NN	O	rs2293347	nsubj	26	SENT_233	[p7l768t3111r1103b3163],
10	is	VBZ	O	be	cop	13	SENT_233	[p7l1137t3109r1183b3163],
11	the	DT	O	the	det	13	SENT_233	[p7l1216t3109r1317b3163],
12	only	JJ	O	only	amod	13	SENT_233	[p7l1350t3109r1489b3176],
13	SNP	NN	ORGANIZATION	snp	_	0	SENT_233	[p7l1519t3111r1644b3163],
14	that	WDT	O	that	dep	16	SENT_233	[p7l1675t3109r1804b3163],
15	is	VBZ	O	be	cop	16	SENT_233	[p7l1835t3109r1881b3163],
16	located	JJ	O	located	rcmod	13	SENT_233	[p7l1915t3109r2146b3163],
17	in	IN	O	in	_	0	SENT_233	[p7l9t3197r68b3249],
18	coding	VBG	O	code	prepc_in	16	SENT_233	[p7l102t3196r317b3263],
19	region	NN	O	region	dobj	18	SENT_233	[p7l350t3197r552b3263],
20	(	CD	NUMBER	(	num	23	SENT_233	[p7l586t3196r762b3263],
21	exon	NN	O	exon	nn	23	SENT_233	[p7l586t3196r762b3263],
22	25	CD	NUMBER	25	num	23	SENT_233	[p7l796t3196r899b3263],
23	)	NN	O	)	nsubj	16	SENT_233	[p7l796t3196r899b3263],
24	and	CC	O	and	_	0	SENT_233	[p7l933t3196r1049b3250],
25	may	MD	O	may	aux	26	SENT_233	[p7l1084t3211r1220b3263],
26	has	VBZ	O	have	conj_and	13	SENT_233	[p7l1253t3196r1357b3250],
27	potential	JJ	O	potential	amod	28	SENT_233	[p7l1393t3196r1679b3263],
28	function	NN	O	function	dobj	26	SENT_233	[p7l1714t3196r1997b3250],
29	.	.	O	.	_	0	SENT_233	[p7l1714t3196r1997b3250],

1	The	DT	O	the	det	2	SENT_234	[p7l2029t3196r2146b3250],
2	correlation	NN	O	correlation	nsubj	11	SENT_234	[p7l9t3282r360b3336],
3	between	IN	O	between	_	0	SENT_234	[p7l379t3282r656b3336],
4	rs2293347	CD	NUMBER	rs2293347	num	5	SENT_234	[p7l675t3285r1011b3336],
5	genotype	NN	O	genotype	prep_between	2	SENT_234	[p7l1031t3290r1327b3350],
6	and	CC	O	and	_	0	SENT_234	[p7l1347t3282r1463b3336],
7	response	NN	O	response	conj_and	5	SENT_234	[p7l1483t3298r1768b3350],
8	to	TO	O	to	_	0	SENT_234	[p7l1787t3290r1848b3336],
9	Geﬁtinib	NNP	PERSON	Geﬁtinib	prep_to	7	SENT_234	[p7l1868t3282r2146b3336],
10	was	VBD	O	be	cop	11	SENT_234	[p7l7t3385r130b3423],
11	further	JJ	O	further	_	0	SENT_234	[p7l154t3369r381b3423],
12	analyzed	VBN	O	analyze	partmod	11	SENT_234	[p7l401t3369r686b3437],
13	as	IN	O	as	mark	14	SENT_234	[p7l709t3385r771b3423],
14	described	VBN	O	describe	advcl	12	SENT_234	[p7l795t3369r1105b3423],
15	below	IN	O	below	prep	14	SENT_234	[p7l1127t3369r1335b3424],
16	.	.	O	.	_	0	SENT_234	[p7l1127t3369r1335b3424],

1	3.3	CD	NUMBER	3.3	_	0	SENT_235	[p7l6t3553r111b3605],
2	.	.	O	.	_	0	SENT_235	[p7l6t3553r111b3605],

1	Other	JJ	O	other	amod	3	SENT_236	[p7l162t3550r336b3604],
2	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_236	[p7l351t3553r510b3604],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_236	[p7l527t3550r1005b3618],
4	and	CC	O	and	_	0	SENT_236	[p7l1027t3550r1140b3604],
5	response	NN	O	response	conj_and	3	SENT_236	[p7l1162t3566r1427b3618],
6	to	TO	O	to	_	0	SENT_236	[p7l1451t3558r1505b3604],
7	Geﬁtinib	NN	O	geﬁtinib	nn	8	SENT_236	[p7l1529t3550r1787b3618],
8	therapy	NN	O	therapy	prep_to	3	SENT_236	[p7l1812t3550r2045b3618],

1	Additional	JJ	O	additional	amod	4	SENT_237	[p8l108t62r444b116],
2	10	CD	NUMBER	10	num	4	SENT_237	[p8l483t64r552b116],
3	common	JJ	O	common	amod	4	SENT_237	[p8l587t77r870b116],
4	SNPs	NNS	O	snp	nsubjpass	10	SENT_237	[p8l905t64r1059b116],
5	with	IN	O	with	_	0	SENT_237	[p8l1093t62r1242b116],
6	heterozygosity	NN	O	heterozygosity	prep_with	4	SENT_237	[p8l1277t62r1751b129],
7	>	JJR	O	>	dep	6	SENT_237	[p8l1785t64r1946b116],
8	0.01	CD	NUMBER	0.01	dep	7	SENT_237	[p8l1785t64r1946b116],
9	were	VBD	O	be	auxpass	10	SENT_237	[p8l1988t77r2146b116],
10	identiﬁed	VBN	O	identiﬁed	_	0	SENT_237	[p8l9t148r318b203],
11	in	IN	O	in	_	0	SENT_237	[p8l337t149r396b202],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_237	[p8l412t151r570b203],
13	exons	NNS	O	exon	prep_in	10	SENT_237	[p8l587t164r768b203],
14	18-21	CD	NUMBER	18-21	dep	13	SENT_237	[p8l791t151r971b203],
15	and	CC	O	and	_	0	SENT_237	[p8l997t149r1113b203],
16	their	PRP$	O	they	poss	18	SENT_237	[p8l1131t149r1285b203],
17	exon/intron	JJ	O	exon/intron	amod	18	SENT_237	[p8l1301t148r1678b216],
18	boundaries	NNS	O	boundary	conj_and	13	SENT_237	[p8l1695t149r2053b203],
19	by	IN	O	by	_	0	SENT_237	[p8l2072t149r2148b216],
20	DNA	NN	O	dna	nn	21	SENT_237	[p8l9t238r153b290],
21	sequencing	NN	O	sequencing	prep_by	18	SENT_237	[p8l175t237r538b303],
22	(	CD	NUMBER	(	num	21	SENT_237	[p8l560t236r1081b303],
23	Supplementary	NNP	O	Supplementary	nn	24	SENT_237	[p8l560t236r1081b303],
24	Table	NNP	O	Table	dep	18	SENT_237	[p8l1100t236r1268b290],
25	1	CD	NUMBER	1	number	26	SENT_237	[p8l1296t236r1369b303],
26	)	CD	NUMBER	)	dep	24	SENT_237	[p8l1296t236r1369b303],
27	.	.	O	.	_	0	SENT_237	[p8l1296t236r1369b303],

1	Although	IN	O	although	mark	6	SENT_238	[p8l1391t236r1690b303],
2	none	NN	O	none	nsubj	6	SENT_238	[p8l1713t252r1870b290],
3	of	IN	O	of	_	0	SENT_238	[p8l1894t236r1960b290],
4	these	DT	O	these	det	5	SENT_238	[p8l1976t236r2146b290],
5	SNPS	NNS	ORGANIZATION	snp	prep_of	2	SENT_238	[p8l9t325r163b376],
6	showed	VBD	O	show	advcl	19	SENT_238	[p8l204t322r450b376],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_238	[p8l491t322r825b390],
8	association	NN	O	association	dobj	6	SENT_238	[p8l863t323r1220b376],
9	with	IN	O	with	_	0	SENT_238	[p8l1257t322r1405b376],
10	response	NN	O	response	prep_with	6	SENT_238	[p8l1444t338r1729b390],
11	to	TO	O	to	_	0	SENT_238	[p8l1767t330r1828b376],
12	Geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_238	[p8l1868t322r2146b376],
13	therapy	NN	O	therapy	prep_to	6	SENT_238	[p8l8t409r266b477],
14	,	,	O	,	_	0	SENT_238	[p8l8t409r266b477],
15	several	JJ	O	several	amod	17	SENT_238	[p8l286t409r508b463],
16	interesting	JJ	O	interesting	amod	17	SENT_238	[p8l527t410r874b477],
17	tendency	NN	O	tendency	nsubjpass	19	SENT_238	[p8l890t409r1187b477],
18	were	VBD	O	be	auxpass	19	SENT_238	[p8l1201t425r1360b463],
19	observed	VBN	O	observe	_	0	SENT_238	[p8l1378t409r1684b464],
20	.	.	O	.	_	0	SENT_238	[p8l1378t409r1684b464],

1	Three	CD	NUMBER	three	num	3	SENT_239	[p8l1700t409r1882b463],
2	responder	NN	O	responder	nn	3	SENT_239	[p8l1901t425r2145b477, p8l9t496r114b550],
3	patients	NNS	O	patient	nsubj	4	SENT_239	[p8l128t497r385b564],
4	carried	VBD	O	carry	_	0	SENT_239	[p8l402t496r625b550],
5	the	DT	O	the	det	8	SENT_239	[p8l641t496r742b550],
6	variant	JJ	O	variant	amod	8	SENT_239	[p8l756t497r984b550],
7	GA	NN	O	ga	nn	8	SENT_239	[p8l998t499r1089b550],
8	genotype	NN	O	genotype	dobj	4	SENT_239	[p8l1101t504r1398b564],
9	at	IN	O	at	_	0	SENT_239	[p8l1413t504r1473b550],
10	155077	CD	NUMBER	155077	num	12	SENT_239	[p8l1491t499r1719b550],
11	polymorphic	JJ	O	polymorphic	amod	12	SENT_239	[p8l1736t496r2147b564],
12	site	NN	O	site	prep_at	4	SENT_239	[p8l10t584r119b638],
13	in	IN	O	in	_	0	SENT_239	[p8l140t584r198b637],
14	intron	NN	O	intron	prep_in	12	SENT_239	[p8l218t584r414b638],
15	18	CD	NUMBER	18	num	14	SENT_239	[p8l436t586r520b646],
16	,	,	O	,	_	0	SENT_239	[p8l436t586r520b646],
17	which	WDT	O	which	nsubjpass	21	SENT_239	[p8l539t584r737b638],
18	has	VBZ	O	have	aux	21	SENT_239	[p8l756t584r860b638],
19	never	RB	O	never	neg	21	SENT_239	[p8l882t599r1061b638],
20	been	VBN	O	be	auxpass	21	SENT_239	[p8l1078t584r1232b638],
21	reported	VBN	O	report	rcmod	14	SENT_239	[p8l1252t584r1528b651],
22	before	RB	O	before	advmod	21	SENT_239	[p8l1547t583r1766b646],
23	,	,	O	,	_	0	SENT_239	[p8l1547t583r1766b646],
24	but	CC	O	but	_	0	SENT_239	[p8l1785t584r1892b638],
25	none	NN	O	none	nsubj	29	SENT_239	[p8l1911t599r2067b638],
26	of	IN	O	of	_	0	SENT_239	[p8l2088t583r2154b638],
27	non-responder	JJ	O	non-responder	amod	28	SENT_239	[p8l9t671r491b738],
28	patients	NNS	O	patient	prep_of	25	SENT_239	[p8l512t672r770b738],
29	carried	VBD	O	carry	conj_but	4	SENT_239	[p8l794t671r1018b725],
30	this	DT	O	this	det	31	SENT_239	[p8l1041t671r1158b725],
31	genotype	NN	O	genotype	dobj	29	SENT_239	[p8l1181t679r1493b738],
32	.	.	O	.	_	0	SENT_239	[p8l1181t679r1493b738],

1	Patients	NNS	O	patient	nsubj	2	SENT_240	[p8l1518t672r1773b725],
2	carried	VBD	O	carry	_	0	SENT_240	[p8l1797t671r2021b725],
3	the	DT	O	the	det	10	SENT_240	[p8l2044t671r2146b725],
4	variant	JJ	O	variant	amod	10	SENT_240	[p8l7t758r234b811],
5	allele	NN	O	allele	nn	10	SENT_240	[p8l249t757r418b811],
6	(	CD	NUMBER	(	num	10	SENT_240	[p8l435t757r551b824],
7	AG	NNP	O	AG	nn	10	SENT_240	[p8l435t757r551b824],
8	orAA	NNP	O	orAA	nn	10	SENT_240	[p8l567t759r738b811],
9	genotype	NN	O	genotype	nn	10	SENT_240	[p8l751t757r1073b825],
10	)	NN	O	)	nsubj	21	SENT_240	[p8l751t757r1073b825],
11	of	IN	O	of	_	0	SENT_240	[p8l1090t757r1157b811],
12	rs1050171	NN	O	rs1050171	prep_of	10	SENT_240	[p8l1166t760r1500b820],
13	,	,	O	,	_	0	SENT_240	[p8l1166t760r1500b820],
14	a	DT	O	a	det	16	SENT_240	[p8l1517t773r1549b811],
15	synonymous	JJ	O	synonymous	amod	16	SENT_240	[p8l1566t773r1971b825],
16	cSNP	NN	O	csnp	appos	10	SENT_240	[p8l1988t760r2148b811],
17	in	IN	O	in	_	0	SENT_240	[p8l9t845r68b898],
18	exon	NN	O	exon	prep_in	16	SENT_240	[p8l90t860r241b898],
19	20	CD	NUMBER	20	num	18	SENT_240	[p8l263t847r355b907],
20	,	,	O	,	_	0	SENT_240	[p8l263t847r355b907],
21	tend	VBP	O	tend	ccomp	2	SENT_240	[p8l378t844r520b898],
22	to	TO	O	to	aux	23	SENT_240	[p8l542t852r603b898],
23	have	VB	O	have	xcomp	21	SENT_240	[p8l626t844r772b898],
24	higher	JJR	O	higher	amod	26	SENT_240	[p8l796t844r1003b912],
25	response	NN	O	response	nn	26	SENT_240	[p8l1024t860r1308b912],
26	rate	NN	O	rate	dobj	23	SENT_240	[p8l1331t852r1452b898],
27	than	IN	O	than	mark	29	SENT_240	[p8l1474t844r1619b898],
28	patients	NNS	O	patient	nsubj	29	SENT_240	[p8l1641t845r1899b912],
29	carried	VBD	O	carry	advcl	23	SENT_240	[p8l1922t844r2146b898],
30	the	DT	O	the	det	33	SENT_240	[p8l8t931r110b985],
31	wild-type	JJ	O	wild-type	amod	33	SENT_240	[p8l131t931r446b999],
32	GG	NNS	O	gg	nn	33	SENT_240	[p8l470t934r564b985],
33	genotype	NN	O	genotype	dobj	29	SENT_240	[p8l586t939r882b999],
34	(	CD	PERCENT	(	number	35	SENT_240	[p8l906t931r1110b998],
35	78.9	CD	PERCENT	78.9	num	36	SENT_240	[p8l906t931r1110b998],
36	%	NN	PERCENT	%	dep	33	SENT_240	[p8l906t931r1110b998],
37	versus	CC	O	versus	_	0	SENT_240	[p8l1131t947r1336b985],
38	55.4	CD	PERCENT	55.4	num	39	SENT_240	[p8l1361t934r1553b994],
39	%	NN	PERCENT	%	conj_versus	33	SENT_240	[p8l1361t934r1553b994],
40	,	,	O	,	_	0	SENT_240	[p8l1361t934r1553b994],
41	P	NN	O	p	appos	39	SENT_240	[p8l1575t935r1660b985],
42	=	JJ	O	=	amod	44	SENT_240	[p8l1575t935r1660b985],
43	0.064	CD	NUMBER	0.064	tmod	42	SENT_240	[p8l1677t931r1896b998],
44	)	NN	O	)	dep	41	SENT_240	[p8l1677t931r1896b998],
45	.	.	O	.	_	0	SENT_240	[p8l1677t931r1896b998],

1	Similar	JJ	O	similar	amod	2	SENT_241	[p8l1920t931r2148b985],
2	result	NN	O	result	nsubjpass	4	SENT_241	[p8l9t1018r192b1072],
3	was	VBD	O	be	auxpass	4	SENT_241	[p8l204t1034r327b1072],
4	seen	VBN	O	see	_	0	SENT_241	[p8l344t1034r487b1072],
5	for	IN	O	for	_	0	SENT_241	[p8l502t1018r592b1072],
6	rs10241326	NN	O	rs10241326	prep_for	4	SENT_241	[p8l605t1021r988b1081],
7	,	,	O	,	_	0	SENT_241	[p8l605t1021r988b1081],
8	a	DT	O	a	det	9	SENT_241	[p8l1005t1034r1037b1072],
9	T	NN	O	t	appos	6	SENT_241	[p8l1049t1022r1088b1072],
10	>	JJR	O	>	amod	12	SENT_241	[p8l1104t1031r1136b1065],
11	C	NN	O	c	nn	12	SENT_241	[p8l1153t1021r1191b1072],
12	SNP	NN	O	snp	dep	6	SENT_241	[p8l1206t1021r1331b1072],
13	located	JJ	O	located	amod	12	SENT_241	[p8l1345t1018r1576b1072],
14	in	IN	O	in	_	0	SENT_241	[p8l1593t1019r1651b1072],
15	intron19	NN	O	intron19	prep_in	13	SENT_241	[p8l1667t1019r1955b1081],
16	,	,	O	,	_	0	SENT_241	[p8l1667t1019r1955b1081],
17	probably	RB	O	probably	advmod	6	SENT_241	[p8l1972t1018r2146b1086, p8l9t1106r142b1173],
18	due	JJ	O	due	_	0	SENT_241	[p8l156t1106r272b1160],
19	to	TO	O	to	_	0	SENT_241	[p8l288t1114r349b1160],
20	its	PRP$	O	its	poss	22	SENT_241	[p8l366t1106r438b1160],
21	strong	JJ	O	strong	amod	22	SENT_241	[p8l456t1114r658b1173],
22	linkage	NN	O	linkage	prep_due_to	6	SENT_241	[p8l673t1106r902b1173],
23	to	TO	O	to	_	0	SENT_241	[p8l918t1114r978b1160],
24	the	DT	O	the	det	26	SENT_241	[p8l994t1106r1096b1160],
25	cSNP	NN	O	csnp	nn	26	SENT_241	[p8l1112t1108r1271b1160],
26	rs1050171	NN	O	rs1050171	prep_to	6	SENT_241	[p8l1286t1108r1602b1160],
27	(	CD	NUMBER	(	num	29	SENT_241	[p8l1627t1106r2148b1173],
28	Supplementary	NNP	O	Supplementary	nn	29	SENT_241	[p8l1627t1106r2148b1173],
29	Table	NNP	O	Table	dep	6	SENT_241	[p8l6t1193r175b1247],
30	1	CD	NUMBER	1	number	31	SENT_241	[p8l201t1193r275b1260],
31	)	CD	NUMBER	)	dep	29	SENT_241	[p8l201t1193r275b1260],
32	.	.	O	.	_	0	SENT_241	[p8l201t1193r275b1260],

1	Because	IN	O	because	_	0	SENT_242	[p8l111t1282r366b1333],
2	rs11543848	NN	O	rs11543848	prep_because	5	SENT_242	[p8l391t1282r761b1333],
3	(	CD	NUMBER	(	num	2	SENT_242	[p8l788t1279r1043b1346],
4	I	PRP	O	I	nsubj	5	SENT_242	[p8l788t1279r1043b1346],
5	(	VBP	O	(	ccomp	28	SENT_242	[p8l788t1279r1043b1346],
6	521R	NN	O	521r	nn	7	SENT_242	[p8l788t1279r1043b1346],
7	)	NN	O	)	nsubj	22	SENT_242	[p8l788t1279r1043b1346],
8	and	CC	O	and	_	0	SENT_242	[p8l1069t1279r1184b1333],
9	rs2293347	NN	O	rs2293347	nn	11	SENT_242	[p8l1211t1282r1546b1333],
10	(	CD	NUMBER	(	num	11	SENT_242	[p8l1572t1279r1844b1346],
11	D994D	NN	O	d994d	conj_and	7	SENT_242	[p8l1572t1279r1844b1346],
12	)	CD	NUMBER	)	num	13	SENT_242	[p8l1572t1279r1844b1346],
13	SNPs	NNS	O	snp	dep	11	SENT_242	[p8l1869t1282r2023b1333],
14	are	VBP	O	be	cop	15	SENT_242	[p8l2049t1295r2146b1333],
15	located	JJ	O	located	ccomp	5	SENT_242	[p8l9t1366r240b1420],
16	in	IN	O	in	_	0	SENT_242	[p8l259t1367r318b1420],
17	the	DT	O	the	det	19	SENT_242	[p8l334t1366r435b1420],
18	coding	VBG	O	code	amod	19	SENT_242	[p8l453t1366r668b1434],
19	region	NN	O	region	prep_in	15	SENT_242	[p8l684t1367r887b1434],
20	and	CC	O	and	_	0	SENT_242	[p8l904t1366r1020b1420],
21	might	MD	O	might	aux	22	SENT_242	[p8l1038t1366r1228b1434],
22	have	VB	O	have	ccomp	5	SENT_242	[p8l1244t1366r1391b1420],
23	functional	JJ	O	functional	amod	24	SENT_242	[p8l1409t1366r1734b1420],
24	signiﬁcance	NN	O	signiﬁcance	dobj	22	SENT_242	[p8l1752t1366r2145b1434],
25	,	,	O	,	_	0	SENT_242	[p8l1752t1366r2145b1434],
26	we	PRP	O	we	nsubj	28	SENT_242	[p8l7t1469r100b1507],
27	further	RB	O	further	advmod	28	SENT_242	[p8l131t1453r358b1507],
28	analyzed	VBD	O	analyze	_	0	SENT_242	[p8l385t1453r669b1521],
29	these	DT	O	these	det	30	SENT_242	[p8l699t1453r869b1507],
30	SNPs	NNS	O	snp	dobj	28	SENT_242	[p8l899t1456r1054b1507],
31	and	CC	O	and	_	0	SENT_242	[p8l1084t1453r1200b1507],
32	outcome	NN	O	outcome	dobj	28	SENT_242	[p8l1231t1461r1510b1507],
33	of	IN	O	of	_	0	SENT_242	[p8l1541t1453r1607b1507],
34	patients	NNS	O	patient	prep_of	30	SENT_242	[p8l1629t1454r1887b1521],
35	treated	VBN	O	treat	partmod	34	SENT_242	[p8l1917t1453r2146b1507],
36	with	IN	O	with	_	0	SENT_242	[p8l7t1540r155b1594],
37	Geﬁtinib	NN	PERSON	geﬁtinib	prep_with	35	SENT_242	[p8l176t1540r470b1595],
38	.	.	O	.	_	0	SENT_242	[p8l176t1540r470b1595],

1	It	PRP	O	it	nsubjpass	3	SENT_243	[p8l492t1544r537b1594],
2	was	VBD	O	be	auxpass	3	SENT_243	[p8l555t1556r678b1594],
3	found	VBN	O	find	_	0	SENT_243	[p8l701t1540r885b1594],
4	that	IN	O	that	complm	23	SENT_243	[p8l906t1540r1035b1594],
5	although	IN	O	although	mark	11	SENT_243	[p8l1055t1540r1341b1608],
6	rs11543848	NN	O	rs11543848	nn	7	SENT_243	[p8l1362t1543r1731b1594],
7	SNP	NN	O	snp	nsubjpass	11	SENT_243	[p8l1755t1543r1880b1594],
8	was	VBD	O	be	auxpass	11	SENT_243	[p8l1898t1556r2021b1594],
9	not	RB	O	not	neg	11	SENT_243	[p8l2043t1548r2148b1594],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_243	[p8l10t1627r403b1695],
11	associated	VBN	O	associate	advcl	23	SENT_243	[p8l419t1628r750b1682],
12	with	IN	O	with	_	0	SENT_243	[p8l767t1628r915b1682],
13	response	NN	O	response	prep_with	11	SENT_243	[p8l934t1643r1218b1695],
14	to	TO	O	to	_	0	SENT_243	[p8l1235t1636r1296b1682],
15	Geﬁtinib	NN	O	geﬁtinib	nn	16	SENT_243	[p8l1315t1627r1593b1682],
16	therapy	NN	O	therapy	prep_to	11	SENT_243	[p8l1610t1628r1868b1695],
17	,	,	O	,	_	0	SENT_243	[p8l1610t1628r1868b1695],
18	patients	NNS	O	patient	nsubj	23	SENT_243	[p8l1887t1628r2145b1695],
19	carrying	VBG	O	carry	partmod	18	SENT_243	[p8l9t1716r275b1782],
20	the	DT	O	the	det	22	SENT_243	[p8l308t1715r409b1769],
21	rs2293347A	NN	O	rs2293347a	nn	22	SENT_243	[p8l445t1717r831b1769],
22	allele	NN	O	allele	dobj	19	SENT_243	[p8l863t1715r1032b1769],
23	had	VBD	O	have	ccomp	3	SENT_243	[p8l1067t1715r1183b1769],
24	signiﬁcantly	RB	O	signiﬁcantly	advmod	25	SENT_243	[p8l1219t1715r1613b1782],
25	lower	JJR	O	lower	amod	27	SENT_243	[p8l1646t1715r1828b1769],
26	response	NN	O	response	nn	27	SENT_243	[p8l1861t1730r2145b1782],
27	rate	NN	O	rate	dobj	23	SENT_243	[p8l9t1809r131b1855],
28	than	IN	O	than	_	0	SENT_243	[p8l167t1801r312b1855],
29	patients	NNS	O	patient	prep_than	23	SENT_243	[p8l348t1802r605b1869],
30	carrying	VBG	O	carry	partmod	29	SENT_243	[p8l643t1802r909b1869],
31	the	DT	O	the	det	33	SENT_243	[p8l943t1801r1044b1855],
32	rs2293347G	NN	O	rs2293347g	nn	33	SENT_243	[p8l1082t1804r1469b1855],
33	allele	NN	O	allele	dobj	30	SENT_243	[p8l1505t1801r1674b1855],
34	(	CD	PERCENT	(	num	36	SENT_243	[p8l1710t1801r1906b1868],
35	37.5	CD	PERCENT	37.5	num	36	SENT_243	[p8l1710t1801r1906b1868],
36	%	NN	PERCENT	%	dep	33	SENT_243	[p8l1710t1801r1906b1868],
37	versus	CC	O	versus	_	0	SENT_243	[p8l1940t1817r2145b1855],
38	71.2	CD	PERCENT	71.2	num	39	SENT_243	[p8l10t1891r194b1951],
39	%	NN	PERCENT	%	dobj	30	SENT_243	[p8l10t1891r194b1951],
40	,	,	O	,	_	0	SENT_243	[p8l10t1891r194b1951],
41	P	NN	O	p	appos	39	SENT_243	[p8l222t1888r543b1956],
42	=	JJ	O	=	amod	44	SENT_243	[p8l222t1888r543b1956],
43	0.004	CD	NUMBER	0.004	tmod	42	SENT_243	[p8l222t1888r543b1956],
44	)	NN	O	)	dep	41	SENT_243	[p8l222t1888r543b1956],
45	.	.	O	.	_	0	SENT_243	[p8l222t1888r543b1956],

1	Besides	IN	O	besides	_	0	SENT_244	[p8l574t1888r810b1942],
2	the	DT	O	the	det	3	SENT_244	[p8l841t1888r942b1942],
3	rs2293347	NN	O	rs2293347	prep_besides	16	SENT_244	[p8l972t1891r1318b1951],
4	,	,	O	,	_	0	SENT_244	[p8l972t1891r1318b1951],
5	another	DT	O	another	det	7	SENT_244	[p8l1349t1888r1599b1942],
6	functional	JJ	O	functional	amod	7	SENT_244	[p8l1627t1888r1952b1942],
7	polymorphism	NN	O	polymorphism	nsubjpass	16	SENT_244	[p8l1982t1888r2145b1956, p8l9t1975r342b2043],
8	in	IN	O	in	_	0	SENT_244	[p8l370t1976r429b2029],
9	intron	NN	O	intron	prep_in	7	SENT_244	[p8l457t1976r653b2029],
10	1	CD	NUMBER	1	num	9	SENT_244	[p8l685t1978r727b2038],
11	,	,	O	,	_	0	SENT_244	[p8l685t1978r727b2038],
12	CA-SSR	NN	O	ca-ssr	appos	9	SENT_244	[p8l756t1978r1002b2038],
13	,	,	O	,	_	0	SENT_244	[p8l756t1978r1002b2038],
14	was	VBD	O	be	auxpass	16	SENT_244	[p8l1029t1991r1152b2029],
15	also	RB	O	also	advmod	16	SENT_244	[p8l1181t1975r1305b2029],
16	associated	VBN	O	associate	_	0	SENT_244	[p8l1334t1975r1665b2029],
17	with	IN	O	with	_	0	SENT_244	[p8l1692t1975r1840b2029],
18	Geﬁtinib	NN	PERSON	geﬁtinib	nn	19	SENT_244	[p8l1868t1975r2146b2029],
19	response	NN	O	response	prep_with	16	SENT_244	[p8l9t2078r310b2130],
20	.	.	O	.	_	0	SENT_244	[p8l9t2078r310b2130],

1	Patients	NNS	O	patient	nsubj	19	SENT_245	[p8l327t2063r582b2117],
2	carrying	VBG	O	carry	partmod	1	SENT_245	[p8l599t2063r865b2130],
3	at	IN	O	at	quantmod	5	SENT_245	[p8l880t2070r939b2116],
4	least	JJS	O	least	mwe	3	SENT_245	[p8l954t2063r1103b2116],
5	one	CD	NUMBER	one	npadvmod	6	SENT_245	[p8l1117t2078r1231b2116],
6	shorter	JJR	O	shorter	amod	9	SENT_245	[p8l1249t2063r1480b2116],
7	CA	NNP	O	CA	nn	9	SENT_245	[p8l1494t2065r1580b2116],
8	repeat	NN	O	repeat	nn	9	SENT_245	[p8l1594t2070r1798b2130],
9	allele	NN	O	allele	dobj	2	SENT_245	[p8l1812t2062r1981b2116],
10	[	CD	NUMBER	[	num	13	SENT_245	[p8l2001t2062r2066b2130],
11	5	CD	NUMBER	5	number	12	SENT_245	[p8l2001t2062r2066b2130],
12	16	CD	NUMBER	16	amod	13	SENT_245	[p8l2077t2065r2146b2116],
13	(	NN	O	(	dep	2	SENT_245	[p8l9t2149r201b2217],
14	CA	NNP	O	CA	nn	15	SENT_245	[p8l9t2149r201b2217],
15	)	NNP	O	)	dep	13	SENT_245	[p8l9t2149r201b2217],
16	,	,	O	,	_	0	SENT_245	[p8l9t2149r201b2217],
17	,	,	O	,	_	0	SENT_245	[p8l9t2149r201b2217],
18	]	NN	O	]	appos	1	SENT_245	[p8l9t2149r201b2217],
19	had	VBD	O	have	dep	32	SENT_245	[p8l224t2150r340b2204],
20	signiﬁcantly	RB	O	signiﬁcantly	advmod	21	SENT_245	[p8l360t2149r753b2217],
21	higher	JJR	O	higher	amod	23	SENT_245	[p8l771t2150r979b2217],
22	response	NN	O	response	nn	23	SENT_245	[p8l996t2165r1281b2217],
23	rate	NN	O	rate	dobj	19	SENT_245	[p8l1300t2158r1422b2204],
24	than	IN	O	than	_	0	SENT_245	[p8l1441t2150r1585b2204],
25	patients	NNS	O	patient	prep_than	19	SENT_245	[p8l1604t2150r1862b2217],
26	carrying	VBG	O	carry	partmod	25	SENT_245	[p8l1881t2150r2148b2217],
27	two	CD	NUMBER	two	npadvmod	28	SENT_245	[p8l8t2245r129b2291],
28	longer	JJR	O	longer	advmod	26	SENT_245	[p8l149t2237r353b2304],
29	CA	NNP	O	CA	nn	31	SENT_245	[p8l370t2239r456b2291],
30	repeat	NN	O	repeat	nn	31	SENT_245	[p8l473t2245r676b2304],
31	alleles	NNS	O	allele	dobj	26	SENT_245	[p8l694t2237r893b2291],
32	(	VBP	O	(	_	0	SENT_245	[p8l913t2237r1118b2304],
33	88.5	CD	PERCENT	88.5	num	34	SENT_245	[p8l913t2237r1118b2304],
34	%	NN	PERCENT	%	nsubj	40	SENT_245	[p8l913t2237r1118b2304],
35	versus	CC	O	versus	prep	34	SENT_245	[p8l1135t2253r1339b2291],
36	48.3	CD	PERCENT	48.3	num	37	SENT_245	[p8l1358t2240r1554b2299],
37	%	NN	PERCENT	%	dep	35	SENT_245	[p8l1358t2240r1554b2299],
38	,	,	O	,	_	0	SENT_245	[p8l1358t2240r1554b2299],
39	P	NN	O	p	appos	37	SENT_245	[p8l1572t2240r1656b2290],
40	<	JJR	O	<	xcomp	32	SENT_245	[p8l1572t2240r1656b2290],
41	0.001	CD	NUMBER	0.001	num	42	SENT_245	[p8l1674t2240r1840b2291],
42	)	NN	O	)	nsubj	32	SENT_245	[p8l1856t2237r1890b2304],
43	.	.	O	.	_	0	SENT_245	[p8l1856t2237r1890b2304],

1	We	PRP	O	we	nsubj	3	SENT_246	[p8l1907t2240r2012b2291],
2	further	RB	O	further	advmod	3	SENT_246	[p8l2032t2237r2145b2291, p8l8t2323r141b2377],
3	analyzed	VBD	O	analyze	_	0	SENT_246	[p8l154t2323r439b2391],
4	whether	IN	O	whether	complm	6	SENT_246	[p8l453t2323r727b2377],
5	there	EX	O	there	expl	6	SENT_246	[p8l739t2323r906b2377],
6	is	VBZ	O	be	ccomp	3	SENT_246	[p8l922t2324r968b2377],
7	a	DT	O	a	det	10	SENT_246	[p8l985t2339r1017b2377],
8	j	NN	O	j	nn	10	SENT_246	[p8l1024t2324r1045b2391],
9	oint	NN	O	oint	nn	10	SENT_246	[p8l1053t2324r1180b2377],
10	effect	NN	O	effect	nsubj	6	SENT_246	[p8l1194t2323r1372b2377],
11	between	IN	O	between	_	0	SENT_246	[p8l1385t2323r1662b2377],
12	rs2293347	NN	O	rs2293347	nn	15	SENT_246	[p8l1678t2326r2013b2377],
13	and	CC	O	and	_	0	SENT_246	[p8l2029t2323r2146b2377],
14	CA-SSR	NN	O	ca-ssr	nn	15	SENT_246	[p8l9t2413r242b2464],
15	genotypes	NNS	O	genotype	prep_between	10	SENT_246	[p8l261t2418r589b2478],
16	on	IN	O	on	_	0	SENT_246	[p8l614t2426r692b2464],
17	response	NN	O	response	prep_on	15	SENT_246	[p8l715t2426r1000b2478],
18	to	TO	O	to	_	0	SENT_246	[p8l1023t2418r1083b2464],
19	Geﬁtinib	NNP	O	Geﬁtinib	nn	21	SENT_246	[p8l1108t2410r1386b2464],
20	(	NNP	O	(	nn	21	SENT_246	[p8l1409t2410r1601b2477],
21	Table	NNP	O	Table	prep_to	17	SENT_246	[p8l1409t2410r1601b2477],
22	4	CD	NUMBER	4	number	23	SENT_246	[p8l1623t2410r1703b2477],
23	)	CD	NUMBER	)	num	21	SENT_246	[p8l1623t2410r1703b2477],
24	.	.	O	.	_	0	SENT_246	[p8l1623t2410r1703b2477],

1	Interestingly	RB	O	interestingly	advmod	7	SENT_247	[p8l1728t2410r2145b2478],
2	,	,	O	,	_	0	SENT_247	[p8l1728t2410r2145b2478],
3	90.5	CD	PERCENT	90.5	num	4	SENT_247	[p8l9t2500r187b2552],
4	%	NN	PERCENT	%	nsubj	7	SENT_247	[p8l9t2500r187b2552],
5	of	IN	O	of	_	0	SENT_247	[p8l205t2497r272b2551],
6	patients	NNS	O	patient	prep_of	4	SENT_247	[p8l282t2498r540b2565],
7	carrying	VBG	O	carry	dep	31	SENT_247	[p8l560t2498r826b2565],
8	both	CC	O	both	preconj	15	SENT_247	[p8l842t2497r986b2551],
9	rs2293347GG	NN	O	rs2293347gg	dep	15	SENT_247	[p8l1005t2500r1441b2551],
10	and	CC	O	and	_	0	SENT_247	[p8l1459t2497r1575b2551],
11	shorter	JJR	O	shorter	amod	14	SENT_247	[p8l1595t2497r1826b2551],
12	CA	NNP	O	CA	nn	14	SENT_247	[p8l1842t2500r1928b2551],
13	repeat	NN	O	repeat	nn	14	SENT_247	[p8l1944t2505r2148b2565],
14	genotypes	NNS	O	genotype	dobj	7	SENT_247	[p8l8t2593r335b2652],
15	response	NN	O	response	dobj	7	SENT_247	[p8l371t2600r656b2652],
16	to	TO	O	to	_	0	SENT_247	[p8l690t2593r750b2639],
17	Geﬁtinib	NN	O	geﬁtinib	nn	18	SENT_247	[p8l786t2584r1064b2639],
18	therapy	NN	O	therapy	prep_to	15	SENT_247	[p8l1098t2585r1362b2652],
19	;	:	O	;	_	0	SENT_247	[p8l1098t2585r1362b2652],
20	however	RB	O	however	advmod	25	SENT_247	[p8l1402t2585r1689b2647],
21	,	,	O	,	_	0	SENT_247	[p8l1402t2585r1689b2647],
22	the	DT	O	the	det	24	SENT_247	[p8l1725t2585r1826b2639],
23	response	NN	O	response	nn	24	SENT_247	[p8l1862t2600r2146b2652],
24	rate	NN	O	rate	nsubj	25	SENT_247	[p8l9t2680r131b2726],
25	decreased	VBD	O	decrease	parataxis	7	SENT_247	[p8l162t2672r482b2726],
26	to	TO	O	to	_	0	SENT_247	[p8l512t2680r573b2726],
27	26.3	CD	PERCENT	26.3	num	28	SENT_247	[p8l604t2675r782b2726],
28	%	NN	PERCENT	%	prep_to	25	SENT_247	[p8l604t2675r782b2726],
29	in	IN	O	in	_	0	SENT_247	[p8l812t2673r872b2725],
30	patients	NNS	O	patient	prep_in	25	SENT_247	[p8l902t2673r1160b2739],
31	carried	VBD	O	carry	_	0	SENT_247	[p8l1191t2672r1414b2726],
32	both	CC	O	both	preconj	33	SENT_247	[p8l1445t2672r1590b2726],
33	rs2293347GA	NN	O	rs2293347ga	nsubj	41	SENT_247	[p8l1620t2674r2054b2726],
34	or	CC	O	or	_	0	SENT_247	[p8l2082t2688r2148b2726],
35	AA	NN	O	aa	conj_or	33	SENT_247	[p8l6t2761r100b2812],
36	and	CC	O	and	_	0	SENT_247	[p8l124t2759r240b2813],
37	longer	JJR	O	longer	amod	40	SENT_247	[p8l268t2759r472b2826],
38	CA	NNP	O	CA	nn	40	SENT_247	[p8l497t2761r583b2813],
39	repeat	NN	O	repeat	nn	40	SENT_247	[p8l608t2767r811b2826],
40	genotypes	NNS	O	genotype	conj_and	33	SENT_247	[p8l836t2767r1163b2826],
41	(	VBP	O	(	ccomp	31	SENT_247	[p8l1190t2759r1298b2826],
42	P	NN	O	p	dep	43	SENT_247	[p8l1190t2759r1298b2826],
43	<	JJR	O	<	dobj	41	SENT_247	[p8l1190t2759r1298b2826],
44	0.001	CD	NUMBER	0.001	num	45	SENT_247	[p8l1316t2759r1533b2826],
45	)	NN	O	)	nsubj	31	SENT_247	[p8l1316t2759r1533b2826],
46	.	.	O	.	_	0	SENT_247	[p8l1316t2759r1533b2826],

1	These	DT	O	these	det	2	SENT_248	[p8l1557t2759r1742b2813],
2	results	NNS	O	result	nsubj	3	SENT_248	[p8l1771t2759r1982b2813],
3	suggest	VBP	O	suggest	_	0	SENT_248	[p8l2011t2775r2146b2826, p8l8t2853r137b2913],
4	a	DT	O	a	det	7	SENT_248	[p8l162t2861r194b2899],
5	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_248	[p8l222t2845r556b2913],
6	joint	JJ	O	joint	amod	7	SENT_248	[p8l573t2846r730b2913],
7	effect	NN	O	effect	dobj	3	SENT_248	[p8l755t2845r933b2899],
8	between	IN	O	between	_	0	SENT_248	[p8l958t2845r1235b2899],
9	the	DT	O	the	det	10	SENT_248	[p8l1261t2845r1362b2899],
10	rs2293347A	NN	O	rs2293347a	prep_between	7	SENT_248	[p8l1390t2847r1776b2899],
11	and	CC	O	and	_	0	SENT_248	[p8l1800t2845r1916b2899],
12	longer	JJR	O	longer	conj_and	10	SENT_248	[p8l1944t2845r2148b2913],

1	Table	NNP	O	Table	nsubj	4	SENT_249	[p8l6t3047r148b3091],
2	4	CD	NUMBER	4	num	4	SENT_249	[p8l164t3050r196b3090],
3	CA-SSR	NN	O	ca-ssr	nn	4	SENT_249	[p8l10t3127r244b3180],
4	alleles	NNS	O	allele	_	0	SENT_249	[p8l271t3125r471b3180],
5	on	IN	O	on	_	0	SENT_249	[p8l503t3140r581b3180],
6	attenuating	VBG	O	attenuate	prepc_on	4	SENT_249	[p8l611t3125r984b3193],
7	response	NN	O	response	dobj	6	SENT_249	[p8l1014t3140r1298b3193],
8	to	TO	O	to	_	0	SENT_249	[p8l1329t3133r1389b3180],
9	the	DT	O	the	det	10	SENT_249	[p8l1420t3125r1521b3180],
10	therapy	NN	O	therapy	prep_to	6	SENT_249	[p8l1552t3125r1810b3193],
11	.	.	O	.	_	0	SENT_249	[p8l1552t3125r1810b3193],

1	Genotype	NN	O	genotype	nn	2	SENT_250	[p8l1842t3127r2150b3193],
2	frequencies	NNS	O	frequency	nsubj	13	SENT_250	[p8l10t3214r379b3282],
3	of	IN	O	of	_	0	SENT_250	[p8l402t3214r468b3269],
4	the	DT	O	the	det	6	SENT_250	[p8l481t3214r583b3269],
5	2293347G	NN	O	2293347g	dep	6	SENT_250	[p8l605t3217r932b3269],
6	>	JJR	O	>	prep_of	2	SENT_250	[p8l950t3226r982b3261],
7	A	DT	O	a	dep	6	SENT_250	[p8l996t3216r1043b3268],
8	and	CC	O	and	_	0	SENT_250	[p8l1062t3214r1178b3269],
9	CA-SSR	NN	O	ca-ssr	dep	6	SENT_250	[p8l1201t3216r1434b3269],
10	were	VBD	O	be	cop	13	SENT_250	[p8l1451t3230r1610b3269],
11	not	RB	O	not	neg	13	SENT_250	[p8l1633t3222r1737b3269],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	13	SENT_250	[p8l1758t3214r2152b3282],
13	different	JJ	O	different	_	0	SENT_250	[p8l10t3302r288b3357],
14	in	IN	O	in	_	0	SENT_250	[p8l315t3303r374b3356],
15	terms	NNS	O	term	prep_in	13	SENT_250	[p8l401t3310r584b3357],
16	of	IN	O	of	_	0	SENT_250	[p8l614t3302r680b3357],
17	sex	NN	O	sex	nn	22	SENT_250	[p8l701t3318r817b3365],
18	,	,	O	,	_	0	SENT_250	[p8l701t3318r817b3365],
19	age	NN	O	age	dep	22	SENT_250	[p8l846t3318r968b3371],
20	,	,	O	,	_	0	SENT_250	[p8l846t3318r968b3371],
21	histological	JJ	O	histological	amod	22	SENT_250	[p8l997t3302r1364b3371],
22	subtype	NN	O	subtype	prep_of	15	SENT_250	[p8l1393t3302r1647b3371],
23	of	IN	O	of	_	0	SENT_250	[p8l1675t3302r1741b3357],
24	the	DT	O	the	det	25	SENT_250	[p8l1761t3302r1862b3357],
25	patients	NNS	O	patient	prep_of	22	SENT_250	[p8l1891t3303r2149b3371],
26	(	IN	O	(	_	0	SENT_250	[p8l10t3391r532b3460],
27	Supplementary	NNP	O	Supplementary	nn	28	SENT_250	[p8l10t3391r532b3460],
28	Table	NNP	O	Table	prep_(	13	SENT_250	[p8l550t3391r718b3446],
29	2	CD	NUMBER	2	number	30	SENT_250	[p8l742t3391r819b3460],
30	)	CD	NUMBER	)	dep	28	SENT_250	[p8l742t3391r819b3460],
31	.	.	O	.	_	0	SENT_250	[p8l742t3391r819b3460],

1	3.4	CD	NUMBER	3.4	_	0	SENT_251	[p8l7t3572r112b3625],
2	.	.	O	.	_	0	SENT_251	[p8l7t3572r112b3625],

1	Genotypes	NNS	O	genotype	_	0	SENT_252	[p8l163t3572r481b3638],
2	of	IN	O	of	_	0	SENT_252	[p8l503t3569r569b3638],
3	rs2293347	NN	O	rs2293347	prep_of	1	SENT_252	[p8l579t3572r906b3624],
4	and	CC	O	and	_	0	SENT_252	[p8l925t3569r1038b3624],
5	CA-SSR	NN	O	ca-ssr	prep_of	1	SENT_252	[p8l1061t3572r1280b3624],
6	and	CC	O	and	_	0	SENT_252	[p8l1302t3569r1415b3624],
7	outcome	NN	O	outcome	prep_of	1	SENT_252	[p8l1437t3577r1701b3624],
8	of	IN	O	of	_	0	SENT_252	[p8l1723t3569r1789b3638],
9	Geﬁtinib	JJ	O	geﬁtinib	amod	10	SENT_252	[p8l11t3658r269b3727],
10	therapy	NN	O	therapy	prep_of	1	SENT_252	[p8l294t3658r528b3727],

1	We	PRP	O	we	nsubj	3	SENT_253	[p9l109t66r214b118],
2	further	RB	O	further	advmod	3	SENT_253	[p9l247t63r475b118],
3	investigated	VBD	O	investigate	_	0	SENT_253	[p9l506t63r895b131],
4	whether	IN	O	whether	complm	6	SENT_253	[p9l927t63r1201b118],
5	there	EX	O	there	expl	6	SENT_253	[p9l1232t63r1398b118],
6	was	VBD	O	be	ccomp	3	SENT_253	[p9l1430t79r1552b118],
7	signiﬁcant	NN	O	signiﬁcant	nn	8	SENT_253	[p9l1587t63r1922b131],
8	difference	NN	O	difference	nn	16	SENT_253	[p9l1953t63r2149b118, p9l10t167r156b206],
9	in	IN	O	in	_	0	SENT_253	[p9l191t152r250b205],
10	progression	NN	O	progression	nn	15	SENT_253	[p9l284t151r815b220],
11	—	CD	NUMBER	—	num	15	SENT_253	[p9l284t151r815b220],
12	free	JJ	O	free	amod	15	SENT_253	[p9l284t151r815b220],
13	survival	NN	O	survival	nn	15	SENT_253	[p9l850t151r1099b206],
14	(	CD	NUMBER	(	num	15	SENT_253	[p9l1134t151r1294b219],
15	PFS	NN	O	pf	prep_in	16	SENT_253	[p9l1134t151r1294b219],
16	)	NN	O	)	nsubj	6	SENT_253	[p9l1134t151r1294b219],
17	and	CC	O	and	_	0	SENT_253	[p9l1329t151r1445b206],
18	overall	JJ	O	overall	advmod	16	SENT_253	[p9l1480t151r1695b206],
19	survival	NN	O	survival	nn	22	SENT_253	[p9l1730t151r1980b206],
20	(	CD	NUMBER	(	num	22	SENT_253	[p9l2015t151r2150b219],
21	OS	NN	O	os	nn	22	SENT_253	[p9l2015t151r2150b219],
22	)	NN	O	)	conj_and	16	SENT_253	[p9l2015t151r2150b219],
23	among	IN	O	among	_	0	SENT_253	[p9l10t256r229b309],
24	patients	NNS	O	patient	prep_among	22	SENT_253	[p9l255t241r513b309],
25	carrying	VBG	O	carry	partmod	24	SENT_253	[p9l541t241r807b309],
26	different	JJ	O	different	amod	29	SENT_253	[p9l833t240r1111b295],
27	EGFR	NN	ORGANIZATION	egfr	nn	29	SENT_253	[p9l1134t243r1292b295],
28	rs2293347	NN	O	rs2293347	nn	29	SENT_253	[p9l1319t243r1654b295],
29	and/or	NN	O	and/or	nsubj	30	SENT_253	[p9l1682t240r1895b309],
30	CA	NNP	O	CA	xcomp	25	SENT_253	[p9l1919t242r2153b295],
31	.	.	O	.	_	0	SENT_253	[p9l1919t242r2153b295],

1	—	NN	O	—	_	0	SENT_254	[p9l1919t242r2153b295],
2	.	.	O	.	_	0	SENT_254	[p9l1919t242r2153b295],

1	SSR	NN	O	ssr	nn	2	SENT_255	[p9l1919t242r2153b295],
2	genotypes	NNS	O	genotype	_	0	SENT_255	[p9l9t337r336b398],
3	after	IN	O	after	_	0	SENT_255	[p9l356t329r506b384],
4	treatment	NN	O	treatment	prep_after	2	SENT_255	[p9l521t337r844b384],
5	with	IN	O	with	_	0	SENT_255	[p9l860t329r1008b384],
6	Geﬁtinib	NN	PERSON	geﬁtinib	prep_with	2	SENT_255	[p9l1026t329r1320b385],
7	.	.	O	.	_	0	SENT_255	[p9l1026t329r1320b385],

1	It	PRP	O	it	nsubjpass	3	SENT_256	[p9l1339t333r1384b384],
2	was	VBD	O	be	auxpass	3	SENT_256	[p9l1399t345r1522b384],
3	found	VBN	O	find	dep	23	SENT_256	[p9l1542t329r1726b384],
4	that	IN	O	that	complm	10	SENT_256	[p9l1744t329r1874b384],
5	patients	NNS	O	patient	nsubj	10	SENT_256	[p9l1891t330r2149b398],
6	carrying	VBG	O	carry	partmod	5	SENT_256	[p9l10t419r276b487],
7	the	DT	O	the	det	9	SENT_256	[p9l296t418r398b473],
8	rs2293347GG	NN	O	rs2293347gg	nn	9	SENT_256	[p9l420t421r858b473],
9	genotype	NN	O	genotype	dobj	6	SENT_256	[p9l878t427r1175b487],
10	had	VBD	O	have	ccomp	3	SENT_256	[p9l1198t418r1313b473],
11	a	DT	O	a	det	14	SENT_256	[p9l1335t434r1367b473],
12	longer	RBR	O	longer	amod	14	SENT_256	[p9l1389t418r1593b487],
13	median	JJ	O	median	amod	14	SENT_256	[p9l1614t418r1855b473],
14	PFS	NN	O	pf	dobj	10	SENT_256	[p9l1876t421r1983b473],
15	than	IN	O	than	_	0	SENT_256	[p9l2005t418r2150b473],
16	patients	NNS	O	patient	prep_than	10	SENT_256	[p9l10t508r268b576],
17	carrying	VBG	O	carry	partmod	16	SENT_256	[p9l289t509r556b576],
18	the	DT	O	the	det	22	SENT_256	[p9l574t508r675b563],
19	CA	NNP	O	CA	nn	22	SENT_256	[p9l696t510r788b563],
20	or	CC	O	or	_	0	SENT_256	[p9l805t523r871b563],
21	AA	NNP	O	AA	conj_or	19	SENT_256	[p9l886t510r980b562],
22	genotypes	NNS	O	genotype	dobj	17	SENT_256	[p9l996t516r1324b576],
23	[	VBP	O	[	_	0	SENT_256	[p9l1348t507r1442b576],
24	10	CD	DURATION	10	num	25	SENT_256	[p9l1348t507r1442b576],
25	months	NNS	NUMBER	month	tmod	23	SENT_256	[p9l1463t508r1706b563],
26	(	JJ	O	(	amod	27	SENT_256	[p9l1726t508r1945b576],
27	range	NN	O	range	nsubj	23	SENT_256	[p9l1726t508r1945b576],
28	,	,	O	,	_	0	SENT_256	[p9l1726t508r1945b576],
29	1-33	CD	NUMBER	1-33	num	30	SENT_256	[p9l1970t508r2150b576],
30	)	CD	NUMBER	)	appos	27	SENT_256	[p9l1970t508r2150b576],
31	versus	CC	O	versus	prep	30	SENT_256	[p9l8t613r213b652],
32	3	CD	DURATION	3	num	33	SENT_256	[p9l242t600r276b652],
33	months	NNS	NUMBER	month	dep	31	SENT_256	[p9l309t597r552b652],
34	(	JJ	O	(	amod	35	SENT_256	[p9l582t597r801b665],
35	range	NN	O	range	dep	33	SENT_256	[p9l582t597r801b665],
36	,	,	O	,	_	0	SENT_256	[p9l582t597r801b665],
37	1-20	CD	NUMBER	1-20	num	38	SENT_256	[p9l835t597r1032b665],
38	)	NN	O	)	appos	33	SENT_256	[p9l835t597r1032b665],
39	,	,	O	,	_	0	SENT_256	[p9l835t597r1032b665],
40	P	NN	O	p	appos	33	SENT_256	[p9l1060t600r1359b660],
41	=	JJ	O	=	amod	40	SENT_256	[p9l1060t600r1359b660],
42	0.002	CD	NUMBER	0.002	tmod	41	SENT_256	[p9l1060t600r1359b660],
43	;	:	O	;	_	0	SENT_256	[p9l1060t600r1359b660],
44	Fig	NN	O	fig	dep	30	SENT_256	[p9l1394t598r1499b665],
45	.	.	O	.	_	0	SENT_256	[p9l1394t598r1499b665],

1	2a	NN	O	2a	_	0	SENT_257	[p9l1529t597r1643b665],
2	]	NN	O	]	dep	1	SENT_257	[p9l1529t597r1643b665],
3	.	.	O	.	_	0	SENT_257	[p9l1529t597r1643b665],

1	Patients	NNS	O	patient	nsubj	7	SENT_258	[p9l1674t598r1929b652],
2	carrying	VBG	O	carry	partmod	1	SENT_258	[p9l1959t613r2149b665, p9l10t686r109b754],
3	the	DT	O	the	det	5	SENT_258	[p9l140t685r241b740],
4	rs2293347GG	NN	O	rs2293347gg	nn	5	SENT_258	[p9l275t688r712b740],
5	genotype	NN	O	genotype	dobj	2	SENT_258	[p9l744t693r1040b754],
6	also	RB	O	also	advmod	7	SENT_258	[p9l1074t685r1197b740],
7	had	VBD	O	have	_	0	SENT_258	[p9l1232t685r1347b740],
8	longer	RBR	O	longer	dep	7	SENT_258	[p9l1381t685r1585b754],
9	median	JJ	O	median	amod	10	SENT_258	[p9l1617t685r1858b740],
10	OS	NN	O	os	dep	8	SENT_258	[p9l1891t688r1972b740],
11	than	IN	O	than	_	0	SENT_258	[p9l2005t685r2150b740],
12	patients	NNS	O	patient	prep_than	10	SENT_258	[p9l10t775r268b843],
13	carrying	VBG	O	carry	partmod	12	SENT_258	[p9l295t775r562b843],
14	the	DT	O	the	det	18	SENT_258	[p9l586t774r688b829],
15	AC	NN	O	ac	nn	18	SENT_258	[p9l712t777r804b829],
16	or	CC	O	or	_	0	SENT_258	[p9l830t790r896b829],
17	AA	NN	O	aa	conj_or	15	SENT_258	[p9l918t777r1011b829],
18	genotypes	NNS	O	genotype	dobj	13	SENT_258	[p9l1033t782r1361b843],
19	although	IN	O	although	mark	25	SENT_258	[p9l1388t774r1675b843],
20	the	DT	O	the	det	21	SENT_258	[p9l1700t774r1801b829],
21	difference	NN	O	difference	nsubj	25	SENT_258	[p9l1828t774r2150b829],
22	was	VBD	O	be	cop	25	SENT_258	[p9l8t879r131b918],
23	not	RB	O	not	neg	25	SENT_258	[p9l169t872r274b918],
24	statistically	RB	O	statistically	advmod	25	SENT_258	[p9l310t863r677b932],
25	signiﬁcant	JJ	O	signiﬁcant	advcl	13	SENT_258	[p9l713t863r1047b932],
26	probably	RB	O	probably	advmod	25	SENT_258	[p9l1083t863r1367b932],
27	due	JJ	O	due	_	0	SENT_258	[p9l1403t863r1519b918],
28	to	TO	O	to	_	0	SENT_258	[p9l1556t872r1617b918],
29	limited	JJ	O	limited	amod	31	SENT_258	[p9l1655t863r1883b918],
30	sample	NN	O	sample	nn	31	SENT_258	[p9l1922t863r2150b932],
31	size	NN	O	size	prep_due_to	25	SENT_258	[p9l11t953r130b1007],
32	in	IN	O	in	_	0	SENT_258	[p9l152t953r211b1007],
33	analysis	NN	O	analysis	prep_in	31	SENT_258	[p9l232t952r485b1021],
34	[	CD	NUMBER	[	num	33	SENT_258	[p9l511t952r599b1021],
35	21	CD	DURATION	21	num	36	SENT_258	[p9l511t952r599b1021],
36	months	NNS	NUMBER	month	tmod	31	SENT_258	[p9l629t952r872b1007],
37	(	JJ	O	(	amod	38	SENT_258	[p9l895t953r1113b1021],
38	range	NN	O	range	tmod	7	SENT_258	[p9l895t953r1113b1021],
39	,	,	O	,	_	0	SENT_258	[p9l895t953r1113b1021],
40	3-48	CD	NUMBER	3-48	num	41	SENT_258	[p9l1135t952r1322b1021],
41	)	CD	NUMBER	)	appos	38	SENT_258	[p9l1135t952r1322b1021],
42	versus	CC	O	versus	prep	41	SENT_258	[p9l1342t968r1547b1007],
43	13	CD	DURATION	13	num	44	SENT_258	[p9l1574t955r1639b1007],
44	months	NNS	NUMBER	month	dep	42	SENT_258	[p9l1665t952r1907b1007],
45	(	JJ	O	(	amod	46	SENT_258	[p9l1931t953r2149b1021],
46	range	NN	O	range	dep	44	SENT_258	[p9l1931t953r2149b1021],
47	,	,	O	,	_	0	SENT_258	[p9l1931t953r2149b1021],
48	1-51	CD	NUMBER	1-51	num	49	SENT_258	[p9l13t1045r156b1097],
49	)	NN	O	)	appos	44	SENT_258	[p9l172t1042r206b1110],
50	,	,	O	,	_	0	SENT_258	[p9l172t1042r206b1110],
51	P	NN	O	p	appos	44	SENT_258	[p9l221t1045r261b1096],
52	=	JJ	O	=	amod	51	SENT_258	[p9l273t1065r306b1081],
53	0.176	CD	NUMBER	0.176	tmod	52	SENT_258	[p9l323t1044r503b1105],
54	;	:	O	;	_	0	SENT_258	[p9l323t1044r503b1105],
55	Fig	NN	O	fig	dep	41	SENT_258	[p9l526t1043r631b1110],
56	.	.	O	.	_	0	SENT_258	[p9l526t1043r631b1110],

1	2b	JJ	O	2b	amod	2	SENT_259	[p9l649t1042r767b1110],
2	)	NN	O	)	_	0	SENT_259	[p9l649t1042r767b1110],
3	.	.	O	.	_	0	SENT_259	[p9l649t1042r767b1110],

1	However	RB	O	however	dep	5	SENT_260	[p9l786t1045r1083b1105],
2	,	,	O	,	_	0	SENT_260	[p9l786t1045r1083b1105],
3	no	DT	O	no	det	5	SENT_260	[p9l1102t1057r1178b1097],
4	signiﬁcant	NN	O	signiﬁcant	nn	5	SENT_260	[p9l1197t1041r1531b1110],
5	difference	NN	O	difference	_	0	SENT_260	[p9l1547t1041r1868b1097],
6	in	IN	O	in	_	0	SENT_260	[p9l1886t1042r1944b1096],
7	either	CC	O	either	preconj	8	SENT_260	[p9l1961t1042r2152b1097],
8	PFS	NN	O	pf	prep_in	5	SENT_260	[p9l10t1134r117b1186],
9	[	CD	NUMBER	[	number	10	SENT_260	[p9l161t1131r256b1199],
10	10	CD	DURATION	10	num	11	SENT_260	[p9l161t1131r256b1199],
11	months	NNS	NUMBER	month	tmod	8	SENT_260	[p9l296t1131r539b1186],
12	(	JJ	O	(	amod	13	SENT_260	[p9l580t1131r799b1199],
13	range	NN	O	range	dep	8	SENT_260	[p9l580t1131r799b1199],
14	,	,	O	,	_	0	SENT_260	[p9l580t1131r799b1199],
15	2-32	CD	NUMBER	2-32	num	16	SENT_260	[p9l840t1131r1024b1199],
16	)	NN	O	)	dep	8	SENT_260	[p9l840t1131r1024b1199],
17	for	IN	O	for	_	0	SENT_260	[p9l1066t1131r1155b1186],
18	shorter	JJR	O	shorter	amod	20	SENT_260	[p9l1194t1131r1426b1186],
19	CA	NNP	O	CA	nn	20	SENT_260	[p9l1463t1133r1549b1186],
20	carriers	NNS	O	carrier	prep_for	16	SENT_260	[p9l1587t1132r1829b1186],
21	versus	CC	O	versus	_	0	SENT_260	[p9l1868t1147r2073b1186],
22	6	CD	DURATION	6	num	23	SENT_260	[p9l2114t1134r2150b1186],
23	months	NNS	NUMBER	month	tmod	24	SENT_260	[p9l10t1219r253b1274],
24	(	JJ	O	(	amod	25	SENT_260	[p9l273t1219r492b1288],
25	range	NN	O	range	dep	8	SENT_260	[p9l273t1219r492b1288],
26	,	,	O	,	_	0	SENT_260	[p9l273t1219r492b1288],
27	1-33	CD	NUMBER	1-33	num	28	SENT_260	[p9l515t1219r695b1287],
28	)	NN	O	)	dep	8	SENT_260	[p9l515t1219r695b1287],
29	for	IN	O	for	_	0	SENT_260	[p9l715t1219r805b1274],
30	longer	JJR	O	longer	amod	32	SENT_260	[p9l822t1219r1027b1288],
31	CA	NNP	O	CA	nn	32	SENT_260	[p9l1044t1221r1130b1274],
32	carriers	NNS	O	carrier	prep_for	28	SENT_260	[p9l1147t1220r1404b1282],
33	,	,	O	,	_	0	SENT_260	[p9l1147t1220r1404b1282],
34	P	NN	O	p	dep	8	SENT_260	[p9l1422t1222r1507b1273],
35	=	JJ	O	=	amod	34	SENT_260	[p9l1422t1222r1507b1273],
36	0.580	CD	NUMBER	0.580	tmod	35	SENT_260	[p9l1524t1222r1719b1283],
37	;	:	O	;	_	0	SENT_260	[p9l1524t1222r1719b1283],
38	Fig	NN	O	fig	dep	8	SENT_260	[p9l1744t1220r1849b1288],
39	.	.	O	.	_	0	SENT_260	[p9l1744t1220r1849b1288],

1	2c	JJ	O	2c	amod	2	SENT_261	[p9l1869t1219r1961b1288],
2	]	NN	O	]	_	0	SENT_261	[p9l1869t1219r1961b1288],
3	or	CC	O	or	_	0	SENT_261	[p9l1984t1235r2050b1274],
4	OS	NN	O	os	conj_or	2	SENT_261	[p9l2067t1222r2149b1274],
5	[	CD	NUMBER	[	dep	2	SENT_261	[p9l13t1308r110b1377],
6	22	CD	DURATION	22	num	7	SENT_261	[p9l13t1308r110b1377],
7	months	NNS	NUMBER	month	tmod	5	SENT_261	[p9l135t1308r378b1363],
8	(	JJ	O	(	amod	9	SENT_261	[p9l401t1308r620b1377],
9	range	NN	O	range	dep	2	SENT_261	[p9l401t1308r620b1377],
10	,	,	O	,	_	0	SENT_261	[p9l401t1308r620b1377],
11	4-36	CD	NUMBER	4-36	num	12	SENT_261	[p9l641t1308r828b1376],
12	)	NN	O	)	appos	9	SENT_261	[p9l641t1308r828b1376],
13	for	IN	O	for	_	0	SENT_261	[p9l851t1308r941b1363],
14	shorter	JJR	O	shorter	amod	16	SENT_261	[p9l962t1308r1193b1363],
15	CA	NNP	O	CA	nn	16	SENT_261	[p9l1214t1311r1300b1363],
16	carriers	NNS	O	carrier	prep_for	12	SENT_261	[p9l1320t1309r1561b1363],
17	versus	CC	O	versus	_	0	SENT_261	[p9l1583t1324r1788b1363],
18	16	CD	DURATION	16	num	19	SENT_261	[p9l1815t1311r1883b1363],
19	months	NNS	NUMBER	month	tmod	20	SENT_261	[p9l1906t1308r2149b1363],
20	(	JJ	O	(	amod	21	SENT_261	[p9l10t1398r228b1466],
21	range	NN	O	range	appos	9	SENT_261	[p9l10t1398r228b1466],
22	,	,	O	,	_	0	SENT_261	[p9l10t1398r228b1466],
23	1-51	CD	NUMBER	1-51	num	24	SENT_261	[p9l261t1398r437b1466],
24	)	NN	O	)	appos	2	SENT_261	[p9l261t1398r437b1466],
25	for	IN	O	for	_	0	SENT_261	[p9l466t1397r555b1452],
26	longer	JJR	O	longer	amod	28	SENT_261	[p9l581t1397r786b1466],
27	CA	NNP	O	CA	nn	28	SENT_261	[p9l811t1400r898b1452],
28	carriers	NNS	O	carrier	prep_for	24	SENT_261	[p9l923t1398r1181b1461],
29	,	,	O	,	_	0	SENT_261	[p9l923t1398r1181b1461],
30	P	NN	O	p	appos	2	SENT_261	[p9l1207t1400r1505b1461],
31	=	JJ	O	=	amod	30	SENT_261	[p9l1207t1400r1505b1461],
32	0.662	CD	NUMBER	0.662	tmod	31	SENT_261	[p9l1207t1400r1505b1461],
33	;	:	O	;	_	0	SENT_261	[p9l1207t1400r1505b1461],
34	Fig	NN	O	fig	dep	30	SENT_261	[p9l1539t1398r1644b1466],
35	.	.	O	.	_	0	SENT_261	[p9l1539t1398r1644b1466],

1	2d	JJ	O	2d	amod	2	SENT_262	[p9l1672t1397r1773b1466],
2	]	NN	O	]	_	0	SENT_262	[p9l1672t1397r1773b1466],
3	in	IN	O	in	_	0	SENT_262	[p9l1804t1398r1863b1452],
4	patients	NNS	O	patient	prep_in	2	SENT_262	[p9l1891t1398r2149b1466],
5	with	IN	O	with	_	0	SENT_262	[p9l8t1487r156b1542],
6	different	JJ	O	different	amod	7	SENT_262	[p9l179t1486r457b1542],
7	CA	NNP	O	CA	prep_with	2	SENT_262	[p9l479t1489r712b1542],
8	.	.	O	.	_	0	SENT_262	[p9l479t1489r712b1542],

1	—	NN	O	—	_	0	SENT_263	[p9l479t1489r712b1542],
2	.	.	O	.	_	0	SENT_263	[p9l479t1489r712b1542],

1	SSR	NN	O	ssr	nn	2	SENT_264	[p9l479t1489r712b1542],
2	genotypes	NNS	O	genotype	nsubjpass	4	SENT_264	[p9l730t1495r1058b1555],
3	was	VBD	O	be	auxpass	4	SENT_264	[p9l1080t1502r1203b1542],
4	observed	VBN	O	observe	_	0	SENT_264	[p9l1227t1487r1533b1542],
5	.	.	O	.	_	0	SENT_264	[p9l1227t1487r1533b1542],

1	Multivariate	JJ	O	multivariate	amod	2	SENT_265	[p9l112t1576r505b1631],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_265	[p9l529t1576r781b1644],
3	was	VBD	O	be	auxpass	4	SENT_265	[p9l804t1591r926b1631],
4	taken	VBN	O	take	_	0	SENT_265	[p9l950t1576r1127b1631],
5	to	TO	O	to	aux	6	SENT_265	[p9l1150t1584r1210b1631],
6	evaluate	VB	O	evaluate	xcomp	4	SENT_265	[p9l1234t1576r1501b1631],
7	whether	IN	O	whether	_	0	SENT_265	[p9l1523t1576r1798b1631],
8	the	DT	O	the	det	10	SENT_265	[p9l1818t1576r1920b1631],
9	apparent	JJ	O	apparent	amod	10	SENT_265	[p9l1943t1591r2149b1644, p9l10t1673r113b1719],
10	association	NN	O	association	prep_whether	6	SENT_265	[p9l146t1666r504b1719],
11	of	IN	O	of	_	0	SENT_265	[p9l538t1665r605b1719],
12	rs2293347	NN	O	rs2293347	prep_of	10	SENT_265	[p9l632t1668r968b1719],
13	or	CC	O	or	_	0	SENT_265	[p9l1005t1681r1071b1719],
14	CA	NNP	O	CA	prep_of	10	SENT_265	[p9l1104t1667r1338b1719],
15	.	.	O	.	_	0	SENT_265	[p9l1104t1667r1338b1719],

1	—	NN	O	—	_	0	SENT_266	[p9l1104t1667r1338b1719],
2	.	.	O	.	_	0	SENT_266	[p9l1104t1667r1338b1719],

1	SSR	NN	O	ssr	nsubjpass	6	SENT_267	[p9l1104t1667r1338b1719],
2	with	IN	O	with	_	0	SENT_267	[p9l1368t1665r1517b1719],
3	outcome	NN	O	outcome	prep_with	1	SENT_267	[p9l1551t1673r1831b1719],
4	could	MD	O	could	aux	6	SENT_267	[p9l1866t1665r2041b1719],
5	be	VB	O	be	auxpass	6	SENT_267	[p9l2075t1665r2150b1719],
6	accounted	VBN	O	account	_	0	SENT_267	[p9l10t1752r339b1807],
7	for	IN	O	for	dep	6	SENT_267	[p9l370t1752r459b1807],
8	by	IN	O	by	_	0	SENT_267	[p9l486t1752r562b1821],
9	other	JJ	O	other	amod	11	SENT_267	[p9l590t1752r762b1807],
10	clinical	JJ	O	clinical	amod	11	SENT_267	[p9l790t1752r1015b1807],
11	factors	NNS	O	factor	agent	6	SENT_267	[p9l1046t1752r1259b1807],
12	which	WDT	O	which	nsubj	14	SENT_267	[p9l1288t1752r1486b1807],
13	may	MD	O	may	aux	14	SENT_267	[p9l1516t1768r1652b1821],
14	affect	VB	O	affect	rcmod	11	SENT_267	[p9l1680t1752r1858b1807],
15	the	DT	O	the	det	16	SENT_267	[p9l1885t1752r1987b1807],
16	outcome	NN	O	outcome	dobj	14	SENT_267	[p9l2017t1760r2149b1807, p9l10t1857r181b1896],
17	of	IN	O	of	_	0	SENT_267	[p9l204t1841r271b1896],
18	Geﬁtinib	NNP	O	Geﬁtinib	prep_of	16	SENT_267	[p9l286t1841r580b1905],
19	,	,	O	,	_	0	SENT_267	[p9l286t1841r580b1905],
20	such	JJ	O	such	_	0	SENT_267	[p9l605t1841r750b1896],
21	as	IN	O	as	_	0	SENT_267	[p9l772t1857r835b1896],
22	sex	NN	O	sex	prep_such_as	11	SENT_267	[p9l860t1857r976b1905],
23	,	,	O	,	_	0	SENT_267	[p9l860t1857r976b1905],
24	smoking	NN	O	smoking	nn	25	SENT_267	[p9l1001t1841r1275b1910],
25	status	NN	O	status	conj_and	22	SENT_267	[p9l1298t1849r1501b1905],
26	,	,	O	,	_	0	SENT_267	[p9l1298t1849r1501b1905],
27	performance	NN	O	performance	nn	28	SENT_267	[p9l1526t1841r1937b1910],
28	status	NN	O	status	conj_and	22	SENT_267	[p9l1962t1849r2149b1896],
29	and	CC	O	and	_	0	SENT_267	[p9l10t1930r126b1985],
30	histological	JJ	O	histological	amod	31	SENT_267	[p9l154t1930r521b1999],
31	subtype	NN	O	subtype	conj_and	22	SENT_267	[p9l550t1930r819b1999],
32	.	.	O	.	_	0	SENT_267	[p9l550t1930r819b1999],

1	For	IN	O	for	mark	14	SENT_268	[p9l848t1934r949b1985],
2	both	CC	O	both	dep	4	SENT_268	[p9l973t1930r1119b1985],
3	functional	JJ	O	functional	amod	4	SENT_268	[p9l1146t1930r1471b1985],
4	polymorphisms	NNS	O	polymorphism	nsubj	14	SENT_268	[p9l1499t1930r2020b1999],
5	,	,	O	,	_	0	SENT_268	[p9l1499t1930r2020b1999],
6	the	DT	O	the	det	8	SENT_268	[p9l2048t1930r2150b1985],
7	rs2293347G	NN	O	rs2293347g	dep	8	SENT_268	[p9l10t2022r508b2075],
8	>	JJR	O	>	dep	4	SENT_268	[p9l10t2022r508b2075],
9	A	DT	O	a	det	11	SENT_268	[p9l10t2022r508b2075],
10	polymorphism	NN	O	polymorphism	nn	11	SENT_268	[p9l539t2020r1013b2088],
11	(	NN	O	(	dep	8	SENT_268	[p9l1047t2020r1347b2088],
12	adjusted	VBN	O	adjust	amod	14	SENT_268	[p9l1047t2020r1347b2088],
13	hazard	NN	O	hazard	nn	14	SENT_268	[p9l1381t2020r1596b2075],
14	ratio	NN	O	ratio	advcl	31	SENT_268	[p9l1631t2020r1994b2083],
15	=	JJ	O	=	amod	14	SENT_268	[p9l1631t2020r1994b2083],
16	2.29	CD	NUMBER	2.29	tmod	15	SENT_268	[p9l1631t2020r1994b2083],
17	,	,	O	,	_	0	SENT_268	[p9l1631t2020r1994b2083],
18	95	CD	PERCENT	95	number	19	SENT_268	[p9l2029t2022r2150b2075],
19	%	NN	PERCENT	%	amod	20	SENT_268	[p9l2029t2022r2150b2075],
20	Cl	NN	O	cl	dobj	14	SENT_268	[p9l10t2112r119b2164],
21	=	JJ	O	=	amod	20	SENT_268	[p9l10t2112r119b2164],
22	1.30-4	CD	NUMBER	1.30-4	num	23	SENT_268	[p9l139t2112r460b2172],
23	.03	CD	NUMBER	.03	tmod	21	SENT_268	[p9l139t2112r460b2172],
24	,	,	O	,	_	0	SENT_268	[p9l139t2112r460b2172],
25	P	NN	O	p	appos	23	SENT_268	[p9l489t2109r795b2177],
26	=	JJ	O	=	amod	28	SENT_268	[p9l489t2109r795b2177],
27	0.004	CD	NUMBER	0.004	num	28	SENT_268	[p9l489t2109r795b2177],
28	)	NN	O	)	nsubj	31	SENT_268	[p9l489t2109r795b2177],
29	was	VBD	O	be	cop	31	SENT_268	[p9l824t2125r947b2164],
30	a	DT	O	a	det	31	SENT_268	[p9l979t2125r1011b2164],
31	predictor	NN	O	predictor	_	0	SENT_268	[p9l1041t2109r1338b2177],
32	of	IN	O	of	_	0	SENT_268	[p9l1367t2109r1434b2164],
33	poor	JJ	O	poor	amod	34	SENT_268	[p9l1457t2125r1605b2177],
34	PFS	NN	O	pf	prep_of	31	SENT_268	[p9l1634t2112r1741b2164],
35	for	IN	O	for	_	0	SENT_268	[p9l1773t2109r1862b2164],
36	patients	NNS	O	patient	prep_for	34	SENT_268	[p9l1891t2110r2149b2177],
37	treated	VBN	O	treat	partmod	36	SENT_268	[p9l9t2198r238b2253],
38	with	IN	O	with	_	0	SENT_268	[p9l259t2198r407b2253],
39	Geﬁtinib	JJ	O	geﬁtinib	amod	42	SENT_268	[p9l430t2198r708b2253],
40	(	NN	O	(	nn	42	SENT_268	[p9l731t2198r1253b2266],
41	Supplementary	NNP	O	Supplementary	nn	42	SENT_268	[p9l731t2198r1253b2266],
42	Table	NNP	O	Table	prep_with	37	SENT_268	[p9l1271t2198r1440b2253],
43	3	CD	NUMBER	3	num	44	SENT_268	[p9l1462t2198r1540b2266],
44	)	NN	O	)	dep	42	SENT_268	[p9l1462t2198r1540b2266],
45	.	.	O	.	_	0	SENT_268	[p9l1462t2198r1540b2266],

1	4	LS	NUMBER	4	_	0	SENT_269	[p9l7t2384r64b2435],
2	.	.	O	.	_	0	SENT_269	[p9l7t2384r64b2435],

1	Discussion	NN	O	discussion	_	0	SENT_270	[p9l110t2380r472b2434],

1	Because	IN	O	because	mark	7	SENT_271	[p9l112t2561r367b2613],
2	response	NN	O	response	nsubjpass	7	SENT_271	[p9l391t2573r676b2626],
3	to	TO	O	to	_	0	SENT_271	[p9l699t2566r759b2613],
4	Geﬁtinib	NNP	PERSON	Geﬁtinib	prep_to	2	SENT_271	[p9l783t2557r1061b2613],
5	has	VBZ	O	have	aux	7	SENT_271	[p9l1085t2558r1189b2613],
6	been	VBN	O	be	auxpass	7	SENT_271	[p9l1212t2558r1367b2613],
7	shown	VBN	O	show	advcl	18	SENT_271	[p9l1391t2558r1602b2613],
8	to	TO	O	to	aux	10	SENT_271	[p9l1624t2566r1685b2613],
9	be	VB	O	be	cop	10	SENT_271	[p9l1708t2558r1782b2613],
10	dependent	JJ	O	dependent	xcomp	7	SENT_271	[p9l1805t2558r2151b2626],
11	on	IN	O	on	_	0	SENT_271	[p9l10t2662r88b2702],
12	mutation	NN	O	mutation	nn	13	SENT_271	[p9l112t2647r408b2702],
13	status	NN	O	status	prep_on	10	SENT_271	[p9l433t2655r620b2702],
14	of	IN	O	of	_	0	SENT_271	[p9l645t2646r712b2702],
15	EGFR	NN	ORGANIZATION	egfr	prep_of	13	SENT_271	[p9l726t2649r899b2710],
16	,	,	O	,	_	0	SENT_271	[p9l726t2649r899b2710],
17	we	PRP	O	we	nsubj	18	SENT_271	[p9l923t2662r1015b2702],
18	examined	VBD	O	examine	_	0	SENT_271	[p9l1040t2647r1356b2702],
19	whether	IN	O	whether	complm	24	SENT_271	[p9l1379t2647r1653b2702],
20	germline	NN	O	germline	nn	21	SENT_271	[p9l1674t2647r1961b2715],
21	polymorphisms	NNS	O	polymorphism	nsubj	24	SENT_271	[p9l1986t2647r2149b2715, p9l10t2736r373b2804],
22	of	IN	O	of	_	0	SENT_271	[p9l405t2736r472b2791],
23	EGFR	NN	ORGANIZATION	egfr	prep_of	21	SENT_271	[p9l493t2739r652b2791],
24	had	VBD	O	have	ccomp	18	SENT_271	[p9l682t2736r798b2791],
25	effect	NN	O	effect	dobj	24	SENT_271	[p9l830t2736r1008b2791],
26	on	IN	O	on	_	0	SENT_271	[p9l1037t2752r1116b2791],
27	clinical	JJ	O	clinical	amod	28	SENT_271	[p9l1147t2736r1373b2791],
28	response	NN	O	response	prep_on	25	SENT_271	[p9l1405t2752r1690b2804],
29	and	CC	O	and	_	0	SENT_271	[p9l1721t2736r1838b2791],
30	outcome	NN	O	outcome	conj_and	28	SENT_271	[p9l1869t2744r2150b2791],
31	in	IN	O	in	_	0	SENT_271	[p9l10t2825r69b2878],
32	advanced	JJ	O	advanced	amod	34	SENT_271	[p9l102t2824r405b2879],
33	NSCLC	NN	O	nsclc	nn	34	SENT_271	[p9l440t2827r645b2879],
34	patients	NNS	O	patient	prep_in	24	SENT_271	[p9l678t2825r936b2893],
35	treated	VBN	O	treat	partmod	34	SENT_271	[p9l970t2824r1198b2879],
36	with	IN	O	with	_	0	SENT_271	[p9l1231t2824r1379b2879],
37	Geﬁtinib	NN	PERSON	geﬁtinib	prep_with	35	SENT_271	[p9l1412t2824r1706b2880],
38	.	.	O	.	_	0	SENT_271	[p9l1412t2824r1706b2880],

1	Using	VBG	O	use	csubj	5	SENT_272	[p9l1739t2825r1921b2893],
2	whole	JJ	O	whole	amod	4	SENT_272	[p9l1951t2824r2150b2879],
3	gene	NN	O	gene	nn	4	SENT_272	[p9l9t2913r377b2982],
4	—	NN	O	—	dobj	1	SENT_272	[p9l9t2913r377b2982],
5	based	VBN	O	base	_	0	SENT_272	[p9l9t2913r377b2982],
6	tag	NN	O	tag	dobj	5	SENT_272	[p9l406t2916r662b2982],
7	.	.	O	.	_	0	SENT_272	[p9l406t2916r662b2982],

1	—	NN	O	—	_	0	SENT_273	[p9l406t2916r662b2982],
2	.	.	O	.	_	0	SENT_273	[p9l406t2916r662b2982],

1	SNP	NN	ORGANIZATION	snp	nn	2	SENT_274	[p9l406t2916r662b2982],
2	approach	NN	O	approach	nsubj	5	SENT_274	[p9l689t2913r1002b2982],
3	,	,	O	,	_	0	SENT_274	[p9l689t2913r1002b2982],
4	we	PRP	O	we	nsubj	5	SENT_274	[p9l1030t2929r1123b2968],
5	found	VBD	O	find	_	0	SENT_274	[p9l1153t2913r1338b2968],
6	that	IN	O	that	complm	18	SENT_274	[p9l1367t2913r1496b2968],
7	the	DT	O	the	det	8	SENT_274	[p9l1523t2913r1625b2968],
8	rs2293347G	NN	O	rs2293347g	nsubjpass	18	SENT_274	[p9l1655t2916r2042b2968],
9	>	JJR	O	>	dep	8	SENT_274	[p9l2060t2916r2152b2968],
10	A	DT	O	a	det	11	SENT_274	[p9l2060t2916r2152b2968],
11	polymorphism	NN	O	polymorphism	dep	8	SENT_274	[p9l10t3002r484b3071],
12	in	IN	O	in	_	0	SENT_274	[p9l531t3003r590b3057],
13	exon	NN	O	exon	prep_in	11	SENT_274	[p9l636t3018r787b3057],
14	25	CD	NUMBER	25	num	13	SENT_274	[p9l833t3005r908b3057],
15	of	IN	O	of	_	0	SENT_274	[p9l957t3002r1023b3057],
16	EGFR	NN	ORGANIZATION	egfr	prep_of	13	SENT_274	[p9l1060t3005r1218b3057],
17	was	VBD	O	be	auxpass	18	SENT_274	[p9l1262t3018r1385b3057],
18	associated	VBN	O	associate	ccomp	5	SENT_274	[p9l1432t3002r1764b3057],
19	with	IN	O	with	_	0	SENT_274	[p9l1809t3002r1957b3057],
20	poor	JJ	O	poor	amod	21	SENT_274	[p9l2004t3018r2152b3071],
21	response	NN	O	response	prep_with	18	SENT_274	[p9l10t3107r295b3160],
22	to	TO	O	to	_	0	SENT_274	[p9l312t3100r372b3147],
23	Geﬁtinib	NNP	PERSON	Geﬁtinib	prep_to	18	SENT_274	[p9l390t3091r684b3147],
24	.	.	O	.	_	0	SENT_274	[p9l390t3091r684b3147],

1	We	PRP	O	we	nsubj	3	SENT_275	[p9l699t3095r804b3147],
2	also	RB	O	also	advmod	3	SENT_275	[p9l821t3092r945b3147],
3	found	VBD	O	find	_	0	SENT_275	[p9l963t3091r1148b3147],
4	that	IN	O	that	_	0	SENT_275	[p9l1165t3092r1295b3147],
5	the	DT	O	the	det	6	SENT_275	[p9l1309t3092r1411b3147],
6	CA	NNP	O	CA	prep_that	3	SENT_275	[p9l1428t3094r1662b3147],
7	.	.	O	.	_	0	SENT_275	[p9l1428t3094r1662b3147],

1	—	NN	O	—	_	0	SENT_276	[p9l1428t3094r1662b3147],
2	.	.	O	.	_	0	SENT_276	[p9l1428t3094r1662b3147],

1	SSR	NN	O	ssr	nn	2	SENT_277	[p9l1428t3094r1662b3147],
2	polymorphism	NN	O	polymorphism	nsubj	9	SENT_277	[p9l1676t3092r2150b3160],
3	in	IN	O	in	_	0	SENT_277	[p9l10t3182r69b3235],
4	intron	NN	O	intron	prep_in	2	SENT_277	[p9l105t3182r301b3236],
5	1	CD	NUMBER	1	num	4	SENT_277	[p9l340t3184r364b3235],
6	of	IN	O	of	_	0	SENT_277	[p9l408t3181r474b3236],
7	the	DT	O	the	det	8	SENT_277	[p9l501t3181r603b3236],
8	gene	NN	O	gene	prep_of	4	SENT_277	[p9l637t3197r788b3249],
9	had	VBD	O	have	_	0	SENT_277	[p9l824t3181r940b3236],
10	effect	NN	O	effect	dobj	9	SENT_277	[p9l976t3181r1154b3236],
11	on	IN	O	on	_	0	SENT_277	[p9l1189t3197r1267b3236],
12	response	NN	O	response	prep_on	10	SENT_277	[p9l1302t3197r1587b3249],
13	to	TO	O	to	_	0	SENT_277	[p9l1623t3189r1683b3236],
14	Geﬁtinib	NNP	O	Geﬁtinib	prep_to	9	SENT_277	[p9l1720t3181r1998b3236],
15	and	CC	O	and	_	0	SENT_277	[p9l2033t3181r2149b3236],
16	patients	NNS	O	patient	conj_and	14	SENT_277	[p9l10t3271r268b3338],
17	carrying	VBG	O	carry	xcomp	9	SENT_277	[p9l297t3271r563b3338],
18	the	DT	O	the	det	20	SENT_277	[p9l589t3270r691b3325],
19	longer	JJR	O	longer	amod	20	SENT_277	[p9l719t3270r923b3338],
20	CA	NNP	O	CA	dobj	17	SENT_277	[p9l949t3272r1183b3325],
21	.	.	O	.	_	0	SENT_277	[p9l949t3272r1183b3325],

1	—	NN	O	—	_	0	SENT_278	[p9l949t3272r1183b3325],
2	.	.	O	.	_	0	SENT_278	[p9l949t3272r1183b3325],

1	SSR	NN	O	ssr	nn	2	SENT_279	[p9l949t3272r1183b3325],
2	allele	NN	O	allele	nsubj	3	SENT_279	[p9l1207t3270r1376b3325],
3	had	VBD	O	have	_	0	SENT_279	[p9l1405t3270r1521b3325],
4	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_279	[p9l1550t3270r1943b3338],
5	lower	JJR	O	lower	amod	7	SENT_279	[p9l1970t3270r2152b3325],
6	response	NN	O	response	nn	7	SENT_279	[p9l10t3374r295b3427],
7	rate	NN	O	rate	dobj	3	SENT_279	[p9l324t3366r446b3413],
8	than	IN	O	than	_	0	SENT_279	[p9l474t3358r618b3413],
9	patients	NNS	O	patient	prep_than	3	SENT_279	[p9l647t3359r905b3427],
10	carrying	VBG	O	carry	partmod	9	SENT_279	[p9l935t3359r1201b3427],
11	the	DT	O	the	det	13	SENT_279	[p9l1228t3358r1329b3413],
12	shorter	JJR	O	shorter	amod	13	SENT_279	[p9l1359t3358r1590b3413],
13	CA	NNP	O	CA	dobj	10	SENT_279	[p9l1617t3360r1850b3413],
14	.	.	O	.	_	0	SENT_279	[p9l1617t3360r1850b3413],

1	—	NN	O	—	_	0	SENT_280	[p9l1617t3360r1850b3413],
2	.	.	O	.	_	0	SENT_280	[p9l1617t3360r1850b3413],

1	SSR	NN	O	ssr	_	0	SENT_281	[p9l1617t3360r1850b3413],
2	allele	NN	O	allele	dep	1	SENT_281	[p9l1875t3358r2061b3414],
3	.	.	O	.	_	0	SENT_281	[p9l1875t3358r2061b3414],

1	In	IN	O	in	_	0	SENT_282	[p9l2090t3361r2150b3412],

1	Analysis	NN	O	analysis	_	0	SENT_283	[p9l6t3502r110b3529],
2	of	IN	O	of	_	0	SENT_283	[p9l119t3502r145b3524],
3	response	NN	O	response	prep_of	1	SENT_283	[p9l151t3508r262b3529],
4	to	TO	O	to	_	0	SENT_283	[p9l271t3505r295b3524],
5	Geﬁtinib	NNP	LOCATION	Geﬁtinib	prep_to	3	SENT_283	[p9l304t3502r413b3524],
6	in	IN	O	in	_	0	SENT_283	[p9l422t3503r445b3524],
7	advanced	JJ	O	advanced	amod	8	SENT_283	[p9l453t3502r572b3524],
8	NSCLC	NNP	O	NSCLC	prep_in	5	SENT_283	[p9l582t3503r669b3524],
9	:	:	O	:	_	0	SENT_283	[p9l582t3503r669b3524],
10	association	NN	O	association	dep	1	SENT_283	[p9l680t3503r820b3524],
11	with	IN	O	with	_	0	SENT_283	[p9l828t3502r886b3524],
12	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_283	[p9l894t3503r956b3524],
13	genetic	JJ	O	genetic	amod	14	SENT_283	[p9l964t3503r1055b3529],
14	polymorphisms	NNS	O	polymorphism	prep_with	10	SENT_283	[p9l1063t3502r1267b3529],
15	.	.	O	.	_	0	SENT_283	[p9l1063t3502r1267b3529],

1	Genotype	NN	O	genotype	nn	2	SENT_284	[p9l6t3563r127b3589],
2	Responder	NN	O	responder	_	0	SENT_284	[p9l800t3562r942b3589],
3	“	CD	NUMBER	“	num	4	SENT_284	[p9l800t3562r942b3589],
4	Non	NNP	O	Non	dep	2	SENT_284	[p9l1415t3559r1617b3589],
5	—	CD	NUMBER	—	num	4	SENT_284	[p9l1415t3559r1617b3589],
6	responder	NN	O	responder	dep	4	SENT_284	[p9l1415t3559r1617b3589],
7	‘	CD	NUMBER	‘	num	6	SENT_284	[p9l1415t3559r1617b3589],
8	°	CD	NUMBER	°	num	9	SENT_284	[p9l1415t3559r1617b3589],
9	P	NN	O	p	dep	2	SENT_284	[p9l2088t3563r2104b3583],

1	No.	NN	PERCENT	no.	nn	4	SENT_285	[p9l1247t3632r1287b3653],
2	%	NN	PERCENT	%	nn	4	SENT_285	[p9l1523t3632r1539b3653],
3	No.	NN	PERCENT	no.	nn	4	SENT_285	[p9l1862t3632r1902b3653],
4	%	NN	PERCENT	%	_	0	SENT_285	[p9l2138t3632r2154b3653],

1	rs2293347	NN	O	rs2293347	nsubj	2	SENT_286	[p9l6t3685r137b3706],
2	c	NN	O	c	_	0	SENT_286	[p9l147t3685r164b3706],
3	>	JJR	O	>	dobj	2	SENT_286	[p9l171t3685r208b3706],
4	A	DT	O	a	det	6	SENT_286	[p9l171t3685r208b3706],
5	(	CD	NUMBER	(	num	6	SENT_286	[p9l215t3684r322b3711],
6	D994D	NN	O	d994d	dep	3	SENT_286	[p9l215t3684r322b3711],
7	)	CD	NUMBER	)	number	8	SENT_286	[p9l215t3684r322b3711],
8	0.004	CD	NUMBER	0.004	dep	6	SENT_286	[p9l6t3721r76b3742],
9	Go	VB	O	go	dep	2	SENT_286	[p9l34t3757r71b3778],
10	42	CD	NUMBER	42	number	11	SENT_286	[p9l800t3757r830b3778],
11	71	CD	NUMBER	71	num	12	SENT_286	[p9l1078t3757r1104b3778],
12	2	CD	NUMBER	2	dobj	9	SENT_286	[p9l1115t3757r1129b3778],

1	GA+AA	NN	O	ga+aa	_	0	SENT_287	[p9l34t3792r139b3813],
2	°	CD	NUMBER	°	number	3	SENT_287	[p9l34t3792r139b3813],
3	9	CD	NUMBER	9	dep	1	SENT_287	[p9l816t3792r830b3813],
4	37.5	CD	NUMBER	37.5	dep	3	SENT_287	[p9l1077t3792r1128b3813],

1	.	.	O	.	_	0	SENT_288	[p9l1418t3757r1429b3812],

1	.	.	O	.	_	0	SENT_289	[p9l1418t3757r1429b3812],

1	—	NN	O	—	_	0	SENT_290	[p9l1418t3757r1429b3812],
2	.	.	O	.	_	0	SENT_290	[p9l1418t3757r1429b3812],

1	t.	NN	O	t.	_	0	SENT_291	[p9l1418t3757r1429b3812],
2	.	.	O	.	_	0	SENT_291	[p9l1418t3757r1429b3812],

1	—	NN	O	—	_	0	SENT_292	[p9l1418t3757r1429b3812],
2	.	.	O	.	_	0	SENT_292	[p9l1418t3757r1429b3812],

1	A	DT	O	a	det	2	SENT_293	[p9l1418t3757r1429b3812],
2	U	NNP	O	U	nsubj	5	SENT_293	[p9l1431t3757r1445b3813],
3	'	POS	O	'	_	0	SENT_293	[p9l1431t3757r1445b3813],
4	I	PRP	O	I	dep	2	SENT_293	[p9l1431t3757r1445b3813],
5	\	VBP	O	\	_	0	SENT_293	[p9l1431t3757r1445b3813],
6	l	NN	O	l	tmod	5	SENT_293	[p9l1431t3757r1445b3813],

1	CA-SSR	NN	O	ca-ssr	_	0	SENT_294	[p10l6t31r98b52],
2	in	IN	O	in	_	0	SENT_294	[p10l105t30r129b52],
3	intron	NN	O	intron	nn	5	SENT_294	[p10l137t30r215b52],
4	1	CD	NUMBER	1	num	5	SENT_294	[p10l224t27r249b52],
5	“	NN	O	“	prep_in	1	SENT_294	[p10l224t27r249b52],
6	<	JJR	O	<	dep	17	SENT_294	[p10l6t66r87b87],
7	0.001	CD	NUMBER	0.001	num	9	SENT_294	[p10l6t66r87b87],
8	Shorter	JJR	O	shorter	amod	9	SENT_294	[p10l33t101r126b123],
9	CA-SSR	NN	O	ca-ssr	dep	6	SENT_294	[p10l134t102r225b123],
10	23	CD	NUMBER	23	number	11	SENT_294	[p10l799t102r828b123],
11	88.5	CD	NUMBER	88.5	num	13	SENT_294	[p10l1076t102r1127b123],
12	3	CD	NUMBER	3	number	13	SENT_294	[p10l1430t102r1443b123],
13	11.5	CD	NUMBER	11.5	dep	9	SENT_294	[p10l1695t102r1742b123],
14	Longer	JJR	O	longer	amod	15	SENT_294	[p10l33t137r118b163],
15	CA-SSR	NN	O	ca-ssr	dep	17	SENT_294	[p10l126t137r218b158],
16	28	CD	NUMBER	28	number	17	SENT_294	[p10l799t137r829b158],
17	48.3	CD	NUMBER	48.3	dep	1	SENT_294	[p10l1074t137r1127b158],
18	30	CD	NUMBER	30	num	20	SENT_294	[p10l1414t137r1445b158],
19	51.7	CD	NUMBER	51.7	num	20	SENT_294	[p10l1693t137r1743b158],
20	Combination	NN	O	combination	dep	17	SENT_294	[p10l6t192r169b214],
21	of	IN	O	of	_	0	SENT_294	[p10l177t192r204b214],
22	rs2293347	CD	NUMBER	rs2293347	prep_of	17	SENT_294	[p10l209t193r341b214],
23	G	NN	O	g	dep	1	SENT_294	[p10l350t193r368b214],
24	>	JJR	O	>	dep	23	SENT_294	[p10l375t197r387b211],
25	A	DT	O	a	dep	23	SENT_294	[p10l393t193r411b214],
26	and	CC	O	and	_	0	SENT_294	[p10l419t192r465b214],
27	CA	NNP	O	CA	conj_and	23	SENT_294	[p10l473t193r565b214],
28	.	.	O	.	_	0	SENT_294	[p10l473t193r565b214],

1	—	NN	O	—	_	0	SENT_295	[p10l473t193r565b214],
2	.	.	O	.	_	0	SENT_295	[p10l473t193r565b214],

1	SSR	NN	O	ssr	_	0	SENT_296	[p10l473t193r565b214],
2	<	JJR	O	<	dep	1	SENT_296	[p10l6t228r87b249],
3	0.001	CD	NUMBER	0.001	num	5	SENT_296	[p10l6t228r87b249],
4	rs2293347	NN	O	rs2293347	nn	5	SENT_296	[p10l34t263r165b284],
5	GG	NNS	O	gg	dep	11	SENT_296	[p10l175t263r212b284],
6	and	CC	O	and	_	0	SENT_296	[p10l220t262r266b284],
7	shorter	JJR	O	shorter	amod	8	SENT_296	[p10l275t262r366b284],
8	CA-SSR	NN	O	ca-ssr	dep	11	SENT_296	[p10l374t263r465b284],
9	19	CD	NUMBER	19	dep	11	SENT_296	[p10l803t263r830b284],
10	90.5	CD	NUMBER	90.5	number	11	SENT_296	[p10l1076t263r1128b284],
11	2	CD	NUMBER	2	dep	25	SENT_296	[p10l1431t263r1445b283],
12	9.5	CD	NUMBER	9.5	num	14	SENT_296	[p10l1707t263r1743b284],
13	rs2293347	NN	O	rs2293347	nn	14	SENT_296	[p10l34t299r165b320],
14	AG	NNP	O	AG	dep	11	SENT_296	[p10l174t299r210b320],
15	+	CC	O	+	_	0	SENT_296	[p10l216t302r229b316],
16	AA	NNP	O	AA	dep	11	SENT_296	[p10l235t299r271b320],
17	and	CC	O	and	_	0	SENT_296	[p10l279t298r324b320],
18	shorter	JJR	O	shorter	amod	19	SENT_296	[p10l333t298r424b320],
19	CA-SSR	NN	O	ca-ssr	dep	25	SENT_296	[p10l432t299r523b320],
20	4	CD	NUMBER	4	number	21	SENT_296	[p10l815t299r831b320],
21	80.0	CD	NUMBER	80.0	dep	19	SENT_296	[p10l1077t299r1129b320],
22	1	CD	NUMBER	1	number	23	SENT_296	[p10l1432t299r1442b320],
23	20.0	CD	NUMBER	20.0	num	25	SENT_296	[p10l1691t299r1744b320],
24	rs2293347	NN	O	rs2293347	nn	25	SENT_296	[p10l34t334r165b355],
25	GG	NNS	O	gg	dep	33	SENT_296	[p10l175t334r212b355],
26	and	CC	O	and	_	0	SENT_296	[p10l220t333r266b355],
27	longer	JJR	O	longer	amod	28	SENT_296	[p10l275t333r355b360],
28	CA-SSR	NN	O	ca-ssr	conj_and	25	SENT_296	[p10l363t334r454b355],
29	23	CD	NUMBER	23	number	30	SENT_296	[p10l800t334r829b355],
30	60.5	CD	NUMBER	60.5	num	28	SENT_296	[p10l1077t334r1128b355],
31	15	CD	NUMBER	15	number	32	SENT_296	[p10l1418t334r1444b355],
32	39.5	CD	NUMBER	39.5	num	33	SENT_296	[p10l1691t334r1743b355],
33	rs2293347	NN	O	rs2293347	dep	45	SENT_296	[p10l34t369r165b390],
34	AG	NNP	O	AG	dep	33	SENT_296	[p10l174t369r210b390],
35	+	CC	O	+	_	0	SENT_296	[p10l216t372r229b386],
36	AA	NNP	O	AA	conj_+	34	SENT_296	[p10l235t369r271b390],
37	and	CC	O	and	_	0	SENT_296	[p10l279t368r324b390],
38	longer	JJR	O	longer	amod	39	SENT_296	[p10l333t368r414b395],
39	CA-SSR	NN	O	ca-ssr	conj_and	33	SENT_296	[p10l421t369r513b390],
40	5	CD	NUMBER	5	number	41	SENT_296	[p10l817t369r830b390],
41	26.3	CD	NUMBER	26.3	num	42	SENT_296	[p10l1077t369r1128b390],
42	14	CD	NUMBER	14	dep	39	SENT_296	[p10l1419t369r1446b390],
43	73.7	CD	NUMBER	73.7	num	44	SENT_296	[p10l1693t369r1744b390],
44	5	CD	NUMBER	5	nsubj	45	SENT_296	[p10l32t421r41b432],
45	Includes	VBZ	O	include	ccomp	2	SENT_296	[p10l57t420r161b442],
46	partial	JJ	O	partial	amod	47	SENT_296	[p10l171t420r252b447],
47	response	NN	O	response	dobj	45	SENT_296	[p10l261t426r372b447],
48	and	CC	O	and	_	0	SENT_296	[p10l381t420r427b442],
49	stable	JJ	O	stable	amod	50	SENT_296	[p10l436t420r509b442],
50	disease	NN	O	disease	dobj	45	SENT_296	[p10l518t420r615b442],
51	.	.	O	.	_	0	SENT_296	[p10l518t420r615b442],
52	"	''	O	"	punct	47	SENT_296	[p10l31t455r41b470],

1	Includes	VBZ	O	include	_	0	SENT_297	[p10l57t458r162b480],
2	progressive	JJ	O	progressive	amod	3	SENT_297	[p10l171t459r314b485],
3	disease	NN	O	disease	dobj	1	SENT_297	[p10l323t458r420b480],
4	.	.	O	.	_	0	SENT_297	[p10l323t458r420b480],

1	5	CD	NUMBER	5	npadvmod	2	SENT_298	[p10l33t497r41b508],
2	Only	RB	O	only	dep	5	SENT_298	[p10l57t496r115b523],
3	one	CD	NUMBER	one	num	5	SENT_298	[p10l123t502r168b518],
4	AA	NN	O	aa	nn	5	SENT_298	[p10l176t497r213b517],
5	genotype	NN	O	genotype	_	0	SENT_298	[p10l220t499r336b523],
6	that	WDT	O	that	nsubj	10	SENT_298	[p10l345t496r396b518],
7	was	VBD	O	be	cop	10	SENT_298	[p10l403t502r451b518],
8	non	JJ	O	non	amod	10	SENT_298	[p10l461t496r680b523],
9	—	NN	O	—	nn	10	SENT_298	[p10l461t496r680b523],
10	responseder	NN	O	responseder	rcmod	5	SENT_298	[p10l461t496r680b523],
11	.	.	O	.	_	0	SENT_298	[p10l461t496r680b523],

1	“	NN	O	“	_	0	SENT_299	[p10l31t531r41b546],
2	Shorter	JJR	O	shorter	amod	3	SENT_299	[p10l57t534r150b556],
3	CA-SSR	NN	O	ca-ssr	dep	1	SENT_299	[p10l158t535r254b559],
4	.	.	O	.	_	0	SENT_299	[p10l158t535r254b559],

1	with	IN	O	with	_	0	SENT_300	[p10l263t534r321b556],
2	any	DT	O	any	det	3	SENT_300	[p10l329t541r374b561],
3	allele	NN	O	allele	pobj	1	SENT_300	[p10l382t534r448b556],
4	of	IN	O	of	_	0	SENT_300	[p10l457t534r483b556],
5	516	CD	NUMBER	516	number	6	SENT_300	[p10l489t536r537b559],
6	(	CD	NUMBER	(	num	9	SENT_300	[p10l546t534r620b561],
7	CA	NNP	O	CA	nn	9	SENT_300	[p10l546t534r620b561],
8	)	CD	NUMBER	)	num	9	SENT_300	[p10l546t534r620b561],
9	n	NN	O	n	prep_of	3	SENT_300	[p10l546t534r620b561],
10	;	:	O	;	_	0	SENT_300	[p10l546t534r620b561],
11	longer	JJR	O	longer	amod	12	SENT_300	[p10l631t534r711b561],
12	CA-SSR	NN	O	ca-ssr	dep	9	SENT_300	[p10l719t535r815b559],
13	,	,	O	,	_	0	SENT_300	[p10l719t535r815b559],
14	with	IN	O	with	_	0	SENT_300	[p10l823t534r881b556],
15	both	DT	O	both	det	16	SENT_300	[p10l890t534r947b556],
16	alleles	NNS	O	allele	prep_with	9	SENT_300	[p10l955t534r1034b556],
17	of	IN	O	of	_	0	SENT_300	[p10l1043t534r1069b556],
18	>	JJR	O	>	prep_of	16	SENT_300	[p10l1075t536r1118b556],
19	16	CD	NUMBER	16	num	20	SENT_300	[p10l1075t536r1118b556],
20	(	NN	O	(	dep	18	SENT_300	[p10l1127t534r1199b561],
21	CA	NNP	O	CA	nn	22	SENT_300	[p10l1127t534r1199b561],
22	)	NNP	O	)	dep	20	SENT_300	[p10l1127t534r1199b561],
23	,	,	O	,	_	0	SENT_300	[p10l1127t534r1199b561],
24	.	.	O	.	_	0	SENT_300	[p10l1127t534r1199b561],

1	.	.	O	.	_	0	SENT_301	[p10l1127t534r1199b561],

1	118	CD	NUMBER	118	num	3	SENT_302	[p10l403t637r447b658],
2	F.	NNP	O	F.	nn	3	SENT_302	[p10l1216t637r1231b658],
3	Ma	NNP	O	Ma	_	0	SENT_302	[p10l1240t637r1278b658],
4	et	FW	O	et	nn	5	SENT_302	[p10l1287t639r1310b658],
5	al.	FW	O	al.	dep	3	SENT_302	[p10l1317t636r1427b663],
6	/	:	O	/	punct	3	SENT_302	[p10l1317t636r1427b663],
7	Lung	NN	O	lung	nn	8	SENT_302	[p10l1317t636r1427b663],
8	Cancer	NN	O	cancer	dep	3	SENT_302	[p10l1434t637r1517b658],
9	66	CD	NUMBER	66	number	10	SENT_302	[p10l1524t637r1554b658],
10	(	CD	NUMBER	(	num	11	SENT_302	[p10l1561t636r1642b663],
11	2009	CD	DATE	2009	dep	8	SENT_302	[p10l1561t636r1642b663],
12	)	CD	NUMBER	)	number	13	SENT_302	[p10l1561t636r1642b663],
13	114-119	CD	NUMBER	114-119	num	11	SENT_302	[p10l1653t637r1756b658],

1	:	:	O	:	_	0	SENT_303	[p10l1015t966r1154b975],
2	rs2.29a3-ill	NN	O	rs2.29a3-ill	_	0	SENT_303	[p10l1207t931r1627b998],
3	?	.	O	?	_	0	SENT_303	[p10l1207t931r1627b998],
4	"	''	O	"	punct	2	SENT_303	[p10l1207t931r1627b998],

1	+	CC	O	+	_	0	SENT_304	[p10l1654t931r1784b1002],

1	U	NNP	O	U	nn	2	SENT_305	[p10l225t1096r283b1177],
2	n	NN	O	n	_	0	SENT_305	[p10l319t1096r372b1181],
3	+	CC	O	+	_	0	SENT_305	[p10l319t1096r372b1181],
4	9	CD	NUMBER	9	num	5	SENT_305	[p10l1015t1087r1047b1100],
5	E	NN	O	e	conj_+	2	SENT_305	[p10l1068t1087r1096b1100],
6	*	CD	NUMBER	*	num	8	SENT_305	[p10l1118t1087r1149b1100],
7	rs2293347	NN	O	rs2293347	nn	8	SENT_305	[p10l1207t1056r1627b1123],
8	GA	NN	O	ga	dep	2	SENT_305	[p10l1658t1056r1788b1127],
9	+	CC	O	+	_	0	SENT_305	[p10l1810t1069r1855b1114],
10	R	NN	O	r	conj_+	8	SENT_305	[p10l1881t1060r2007b1123],
11	+	CC	O	+	rcmod	10	SENT_305	[p10l1881t1060r2007b1123],

1	Survival	NN	O	survival	_	0	SENT_306	[p10l41t1636r122b2052],
2	Pmbablillty	NN	O	pmbablillty	nn	3	SENT_306	[p10l41t1020r149b1591],
3	g	NN	O	g	dep	1	SENT_306	[p10l28t823r153b922],

1	E	NN	O	e	_	0	SENT_307	[p10l229t819r373b904],

1	PFS	NN	O	pf	_	0	SENT_308	[p10l948t2433r1154b2518],
2	(	CD	NUMBER	(	num	3	SENT_308	[p10l1194t2433r1605b2540],
3	month	NN	NUMBER	month	dep	1	SENT_308	[p10l1194t2433r1605b2540],
4	)	NN	O	)	dep	1	SENT_308	[p10l1194t2433r1605b2540],

1	—	NN	O	—	_	0	SENT_309	[p11l1015t174r1154b184],
2	Slwrter	NN	O	slwrter	nn	3	SENT_309	[p11l1207t148r1520b215],
3	GA-SSH	NN	O	ga-ssh	dep	1	SENT_309	[p11l1546t148r1877b215],
4	.	.	O	.	_	0	SENT_309	[p11l262t318r265b321],

1	.	.	O	.	_	0	SENT_310	[p11l332t322r335b325],

1	---	CD	NUMBER	---	num	2	SENT_311	[p11l1015t304r1149b313],
2	͈	CD	NUMBER	͈	_	0	SENT_311	[p11l1207t268r1492b335],
3	\	SYM	O	\	dep	2	SENT_311	[p11l1207t268r1492b335],
4	-	:	O	-	_	0	SENT_311	[p11l1207t268r1492b335],
5	+	CC	O	+	cc	6	SENT_311	[p11l1207t268r1492b335],
6	CA-SSE	NN	O	ca-sse	dep	2	SENT_311	[p11l1529t264r1863b336],
7	0	CD	NUMBER	0	nn	10	SENT_311	[p11l224t317r377b402],
8	'	''	O	'	_	0	SENT_311	[p11l224t317r377b402],
9	3	CD	NUMBER	3	dep	7	SENT_311	[p11l224t317r377b402],
10	anger	NN	O	anger	dep	6	SENT_311	[p11l1261t282r1506b353],

1	SL1rvi	NN	O	sl1rvus	_	0	SENT_312	[p11l6t259r113b1287],
2	*	CD	NUMBER	*	num	3	SENT_312	[p11l6t259r113b1287],
3	vaIF	NN	O	vaif	nn	6	SENT_312	[p11l6t259r113b1287],
4	'	''	O	'	_	0	SENT_312	[p11l6t259r113b1287],
5	rubahIiIIty	NN	O	rubahiiiity	nn	6	SENT_312	[p11l6t259r113b1287],
6	h	NN	O	h	nsubj	9	SENT_312	[p11l11t81r91b161],
7	_	SYM	O	_	dep	9	SENT_312	[p11l11t81r91b161],
8	-	:	O	-	_	0	SENT_312	[p11l11t81r91b161],
9	+	CC	O	+	rcmod	1	SENT_312	[p11l11t81r91b161],

1	-	:	O	-	_	0	SENT_313	[p11l224t572r279b657],
2	i	FW	O	i	_	0	SENT_313	[p11l224t572r279b657],
3	by	IN	O	by	prep	2	SENT_313	[p11l296t572r377b657],

1	A	DT	O	a	det	2	SENT_314	[p11l319t1367r322b1371],
2	U	NNP	O	U	_	0	SENT_314	[p11l385t1399r444b1532],
3	10	CD	NUMBER	10	number	4	SENT_314	[p11l774t1404r890b1532],
4	20	CD	NUMBER	20	dep	2	SENT_314	[p11l1194t1404r1319b1532],
5	30	CD	NUMBER	30	dep	4	SENT_314	[p11l1609t1399r1734b1532],

1	PFS	NN	O	pf	_	0	SENT_315	[p11l948t1603r1154b1688],
2	(	CD	NUMBER	(	num	4	SENT_315	[p11l1194t1603r1605b1706],
3	manth	NN	O	manth	nn	4	SENT_315	[p11l1194t1603r1605b1706],
4	}	NN	O	}	dep	1	SENT_315	[p11l1194t1603r1605b1706],

1	—	NN	O	—	_	0	SENT_316	[p11l1099t2061r1232b2070],
2	rs2293	NN	O	rs2293	dep	1	SENT_316	[p11l1283t2027r1686b2092],
3	“	CD	NUMBER	“	rcmod	2	SENT_316	[p11l1283t2027r1686b2092],
4	34	CD	NUMBER	34	amod	3	SENT_316	[p11l1283t2027r1686b2092],
5	'	''	O	'	_	0	SENT_316	[p11l1283t2027r1686b2092],
6	:	:	O	:	_	0	SENT_316	[p11l1283t2027r1686b2092],
7	"	``	O	"	punct	8	SENT_316	[p11l1283t2027r1686b2092],
8	DW	NNP	O	DW	dep	3	SENT_316	[p11l1712t2027r1836b2095],
9	`	``	O	`	_	0	SENT_316	[p11l1712t2027r1836b2095],
10	-	:	O	-	_	0	SENT_316	[p11l1712t2027r1836b2095],
11	+	CC	O	+	dep	8	SENT_316	[p11l1712t2027r1836b2095],

1	P	NN	O	p	_	0	SENT_317	[p11l1202t2469r1348b2546],
2	=	JJ	O	=	amod	1	SENT_317	[p11l1202t2469r1348b2546],
3	0.176	CD	NUMBER	0.176	tmod	2	SENT_317	[p11l1386t2473r1635b2546],

1	S	NN	O	s	_	0	SENT_318	[p11l27t2704r105b3103],
2	»	CD	NUMBER	»	num	5	SENT_318	[p11l27t2704r105b3103],
3	ur-uélval	JJ	O	ur-uélval	amod	5	SENT_318	[p11l27t2704r105b3103],
4	Frabablillty	NN	O	frabablillty	nn	5	SENT_318	[p11l27t2113r130b2661],
5	E	NN	O	e	dep	1	SENT_318	[p11l6t1924r126b2019],

1	If	IN	O	if	_	0	SENT_319	[p11l220t2447r272b2524],
2	!	.	O	!	_	0	SENT_319	[p11l220t2447r272b2524],

1	U	NNP	O	U	nn	2	SENT_320	[p11l310t2447r362b2525],
2	}	NNP	O	}	_	0	SENT_320	[p11l310t2447r362b2525],

1	U	NNP	O	U	_	0	SENT_321	[p11l370t3279r422b3403],
2	1	CD	NUMBER	1	num	1	SENT_321	[p11l627t3326r735b3403],
3	20	CD	NUMBER	20	dep	1	SENT_321	[p11l914t3326r1026b3403],
4	30	CD	NUMBER	30	number	5	SENT_321	[p11l1184t3326r1296b3403],
5	40	CD	NUMBER	40	num	9	SENT_321	[p11l1467t3326r1579b3403],
6	OS	NN	O	os	nn	9	SENT_321	[p11l983t3469r1129b3551],
7	(	NN	O	(	nn	9	SENT_321	[p11l1167t3469r1558b3572],
8	mimth	NN	O	mimth	nn	9	SENT_321	[p11l1167t3469r1558b3572],
9	)	NN	O	)	dep	3	SENT_321	[p11l1167t3469r1558b3572],

1	=	JJ	O	=	amod	2	SENT_322	[p11l1099t2177r1129b2190],
2	E	NN	O	e	_	0	SENT_322	[p11l1150t2177r1180b2190],
3	*	CD	NUMBER	*	num	4	SENT_322	[p11l1197t2177r1228b2190],
4	IIE229334	NN	O	iie229334	dep	2	SENT_322	[p11l1283t2147r1686b2212],
5	?	.	O	?	_	0	SENT_322	[p11l1283t2147r1686b2212],

1	GA	NN	O	ga	_	0	SENT_323	[p11l1716t2147r1840b2216],
2	+	CC	O	+	cc	3	SENT_323	[p11l1861t2160r1905b2203],
3	AA	NN	O	aa	dep	1	SENT_323	[p11l1930t2151r2050b2212],

1	(	NN	O	(	nn	2	SENT_324	[p12l10t78r135b172],
2	D	NN	O	d	_	0	SENT_324	[p12l10t78r135b172],
3	)	CD	NUMBER	)	number	4	SENT_324	[p12l10t78r135b172],
4	1	CD	NUMBER	1	dep	2	SENT_324	[p12l229t86r263b164],
5	D	NN	O	d	dep	4	SENT_324	[p12l319t86r375b168],
6	‘	CD	NUMBER	‘	num	7	SENT_324	[p12l1099t151r1232b160],
7	Shorter	JJR	O	shorter	dep	2	SENT_324	[p12l1283t117r1587b185],
8	CA	NNP	O	CA	dep	7	SENT_324	[p12l1609t117r1930b185],
9	!	.	O	!	_	0	SENT_324	[p12l1609t117r1930b185],

1	-	:	O	-	_	0	SENT_325	[p12l1609t117r1930b185],
2	SSR	NN	O	ssr	_	0	SENT_325	[p12l1609t117r1930b185],
3	.	.	O	.	_	0	SENT_325	[p12l1609t117r1930b185],

1	3	CD	NUMBER	3	_	0	SENT_326	[p12l27t224r126b322],
2	;	:	O	;	_	0	SENT_326	[p12l27t224r126b322],
3	.	.	O	.	_	0	SENT_326	[p12l1099t275r1129b284],

1	-	:	O	-	_	0	SENT_327	[p12l1099t275r1129b284],
2	-	:	O	-	_	0	SENT_327	[p12l1150t275r1180b284],
3	-	:	O	-	_	0	SENT_327	[p12l1197t275r1228b284],
4	Longer	JJR	O	longer	dobj	2	SENT_327	[p12l1287t232r1570b310],
5	CA	NNP	O	CA	dep	4	SENT_327	[p12l1596t232r1913b297],
6	.	.	O	.	_	0	SENT_327	[p12l1596t232r1913b297],

1	—	NN	O	—	_	0	SENT_328	[p12l1596t232r1913b297],
2	.	.	O	.	_	0	SENT_328	[p12l1596t232r1913b297],

1	SSR	NN	O	ssr	_	0	SENT_329	[p12l1596t232r1913b297],
2	,	,	O	,	_	0	SENT_329	[p12l1596t232r1913b297],
3	j	NN	O	j	appos	1	SENT_329	[p12l27t326r105b344],

1	D	NNP	O	D	nn	2	SENT_330	[p12l27t416r105b473],
2	W	NNP	O	W	_	0	SENT_330	[p12l44t477r105b544],
3	,	,	O	,	_	0	SENT_330	[p12l365t554r366b557],
4	,	,	O	,	_	0	SENT_330	[p12l1159t477r1231b554],
5	P	NN	O	p	nn	6	SENT_330	[p12l1159t477r1231b554],
6	‘	NN	O	‘	appos	2	SENT_330	[p12l1159t477r1231b554],
7	2	CD	NUMBER	2	num	8	SENT_330	[p12l1257t498r1309b533],
8	0,652	CD	NUMBER	0,652	dep	2	SENT_330	[p12l1347t481r1596b554],

1	I	PRP	O	I	nsubj	2	SENT_331	[p12l45t665r105b700, p12l27t815r105b833],
2	—	VBP	O	—	_	0	SENT_331	[p12l45t665r105b700, p12l27t815r105b833],

1	gl	NN	O	gl	nn	2	SENT_332	[p12l220t790r290b875],
2	bD	NN	O	bd	nsubj	3	SENT_332	[p12l314t790r370b875],
3	+	CC	O	+	_	0	SENT_332	[p12l314t790r370b875],
4	-	:	O	-	_	0	SENT_332	[p12l987t819r1099b854],
5	.	.	O	.	_	0	SENT_332	[p12l987t819r1099b854],

1	A1	NN	O	a1	nn	2	SENT_333	[p12l1250t852r1296b854],
2	E	NN	O	e	_	0	SENT_333	[p12l44t841r105b948],
3	*	CD	NUMBER	*	number	4	SENT_333	[p12l289t858r302b875],
4	‘	NN	O	‘	dep	2	SENT_333	[p12l359t863r362b871],
5	in	IN	O	in	_	0	SENT_333	[p12l1081t858r1146b901],
6	I	PRP	O	I	prep_in	4	SENT_333	[p12l1159t875r1184b901],
7	1	LS	NUMBER	1	dep	2	SENT_333	[p12l1197t875r1257b901],
8	-	:	O	-	_	0	SENT_333	[p12l1197t875r1257b901],
9	!	.	O	!	_	0	SENT_333	[p12l1197t875r1257b901],

1	in	IN	O	in	dep	3	SENT_334	[p12l1266t875r1292b901],
2	iii	LS	O	iii	dep	3	SENT_334	[p12l1339t875r1399b901],
3	iv	NN	O	iv	_	0	SENT_334	[p12l1412t876r1437b901],
4	3	CD	NUMBER	3	num	3	SENT_334	[p12l1450t875r1493b905],
5	.	.	O	.	_	0	SENT_334	[p12l1450t875r1493b905],

1	‘	NN	O	‘	nn	2	SENT_335	[p12l1471t914r1493b939],
2	I	NN	O	i	_	0	SENT_335	[p12l1471t914r1493b939],

1	3	CD	NUMBER	3	num	2	SENT_336	[p12l27t946r105b1038],
2	1	CD	NUMBER	1	_	0	SENT_336	[p12l1471t944r1506b991],
3	»	NN	O	»	dep	2	SENT_336	[p12l1471t944r1506b991],
4	!	.	O	!	_	0	SENT_336	[p12l1519t965r1540b991],

1	bD	NN	O	bd	_	0	SENT_337	[p12l1549t961r1609b991],
2	+	CC	O	+	_	0	SENT_337	[p12l1549t961r1609b991],
3	4	LS	NUMBER	4	conj_+	1	SENT_337	[p12l1622t965r1652b991],
4	-	:	O	-	_	0	SENT_337	[p12l1622t965r1652b991],
5	an	DT	O	a	det	6	SENT_337	[p12l1660t965r1686b991],
6	I	PRP	O	I	dep	1	SENT_337	[p12l1698t965r1720b991],
7	In	IN	O	in	_	0	SENT_337	[p12l1733t961r1827b991],
8	!!!	CD	NUMBER	!!!	prep_in	6	SENT_337	[p12l1733t961r1827b991],

1	It	PRP	O	it	nsubj	9	SENT_338	[p12l1836t961r1870b991],
2	"	``	O	"	punct	9	SENT_338	[p12l44t1042r105b1073],
3	'	''	O	'	_	0	SENT_338	[p12l44t1042r105b1073],
4	Cl	NN	O	cl	nsubj	9	SENT_338	[p12l220t1038r276b1120],
5	2	CD	NUMBER	2	num	4	SENT_338	[p12l314t1038r370b1120],
6	:3	CD	NUMBER	:3	number	8	SENT_338	[p12l27t1090r105b1214],
7	m	NN	O	m	dep	8	SENT_338	[p12l289t1107r302b1120],
8	bD	NN	O	bd	amod	4	SENT_338	[p12l289t1107r302b1120],
9	+	CC	O	+	_	0	SENT_338	[p12l289t1107r302b1120],

1	El	NNP	O	El	_	0	SENT_339	[p12l387t1372r443b1454],
2	10	CD	PERCENT	10	number	4	SENT_339	[p12l644t1372r756b1454],
3	20	CD	PERCENT	20	number	4	SENT_339	[p12l923t1372r1043b1454],
4	%	NN	PERCENT	%	amod	5	SENT_339	[p12l923t1372r1043b1454],
5	3D	NN	O	3d	dep	1	SENT_339	[p12l1197t1372r1317b1454],
6	40	CD	NUMBER	40	number	7	SENT_339	[p12l1476t1372r1596b1454],
7	50	CD	NUMBER	50	dep	1	SENT_339	[p12l1754t1372r1875b1454],
8	640	CD	NUMBER	640	dep	7	SENT_339	[p12l2033t1372r2153b1454],

1	Fig	NN	O	fig	_	0	SENT_340	[p12l6t1665r51b1692],
2	.	.	O	.	_	0	SENT_340	[p12l6t1665r51b1692],

1	2	LS	NUMBER	2	_	0	SENT_341	[p12l62t1666r84b1687],
2	.	.	O	.	_	0	SENT_341	[p12l62t1666r84b1687],

1	I	PRP	O	I	nsubj	2	SENT_342	[p12l100t1665r277b1692],
2	(	VBP	O	(	_	0	SENT_342	[p12l100t1665r277b1692],
3	aplan	NN	O	aplan	dobj	2	SENT_342	[p12l100t1665r277b1692],
4	.	.	O	.	_	0	SENT_342	[p12l100t1665r277b1692],

1	—	NN	O	—	_	0	SENT_343	[p12l100t1665r277b1692],
2	.	.	O	.	_	0	SENT_343	[p12l100t1665r277b1692],

1	Meier	JJR	PERSON	meier	amod	2	SENT_344	[p12l100t1665r277b1692],
2	plots	NNS	O	plot	_	0	SENT_344	[p12l287t1665r347b1692],
3	and	CC	O	and	_	0	SENT_344	[p12l358t1665r404b1687],
4	log	NN	O	log	conj_and	2	SENT_344	[p12l415t1665r521b1692],
5	—	CD	NUMBER	—	num	7	SENT_344	[p12l415t1665r521b1692],
6	rank	NN	O	rank	nn	7	SENT_344	[p12l415t1665r521b1692],
7	tests	NNS	O	test	nsubj	20	SENT_344	[p12l531t1668r588b1687],
8	for	IN	O	for	_	0	SENT_344	[p12l599t1665r634b1687],
9	progression	NN	O	progression	nn	12	SENT_344	[p12l644t1665r852b1692],
10	—	CD	NUMBER	—	num	12	SENT_344	[p12l644t1665r852b1692],
11	free	JJ	O	free	amod	12	SENT_344	[p12l644t1665r852b1692],
12	survival	NN	O	survival	prep_for	7	SENT_344	[p12l863t1665r960b1687],
13	and	CC	O	and	_	0	SENT_344	[p12l971t1665r1017b1687],
14	overall	JJ	O	overall	amod	15	SENT_344	[p12l1028t1665r1112b1687],
15	survival	NN	O	survival	prep_for	7	SENT_344	[p12l1123t1665r1221b1687],
16	in	IN	O	in	_	0	SENT_344	[p12l1232t1666r1255b1687],
17	advanced	JJ	O	advanced	amod	19	SENT_344	[p12l1266t1665r1384b1687],
18	NSCLC	NN	O	nsclc	nn	19	SENT_344	[p12l1396t1666r1476b1687],
19	patients	NNS	O	patient	prep_in	7	SENT_344	[p12l1487t1621r1588b1692],
20	treated	VBN	O	treat	rcmod	2	SENT_344	[p12l1598t1665r1688b1687],
21	with	IN	O	with	_	0	SENT_344	[p12l1698t1665r1756b1687],
22	Geﬁtinib	NNP	O	Geﬁtinib	prep_with	20	SENT_344	[p12l1767t1665r1884b1687],
23	:	:	O	:	_	0	SENT_344	[p12l1767t1665r1884b1687],
24	association	NN	O	association	dep	2	SENT_344	[p12l1896t1666r2036b1687],
25	with	IN	O	with	_	0	SENT_344	[p12l2046t1665r2104b1687],
26	EGFR	NN	ORGANIZATION	egfr	nn	27	SENT_344	[p12l6t1702r68b1723],
27	polymorphisms	NNS	O	polymorphism	prep_with	24	SENT_344	[p12l78t1701r282b1728],
28	.	.	O	.	_	0	SENT_344	[p12l78t1701r282b1728],

1	Progression	NN	O	progression	npadvmod	3	SENT_345	[p12l293t1701r499b1728],
2	—	CD	NUMBER	—	num	1	SENT_345	[p12l293t1701r499b1728],
3	free	JJ	O	free	amod	5	SENT_345	[p12l293t1701r499b1728],
4	survival	NN	O	survival	nn	5	SENT_345	[p12l510t1701r607b1723],
5	curves	NNS	O	curve	nsubj	9	SENT_345	[p12l618t1707r698b1723],
6	for	IN	O	for	_	0	SENT_345	[p12l709t1701r744b1723],
7	rs2293347	NN	O	rs2293347	nn	8	SENT_345	[p12l754t1702r885b1723],
8	genotypes	NNS	O	genotype	prep_for	5	SENT_345	[p12l895t1704r1024b1728],
9	(	VBP	O	(	_	0	SENT_345	[p12l1034t1701r1071b1728],
10	A	DT	O	a	det	11	SENT_345	[p12l1034t1701r1071b1728],
11	)	NN	O	)	dobj	9	SENT_345	[p12l1034t1701r1071b1728],
12	and	CC	O	and	_	0	SENT_345	[p12l1081t1701r1127b1723],
13	CA	NNP	O	CA	dobj	9	SENT_345	[p12l1137t1702r1228b1723],
14	.	.	O	.	_	0	SENT_345	[p12l1137t1702r1228b1723],

1	—	NN	O	—	_	0	SENT_346	[p12l1137t1702r1228b1723],
2	.	.	O	.	_	0	SENT_346	[p12l1137t1702r1228b1723],

1	SSR	NN	O	ssr	nn	2	SENT_347	[p12l1137t1702r1228b1723],
2	genotypes	NNS	O	genotype	nsubj	3	SENT_347	[p12l1237t1704r1365b1728],
3	(	VBP	O	(	_	0	SENT_347	[p12l1376t1701r1419b1728],
4	C	NN	O	c	dobj	3	SENT_347	[p12l1376t1701r1419b1728],
5	)	CD	NUMBER	)	num	4	SENT_347	[p12l1376t1701r1419b1728],
6	:	:	O	:	_	0	SENT_347	[p12l1376t1701r1419b1728],
7	Overall	JJ	O	overall	amod	9	SENT_347	[p12l1431t1701r1520b1723],
8	survival	NN	O	survival	nn	9	SENT_347	[p12l1531t1701r1628b1723],
9	curves	NNS	O	curve	nsubj	13	SENT_347	[p12l1639t1707r1719b1723],
10	for	IN	O	for	_	0	SENT_347	[p12l1730t1701r1765b1723],
11	rs2293347	NN	O	rs2293347	nn	12	SENT_347	[p12l1775t1702r1906b1723],
12	genotypes	NNS	O	genotype	prep_for	9	SENT_347	[p12l1916t1704r2044b1728],
13	(	VBP	O	(	parataxis	3	SENT_347	[p12l2055t1701r2090b1728],
14	B	NN	O	b	nn	15	SENT_347	[p12l2055t1701r2090b1728],
15	)	NN	O	)	dobj	13	SENT_347	[p12l2055t1701r2090b1728],
16	and	CC	O	and	_	0	SENT_347	[p12l2101t1701r2146b1723],
17	CA	NNP	O	CA	conj_and	15	SENT_347	[p12l6t1737r192b1779],
18	.	.	O	.	_	0	SENT_347	[p12l6t1737r192b1779],

1	—	NN	O	—	_	0	SENT_348	[p12l6t1737r192b1779],
2	.	.	O	.	_	0	SENT_348	[p12l6t1737r192b1779],

1	SSR	NN	O	ssr	nn	2	SENT_349	[p12l6t1737r192b1779],
2	genotypes	NNS	O	genotype	nsubj	3	SENT_349	[p12l8t1804r270b1852],
3	(	VBP	O	(	_	0	SENT_349	[p12l289t1797r380b1852],
4	D	NN	O	d	nn	5	SENT_349	[p12l289t1797r380b1852],
5	)	NN	O	)	dobj	3	SENT_349	[p12l289t1797r380b1852],
6	.	.	O	.	_	0	SENT_349	[p12l289t1797r380b1852],

1	addition	NN	O	addition	nsubjpass	14	SENT_350	[p12l9t2007r277b2062],
2	to	TO	O	to	_	0	SENT_350	[p12l307t2015r367b2062],
3	the	DT	O	the	det	5	SENT_350	[p12l398t2007r500b2062],
4	response	NN	O	response	nn	5	SENT_350	[p12l531t2022r816b2075],
5	rate	NN	O	rate	prep_to	1	SENT_350	[p12l848t2015r985b2070],
6	,	,	O	,	_	0	SENT_350	[p12l848t2015r985b2070],
7	the	DT	O	the	det	8	SENT_350	[p12l1016t2007r1118b2062],
8	rs2293347G	NN	O	rs2293347g	appos	5	SENT_350	[p12l1149t2009r1647b2062],
9	>	JJR	O	>	amod	11	SENT_350	[p12l1149t2009r1647b2062],
10	A	DT	O	a	det	11	SENT_350	[p12l1149t2009r1647b2062],
11	polymorphism	NN	O	polymorphism	dep	8	SENT_350	[p12l1676t2007r2150b2075],
12	was	VBD	O	be	auxpass	14	SENT_350	[p12l8t2112r131b2151],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_350	[p12l155t2096r548b2164],
14	associated	VBN	O	associate	_	0	SENT_350	[p12l569t2096r900b2151],
15	with	IN	O	with	_	0	SENT_350	[p12l921t2096r1069b2151],
16	poor	JJ	O	poor	amod	17	SENT_350	[p12l1091t2112r1240b2164],
17	PFS	NN	O	pf	prep_with	14	SENT_350	[p12l1260t2099r1367b2151],
18	in	IN	O	in	_	0	SENT_350	[p12l1390t2097r1449b2150],
19	patients	NNS	O	patient	prep_in	14	SENT_350	[p12l1471t2097r1729b2164],
20	treated	VBN	O	treat	partmod	19	SENT_350	[p12l1752t2096r1981b2151],
21	with	IN	O	with	_	0	SENT_350	[p12l2002t2096r2150b2151],
22	Geﬁtinib	NN	PERSON	geﬁtinib	prep_with	20	SENT_350	[p12l10t2183r303b2238],
23	.	.	O	.	_	0	SENT_350	[p12l10t2183r303b2238],

1	These	DT	O	these	det	2	SENT_351	[p12l333t2183r518b2237],
2	results	NNS	O	result	nsubj	3	SENT_351	[p12l550t2183r762b2237],
3	indicate	VBP	O	indicate	_	0	SENT_351	[p12l795t2183r1049b2237],
4	that	IN	O	that	complm	18	SENT_351	[p12l1080t2183r1224b2246],
5	,	,	O	,	_	0	SENT_351	[p12l1080t2183r1224b2246],
6	besides	IN	O	besides	_	0	SENT_351	[p12l1255t2183r1492b2237],
7	somatic	JJ	O	somatic	amod	8	SENT_351	[p12l1525t2184r1775b2237],
8	mutations	NNS	O	mutation	prep_besides	18	SENT_351	[p12l1806t2184r2149b2246],
9	,	,	O	,	_	0	SENT_351	[p12l1806t2184r2149b2246],
10	naturally	RB	O	naturally	advmod	11	SENT_351	[p12l10t2271r299b2340],
11	occurring	VBG	O	occur	csubjpass	28	SENT_351	[p12l318t2272r625b2340],
12	sequence	NN	O	sequence	nn	13	SENT_351	[p12l644t2287r940b2340],
13	variations	NNS	O	variation	dobj	11	SENT_351	[p12l959t2272r1277b2326],
14	in	IN	O	in	_	0	SENT_351	[p12l1299t2272r1358b2326],
15	EGFR	NN	ORGANIZATION	egfr	prep_in	11	SENT_351	[p12l1375t2274r1534b2326],
16	may	MD	O	may	aux	18	SENT_351	[p12l1554t2287r1690b2340],
17	also	RB	O	also	advmod	18	SENT_351	[p12l1709t2271r1833b2326],
18	inﬂuence	VB	O	inﬂuence	ccomp	3	SENT_351	[p12l1854t2271r2149b2326],
19	the	DT	O	the	det	20	SENT_351	[p12l9t2360r110b2415],
20	efﬁcacy	NN	O	efﬁcacy	dobj	18	SENT_351	[p12l138t2360r383b2429],
21	of	IN	O	of	_	0	SENT_351	[p12l408t2360r475b2415],
22	Geﬁtinib	JJ	O	geﬁtinib	amod	23	SENT_351	[p12l494t2360r772b2415],
23	treatment	NN	O	treatment	prep_of	20	SENT_351	[p12l798t2368r1122b2415],
24	and	CC	O	and	_	0	SENT_351	[p12l1147t2360r1263b2415],
25	thus	RB	O	thus	advmod	18	SENT_351	[p12l1290t2360r1428b2415],
26	should	MD	O	should	aux	28	SENT_351	[p12l1456t2360r1670b2415],
27	be	VB	O	be	auxpass	28	SENT_351	[p12l1696t2360r1771b2415],
28	considered	VBN	O	consider	conj_and	18	SENT_351	[p12l1798t2360r2149b2415],
29	as	RB	O	as	advmod	30	SENT_351	[p12l9t2465r72b2505],
30	important	JJ	O	important	amod	31	SENT_351	[p12l112t2450r438b2518],
31	modiﬁers	NNS	O	modiﬁers	dobj	28	SENT_351	[p12l476t2449r780b2505],
32	for	IN	O	for	_	0	SENT_351	[p12l820t2449r910b2505],
33	advanced	JJ	O	advanced	amod	34	SENT_351	[p12l946t2450r1249b2505],
34	NSCLC	NN	O	nsclc	prep_for	28	SENT_351	[p12l1289t2452r1495b2505],
35	treated	VBN	O	treat	partmod	34	SENT_351	[p12l1532t2450r1761b2505],
36	with	IN	O	with	_	0	SENT_351	[p12l1799t2450r1947b2505],
37	EGFR	NN	ORGANIZATION	egfr	nn	38	SENT_351	[p12l1986t2452r2152b2505],
38	inhibitors	NNS	O	inhibitor	prep_with	35	SENT_351	[p12l10t2539r336b2594],
39	.	.	O	.	_	0	SENT_351	[p12l10t2539r336b2594],

1	The	DT	O	the	det	2	SENT_352	[p12l108t2626r225b2681],
2	rs2293347G	NN	O	rs2293347g	nsubj	23	SENT_352	[p12l250t2629r638b2681],
3	>	JJR	O	>	amod	5	SENT_352	[p12l655t2628r748b2680],
4	A	DT	O	a	det	5	SENT_352	[p12l655t2628r748b2680],
5	polymorphism	NN	O	polymorphism	nsubj	16	SENT_352	[p12l770t2626r1244b2695],
6	located	JJ	O	located	amod	5	SENT_352	[p12l1269t2626r1500b2681],
7	in	IN	O	in	_	0	SENT_352	[p12l1526t2627r1584b2681],
8	exon	NN	O	exon	prep_in	6	SENT_352	[p12l1608t2642r1759b2681],
9	25	CD	NUMBER	25	num	8	SENT_352	[p12l1783t2629r1858b2681],
10	is	VBZ	O	be	cop	16	SENT_352	[p12l1885t2627r1931b2681],
11	a	DT	O	a	det	16	SENT_352	[p12l1956t2642r1989b2681],
12	synonymous	JJ	O	synonymous	amod	16	SENT_352	[p12l2013t2642r2149b2695, p12l9t2731r302b2784],
13	SNP	NN	O	snp	nn	16	SENT_352	[p12l337t2718r462b2770],
14	(	CD	NUMBER	(	num	16	SENT_352	[p12l493t2715r765b2783],
15	D994D	NN	O	d994d	nn	16	SENT_352	[p12l493t2715r765b2783],
16	)	NN	O	)	rcmod	2	SENT_352	[p12l493t2715r765b2783],
17	and	CC	O	and	_	0	SENT_352	[p12l798t2715r914b2770],
18	a	DT	O	a	det	20	SENT_352	[p12l947t2731r980b2770],
19	synonymous	JJ	O	synonymous	amod	20	SENT_352	[p12l1013t2731r1418b2784],
20	SNP	NN	O	snp	conj_and	16	SENT_352	[p12l1453t2718r1578b2770],
21	does	VBZ	O	do	aux	23	SENT_352	[p12l1610t2715r1754b2770],
22	not	RB	O	not	neg	23	SENT_352	[p12l1789t2723r1893b2770],
23	change	VB	O	change	_	0	SENT_352	[p12l1925t2715r2149b2784],
24	amino	NN	O	amino	nn	26	SENT_352	[p12l9t2805r210b2859],
25	acid	NN	O	acid	nn	26	SENT_352	[p12l246t2804r375b2859],
26	sequence	NN	O	sequence	dobj	23	SENT_352	[p12l411t2820r707b2873],
27	of	IN	O	of	_	0	SENT_352	[p12l744t2804r810b2859],
28	the	DT	O	the	det	29	SENT_352	[p12l837t2804r939b2859],
29	protein	NN	O	protein	prep_of	26	SENT_352	[p12l975t2805r1222b2873],
30	,	,	O	,	_	0	SENT_352	[p12l975t2805r1222b2873],
31	which	WDT	O	which	nsubj	34	SENT_352	[p12l1256t2804r1454b2859],
32	might	MD	O	might	aux	34	SENT_352	[p12l1490t2804r1680b2873],
33	not	RB	O	not	neg	34	SENT_352	[p12l1715t2812r1819b2859],
34	inﬂuence	VB	O	inﬂuence	rcmod	29	SENT_352	[p12l1854t2804r2149b2859],
35	biological	JJ	O	biological	amod	36	SENT_352	[p12l9t2893r318b2962],
36	function	NN	O	function	dobj	34	SENT_352	[p12l361t2893r629b2948],
37	of	IN	O	of	_	0	SENT_352	[p12l671t2893r737b2948],
38	the	DT	O	the	det	39	SENT_352	[p12l771t2893r872b2948],
39	protein	NN	O	protein	prep_of	36	SENT_352	[p12l915t2894r1146b2962],
40	itself	PRP	O	itself	advmod	39	SENT_352	[p12l1188t2893r1359b2949],
41	.	.	O	.	_	0	SENT_352	[p12l1188t2893r1359b2949],

1	However	RB	O	however	advmod	6	SENT_353	[p12l1402t2897r1700b2957],
2	,	,	O	,	_	0	SENT_353	[p12l1402t2897r1700b2957],
3	synonymous	JJ	O	synonymous	amod	4	SENT_353	[p12l1743t2909r2149b2962],
4	SNPs	NNS	O	snp	nsubj	6	SENT_353	[p12l10t2985r164b3038],
5	may	MD	O	may	aux	6	SENT_353	[p12l196t2998r332b3051],
6	affect	VB	O	affect	_	0	SENT_353	[p12l360t2982r538b3038],
7	mRNA	NN	O	mrna	nn	8	SENT_353	[p12l567t2985r770b3037],
8	stability	NN	O	stability	dobj	6	SENT_353	[p12l798t2983r1067b3051],
9	,	,	O	,	_	0	SENT_353	[p12l798t2983r1067b3051],
10	translational	JJ	O	translational	amod	11	SENT_353	[p12l1098t2982r1504b3038],
11	kinetics	NNS	O	kinetics	conj_and	8	SENT_353	[p12l1535t2982r1798b3046],
12	,	,	O	,	_	0	SENT_353	[p12l1535t2982r1798b3046],
13	and	CC	O	and	_	0	SENT_353	[p12l1829t2983r1945b3038],
14	splicing	NN	O	splicing	conj_and	8	SENT_353	[p12l1977t2983r2149b3051, p12l10t3073r122b3140],
15	,	,	O	,	_	0	SENT_353	[p12l1977t2983r2149b3051, p12l10t3073r122b3140],
16	resulting	VBG	O	result	partmod	6	SENT_353	[p12l145t3072r431b3140],
17	in	IN	O	in	_	0	SENT_353	[p12l451t3073r510b3126],
18	alteration	NN	O	alteration	prep_in	16	SENT_353	[p12l531t3072r842b3127],
19	of	IN	O	of	_	0	SENT_353	[p12l863t3072r929b3127],
20	protein	NN	O	protein	nn	21	SENT_353	[p12l943t3073r1175b3140],
21	amount	NN	O	amount	prep_of	18	SENT_353	[p12l1196t3080r1460b3135],
22	,	,	O	,	_	0	SENT_353	[p12l1196t3080r1460b3135],
23	structure	NN	O	structure	appos	21	SENT_353	[p12l1484t3080r1774b3127],
24	or	CC	O	or	_	0	SENT_353	[p12l1796t3088r1862b3127],
25	function	NN	O	function	appos	21	SENT_353	[p12l1882t3072r2150b3127],
26	[	CD	NUMBER	[	number	27	SENT_353	[p12l13t3160r149b3229],
27	31	CD	NUMBER	31	num	28	SENT_353	[p12l13t3160r149b3229],
28	]	NN	O	]	dep	23	SENT_353	[p12l13t3160r149b3229],
29	.	.	O	.	_	0	SENT_353	[p12l13t3160r149b3229],

1	For	IN	O	for	_	0	SENT_354	[p12l189t3163r290b3215],
2	example	NN	O	example	prep_for	7	SENT_354	[p12l325t3160r613b3229],
3	,	,	O	,	_	0	SENT_354	[p12l325t3160r613b3229],
4	it	PRP	O	it	nsubjpass	7	SENT_354	[p12l653t3161r696b3215],
5	has	VBZ	O	have	aux	7	SENT_354	[p12l733t3160r838b3215],
6	been	VBN	O	be	auxpass	7	SENT_354	[p12l876t3160r1031b3215],
7	reported	VBN	O	report	_	0	SENT_354	[p12l1069t3160r1345b3229],
8	that	IN	O	that	complm	11	SENT_354	[p12l1383t3160r1512b3215],
9	synonymous	JJ	O	synonymous	amod	10	SENT_354	[p12l1549t3176r1955b3229],
10	SNPs	NNS	O	snp	nsubj	11	SENT_354	[p12l1994t3163r2149b3215],
11	alter	VBP	O	alter	ccomp	7	SENT_354	[p12l9t3249r156b3304],
12	the	DT	O	the	det	13	SENT_354	[p12l179t3249r280b3304],
13	interaction	NN	O	interaction	dobj	11	SENT_354	[p12l306t3250r657b3304],
14	of	IN	O	of	_	0	SENT_354	[p12l682t3249r748b3304],
15	ABC	NNP	ORGANIZATION	ABC	nn	17	SENT_354	[p12l763t3251r893b3304],
16	transporter	NN	O	transporter	nn	17	SENT_354	[p12l917t3257r1283b3318],
17	ABCB1	NN	O	abcb1	prep_of	13	SENT_354	[p12l1304t3252r1527b3313],
18	,	,	O	,	_	0	SENT_354	[p12l1304t3252r1527b3313],
19	with	IN	O	with	_	0	SENT_354	[p12l1551t3249r1699b3304],
20	its	PRP$	O	its	poss	21	SENT_354	[p12l1725t3250r1797b3304],
21	substrates	NNS	O	substrate	prep_with	11	SENT_354	[p12l1824t3249r2149b3304],
22	and	CC	O	and	_	0	SENT_354	[p12l9t3338r126b3393],
23	inhibitors	NNS	O	inhibitor	conj_and	21	SENT_354	[p12l150t3338r460b3393],
24	plausibly	RB	O	plausibly	advmod	25	SENT_354	[p12l485t3338r776b3407],
25	mediated	VBN	O	mediate	partmod	21	SENT_354	[p12l798t3338r1101b3393],
26	by	IN	O	by	_	0	SENT_354	[p12l1124t3338r1201b3407],
27	translational	JJ	O	translational	agent	25	SENT_354	[p12l1222t3338r1628b3393],
28	pauses	VBZ	O	pause	dep	21	SENT_354	[p12l1653t3354r1868b3407],
29	induced	VBN	O	induce	dep	28	SENT_354	[p12l1893t3338r2149b3393],
30	by	IN	O	by	_	0	SENT_354	[p12l9t3427r85b3496],
31	rare	JJ	O	rare	amod	32	SENT_354	[p12l116t3443r240b3482],
32	codons	NNS	O	codon	prep_by	29	SENT_354	[p12l273t3427r514b3491],
33	,	,	O	,	_	0	SENT_354	[p12l273t3427r514b3491],
34	because	IN	O	because	mark	47	SENT_354	[p12l546t3427r801b3482],
35	the	DT	O	the	det	37	SENT_354	[p12l834t3427r935b3482],
36	synonymous	JJ	O	synonymous	amod	37	SENT_354	[p12l969t3443r1374b3496],
37	SNPs	NNS	MISC	snp	nsubj	47	SENT_354	[p12l1408t3430r1562b3482],
38	that	WDT	O	that	nsubj	39	SENT_354	[p12l1595t3427r1724b3482],
39	produce	VBP	O	produce	rcmod	37	SENT_354	[p12l1755t3427r2016b3496],
40	the	DT	O	the	det	41	SENT_354	[p12l2048t3427r2149b3482],
41	phenotype	NN	O	phenotype	dobj	39	SENT_354	[p12l10t3517r353b3585],
42	all	DT	O	all	nsubj	43	SENT_354	[p12l385t3517r458b3572],
43	use	VBP	O	use	rcmod	41	SENT_354	[p12l491t3532r597b3572],
44	relatively	RB	O	relatively	advmod	45	SENT_354	[p12l629t3516r929b3585],
45	rare	JJ	O	rare	amod	46	SENT_354	[p12l959t3532r1083b3572],
46	codons	NNS	O	codon	dobj	43	SENT_354	[p12l1115t3517r1340b3572],
47	[	VBP	O	[	dep	21	SENT_354	[p12l1376t3516r1516b3585],
48	32	CD	NUMBER	32	number	49	SENT_354	[p12l1376t3516r1516b3585],
49	]	CD	NUMBER	]	dobj	47	SENT_354	[p12l1376t3516r1516b3585],
50	.	.	O	.	_	0	SENT_354	[p12l1376t3516r1516b3585],

1	Synonymous	JJ	O	synonymous	amod	2	SENT_355	[p12l1549t3519r1961b3585],
2	SNPs	NNS	O	snp	nsubjpass	5	SENT_355	[p12l1994t3519r2148b3572],
3	were	VBD	O	be	auxpass	5	SENT_355	[p13l8t33r166b72],
4	also	RB	O	also	advmod	5	SENT_355	[p13l196t17r320b72],
5	shown	VBN	O	show	_	0	SENT_355	[p13l351t17r562b72],
6	to	TO	O	to	_	0	SENT_355	[p13l591t25r651b72],
7	inﬂuence	NN	O	inﬂuence	nn	10	SENT_355	[p13l682t17r977b72],
8	protein	NN	O	protein	nn	10	SENT_355	[p13l1008t18r1239b85],
9	expression	NN	O	expression	nn	10	SENT_355	[p13l1268t18r1613b85],
10	(	NN	O	(	prep_to	5	SENT_355	[p13l1642t17r1785b85],
11	and	CC	O	and	_	0	SENT_355	[p13l1642t17r1785b85],
12	thus	RB	O	thus	advmod	13	SENT_355	[p13l1814t17r1952b72],
13	function	VBP	O	function	conj_and	5	SENT_355	[p13l1983t17r2149b72, p13l9t105r161b173],
14	)	CD	NUMBER	)	dobj	13	SENT_355	[p13l1983t17r2149b72, p13l9t105r161b173],
15	by	IN	O	by	prep	13	SENT_355	[p13l194t105r270b174],
16	either	CC	O	either	dep	15	SENT_355	[p13l302t105r493b160],
17	alteration	NN	O	alteration	conj	15	SENT_355	[p13l525t105r836b160],
18	in	IN	O	in	_	0	SENT_355	[p13l870t106r929b159],
19	the	DT	O	the	det	20	SENT_355	[p13l962t105r1063b160],
20	stability	NN	O	stability	prep_in	15	SENT_355	[p13l1098t105r1357b174],
21	of	IN	O	of	_	0	SENT_355	[p13l1389t105r1456b160],
22	the	DT	O	the	det	26	SENT_355	[p13l1481t105r1583b160],
23	mRNA	NN	O	mrna	nn	26	SENT_355	[p13l1617t107r1820b160],
24	or	CC	O	or	_	0	SENT_355	[p13l1851t121r1918b160],
25	mRNA	NN	O	mrna	nn	26	SENT_355	[p13l1949t107r2152b160],
26	splicing	NN	O	splicing	prep_of	20	SENT_355	[p13l10t194r258b263],
27	[	CD	NUMBER	[	dep	26	SENT_355	[p13l291t194r552b263],
28	33	CD	NUMBER	33	num	31	SENT_355	[p13l291t194r552b263],
29	—	NN	O	—	nn	31	SENT_355	[p13l291t194r552b263],
30	35	CD	NUMBER	35	num	31	SENT_355	[p13l291t194r552b263],
31	]	NN	O	]	nsubj	13	SENT_355	[p13l291t194r552b263],
32	.	.	O	.	_	0	SENT_355	[p13l291t194r552b263],

1	Our	PRP$	O	we	nsubj	2	SENT_356	[p13l584t197r703b249],
2	result	VBP	O	result	_	0	SENT_356	[p13l733t194r915b249],
3	showing	VBG	O	show	xcomp	2	SENT_356	[p13l946t194r1218b263],
4	an	DT	O	a	det	5	SENT_356	[p13l1247t210r1322b249],
5	association	NN	O	association	iobj	3	SENT_356	[p13l1353t195r1710b249],
6	between	IN	O	between	_	0	SENT_356	[p13l1740t194r2018b249],
7	the	DT	O	the	det	8	SENT_356	[p13l2048t194r2149b249],
8	rs2293347G	NN	O	rs2293347g	prep_between	5	SENT_356	[p13l10t286r397b338],
9	>	JJR	O	>	dobj	3	SENT_356	[p13l415t296r447b331],
10	A	DT	O	a	det	14	SENT_356	[p13l460t286r508b338],
11	polymorphism	NN	O	polymorphism	nn	14	SENT_356	[p13l524t283r998b352],
12	and	CC	O	and	_	0	SENT_356	[p13l1016t283r1132b338],
13	poor	JJ	O	poor	conj_and	11	SENT_356	[p13l1151t299r1299b352],
14	response	NN	O	response	nsubj	22	SENT_356	[p13l1316t299r1600b352],
15	to	TO	O	to	_	0	SENT_356	[p13l1618t291r1679b338],
16	Geﬁtinib	NN	O	geﬁtinib	nn	17	SENT_356	[p13l1698t283r1976b338],
17	therapy	NN	O	therapy	prep_to	14	SENT_356	[p13l1993t283r2149b338, p13l9t388r122b441],
18	among	IN	O	among	_	0	SENT_356	[p13l138t388r357b441],
19	patients	NNS	O	patient	prep_among	17	SENT_356	[p13l373t373r631b441],
20	with	IN	O	with	_	0	SENT_356	[p13l648t372r796b427],
21	NSCLC	NN	ORGANIZATION	nsclc	prep_with	19	SENT_356	[p13l813t375r1019b427],
22	suggests	VBZ	O	suggest	rcmod	9	SENT_356	[p13l1036t380r1305b441],
23	that	IN	O	that	complm	28	SENT_356	[p13l1322t372r1452b427],
24	this	DT	O	this	det	26	SENT_356	[p13l1466t372r1583b427],
25	synonymous	JJ	O	synonymous	amod	26	SENT_356	[p13l1602t388r2007b441],
26	SNP	NN	O	snp	nsubj	28	SENT_356	[p13l2026t375r2151b427],
27	might	MD	O	might	aux	28	SENT_356	[p13l10t462r200b530],
28	be	VB	O	be	ccomp	22	SENT_356	[p13l221t462r295b517],
29	of	IN	O	of	_	0	SENT_356	[p13l319t461r386b517],
30	functional	JJ	O	functional	amod	31	SENT_356	[p13l402t461r727b517],
31	relevance	NN	O	relevance	prep_of	28	SENT_356	[p13l751t462r1071b517],
32	.	.	O	.	_	0	SENT_356	[p13l751t462r1071b517],

1	Further	JJ	O	further	amod	2	SENT_357	[p13l1096t462r1334b517],
2	studies	NNS	O	study	nsubj	3	SENT_357	[p13l1356t462r1581b517],
3	are	VBP	O	be	_	0	SENT_357	[p13l1605t477r1702b517],
4	under	IN	O	under	_	0	SENT_357	[p13l1726t462r1917b517],
5	way	NN	O	way	prep_under	3	SENT_357	[p13l1936t477r2068b530],
6	to	TO	O	to	aux	7	SENT_357	[p13l2088t470r2149b517],
7	examine	VB	O	examine	xcomp	3	SENT_357	[p13l9t552r282b606],
8	whether	IN	O	whether	complm	11	SENT_357	[p13l303t551r577b606],
9	this	DT	O	this	det	10	SENT_357	[p13l597t551r713b606],
10	SNP	NN	O	snp	nsubj	11	SENT_357	[p13l737t554r862b606],
11	affects	VBZ	O	affect	ccomp	7	SENT_357	[p13l883t551r1090b606],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_357	[p13l1111t554r1269b606],
13	expression	NN	O	expression	dobj	11	SENT_357	[p13l1291t552r1635b619],
14	or	CC	O	or	_	0	SENT_357	[p13l1658t567r1723b606],
15	its	PRP$	O	its	poss	17	SENT_357	[p13l1744t552r1817b606],
16	biological	JJ	O	biological	amod	17	SENT_357	[p13l1839t551r2149b619],
17	function	NN	O	function	conj_or	13	SENT_357	[p13l10t639r293b694],
18	.	.	O	.	_	0	SENT_357	[p13l10t639r293b694],

1	Several	JJ	O	several	amod	2	SENT_358	[p13l111t727r340b782],
2	studies	NNS	O	study	nsubjpass	18	SENT_358	[p13l380t727r606b782],
3	addressing	VBG	O	address	partmod	2	SENT_358	[p13l645t727r994b796],
4	the	DT	O	the	det	5	SENT_358	[p13l1030t727r1132b782],
5	effects	NNS	O	effect	dobj	3	SENT_358	[p13l1172t727r1379b782],
6	of	IN	O	of	_	0	SENT_358	[p13l1419t727r1486b782],
7	naturally	RB	O	naturally	advmod	8	SENT_358	[p13l1517t727r1807b796],
8	occurring	VBG	O	occur	prepc_of	5	SENT_358	[p13l1844t728r2151b796],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_358	[p13l7t819r166b871],
10	polymorphisms	NNS	O	polymorphism	dobj	8	SENT_358	[p13l184t816r689b885],
11	on	IN	O	on	_	0	SENT_358	[p13l709t832r787b871],
12	efﬁcacy	NN	O	efﬁcacy	prep_on	8	SENT_358	[p13l806t816r1051b885],
13	of	IN	O	of	_	0	SENT_358	[p13l1069t816r1135b871],
14	EGFR	NN	ORGANIZATION	egfr	nn	15	SENT_358	[p13l1147t819r1314b871],
15	inhibitors	NNS	O	inhibitor	prep_of	12	SENT_358	[p13l1330t816r1640b871],
16	have	VBP	O	have	aux	18	SENT_358	[p13l1661t816r1807b871],
17	been	VBN	O	be	auxpass	18	SENT_358	[p13l1826t816r1981b871],
18	published	VBN	O	publish	_	0	SENT_358	[p13l2000t816r2149b885, p13l10t906r217b961],
19	.	.	O	.	_	0	SENT_358	[p13l2000t816r2149b885, p13l10t906r217b961],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_359	[p13l235t906r736b974],
2	in	IN	O	in	_	0	SENT_359	[p13l754t906r813b960],
3	the	DT	O	the	det	5	SENT_359	[p13l829t906r930b961],
4	essential	JJ	O	essential	amod	5	SENT_359	[p13l947t906r1227b961],
5	promoter	NN	O	promoter	prep_in	1	SENT_359	[p13l1245t914r1548b974],
6	of	IN	O	of	_	0	SENT_359	[p13l1563t905r1629b961],
7	EGFR	NN	ORGANIZATION	egfr	prep_of	1	SENT_359	[p13l1636t908r1794b961],
8	(	CD	NUMBER	(	num	7	SENT_359	[p13l1810t906r2049b974],
9	.	.	O	.	_	0	SENT_359	[p13l1810t906r2049b974],

1	—	NN	O	—	_	0	SENT_360	[p13l1810t906r2049b974],
2	.	.	O	.	_	0	SENT_360	[p13l1810t906r2049b974],

1	216G	CD	NUMBER	216g	num	3	SENT_361	[p13l1810t906r2049b974],
2	>	JJR	O	>	amod	3	SENT_361	[p13l2067t918r2099b953],
3	T	NN	O	t	nsubjpass	21	SENT_361	[p13l2112t909r2152b960],
4	and	CC	O	and	_	0	SENT_361	[p13l9t995r126b1050],
5	—	NN	O	—	nn	6	SENT_361	[p13l156t998r360b1050],
6	191C	NN	O	191c	conj_and	3	SENT_361	[p13l156t998r360b1050],
7	>	JJR	O	>	amod	9	SENT_361	[p13l377t995r509b1063],
8	A	DT	O	a	det	9	SENT_361	[p13l377t995r509b1063],
9	)	NN	O	)	dep	6	SENT_361	[p13l377t995r509b1063],
10	,	,	O	,	_	0	SENT_361	[p13l377t995r509b1063],
11	which	WDT	O	which	nsubj	13	SENT_361	[p13l536t995r734b1050],
12	might	MD	O	might	aux	13	SENT_361	[p13l761t995r952b1063],
13	affect	VB	O	affect	rcmod	3	SENT_361	[p13l977t995r1156b1050],
14	transcription	NN	O	transcription	nn	17	SENT_361	[p13l1181t996r1598b1063],
15	factor	NN	O	factor	nn	17	SENT_361	[p13l1626t995r1810b1050],
16	Spl	NN	O	spl	nn	17	SENT_361	[p13l1836t998r1943b1063],
17	binding	NN	O	binding	dobj	13	SENT_361	[p13l1978t995r2149b1050, p13l10t1085r122b1152],
18	,	,	O	,	_	0	SENT_361	[p13l1978t995r2149b1050, p13l10t1085r122b1152],
19	have	VBP	O	have	aux	21	SENT_361	[p13l150t1084r296b1139],
20	been	VBN	O	be	auxpass	21	SENT_361	[p13l322t1084r477b1139],
21	shown	VBN	O	show	_	0	SENT_361	[p13l503t1084r715b1139],
22	to	TO	O	to	aux	24	SENT_361	[p13l740t1092r800b1139],
23	be	VB	O	be	auxpass	24	SENT_361	[p13l826t1084r900b1139],
24	associated	VBN	O	associate	xcomp	21	SENT_361	[p13l927t1084r1258b1139],
25	with	IN	O	with	_	0	SENT_361	[p13l1283t1084r1431b1139],
26	the	DT	O	the	det	28	SENT_361	[p13l1457t1084r1558b1139],
27	clinical	JJ	O	clinical	amod	28	SENT_361	[p13l1585t1084r1811b1139],
28	outcomes	NNS	O	outcome	prep_with	24	SENT_361	[p13l1838t1092r2149b1139],
29	and	CC	O	and	_	0	SENT_361	[p13l9t1172r125b1227],
30	toxicity	NN	O	toxicity	conj_and	28	SENT_361	[p13l161t1173r402b1241],
31	in	IN	O	in	_	0	SENT_361	[p13l436t1173r495b1226],
32	patients	NNS	O	patient	prep_in	24	SENT_361	[p13l531t1173r788b1241],
33	treated	VBN	O	treat	partmod	32	SENT_361	[p13l824t1172r1053b1227],
34	with	IN	O	with	_	0	SENT_361	[p13l1087t1172r1235b1227],
35	EGFR	NN	ORGANIZATION	egfr	nn	37	SENT_361	[p13l1271t1175r1438b1227],
36	inhibitor	NN	O	inhibitor	nn	37	SENT_361	[p13l1470t1172r1752b1227],
37	[	NN	O	[	prep_with	33	SENT_361	[p13l1788t1172r2148b1241],
38	24,26	CD	NUMBER	24,26	number	39	SENT_361	[p13l1788t1172r2148b1241],
39	—	CD	NUMBER	—	dep	37	SENT_361	[p13l1788t1172r2148b1241],
40	28	CD	NUMBER	28	num	41	SENT_361	[p13l1788t1172r2148b1241],
41	]	NN	O	]	dep	39	SENT_361	[p13l1788t1172r2148b1241],
42	.	.	O	.	_	0	SENT_361	[p13l1788t1172r2148b1241],

1	However	RB	O	however	advmod	11	SENT_362	[p13l10t1265r307b1325],
2	,	,	O	,	_	0	SENT_362	[p13l10t1265r307b1325],
3	the	DT	O	the	det	4	SENT_362	[p13l339t1261r441b1316],
4	frequencies	NNS	O	frequency	nsubj	11	SENT_362	[p13l474t1261r842b1330],
5	of	IN	O	of	_	0	SENT_362	[p13l875t1261r942b1316],
6	the	DT	O	the	det	8	SENT_362	[p13l965t1261r1066b1316],
7	two	CD	NUMBER	two	num	8	SENT_362	[p13l1098t1269r1219b1316],
8	SNPs	NNS	O	snp	prep_of	4	SENT_362	[p13l1252t1264r1406b1316],
9	are	VBP	O	be	cop	11	SENT_362	[p13l1439t1277r1536b1316],
10	very	RB	O	very	advmod	11	SENT_362	[p13l1566t1277r1707b1330],
11	low	JJ	O	low	_	0	SENT_362	[p13l1738t1261r1855b1316],
12	in	IN	O	in	_	0	SENT_362	[p13l1886t1262r1944b1316],
13	Asian	JJ	LOCATION	asian	amod	14	SENT_362	[p13l1973t1262r2150b1316],
14	populations	NNS	O	population	prep_in	11	SENT_362	[p13l10t1350r390b1419],
15	[	VBP	O	[	rcmod	14	SENT_362	[p13l428t1350r568b1419],
16	28	CD	NUMBER	28	num	17	SENT_362	[p13l428t1350r568b1419],
17	]	CD	NUMBER	]	dobj	15	SENT_362	[p13l428t1350r568b1419],
18	,	,	O	,	_	0	SENT_362	[p13l428t1350r568b1419],
19	and	CC	O	and	_	0	SENT_362	[p13l603t1350r719b1405],
20	were	VBD	O	be	auxpass	23	SENT_362	[p13l751t1366r909b1405],
21	therefore	RB	O	therefore	advmod	23	SENT_362	[p13l943t1350r1238b1405],
22	not	RB	O	not	neg	23	SENT_362	[p13l1273t1358r1377b1405],
23	analyzed	VBN	O	analyze	rcmod	14	SENT_362	[p13l1409t1350r1694b1419],
24	in	IN	O	in	_	0	SENT_362	[p13l1728t1351r1788b1405],
25	our	PRP$	O	we	poss	26	SENT_362	[p13l1821t1366r1929b1405],
26	study	NN	O	study	prep_in	23	SENT_362	[p13l1962t1350r2149b1419],
27	.	.	O	.	_	0	SENT_362	[p13l1962t1350r2149b1419],

1	Another	DT	O	another	det	7	SENT_363	[p13l6t1439r270b1493],
2	CSNP	NNP	O	CSNP	nn	7	SENT_363	[p13l298t1441r465b1501],
3	,	,	O	,	_	0	SENT_363	[p13l298t1441r465b1501],
4	rs11543848	CD	NUMBER	rs11543848	number	5	SENT_363	[p13l496t1441r866b1493],
5	(	CD	NUMBER	(	num	7	SENT_363	[p13l897t1439r1143b1506],
6	R521I	NN	O	r521us	nn	7	SENT_363	[p13l897t1439r1143b1506],
7	(	NN	O	(	nsubjpass	31	SENT_363	[p13l897t1439r1143b1506],
8	,	,	O	,	_	0	SENT_363	[p13l897t1439r1143b1506],
9	also	RB	O	also	advmod	10	SENT_363	[p13l1174t1438r1298b1493],
10	assigned	VBN	O	assign	partmod	7	SENT_363	[p13l1328t1439r1604b1506],
11	as	IN	O	as	_	0	SENT_363	[p13l1635t1454r1697b1493],
12	R497I	NN	O	r497us	nn	13	SENT_363	[p13l1728t1441r1937b1493],
13	(	NN	O	(	prep_as	10	SENT_363	[p13l1728t1441r1937b1493],
14	in	IN	O	in	_	0	SENT_363	[p13l1965t1439r2024b1492],
15	literature	NN	O	literature	nn	16	SENT_363	[p13l2054t1438r2146b1493, p13l9t1526r281b1593],
16	)	NN	O	)	prep_in	10	SENT_363	[p13l2054t1438r2146b1493, p13l9t1526r281b1593],
17	,	,	O	,	_	0	SENT_363	[p13l2054t1438r2146b1493, p13l9t1526r281b1593],
18	which	WDT	O	which	nsubj	19	SENT_363	[p13l311t1526r509b1580],
19	seems	VBZ	O	seem	rcmod	16	SENT_363	[p13l540t1541r736b1580],
20	to	TO	O	to	aux	21	SENT_363	[p13l766t1534r827b1580],
21	decrease	VB	O	decrease	xcomp	19	SENT_363	[p13l858t1526r1136b1580],
22	the	DT	O	the	det	23	SENT_363	[p13l1167t1526r1268b1580],
23	activity	NN	O	activity	dobj	21	SENT_363	[p13l1299t1527r1537b1593],
24	of	IN	O	of	_	0	SENT_363	[p13l1566t1526r1632b1580],
25	EGFR	NN	ORGANIZATION	egfr	prep_of	23	SENT_363	[p13l1655t1529r1822b1580],
26	[	CD	NUMBER	[	num	25	SENT_363	[p13l1853t1526r1993b1593],
27	36	CD	NUMBER	36	num	28	SENT_363	[p13l1853t1526r1993b1593],
28	]	NN	O	]	dep	25	SENT_363	[p13l1853t1526r1993b1593],
29	,	,	O	,	_	0	SENT_363	[p13l1853t1526r1993b1593],
30	was	VBD	O	be	auxpass	31	SENT_363	[p13l2022t1541r2145b1580],
31	reported	VBN	O	report	_	0	SENT_363	[p13l10t1612r285b1680],
32	to	TO	O	to	aux	34	SENT_363	[p13l311t1620r372b1666],
33	be	VB	O	be	cop	34	SENT_363	[p13l397t1612r471b1666],
34	weekly	JJ	SET	weekly	xcomp	31	SENT_363	[p13l496t1612r727b1680],
35	associated	VBN	O	associate	partmod	34	SENT_363	[p13l751t1612r1081b1666],
36	with	IN	O	with	_	0	SENT_363	[p13l1106t1612r1255b1666],
37	relative	JJ	O	relative	amod	38	SENT_363	[p13l1280t1612r1518b1666],
38	resistance	NN	O	resistance	prep_with	35	SENT_363	[p13l1545t1613r1864b1666],
39	to	TO	O	to	_	0	SENT_363	[p13l1890t1620r1951b1666],
40	some	DT	O	some	det	42	SENT_363	[p13l1978t1628r2146b1666],
41	EGFR	NN	ORGANIZATION	egfr	nn	42	SENT_363	[p13l10t1702r176b1753],
42	inhibitors	NNS	O	inhibitor	prep_to	35	SENT_363	[p13l192t1699r501b1753],
43	in	IN	O	in	_	0	SENT_363	[p13l521t1700r579b1753],
44	NCI60	NN	O	nci60	nn	46	SENT_363	[p13l597t1702r789b1753],
45	cell	NN	O	cell	nn	46	SENT_363	[p13l807t1699r915b1753],
46	lines	NNS	O	line	prep_in	42	SENT_363	[p13l934t1699r1081b1753],
47	in	FW	O	in	nn	48	SENT_363	[p13l1101t1700r1160b1753],
48	vitro	FW	O	vitro	advmod	31	SENT_363	[p13l1176t1700r1326b1753],
49	only	RB	O	only	advmod	31	SENT_363	[p13l1345t1699r1483b1767],
50	in	IN	O	in	_	0	SENT_363	[p13l1500t1700r1559b1753],
51	combination	NN	O	combination	prep_in	31	SENT_363	[p13l1576t1699r1983b1753],
52	with	IN	O	with	_	0	SENT_363	[p13l1999t1699r2147b1753],
53	the	DT	O	the	det	58	SENT_363	[p13l9t1786r110b1841],
54	—	CD	NUMBER	—	num	55	SENT_363	[p13l143t1789r455b1841],
55	216G	NN	O	216g	npadvmod	56	SENT_363	[p13l143t1789r455b1841],
56	>	JJR	O	>	amod	58	SENT_363	[p13l143t1789r455b1841],
57	T	NN	O	t	nn	58	SENT_363	[p13l143t1789r455b1841],
58	SNP	NN	O	snp	prep_with	31	SENT_363	[p13l483t1789r608b1841],
59	[	CD	NUMBER	[	number	60	SENT_363	[p13l639t1786r777b1854],
60	37	CD	NUMBER	37	num	61	SENT_363	[p13l639t1786r777b1854],
61	]	NN	O	]	dep	58	SENT_363	[p13l639t1786r777b1854],
62	.	.	O	.	_	0	SENT_363	[p13l639t1786r777b1854],

1	In	IN	O	in	_	0	SENT_364	[p13l808t1790r867b1840],
2	the	DT	O	the	det	4	SENT_364	[p13l896t1786r997b1841],
3	present	JJ	DATE	present	amod	4	SENT_364	[p13l1028t1794r1269b1854],
4	study	NN	O	study	prep_in	9	SENT_364	[p13l1297t1786r1485b1854],
5	,	,	O	,	_	0	SENT_364	[p13l1297t1786r1485b1854],
6	we	PRP	O	we	nsubj	9	SENT_364	[p13l1513t1802r1606b1841],
7	did	VBD	O	do	aux	9	SENT_364	[p13l1636t1786r1736b1840],
8	not	RB	O	not	neg	9	SENT_364	[p13l1766t1794r1870b1841],
9	observe	VB	O	observe	_	0	SENT_364	[p13l1898t1786r2146b1841],
10	any	DT	O	any	det	12	SENT_364	[p13l9t1889r122b1941],
11	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_364	[p13l145t1873r478b1941],
12	association	NN	O	association	dobj	9	SENT_364	[p13l500t1874r857b1928],
13	between	IN	O	between	_	0	SENT_364	[p13l880t1873r1157b1928],
14	the	DT	O	the	det	17	SENT_364	[p13l1180t1873r1281b1928],
15	R521I	NN	O	r521us	nn	17	SENT_364	[p13l1306t1876r1511b1928],
16	(	CD	NUMBER	(	num	17	SENT_364	[p13l1306t1876r1511b1928],
17	polymorphism	NN	O	polymorphism	prep_between	12	SENT_364	[p13l1533t1874r2007b1941],
18	and	CC	O	and	_	0	SENT_364	[p13l2030t1874r2146b1928],
19	response	NN	O	response	prep_between	12	SENT_364	[p13l10t1976r294b2028],
20	to	TO	O	to	_	0	SENT_364	[p13l312t1969r372b2015],
21	Geﬁtinib	NNP	LOCATION	Geﬁtinib	prep_to	9	SENT_364	[p13l391t1961r669b2015],
22	in	IN	O	in	_	0	SENT_364	[p13l687t1962r746b2014],
23	advanced	JJ	O	advanced	amod	25	SENT_364	[p13l764t1961r1067b2015],
24	NSCLC	NN	O	nsclc	nn	25	SENT_364	[p13l1086t1964r1291b2015],
25	patients	NNS	O	patient	prep_in	9	SENT_364	[p13l1308t1962r1583b2028],
26	.	.	O	.	_	0	SENT_364	[p13l1308t1962r1583b2028],

1	The	DT	O	the	det	3	SENT_365	[p13l1599t1961r1716b2015],
2	CA-SSR	NN	O	ca-ssr	nn	3	SENT_365	[p13l1734t1963r1967b2015],
3	polymorphism	NN	O	polymorphism	nsubjpass	11	SENT_365	[p13l1982t1961r2146b2028, p13l10t2047r342b2115],
4	in	IN	O	in	_	0	SENT_365	[p13l370t2048r428b2101],
5	intron	NN	O	intron	prep_in	3	SENT_365	[p13l456t2048r652b2101],
6	1	CD	NUMBER	1	num	5	SENT_365	[p13l682t2050r707b2101],
7	of	IN	O	of	_	0	SENT_365	[p13l743t2047r809b2101],
8	EGFR	NN	ORGANIZATION	egfr	prep_of	5	SENT_365	[p13l826t2050r985b2101],
9	has	VBZ	O	have	aux	11	SENT_365	[p13l1011t2047r1116b2101],
10	been	VBN	O	be	auxpass	11	SENT_365	[p13l1144t2047r1299b2101],
11	studied	VBN	O	study	_	0	SENT_365	[p13l1326t2047r1563b2101],
12	more	RBR	O	more	advmod	13	SENT_365	[p13l1592t2063r1756b2101],
13	intensively	RB	O	intensively	advmod	11	SENT_365	[p13l1784t2047r2145b2115],
14	.	.	O	.	_	0	SENT_365	[p13l1784t2047r2145b2115],

1	It	PRP	O	it	nsubjpass	4	SENT_366	[p13l10t2137r54b2188],
2	has	VBZ	O	have	aux	4	SENT_366	[p13l82t2134r187b2188],
3	been	VBN	O	be	auxpass	4	SENT_366	[p13l217t2134r372b2188],
4	shown	VBN	O	show	_	0	SENT_366	[p13l401t2134r613b2188],
5	in	IN	O	in	_	0	SENT_366	[p13l642t2135r701b2188],
6	an	DT	O	a	prep_in	4	SENT_366	[p13l730t2150r805b2188],
7	in	FW	O	in	nn	8	SENT_366	[p13l835t2135r894b2188],
8	vitro	FW	O	vitro	advmod	9	SENT_366	[p13l921t2135r1071b2188],
9	study	NN	O	study	dep	6	SENT_366	[p13l1102t2134r1279b2202],
10	that	IN	O	that	_	0	SENT_366	[p13l1306t2134r1435b2188],
11	head	NN	O	head	prep_that	9	SENT_366	[p13l1464t2134r1616b2188],
12	and	CC	O	and	_	0	SENT_366	[p13l1646t2134r1762b2188],
13	neck	NN	O	neck	nn	16	SENT_366	[p13l1793t2134r1942b2188],
14	carcinoma	NN	O	carcinoma	nn	16	SENT_366	[p13l1969t2135r2146b2188, p13l10t2237r189b2275],
15	cell	NN	O	cell	nn	16	SENT_366	[p13l221t2221r329b2275],
16	lines	NNS	O	line	conj_and	6	SENT_366	[p13l361t2221r509b2275],
17	with	IN	O	with	_	0	SENT_366	[p13l540t2221r688b2275],
18	shorter	JJR	O	shorter	amod	20	SENT_366	[p13l721t2221r952b2275],
19	CA	NNP	O	CA	nn	20	SENT_366	[p13l982t2224r1068b2275],
20	repeat	NN	O	repeat	prep_with	16	SENT_366	[p13l1098t2229r1301b2289],
21	displayed	VBD	O	display	rcmod	20	SENT_366	[p13l1332t2221r1637b2289],
22	higher	JJR	O	higher	amod	23	SENT_366	[p13l1670t2221r1877b2289],
23	level	NN	O	level	dobj	21	SENT_366	[p13l1908t2221r2055b2275],
24	of	IN	O	of	_	0	SENT_366	[p13l2088t2221r2154b2275],
25	EGFR	NN	ORGANIZATION	egfr	nn	26	SENT_366	[p13l7t2311r165b2363],
26	mRNA	NN	O	mrna	prep_of	23	SENT_366	[p13l197t2311r400b2362],
27	and	CC	O	and	_	0	SENT_366	[p13l429t2308r546b2363],
28	protein	NN	O	protein	nn	29	SENT_366	[p13l579t2309r809b2376],
29	expression	NN	O	expression	prep_of	23	SENT_366	[p13l842t2309r1186b2376],
30	and	CC	O	and	_	0	SENT_366	[p13l1218t2308r1334b2363],
31	were	VBD	O	be	cop	34	SENT_366	[p13l1365t2324r1523b2363],
32	signiﬁcantly	RB	O	signiﬁcantly	advmod	34	SENT_366	[p13l1557t2308r1950b2376],
33	more	RBR	O	more	advmod	34	SENT_366	[p13l1981t2324r2146b2363],
34	sensitive	JJ	O	sensitive	rcmod	20	SENT_366	[p13l10t2396r288b2450],
35	than	IN	O	than	_	0	SENT_366	[p13l318t2396r462b2450],
36	those	DT	O	those	prep_than	34	SENT_366	[p13l490t2396r663b2450],
37	with	IN	O	with	_	0	SENT_366	[p13l691t2396r839b2450],
38	longer	JJR	O	longer	amod	40	SENT_366	[p13l868t2396r1073b2463],
39	CA	NNP	O	CA	nn	40	SENT_366	[p13l1100t2398r1186b2450],
40	repeat	NN	O	repeat	prep_with	36	SENT_366	[p13l1213t2404r1416b2463],
41	to	TO	O	to	_	0	SENT_366	[p13l1444t2404r1504b2450],
42	inhibitory	JJ	O	inhibitory	amod	43	SENT_366	[p13l1535t2396r1855b2463],
43	effect	NN	O	effect	prep_to	40	SENT_366	[p13l1882t2395r2060b2450],
44	of	IN	O	of	_	0	SENT_366	[p13l2088t2395r2154b2450],
45	Erlotinib	NNP	LOCATION	Erlotinib	prep_of	43	SENT_366	[p13l10t2483r300b2545],
46	,	,	O	,	_	0	SENT_366	[p13l10t2483r300b2545],
47	another	DT	O	another	det	50	SENT_366	[p13l322t2483r573b2537],
48	EGFR	NN	ORGANIZATION	egfr	nn	50	SENT_366	[p13l593t2486r759b2537],
49	inhibitor	NN	O	inhibitor	nn	50	SENT_366	[p13l778t2483r1060b2537],
50	[	NN	O	[	appos	45	SENT_366	[p13l1082t2483r1216b2550],
51	18	CD	NUMBER	18	num	52	SENT_366	[p13l1082t2483r1216b2550],
52	]	NN	O	]	dep	50	SENT_366	[p13l1082t2483r1216b2550],
53	.	.	O	.	_	0	SENT_366	[p13l1082t2483r1216b2550],

1	In	IN	O	in	_	0	SENT_367	[p13l1239t2486r1299b2536],
2	this	DT	O	this	det	3	SENT_367	[p13l1319t2483r1436b2537],
3	report	NN	O	report	prep_in	32	SENT_367	[p13l1459t2491r1672b2550],
4	,	,	O	,	_	0	SENT_367	[p13l1459t2491r1672b2550],
5	an	DT	O	a	det	6	SENT_367	[p13l1694t2498r1769b2537],
6	association	NN	O	association	nsubjpass	32	SENT_367	[p13l1789t2484r2147b2537],
7	between	IN	O	between	_	0	SENT_367	[p13l8t2569r285b2623],
8	shorter	JJR	O	shorter	amod	10	SENT_367	[p13l309t2569r541b2623],
9	CA	NNP	O	CA	nn	10	SENT_367	[p13l562t2571r648b2623],
10	repeat	NN	O	repeat	prep_between	6	SENT_367	[p13l669t2577r873b2637],
11	genotype	NN	O	genotype	dep	10	SENT_367	[p13l894t2577r1190b2637],
12	and	CC	O	and	_	0	SENT_367	[p13l1214t2569r1330b2623],
13	skin	NN	O	skin	nn	14	SENT_367	[p13l1355t2569r1484b2623],
14	toxicity	NN	O	toxicity	conj_and	10	SENT_367	[p13l1507t2570r1748b2637],
15	of	IN	O	of	_	0	SENT_367	[p13l1770t2569r1836b2623],
16	Geﬁtinib	NNP	O	Geﬁtinib	prep_of	14	SENT_367	[p13l1852t2569r2145b2631],
17	,	,	O	,	_	0	SENT_367	[p13l1852t2569r2145b2631],
18	which	WDT	O	which	nsubjpass	21	SENT_367	[p13l7t2656r205b2710],
19	may	MD	O	may	aux	21	SENT_367	[p13l232t2672r368b2724],
20	be	VB	O	be	auxpass	21	SENT_367	[p13l393t2656r467b2710],
21	related	VBN	O	relate	rcmod	6	SENT_367	[p13l495t2656r717b2710],
22	to	TO	O	to	_	0	SENT_367	[p13l744t2664r804b2710],
23	the	DT	O	the	det	25	SENT_367	[p13l831t2656r933b2710],
24	antitumor	NN	O	antitumor	nn	25	SENT_367	[p13l960t2657r1288b2710],
25	activity	NN	O	activity	prep_to	21	SENT_367	[p13l1313t2657r1550b2724],
26	of	IN	O	of	_	0	SENT_367	[p13l1576t2656r1642b2710],
27	this	DT	O	this	det	28	SENT_367	[p13l1661t2656r1777b2710],
28	agent	NN	O	agent	prep_of	25	SENT_367	[p13l1805t2664r1996b2724],
29	,	,	O	,	_	0	SENT_367	[p13l1805t2664r1996b2724],
30	was	VBD	O	be	auxpass	32	SENT_367	[p13l2022t2672r2145b2710],
31	also	RB	O	also	advmod	32	SENT_367	[p13l9t2743r133b2797],
32	observed	VBN	O	observe	_	0	SENT_367	[p13l156t2743r446b2797],
33	in	IN	O	in	_	0	SENT_367	[p13l470t2744r528b2797],
34	colorectal	JJ	O	colorectal	amod	36	SENT_367	[p13l551t2743r863b2797],
35	cancer	NN	O	cancer	nn	36	SENT_367	[p13l886t2759r1096b2797],
36	patients	NNS	O	patient	prep_in	32	SENT_367	[p13l1117t2744r1374b2811],
37	[	CD	NUMBER	[	number	38	SENT_367	[p13l1401t2743r1536b2811],
38	18	CD	NUMBER	18	num	39	SENT_367	[p13l1401t2743r1536b2811],
39	]	NN	O	]	dep	32	SENT_367	[p13l1401t2743r1536b2811],
40	.	.	O	.	_	0	SENT_367	[p13l1401t2743r1536b2811],

1	Recently	RB	DATE	recently	advmod	6	SENT_368	[p13l1560t2743r1845b2811],
2	,	,	O	,	_	0	SENT_368	[p13l1560t2743r1845b2811],
3	Nie	NNP	PERSON	Nie	nsubj	6	SENT_368	[p13l1869t2744r1973b2797],
4	et	FW	O	et	nn	5	SENT_368	[p13l1996t2751r2056b2797],
5	al.	FW	O	al.	dep	3	SENT_368	[p13l2077t2743r2145b2798],
6	reported	VBN	O	report	_	0	SENT_368	[p13l10t2830r285b2898],
7	that	IN	O	that	complm	18	SENT_368	[p13l305t2830r434b2885],
8	Chinese	JJ	MISC	chinese	amod	10	SENT_368	[p13l452t2830r702b2885],
9	NSCLC	NN	O	nsclc	nn	10	SENT_368	[p13l722t2833r928b2885],
10	patients	NNS	O	patient	nsubj	18	SENT_368	[p13l946t2831r1204b2898],
11	with	IN	O	with	_	0	SENT_368	[p13l1223t2830r1371b2885],
12	shorter	JJR	O	shorter	amod	14	SENT_368	[p13l1391t2830r1622b2885],
13	CA	NNP	O	CA	nn	14	SENT_368	[p13l1640t2833r1726b2884],
14	repeat	NN	O	repeat	prep_with	10	SENT_368	[p13l1743t2838r1947b2898],
15	genotype	NN	O	genotype	dep	14	SENT_368	[p13l1964t2846r2146b2898, p13l9t2926r148b2985],
16	were	VBD	O	be	cop	18	SENT_368	[p13l167t2933r325b2972],
17	more	RBR	O	more	advmod	18	SENT_368	[p13l346t2933r511b2972],
18	sensitive	JJ	O	sensitive	ccomp	6	SENT_368	[p13l533t2918r811b2972],
19	to	TO	O	to	_	0	SENT_368	[p13l832t2926r892b2972],
20	Geﬁtinib	NNP	O	Geﬁtinib	prep_to	18	SENT_368	[p13l914t2917r1192b2972],
21	than	IN	O	than	_	0	SENT_368	[p13l1212t2918r1356b2972],
22	patients	NNS	O	patient	prep_than	18	SENT_368	[p13l1376t2918r1634b2985],
23	with	IN	O	with	_	0	SENT_368	[p13l1654t2918r1802b2972],
24	the	DT	O	the	det	27	SENT_368	[p13l1822t2918r1923b2972],
25	longer	JJR	O	longer	amod	27	SENT_368	[p13l1944t2918r2148b2985],
26	repeat	NN	O	repeat	nn	27	SENT_368	[p13l10t3013r213b3072],
27	genotype	NN	O	genotype	prep_with	22	SENT_368	[p13l233t3013r530b3072],
28	[	CD	NUMBER	[	number	29	SENT_368	[p13l557t3005r696b3072],
29	38	CD	NUMBER	38	num	30	SENT_368	[p13l557t3005r696b3072],
30	]	NN	O	]	dep	27	SENT_368	[p13l557t3005r696b3072],
31	,	,	O	,	_	0	SENT_368	[p13l557t3005r696b3072],
32	which	WDT	O	which	nsubj	34	SENT_368	[p13l719t3005r916b3059],
33	is	VBZ	O	be	cop	34	SENT_368	[p13l939t3006r985b3059],
34	consistent	JJ	O	consistent	rcmod	27	SENT_368	[p13l1009t3006r1338b3059],
35	with	IN	O	with	_	0	SENT_368	[p13l1358t3005r1506b3059],
36	our	PRP$	O	we	poss	37	SENT_368	[p13l1528t3021r1637b3059],
37	results	NNS	O	result	prep_with	34	SENT_368	[p13l1658t3005r1886b3059],
38	.	.	O	.	_	0	SENT_368	[p13l1658t3005r1886b3059],

1	In	IN	O	in	_	0	SENT_369	[p13l1911t3008r1970b3058],
2	Nie	NN	PERSON	nie	poss	4	SENT_369	[p13l1993t3006r2145b3059],
3	’s	POS	O	’s	_	0	SENT_369	[p13l1993t3006r2145b3059],
4	study	NN	O	study	prep_in	9	SENT_369	[p13l10t3091r197b3159],
5	,	,	O	,	_	0	SENT_369	[p13l10t3091r197b3159],
6	a	DT	O	a	det	7	SENT_369	[p13l216t3107r248b3145],
7	correlation	NN	O	correlation	nsubjpass	9	SENT_369	[p13l266t3091r617b3145],
8	was	VBD	O	be	auxpass	9	SENT_369	[p13l634t3107r756b3145],
9	found	VBN	O	find	_	0	SENT_369	[p13l776t3091r961b3145],
10	between	IN	O	between	_	0	SENT_369	[p13l979t3091r1256b3145],
11	the	DT	O	the	det	15	SENT_369	[p13l1273t3091r1375b3145],
12	shorter	JJR	O	shorter	amod	15	SENT_369	[p13l1395t3091r1626b3145],
13	CA	NNP	O	CA	nn	15	SENT_369	[p13l1642t3093r1728b3145],
14	repeat	NN	O	repeat	nn	15	SENT_369	[p13l1744t3099r1948b3159],
15	genotype	NN	O	genotype	prep_between	9	SENT_369	[p13l1964t3107r2146b3159, p13l9t3186r148b3246],
16	and	CC	O	and	_	0	SENT_369	[p13l169t3178r285b3232],
17	longer	JJR	O	longer	amod	18	SENT_369	[p13l308t3178r512b3246],
18	patients	NNS	O	patient	prep_between	9	SENT_369	[p13l531t3179r805b3246],
19	’	CD	NUMBER	’	num	21	SENT_369	[p13l531t3179r805b3246],
20	survival	NN	O	survival	nn	21	SENT_369	[p13l829t3178r1078b3232],
21	time	NN	O	time	dep	18	SENT_369	[p13l1099t3179r1244b3232],
22	[	CD	NUMBER	[	number	23	SENT_369	[p13l1269t3178r1413b3246],
23	38	CD	NUMBER	38	num	24	SENT_369	[p13l1269t3178r1413b3246],
24	]	NN	O	]	dep	21	SENT_369	[p13l1269t3178r1413b3246],
25	;	:	O	;	_	0	SENT_369	[p13l1269t3178r1413b3246],
26	in	IN	O	in	_	0	SENT_369	[p13l1440t3179r1499b3232],
27	our	PRP$	O	we	poss	28	SENT_369	[p13l1520t3194r1629b3232],
28	study	NN	O	study	prep_in	36	SENT_369	[p13l1648t3178r1835b3246],
29	,	,	O	,	_	0	SENT_369	[p13l1648t3178r1835b3246],
30	however	RB	O	however	advmod	36	SENT_369	[p13l1858t3178r2145b3241],
31	,	,	O	,	_	0	SENT_369	[p13l1858t3178r2145b3241],
32	no	DT	O	no	det	34	SENT_369	[p13l10t3281r86b3320],
33	such	JJ	O	such	amod	34	SENT_369	[p13l108t3265r252b3320],
34	effect	NN	O	effect	nsubjpass	36	SENT_369	[p13l273t3265r451b3320],
35	was	VBD	O	be	auxpass	36	SENT_369	[p13l468t3281r591b3320],
36	observed	VBN	O	observe	parataxis	9	SENT_369	[p13l612t3265r902b3320],
37	in	IN	O	in	_	0	SENT_369	[p13l923t3266r982b3319],
38	patients	NNS	O	patient	prep_in	36	SENT_369	[p13l1002t3266r1260b3333],
39	treated	VBN	O	treat	partmod	38	SENT_369	[p13l1281t3265r1509b3320],
40	with	IN	O	with	_	0	SENT_369	[p13l1528t3265r1676b3319],
41	Geﬁtinib	NN	PERSON	geﬁtinib	prep_with	39	SENT_369	[p13l1697t3265r1990b3320],
42	.	.	O	.	_	0	SENT_369	[p13l1697t3265r1990b3320],

1	Several	JJ	O	several	amod	3	SENT_370	[p13l2012t3268r2146b3320, p13l9t3352r126b3407],
2	other	JJ	O	other	amod	3	SENT_370	[p13l148t3352r320b3407],
3	studies	NNS	O	study	nsubj	4	SENT_370	[p13l340t3352r564b3407],
4	showed	VBD	O	show	dep	21	SENT_370	[p13l588t3352r834b3407],
5	that	IN	O	that	complm	15	SENT_370	[p13l855t3352r984b3407],
6	the	DT	O	the	det	10	SENT_370	[p13l1003t3352r1105b3407],
7	shorter	JJR	O	shorter	amod	10	SENT_370	[p13l1128t3352r1359b3407],
8	CA	NNP	O	CA	nn	10	SENT_370	[p13l1378t3355r1464b3406],
9	repeat	NN	O	repeat	nn	10	SENT_370	[p13l1484t3360r1687b3420],
10	genotype	NN	O	genotype	nsubj	15	SENT_370	[p13l1706t3360r2003b3420],
11	was	VBD	O	be	cop	15	SENT_370	[p13l2022t3368r2145b3407],
12	a	DT	O	a	det	15	SENT_370	[p13l9t3455r41b3494],
13	poor	JJ	O	poor	amod	15	SENT_370	[p13l58t3455r206b3507],
14	prognostic	JJ	O	prognostic	amod	15	SENT_370	[p13l221t3440r560b3507],
15	indicator	NN	O	indicator	ccomp	4	SENT_370	[p13l577t3440r865b3494],
16	for	IN	O	for	_	0	SENT_370	[p13l881t3439r970b3494],
17	NSCLC	NNP	O	NSCLC	prep_for	15	SENT_370	[p13l985t3442r1190b3494],
18	and	CC	O	and	_	0	SENT_370	[p13l1206t3440r1322b3494],
19	other	JJ	O	other	amod	20	SENT_370	[p13l1339t3440r1510b3494],
20	cancers	NNS	O	cancer	prep_for	15	SENT_370	[p13l1525t3455r1764b3494],
21	[	VBP	O	[	_	0	SENT_370	[p13l1785t3439r2145b3507],
22	23,38	CD	NUMBER	23,38	num	23	SENT_370	[p13l1785t3439r2145b3507],
23	—	CD	NUMBER	—	dobj	21	SENT_370	[p13l1785t3439r2145b3507],
24	40	CD	NUMBER	40	num	25	SENT_370	[p13l1785t3439r2145b3507],
25	]	NN	O	]	nsubj	21	SENT_370	[p13l1785t3439r2145b3507],
26	.	.	O	.	_	0	SENT_370	[p13l1785t3439r2145b3507],

1	The	DT	O	the	det	2	SENT_371	[p13l6t3527r123b3581],
2	conﬂict	NN	O	conﬂict	nsubj	3	SENT_371	[p13l146t3527r384b3581],
3	results	VBZ	O	result	_	0	SENT_371	[p13l405t3527r616b3581],
4	in	IN	O	in	mark	9	SENT_371	[p13l640t3528r699b3580],
5	these	DT	O	these	det	6	SENT_371	[p13l720t3527r890b3581],
6	studies	NNS	O	study	nsubj	9	SENT_371	[p13l914t3527r1138b3581],
7	might	MD	O	might	aux	9	SENT_371	[p13l1163t3527r1352b3594],
8	be	VB	O	be	cop	9	SENT_371	[p13l1373t3527r1447b3581],
9	due	JJ	O	due	advcl	3	SENT_371	[p13l1469t3527r1586b3581],
10	to	TO	O	to	_	0	SENT_371	[p13l1607t3535r1668b3581],
11	Geﬁtinib	JJ	O	geﬁtinib	amod	12	SENT_371	[p13l1691t3527r1969b3581],
12	therapy	NN	O	therapy	prep_to	9	SENT_371	[p13l1991t3527r2146b3581, p13l9t3629r132b3681],
13	,	,	O	,	_	0	SENT_371	[p13l1991t3527r2146b3581, p13l9t3629r132b3681],
14	subsequent	JJ	O	subsequent	amod	19	SENT_371	[p13l161t3613r529b3681],
15	treatment	NN	O	treatment	nn	19	SENT_371	[p13l554t3621r878b3667],
16	and/or	NN	O	and/or	nn	19	SENT_371	[p13l903t3613r1116b3681],
17	other	JJ	O	other	amod	19	SENT_371	[p13l1141t3613r1312b3667],
18	unknown	JJ	O	unknown	amod	19	SENT_371	[p13l1337t3613r1642b3667],
19	factors	NNS	O	factor	conj_or	12	SENT_371	[p13l1670t3613r1882b3667],
20	such	JJ	O	such	_	0	SENT_371	[p13l1912t3613r2056b3667],
21	as	IN	O	as	_	0	SENT_371	[p13l2083t3629r2145b3667],
22	the	DT	O	the	det	23	SENT_371	[p13l9t3700r110b3754],
23	presence	NN	O	presence	prep_such_as	19	SENT_371	[p13l135t3716r419b3768],
24	of	IN	O	of	_	0	SENT_371	[p13l443t3700r509b3754],
25	other	JJ	O	other	amod	26	SENT_371	[p13l526t3700r697b3754],
26	SNPs	NNS	O	snp	prep_of	23	SENT_371	[p13l719t3703r873b3754],
27	or	CC	O	or	_	0	SENT_371	[p13l899t3716r965b3754],
28	somatic	JJ	O	somatic	amod	29	SENT_371	[p13l987t3701r1237b3754],
29	mutations	NNS	O	mutation	prep_to	9	SENT_371	[p13l1261t3701r1587b3754],
30	in	IN	O	in	_	0	SENT_371	[p13l1612t3701r1672b3754],
31	EGFR	NN	ORGANIZATION	egfr	prep_in	29	SENT_371	[p13l1693t3703r1866b3755],
32	.	.	O	.	_	0	SENT_371	[p13l1693t3703r1866b3755],

1	Because	IN	O	because	mark	6	SENT_372	[p13l1891t3704r2146b3754],
2	the	DT	O	the	det	4	SENT_372	[p14l9t16r110b71],
3	CA-SSR	NN	O	ca-ssr	nn	4	SENT_372	[p14l126t19r359b71],
4	polymorphism	NN	O	polymorphism	nsubjpass	6	SENT_372	[p14l372t16r845b84],
5	is	VBZ	O	be	auxpass	6	SENT_372	[p14l861t17r907b71],
6	associated	VBN	O	associate	advcl	19	SENT_372	[p14l923t16r1255b71],
7	with	IN	O	with	_	0	SENT_372	[p14l1269t16r1417b71],
8	the	DT	O	the	det	9	SENT_372	[p14l1431t16r1533b71],
9	expression	NN	O	expression	prep_with	6	SENT_372	[p14l1549t17r1893b84],
10	of	IN	O	of	_	0	SENT_372	[p14l1908t16r1974b71],
11	EFGR	NN	O	efgr	prep_of	9	SENT_372	[p14l1982t19r2149b71],
12	[	CD	NUMBER	[	num	11	SENT_372	[p14l12t103r147b171],
13	18	CD	NUMBER	18	num	14	SENT_372	[p14l12t103r147b171],
14	]	NN	O	]	dep	11	SENT_372	[p14l12t103r147b171],
15	,	,	O	,	_	0	SENT_372	[p14l12t103r147b171],
16	Geﬁtinib	NN	PERSON	geﬁtinib	nn	17	SENT_372	[p14l167t103r445b158],
17	therapy	NN	O	therapy	nsubj	19	SENT_372	[p14l464t104r711b171],
18	may	MD	O	may	aux	19	SENT_372	[p14l729t119r865b171],
19	subvert	VB	O	subvert	_	0	SENT_372	[p14l883t104r1121b158],
20	the	DT	O	the	det	23	SENT_372	[p14l1138t104r1240b158],
21	intrinsic	JJ	O	intrinsic	amod	23	SENT_372	[p14l1260t104r1524b158],
22	clinical	JJ	O	clinical	amod	23	SENT_372	[p14l1543t104r1769b158],
23	outcome	NN	O	outcome	dobj	19	SENT_372	[p14l1788t112r2068b158],
24	in	IN	O	in	_	0	SENT_372	[p14l2088t104r2147b157],
25	patients	NNS	O	patient	prep_in	19	SENT_372	[p14l9t192r267b258],
26	with	IN	O	with	_	0	SENT_372	[p14l283t191r431b245],
27	different	JJ	O	different	amod	29	SENT_372	[p14l447t191r726b245],
28	CA-SSR	NN	O	ca-ssr	nn	29	SENT_372	[p14l741t193r974b245],
29	genotypes	NNS	O	genotype	prep_with	25	SENT_372	[p14l986t199r1330b258],
30	.	.	O	.	_	0	SENT_372	[p14l986t199r1330b258],

1	However	RB	O	however	advmod	10	SENT_373	[p14l1348t194r1646b253],
2	,	,	O	,	_	0	SENT_373	[p14l1348t194r1646b253],
3	the	DT	O	the	det	5	SENT_373	[p14l1663t191r1764b245],
4	sample	NN	O	sample	nn	5	SENT_373	[p14l1782t191r2009b258],
5	size	NN	O	size	nsubj	10	SENT_373	[p14l2027t192r2146b245],
6	in	IN	O	in	_	0	SENT_373	[p14l10t279r69b331],
7	Nie	NNP	PERSON	Nie	poss	9	SENT_373	[p14l93t279r245b332],
8	’s	POS	O	’s	_	0	SENT_373	[p14l93t279r245b332],
9	study	NN	O	study	prep_in	5	SENT_373	[p14l271t278r448b345],
10	(	VBD	O	(	_	0	SENT_373	[p14l470t278r571b345],
11	70	CD	NUMBER	70	num	12	SENT_373	[p14l470t278r571b345],
12	patients	NNS	O	patient	dobj	10	SENT_373	[p14l596t278r881b345],
13	)	NN	O	)	nn	16	SENT_373	[p14l596t278r881b345],
14	and	CC	O	and	_	0	SENT_373	[p14l905t278r1022b332],
15	ours	JJ	O	ours	nn	16	SENT_373	[p14l1047t293r1183b332],
16	(	NN	O	(	tmod	10	SENT_373	[p14l1209t278r1312b345],
17	84	CD	NUMBER	84	num	19	SENT_373	[p14l1209t278r1312b345],
18	patients	NNS	O	patient	nn	19	SENT_373	[p14l1336t278r1621b345],
19	)	NN	O	)	nsubj	22	SENT_373	[p14l1336t278r1621b345],
20	was	VBD	O	be	cop	22	SENT_373	[p14l1644t293r1767b332],
21	too	RB	O	too	advmod	22	SENT_373	[p14l1792t286r1892b332],
22	limited	JJ	O	limited	rcmod	16	SENT_373	[p14l1918t278r2146b332],
23	to	TO	O	to	aux	24	SENT_373	[p14l8t372r69b418],
24	address	VB	O	address	xcomp	22	SENT_373	[p14l91t364r333b418],
25	this	DT	O	this	det	26	SENT_373	[p14l354t364r471b418],
26	hypothesis	NN	O	hypothesis	dobj	24	SENT_373	[p14l494t364r854b432],
27	.	.	O	.	_	0	SENT_373	[p14l494t364r854b432],

1	The	DT	O	the	det	3	SENT_374	[p14l874t364r990b418],
2	exact	JJ	O	exact	amod	3	SENT_374	[p14l1012t372r1180b418],
3	effect	NN	O	effect	nsubj	19	SENT_374	[p14l1200t364r1378b418],
4	of	IN	O	of	_	0	SENT_374	[p14l1397t364r1464b418],
5	the	DT	O	the	det	7	SENT_374	[p14l1476t364r1578b418],
6	CA-SSR	NN	O	ca-ssr	nn	7	SENT_374	[p14l1599t366r1832b418],
7	genotype	NN	O	genotype	prep_of	3	SENT_374	[p14l1849t372r2146b432],
8	on	IN	O	on	_	0	SENT_374	[p14l9t467r87b505],
9	survival	NN	O	survival	nn	10	SENT_374	[p14l106t451r355b505],
10	time	NN	O	time	prep_on	7	SENT_374	[p14l373t452r518b505],
11	of	IN	O	of	_	0	SENT_374	[p14l536t451r602b505],
12	patients	NNS	O	patient	prep_of	10	SENT_374	[p14l613t452r870b519],
13	treated	VBN	O	treat	conj_or	13	SENT_374	[p14l889t451r1117b505],
14	with	IN	O	with	_	0	SENT_374	[p14l1134t451r1282b505],
15	or	CC	O	or	_	0	SENT_374	[p14l1299t467r1365b505],
16	without	IN	O	without	_	0	SENT_374	[p14l1379t451r1637b505],
17	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_374	[p14l1654t454r1821b505],
18	inhibitors	NNS	O	inhibitor	prep_with	13	SENT_374	[p14l1836t451r2145b505],
19	needs	VBZ	O	need	_	0	SENT_374	[p14l10t538r194b593],
20	further	JJ	O	further	amod	22	SENT_374	[p14l218t538r445b593],
21	clinical	JJ	O	clinical	amod	22	SENT_374	[p14l466t538r692b593],
22	investigations	NNS	O	investigation	dobj	19	SENT_374	[p14l715t539r1161b606],
23	with	IN	O	with	_	0	SENT_374	[p14l1182t538r1330b592],
24	larger	JJR	O	larger	amod	26	SENT_374	[p14l1353t538r1539b606],
25	sample	NN	O	sample	nn	26	SENT_374	[p14l1561t538r1788b606],
26	size	NN	O	size	prep_with	19	SENT_374	[p14l1812t539r1947b593],
27	.	.	O	.	_	0	SENT_374	[p14l1812t539r1947b593],

1	F.	NNP	O	F.	nn	2	SENT_375	[p14l401t682r417b703],
2	Ma	NNP	O	Ma	_	0	SENT_375	[p14l426t682r464b703],
3	et	FW	O	et	nn	4	SENT_375	[p14l473t684r496b703],
4	al.	FW	O	al.	dep	2	SENT_375	[p14l503t681r613b708],
5	/	:	O	/	punct	2	SENT_375	[p14l503t681r613b708],
6	Lung	NN	O	lung	nn	7	SENT_375	[p14l503t681r613b708],
7	Cancer	NN	O	cancer	dep	2	SENT_375	[p14l620t682r703b703],
8	66	CD	NUMBER	66	number	9	SENT_375	[p14l710t682r740b703],
9	(	CD	NUMBER	(	num	10	SENT_375	[p14l747t681r828b708],
10	2009	CD	DATE	2009	dep	7	SENT_375	[p14l747t681r828b708],
11	)	CD	NUMBER	)	number	12	SENT_375	[p14l747t681r828b708],
12	114-1	CD	NUMBER	114-1	num	10	SENT_375	[p14l839t682r908b703],
13	19	CD	NUMBER	19	number	14	SENT_375	[p14l916t682r942b703],
14	119	CD	NUMBER	119	num	10	SENT_375	[p14l1715t682r1759b703],

1	The	DT	O	the	det	3	SENT_376	[p14l110t821r227b876],
2	present	JJ	DATE	present	amod	3	SENT_376	[p14l250t829r491b889],
3	study	NN	O	study	nsubj	5	SENT_376	[p14l513t821r690b889],
4	might	MD	O	might	aux	5	SENT_376	[p14l711t821r901b889],
5	have	VB	O	have	_	0	SENT_376	[p14l923t821r1069b876],
6	some	DT	O	some	det	7	SENT_376	[p14l1093t836r1261b876],
7	limitations	NNS	O	limitation	dobj	5	SENT_376	[p14l1284t821r1648b876],
8	.	.	O	.	_	0	SENT_376	[p14l1284t821r1648b876],

1	With	IN	O	with	_	0	SENT_377	[p14l1669t820r1831b876],
2	the	DT	O	the	det	3	SENT_377	[p14l1852t821r1954b876],
3	number	NN	O	number	prep_with	7	SENT_377	[p14l1977t836r2151b876, p14l10t910r116b965],
4	of	IN	O	of	_	0	SENT_377	[p14l149t910r216b965],
5	variables	NNS	O	variable	prep_of	3	SENT_377	[p14l241t910r528b965],
6	we	PRP	O	we	nsubj	7	SENT_377	[p14l563t926r656b965],
7	analyzed	VBD	O	analyze	ccomp	17	SENT_377	[p14l692t910r993b978],
8	,	,	O	,	_	0	SENT_377	[p14l692t910r993b978],
9	in	IN	O	in	_	0	SENT_377	[p14l1030t911r1089b964],
10	a	DT	O	a	det	12	SENT_377	[p14l1124t926r1156b965],
11	sample	NN	O	sample	nn	12	SENT_377	[p14l1192t910r1419b978],
12	size	NN	O	size	prep_in	7	SENT_377	[p14l1456t911r1575b965],
13	of	IN	O	of	_	0	SENT_377	[p14l1611t910r1678b965],
14	84	CD	NUMBER	84	prep_of	12	SENT_377	[p14l1706t913r1798b973],
15	,	,	O	,	_	0	SENT_377	[p14l1706t913r1798b973],
16	there	EX	O	there	expl	17	SENT_377	[p14l1834t910r2001b965],
17	is	VBZ	O	be	_	0	SENT_377	[p14l2037t911r2083b965],
18	a	DT	O	a	det	19	SENT_377	[p14l2119t926r2152b965],
19	likelihood	NN	O	likelihood	nsubj	17	SENT_377	[p14l11t998r331b1053],
20	of	IN	O	of	_	0	SENT_377	[p14l358t998r425b1053],
21	identifying	VBG	O	identify	prepc_of	19	SENT_377	[p14l444t998r795b1067],
22	spurious	JJ	O	spurious	amod	23	SENT_377	[p14l821t999r1094b1067],
23	associations	NNS	O	association	dobj	21	SENT_377	[p14l1121t999r1509b1053],
24	by	IN	O	by	_	0	SENT_377	[p14l1536t998r1612b1067],
25	random	JJ	O	random	amod	26	SENT_377	[p14l1637t998r1887b1053],
26	chance	NN	O	chance	prep_by	21	SENT_377	[p14l1913t998r2150b1054],
27	.	.	O	.	_	0	SENT_377	[p14l1913t998r2150b1054],

1	The	DT	O	the	det	2	SENT_378	[p14l8t1087r125b1142],
2	conﬁrmation	NN	O	conﬁrmation	nsubj	6	SENT_378	[p14l159t1087r577b1142],
3	of	IN	O	of	_	0	SENT_378	[p14l611t1087r677b1142],
4	apparent	JJ	O	apparent	amod	5	SENT_378	[p14l703t1095r992b1156],
5	correlation	NN	O	correlation	prep_of	2	SENT_378	[p14l1024t1087r1376b1142],
6	is	VBZ	O	be	_	0	SENT_378	[p14l1410t1088r1456b1142],
7	in	IN	O	in	_	0	SENT_378	[p14l1491t1088r1550b1142],
8	progress	NN	O	progress	prep_in	6	SENT_378	[p14l1584t1103r1854b1156],
9	in	IN	O	in	_	0	SENT_378	[p14l1890t1088r1948b1142],
10	some	DT	O	some	det	13	SENT_378	[p14l1983t1103r2151b1142],
11	independent	JJ	O	independent	amod	13	SENT_378	[p14l11t1176r422b1245],
12	data	NN	O	datum	nn	13	SENT_378	[p14l438t1176r575b1231],
13	set	NN	O	set	prep_in	8	SENT_378	[p14l593t1184r697b1232],
14	.	.	O	.	_	0	SENT_378	[p14l593t1184r697b1232],

1	In	IN	O	in	_	0	SENT_379	[p14l716t1180r776b1231],
2	addition	NN	O	addition	prep_in	16	SENT_379	[p14l793t1176r1076b1240],
3	,	,	O	,	_	0	SENT_379	[p14l793t1176r1076b1240],
4	although	IN	O	although	mark	6	SENT_379	[p14l1095t1176r1381b1245],
5	we	PRP	O	we	nsubj	6	SENT_379	[p14l1397t1192r1490b1231],
6	captured	VBD	O	capture	advcl	16	SENT_379	[p14l1508t1176r1791b1245],
7	most	RBS	O	most	advmod	8	SENT_379	[p14l1809t1184r1968b1231],
8	functional	JJ	O	functional	amod	9	SENT_379	[p14l1985t1176r2151b1231, p14l10t1265r194b1320],
9	SNPs	NNS	O	snp	dobj	6	SENT_379	[p14l217t1268r371b1320],
10	in	IN	O	in	_	0	SENT_379	[p14l394t1266r453b1320],
11	EGFR	NN	ORGANIZATION	egfr	prep_in	6	SENT_379	[p14l472t1268r646b1329],
12	,	,	O	,	_	0	SENT_379	[p14l472t1268r646b1329],
13	we	PRP	O	we	nsubj	16	SENT_379	[p14l667t1281r760b1320],
14	did	VBD	O	do	aux	16	SENT_379	[p14l782t1265r882b1320],
15	not	RB	O	not	neg	16	SENT_379	[p14l904t1273r1009b1320],
16	analyze	VB	O	analyze	_	0	SENT_379	[p14l1029t1265r1271b1334],
17	somatic	JJ	O	somatic	amod	18	SENT_379	[p14l1294t1266r1544b1320],
18	mutations	NNS	O	mutation	dobj	16	SENT_379	[p14l1566t1266r1892b1320],
19	of	IN	O	of	_	0	SENT_379	[p14l1915t1265r1982b1320],
20	EGFR	NN	ORGANIZATION	egfr	prep_of	18	SENT_379	[p14l1993t1268r2152b1320],
21	in	IN	O	in	_	0	SENT_379	[p14l11t1355r71b1409],
22	target	NN	O	target	nn	23	SENT_379	[p14l90t1363r279b1423],
23	tissues	NNS	O	tissue	prep_in	20	SENT_379	[p14l297t1355r514b1410],
24	because	IN	O	because	_	0	SENT_379	[p14l535t1355r790b1410],
25	of	IN	O	of	prepc_because_of	16	SENT_379	[p14l811t1354r877b1410],
26	lacking	VBG	O	lack	pcomp	16	SENT_379	[p14l890t1355r1119b1423],
27	lung	NN	O	lung	nn	30	SENT_379	[p14l1138t1355r1279b1423],
28	cancer	NN	O	cancer	nn	30	SENT_379	[p14l1298t1370r1508b1410],
29	tissue	NN	O	tissue	nn	30	SENT_379	[p14l1526t1355r1712b1410],
30	specimens	NNS	O	specimen	dobj	26	SENT_379	[p14l1734t1355r2087b1423],
31	.	.	O	.	_	0	SENT_379	[p14l1734t1355r2087b1423],

1	It	PRP	O	it	nsubjpass	4	SENT_380	[p14l2109t1358r2153b1410],
2	has	VBZ	O	have	aux	4	SENT_380	[p14l11t1444r116b1499],
3	been	VBN	O	be	auxpass	4	SENT_380	[p14l139t1444r294b1499],
4	shown	VBN	O	show	_	0	SENT_380	[p14l317t1444r528b1499],
5	that	IN	O	that	complm	12	SENT_380	[p14l549t1444r679b1499],
6	some	DT	O	some	det	7	SENT_380	[p14l701t1460r869b1499],
7	polymorphisms	NNS	O	polymorphism	nsubjpass	12	SENT_380	[p14l892t1444r1396b1512],
8	in	IN	O	in	_	0	SENT_380	[p14l1420t1445r1480b1498],
9	EGFR	NN	ORGANIZATION	egfr	prep_in	7	SENT_380	[p14l1499t1447r1658b1499],
10	might	MD	O	might	aux	12	SENT_380	[p14l1680t1444r1870b1512],
11	be	VB	O	be	auxpass	12	SENT_380	[p14l1890t1444r1964b1499],
12	associated	VBN	O	associate	ccomp	4	SENT_380	[p14l1987t1460r2151b1499, p14l11t1532r203b1587],
13	with	IN	O	with	_	0	SENT_380	[p14l225t1532r374b1587],
14	somatic	JJ	O	somatic	amod	15	SENT_380	[p14l398t1533r648b1587],
15	mutations	NNS	O	mutation	prep_with	12	SENT_380	[p14l672t1533r999b1587],
16	[	VBP	O	[	dep	15	SENT_380	[p14l1026t1532r1167b1601],
17	28	CD	NUMBER	28	num	18	SENT_380	[p14l1026t1532r1167b1601],
18	]	CD	NUMBER	]	dobj	16	SENT_380	[p14l1026t1532r1167b1601],
19	.	.	O	.	_	0	SENT_380	[p14l1026t1532r1167b1601],

1	In	IN	O	in	_	0	SENT_381	[p14l1192t1535r1252b1586],
2	addition	NN	O	addition	prep_in	5	SENT_381	[p14l1275t1532r1559b1595],
3	,	,	O	,	_	0	SENT_381	[p14l1275t1532r1559b1595],
4	we	PRP	O	we	nsubj	5	SENT_381	[p14l1582t1548r1675b1587],
5	observed	VBD	O	observe	_	0	SENT_381	[p14l1699t1532r1990b1587],
6	only	RB	O	only	advmod	8	SENT_381	[p14l2014t1532r2153b1601],
7	certain	JJ	O	certain	amod	8	SENT_381	[p14l11t1622r233b1676],
8	variants	NNS	O	variant	dobj	5	SENT_381	[p14l264t1622r520b1676],
9	but	CC	O	but	_	0	SENT_381	[p14l553t1621r660b1676],
10	not	RB	O	not	_	0	SENT_381	[p14l691t1629r795b1676],
11	all	DT	O	all	det	12	SENT_381	[p14l826t1621r900b1676],
12	polymorphisms	NNS	O	polymorphism	conj_negcc	8	SENT_381	[p14l933t1621r1437b1690],
13	that	WDT	O	that	nsubjpass	15	SENT_381	[p14l1470t1621r1599b1676],
14	were	VBD	O	be	auxpass	15	SENT_381	[p14l1628t1637r1787b1676],
15	associated	VBN	O	associate	rcmod	12	SENT_381	[p14l1819t1621r2151b1676],
16	with	IN	O	with	_	0	SENT_381	[p14l9t1710r158b1765],
17	efﬁcacy	NN	O	efﬁcacy	prep_with	15	SENT_381	[p14l192t1710r437b1779],
18	of	IN	O	of	_	0	SENT_381	[p14l470t1710r536b1765],
19	Geﬁtinib	NNP	LOCATION	Geﬁtinib	prep_of	17	SENT_381	[p14l563t1710r857b1774],
20	,	,	O	,	_	0	SENT_381	[p14l563t1710r857b1774],
21	suggesting	VBG	O	suggest	dobj	5	SENT_381	[p14l894t1711r1236b1779],
22	that	IN	O	that	complm	28	SENT_381	[p14l1269t1710r1398b1765],
23	these	DT	O	these	det	24	SENT_381	[p14l1430t1710r1601b1765],
24	effects	NNS	O	effect	nsubj	28	SENT_381	[p14l1635t1710r1843b1765],
25	may	MD	O	may	aux	28	SENT_381	[p14l1879t1726r2015b1779],
26	not	RB	O	not	neg	28	SENT_381	[p14l2048t1718r2153b1765],
27	be	VB	O	be	cop	28	SENT_381	[p14l10t1799r84b1854],
28	due	JJ	O	due	ccomp	21	SENT_381	[p14l108t1799r225b1854],
29	to	TO	O	to	_	0	SENT_381	[p14l248t1808r309b1854],
30	EGFR	NN	ORGANIZATION	egfr	nn	32	SENT_381	[p14l330t1802r489b1854],
31	somatic	JJ	O	somatic	amod	32	SENT_381	[p14l513t1800r763b1854],
32	mutations	NNS	O	mutation	prep_to	28	SENT_381	[p14l786t1800r1129b1855],
33	.	.	O	.	_	0	SENT_381	[p14l786t1800r1129b1855],

1	Furthermore	RB	O	furthermore	advmod	9	SENT_382	[p14l1154t1799r1577b1863],
2	,	,	O	,	_	0	SENT_382	[p14l1154t1799r1577b1863],
3	genetic	JJ	O	genetic	amod	4	SENT_382	[p14l1600t1800r1833b1868],
4	polymorphisms	NNS	O	polymorphism	nsubjpass	9	SENT_382	[p14l1855t1799r2150b1868, p14l11t1889r240b1957],
5	of	IN	O	of	_	0	SENT_382	[p14l258t1888r324b1944],
6	EGFR	NN	ORGANIZATION	egfr	prep_of	4	SENT_382	[p14l330t1891r489b1944],
7	have	VBP	O	have	aux	9	SENT_382	[p14l505t1889r652b1944],
8	been	VBN	O	be	auxpass	9	SENT_382	[p14l668t1889r823b1944],
9	reported	VBN	O	report	dep	18	SENT_382	[p14l840t1889r1116b1957],
10	to	TO	O	to	aux	11	SENT_382	[p14l1133t1897r1193b1944],
11	affect	VB	O	affect	xcomp	9	SENT_382	[p14l1210t1888r1389b1944],
12	the	DT	O	the	det	14	SENT_382	[p14l1403t1889r1504b1944],
13	therapeutic	JJ	O	therapeutic	amod	14	SENT_382	[p14l1521t1889r1892b1957],
14	efﬁcacy	NN	O	efﬁcacy	dobj	11	SENT_382	[p14l1908t1888r2153b1957],
15	of	IN	O	of	_	0	SENT_382	[p14l11t1978r78b2033],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_382	[p14l95t1981r261b2033],
17	inhibitors	NNS	O	inhibitor	prep_of	14	SENT_382	[p14l283t1978r593b2033],
18	[	VBP	O	[	_	0	SENT_382	[p14l622t1978r1073b2046],
19	18,24,37	CD	NUMBER	18,24,37	num	20	SENT_382	[p14l622t1978r1073b2046],
20	—	CD	NUMBER	—	dobj	18	SENT_382	[p14l622t1978r1073b2046],
21	38	CD	NUMBER	38	num	22	SENT_382	[p14l622t1978r1073b2046],
22	]	NN	O	]	nsubj	18	SENT_382	[p14l622t1978r1073b2046],
23	.	.	O	.	_	0	SENT_382	[p14l622t1978r1073b2046],

1	A	DT	O	a	det	2	SENT_383	[p14l1096t1980r1143b2032],
2	study	NN	O	study	nsubj	3	SENT_383	[p14l1165t1978r1342b2046],
3	has	VBZ	O	have	_	0	SENT_383	[p14l1365t1978r1470b2033],
4	being	VBG	O	be	auxpass	5	SENT_383	[p14l1495t1978r1673b2046],
5	undertaken	VBN	O	undertake	xcomp	3	SENT_383	[p14l1696t1978r2067b2033],
6	to	TO	O	to	aux	7	SENT_383	[p14l2090t1986r2151b2033],
7	compare	VB	O	compare	xcomp	5	SENT_383	[p14l11t2082r289b2135],
8	the	DT	O	the	det	9	SENT_383	[p14l324t2066r426b2121],
9	effect	NN	O	effect	dobj	7	SENT_383	[p14l462t2066r640b2121],
10	between	IN	O	between	_	0	SENT_383	[p14l673t2066r951b2121],
11	the	DT	O	the	det	13	SENT_383	[p14l985t2066r1087b2121],
12	EGFR	NN	ORGANIZATION	egfr	nn	13	SENT_383	[p14l1120t2069r1279b2121],
13	CA-SSR	NN	O	ca-ssr	prep_between	9	SENT_383	[p14l1314t2068r1547b2121],
14	and	CC	O	and	_	0	SENT_383	[p14l1579t2066r1696b2121],
15	D994D	NN	O	d994d	nn	16	SENT_383	[p14l1732t2069r1951b2121],
16	polymorphisms	NNS	O	polymorphism	dobj	7	SENT_383	[p14l1987t2066r2151b2135, p14l11t2155r374b2224],
17	and	CC	O	and	_	0	SENT_383	[p14l404t2155r520b2210],
18	EGFR	NN	ORGANIZATION	egfr	nn	19	SENT_383	[p14l547t2158r705b2210],
19	mutations	NNS	O	mutation	conj_and	16	SENT_383	[p14l733t2156r1060b2210],
20	in	IN	O	in	_	0	SENT_383	[p14l1090t2156r1149b2210],
21	terms	NNS	O	term	prep_in	16	SENT_383	[p14l1177t2163r1360b2210],
22	of	IN	O	of	_	0	SENT_383	[p14l1389t2155r1456b2210],
23	outcome	NN	O	outcome	prep_of	21	SENT_383	[p14l1477t2163r1757b2210],
24	of	IN	O	of	_	0	SENT_383	[p14l1786t2155r1852b2210],
25	Geﬁtinib	JJ	O	geﬁtinib	amod	26	SENT_383	[p14l1873t2155r2151b2210],
26	therapy	NN	O	therapy	prep_of	23	SENT_383	[p14l10t2244r268b2313],
27	.	.	O	.	_	0	SENT_383	[p14l10t2244r268b2313],

1	5	CD	NUMBER	5	_	0	SENT_384	[p14l11t2438r66b2489],
2	.	.	O	.	_	0	SENT_384	[p14l11t2438r66b2489],

1	Conclusion	NN	O	conclusion	_	0	SENT_385	[p14l112t2434r489b2489],

1	This	DT	O	this	det	3	SENT_386	[p14l110t2612r242b2667],
2	comprehensive	JJ	O	comprehensive	amod	3	SENT_386	[p14l276t2612r766b2680],
3	analysis	NN	O	analysis	nsubj	7	SENT_386	[p14l799t2612r1051b2680],
4	of	IN	O	of	_	0	SENT_386	[p14l1085t2612r1152b2667],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_386	[p14l1175t2615r1333b2667],
6	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_386	[p14l1365t2612r1870b2680],
7	showed	VBD	O	show	_	0	SENT_386	[p14l1904t2612r2151b2667],
8	that	IN	O	that	complm	17	SENT_386	[p14l10t2700r140b2755],
9	rs2293347	NN	O	rs2293347	nn	12	SENT_386	[p14l172t2703r508b2755],
10	(	CD	NUMBER	(	num	12	SENT_386	[p14l543t2700r815b2768],
11	D994D	NN	O	d994d	nn	12	SENT_386	[p14l543t2700r815b2768],
12	)	NN	O	)	nsubjpass	17	SENT_386	[p14l543t2700r815b2768],
13	and	CC	O	and	_	0	SENT_386	[p14l848t2700r964b2755],
14	CA-SSR	NN	O	ca-ssr	nn	15	SENT_386	[p14l999t2702r1232b2755],
15	polymorphisms	NNS	O	polymorphism	conj_and	12	SENT_386	[p14l1263t2700r1767b2769],
16	are	VBP	O	be	auxpass	17	SENT_386	[p14l1802t2716r1898b2755],
17	associated	VBN	O	associate	ccomp	7	SENT_386	[p14l1932t2701r2150b2755, p14l11t2789r147b2844],
18	with	IN	O	with	_	0	SENT_386	[p14l163t2789r311b2844],
19	outcome	NN	O	outcome	prep_with	17	SENT_386	[p14l328t2797r608b2844],
20	of	IN	O	of	_	0	SENT_386	[p14l625t2789r692b2844],
21	Geﬁtinib	JJ	O	geﬁtinib	amod	22	SENT_386	[p14l701t2789r979b2844],
22	therapy	NN	O	therapy	prep_of	19	SENT_386	[p14l995t2789r1242b2858],
23	in	IN	O	in	_	0	SENT_386	[p14l1258t2790r1317b2844],
24	advanced	JJ	O	advanced	amod	26	SENT_386	[p14l1333t2789r1636b2844],
25	NSCLC	NN	O	nsclc	nn	26	SENT_386	[p14l1654t2792r1860b2844],
26	patients	NNS	O	patient	prep_in	22	SENT_386	[p14l1876t2790r2150b2858],
27	.	.	O	.	_	0	SENT_386	[p14l1876t2790r2150b2858],

1	These	DT	O	these	det	2	SENT_387	[p14l8t2878r194b2933],
2	results	NNS	O	result	nsubj	3	SENT_387	[p14l224t2878r435b2933],
3	suggest	VBP	O	suggest	_	0	SENT_387	[p14l466t2886r706b2947],
4	that	IN	O	that	complm	10	SENT_387	[p14l732t2878r862b2933],
5	rs2293347	NN	O	rs2293347	nn	8	SENT_387	[p14l889t2881r1225b2933],
6	and	CC	O	and	_	0	SENT_387	[p14l1255t2878r1371b2933],
7	CA-SSR	NN	O	ca-ssr	nn	8	SENT_387	[p14l1401t2881r1634b2933],
8	genotypes	NNS	O	genotype	nsubj	10	SENT_387	[p14l1659t2886r1986b2947],
9	may	MD	O	may	aux	10	SENT_387	[p14l2017t2894r2153b2947],
10	have	VB	O	have	ccomp	3	SENT_387	[p14l11t2968r158b3023],
11	potential	JJ	O	potential	nsubj	13	SENT_387	[p14l182t2968r468b3036],
12	to	TO	O	to	aux	13	SENT_387	[p14l491t2976r552b3023],
13	serve	VB	O	serve	ccomp	10	SENT_387	[p14l576t2983r742b3023],
14	as	IN	O	as	_	0	SENT_387	[p14l765t2983r828b3023],
15	predictors	NNS	O	predictor	prep_as	13	SENT_387	[p14l852t2968r1177b3036],
16	for	IN	O	for	_	0	SENT_387	[p14l1201t2967r1290b3023],
17	clinical	JJ	O	clinical	amod	18	SENT_387	[p14l1312t2968r1538b3023],
18	outcome	NN	O	outcome	prep_for	15	SENT_387	[p14l1561t2976r1841b3023],
19	of	IN	O	of	_	0	SENT_387	[p14l1865t2967r1931b3023],
20	NSCLC	NN	ORGANIZATION	nsclc	nn	21	SENT_387	[p14l1947t2970r2152b3023],
21	patients	NNS	O	patient	prep_of	18	SENT_387	[p14l11t3058r269b3125],
22	treated	VBN	O	treat	partmod	21	SENT_387	[p14l292t3057r521b3112],
23	with	IN	O	with	_	0	SENT_387	[p14l543t3057r691b3112],
24	Geﬁtinib	NN	PERSON	geﬁtinib	prep_with	22	SENT_387	[p14l713t3057r1007b3112],
25	.	.	O	.	_	0	SENT_387	[p14l713t3057r1007b3112],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_388	[p14l10t3247r272b3301],
2	of	IN	O	of	_	0	SENT_388	[p14l292t3247r364b3301],
3	interest	NN	O	interest	prep_of	1	SENT_388	[p14l379t3247r642b3301],

1	None	NN	O	none	nsubj	2	SENT_389	[p14l113t3428r279b3478],
2	declared	VBD	O	declare	_	0	SENT_389	[p14l302t3424r591b3479],
3	.	.	O	.	_	0	SENT_389	[p14l302t3424r591b3479],

1	Acknowledgement	NN	O	acknowledgement	_	0	SENT_390	[p14l7t3614r646b3683],

1	This	DT	O	this	det	2	SENT_391	[p15l110t62r242b117],
2	work	NN	O	work	nsubjpass	4	SENT_391	[p15l263t61r429b117],
3	was	VBD	O	be	auxpass	4	SENT_391	[p15l447t77r570b117],
4	supported	VBN	O	support	_	0	SENT_391	[p15l594t62r921b130],
5	in	IN	O	in	_	0	SENT_391	[p15l944t62r1003b116],
6	part	NN	O	part	prep_in	4	SENT_391	[p15l1025t70r1155b130],
7	by	IN	O	by	_	0	SENT_391	[p15l1175t62r1252b130],
8	the	DT	O	the	det	10	SENT_391	[p15l1271t62r1373b117],
9	Chinese	JJ	ORGANIZATION	chinese	amod	10	SENT_391	[p15l1395t62r1645b117],
10	Society	NN	ORGANIZATION	society	agent	4	SENT_391	[p15l1668t62r1899b130],
11	of	IN	ORGANIZATION	of	_	0	SENT_391	[p15l1919t61r1985b117],
12	Clinical	JJ	ORGANIZATION	clinical	amod	16	SENT_391	[p15l2000t62r2151b117, p15l11t151r118b206],
13	Oncology	NNP	ORGANIZATION	Oncology	nn	16	SENT_391	[p15l144t151r446b219],
14	Science	NNP	ORGANIZATION	Science	nn	16	SENT_391	[p15l470t152r707b206],
15	Foundation	NNP	ORGANIZATION	Foundation	nn	16	SENT_391	[p15l733t151r1098b206],
16	Y	NN	ORGANIZATION	y	prep_of	10	SENT_391	[p15l1120t154r1537b206],
17	.	.	O	.	_	0	SENT_391	[p15l1120t154r1537b206],

1	—	NN	O	—	_	0	SENT_392	[p15l1120t154r1537b206],
2	.	.	O	.	_	0	SENT_392	[p15l1120t154r1537b206],

1	2005	CD	DATE	2005	_	0	SENT_393	[p15l1120t154r1537b206],
2	.	.	O	.	_	0	SENT_393	[p15l1120t154r1537b206],

1	—	NN	O	—	_	0	SENT_394	[p15l1120t154r1537b206],
2	.	.	O	.	_	0	SENT_394	[p15l1120t154r1537b206],

1	OO18	NN	O	oo18	nn	7	SENT_395	[p15l1120t154r1537b206],
2	and	CC	O	and	_	0	SENT_395	[p15l1563t151r1680b206],
3	National	NNP	O	National	nn	7	SENT_395	[p15l1706t151r1976b206],
4	High	NNP	O	High	nn	7	SENT_395	[p15l2001t151r2152b219],
5	Technology	NNP	O	Technology	nn	7	SENT_395	[p15l8t240r378b309],
6	Project	NNP	O	Project	nn	7	SENT_395	[p15l399t241r622b309],
7	Grant	NNP	O	Grant	_	0	SENT_395	[p15l643t243r823b295],
8	2006AAO2A401	NN	O	2006aao2a401	dep	7	SENT_395	[p15l844t242r1357b296],
9	.	.	O	.	_	0	SENT_395	[p15l844t242r1357b296],

1	Appendix	NNP	O	Appendix	nn	3	SENT_396	[p15l7t430r335b499],
2	A.	NNP	O	A.	nn	3	SENT_396	[p15l351t433r417b486],
3	Supplementary	NNP	O	Supplementary	_	0	SENT_396	[p15l462t430r985b499],
4	data	NNS	O	datum	dep	3	SENT_396	[p15l1003t430r1150b485],

1	Supplementary	NNP	O	Supplementary	nn	2	SENT_397	[p15l113t608r609b677],
2	data	NNS	O	datum	nsubjpass	9	SENT_397	[p15l626t608r763b663],
3	associated	VBN	O	associate	partmod	2	SENT_397	[p15l781t608r1113b663],
4	with	IN	O	with	_	0	SENT_397	[p15l1130t608r1278b663],
5	this	DT	O	this	det	6	SENT_397	[p15l1296t608r1413b663],
6	article	NN	O	article	prep_with	3	SENT_397	[p15l1432t608r1632b663],
7	can	MD	O	can	aux	9	SENT_397	[p15l1651t624r1760b663],
8	be	VB	O	be	auxpass	9	SENT_397	[p15l1778t608r1852b663],
9	found	VBN	O	find	_	0	SENT_397	[p15l1871t608r2073b672],
10	,	,	O	,	_	0	SENT_397	[p15l1871t608r2073b672],
11	in	IN	O	in	_	0	SENT_397	[p15l2093t609r2152b663],
12	the	DT	O	the	det	14	SENT_397	[p15l10t697r112b753],
13	online	JJ	O	online	amod	14	SENT_397	[p15l135t698r335b753],
14	version	NN	O	version	prep_in	9	SENT_397	[p15l356t698r608b761],
15	,	,	O	,	_	0	SENT_397	[p15l356t698r608b761],
16	at	IN	O	at	_	0	SENT_397	[p15l631t706r691b753],
17	doi	FW	O	doi	nn	18	SENT_397	[p15l712t697r1824b766],
18	:10.1016	FW	O	:10.1016	prep_at	9	SENT_397	[p15l712t697r1824b766],
19	/	:	O	/	punct	21	SENT_397	[p15l712t697r1824b766],
20	j.	NN	O	j.	nn	21	SENT_397	[p15l712t697r1824b766],
21	lungcan	NN	O	lungcan	dep	18	SENT_397	[p15l712t697r1824b766],
22	.2008.12.025	CD	NUMBER	.2008.12.025	dep	21	SENT_397	[p15l712t697r1824b766],
23	.	.	O	.	_	0	SENT_397	[p15l712t697r1824b766],

1	References	NNS	O	reference	_	0	SENT_398	[p15l10t888r376b942],

1	[	NN	O	[	nn	6	SENT_399	[p15l40t1054r104b1108],
2	1	CD	NUMBER	1	num	6	SENT_399	[p15l40t1054r104b1108],
3	]	CD	NUMBER	]	num	6	SENT_399	[p15l40t1054r104b1108],
4	Walker	NNP	O	Walker	nn	6	SENT_399	[p15l137t1054r323b1098],
5	S.	NNP	O	S.	nn	6	SENT_399	[p15l369t1056r407b1098],
6	Updates	NNP	O	Updates	_	0	SENT_399	[p15l454t1054r662b1108],
7	in	IN	O	in	_	0	SENT_399	[p15l711t1055r758b1097],
8	non	JJ	O	non	amod	13	SENT_399	[p15l805t1054r1065b1098],
9	—	JJ	O	—	amod	13	SENT_399	[p15l805t1054r1065b1098],
10	small	JJ	O	small	amod	13	SENT_399	[p15l805t1054r1065b1098],
11	cell	NN	O	cell	nn	13	SENT_399	[p15l1113t1054r1200b1098],
12	lung	NN	O	lung	nn	13	SENT_399	[p15l1248t1054r1361b1108],
13	cancer	NN	O	cancer	prep_in	6	SENT_399	[p15l1407t1067r1583b1098],
14	.	.	O	.	_	0	SENT_399	[p15l1407t1067r1583b1098],

1	Clin	NN	O	clin	nn	4	SENT_400	[p15l1632t1054r1730b1098],
2	J	NN	O	j	nn	4	SENT_400	[p15l1771t1057r1791b1108],
3	Oncol	NN	O	oncol	nn	4	SENT_400	[p15l1839t1054r1985b1098],
4	Nurs	NNS	O	nur	_	0	SENT_400	[p15l2033t1057r2151b1098],

1	[	NN	O	[	nn	5	SENT_401	[p15l40t1186r104b1240],
2	2	CD	NUMBER	2	num	5	SENT_401	[p15l40t1186r104b1240],
3	]	CD	NUMBER	]	num	5	SENT_401	[p15l40t1186r104b1240],
4	Spira	NNP	PERSON	Spira	nn	5	SENT_401	[p15l139t1187r267b1240],
5	A	NNP	O	A	_	0	SENT_401	[p15l278t1188r327b1236],
6	,	,	O	,	_	0	SENT_401	[p15l278t1188r327b1236],
7	Ettinger	NNP	O	Ettinger	nn	8	SENT_401	[p15l342t1187r548b1240],
8	DS	NN	O	d	appos	5	SENT_401	[p15l559t1188r638b1230],
9	.	.	O	.	_	0	SENT_401	[p15l559t1188r638b1230],

1	Multidisciplinary	JJ	O	multidisciplinary	amod	2	SENT_402	[p15l652t1186r1097b1240],
2	management	NN	O	management	_	0	SENT_402	[p15l1110t1192r1449b1240],
3	of	IN	O	of	_	0	SENT_402	[p15l1461t1186r1515b1229],
4	lung	NN	O	lung	nn	5	SENT_402	[p15l1522t1186r1635b1240],
5	cancer	NN	O	cancer	prep_of	2	SENT_402	[p15l1647t1198r1823b1230],
6	.	.	O	.	_	0	SENT_402	[p15l1647t1198r1823b1230],

1	N	NN	O	n	nn	3	SENT_403	[p15l1838t1189r1875b1229],
2	Engl	NNP	O	Engl	nn	3	SENT_403	[p15l1889t1186r2025b1240],
3	]	NNP	O	]	nsubj	4	SENT_403	[p15l1889t1186r2025b1240],
4	Med	VBD	O	med	_	0	SENT_403	[p15l2039t1186r2151b1229],

1	[	NN	O	[	nn	3	SENT_404	[p15l40t1317r104b1372],
2	3	CD	NUMBER	3	num	3	SENT_404	[p15l40t1317r104b1372],
3	]	NN	O	]	_	0	SENT_404	[p15l40t1317r104b1372],
4	Schiller	NNP	PERSON	Schiller	nn	5	SENT_404	[p15l139t1318r331b1361],
5	JH	NNP	O	JH	dep	3	SENT_404	[p15l346t1320r421b1372],
6	,	,	O	,	_	0	SENT_404	[p15l346t1320r421b1372],
7	Harrington	NNP	PERSON	Harrington	nn	8	SENT_404	[p15l446t1318r729b1372],
8	D	NNP	O	D	appos	5	SENT_404	[p15l752t1320r801b1368],
9	,	,	O	,	_	0	SENT_404	[p15l752t1320r801b1368],
10	Belani	NNP	PERSON	Belani	nn	11	SENT_404	[p15l826t1318r982b1361],
11	CP	NNP	O	CP	appos	5	SENT_404	[p15l1007t1320r1076b1368],
12	,	,	O	,	_	0	SENT_404	[p15l1007t1320r1076b1368],
13	et	FW	O	et	nn	14	SENT_404	[p15l1101t1324r1148b1361],
14	al.	FW	O	al.	appos	5	SENT_404	[p15l1170t1318r1225b1362],
15	.	.	O	.	_	0	SENT_404	[p15l1170t1318r1225b1362],

1	Comparison	NN	O	comparison	_	0	SENT_405	[p15l1250t1318r1559b1372],
2	of	IN	O	of	_	0	SENT_405	[p15l1583t1317r1636b1361],
3	four	CD	NUMBER	four	num	5	SENT_405	[p15l1653t1317r1759b1361],
4	chemotherapy	NN	O	chemotherapy	nn	5	SENT_405	[p15l1781t1318r2153b1372],
5	regimens	NNS	O	regimen	prep_of	1	SENT_405	[p15l139t1385r376b1438],
6	for	IN	O	for	_	0	SENT_405	[p15l390t1384r461b1428],
7	advanced	JJ	O	advanced	amod	9	SENT_405	[p15l472t1384r715b1428],
8	non	JJ	O	non	amod	9	SENT_405	[p15l728t1384r988b1428],
9	—	NN	O	—	prep_for	1	SENT_405	[p15l728t1384r988b1428],
10	small	JJ	O	small	amod	13	SENT_405	[p15l728t1384r988b1428],
11	cell	NN	O	cell	nn	13	SENT_405	[p15l1001t1384r1088b1428],
12	lung	NN	O	lung	nn	13	SENT_405	[p15l1101t1384r1214b1438],
13	cancer	NN	O	cancer	dep	9	SENT_405	[p15l1226t1397r1402b1428],
14	.	.	O	.	_	0	SENT_405	[p15l1226t1397r1402b1428],

1	N	NN	O	n	nn	3	SENT_406	[p15l1416t1387r1453b1427],
2	Engl	NNP	O	Engl	nn	3	SENT_406	[p15l1466t1384r1603b1438],
3	]	NNP	O	]	nsubj	4	SENT_406	[p15l1466t1384r1603b1438],
4	Med	VBD	O	med	_	0	SENT_406	[p15l1615t1384r1727b1428],
5	2002	CD	DATE	2002	dobj	4	SENT_406	[p15l1741t1386r2151b1434],
6	;	:	O	;	_	0	SENT_406	[p15l1741t1386r2151b1434],
7	346:92	CD	NUMBER	346:92	number	8	SENT_406	[p15l1741t1386r2151b1434],
8	—	CD	NUMBER	—	dep	5	SENT_406	[p15l1741t1386r2151b1434],
9	8	CD	NUMBER	8	dep	8	SENT_406	[p15l1741t1386r2151b1434],
10	.	.	O	.	_	0	SENT_406	[p15l1741t1386r2151b1434],

1	[	NN	O	[	_	0	SENT_407	[p15l40t1449r104b1504],
2	4	CD	NUMBER	4	num	1	SENT_407	[p15l40t1449r104b1504],
3	]	CD	NUMBER	]	num	5	SENT_407	[p15l40t1449r104b1504],
4	Fossella	NNP	PERSON	Fossella	nn	5	SENT_407	[p15l139t1449r339b1493],
5	F	NN	PERSON	f	dep	1	SENT_407	[p15l361t1452r395b1500],
6	,	,	O	,	_	0	SENT_407	[p15l361t1452r395b1500],
7	Pereira	NNP	PERSON	Pereira	nn	8	SENT_407	[p15l418t1450r597b1493],
8	JR	NNP	O	JR	appos	5	SENT_407	[p15l612t1452r680b1504],
9	,	,	O	,	_	0	SENT_407	[p15l612t1452r680b1504],
10	von	NNP	O	von	nn	12	SENT_407	[p15l702t1462r796b1493],
11	Pawel	NNP	PERSON	Pawel	nn	12	SENT_407	[p15l818t1449r967b1493],
12	J	NNP	PERSON	J	appos	5	SENT_407	[p15l983t1452r1016b1504],
13	,	,	O	,	_	0	SENT_407	[p15l983t1452r1016b1504],
14	et	FW	O	et	nn	15	SENT_407	[p15l1039t1456r1087b1493],
15	al.	FW	O	al.	appos	5	SENT_407	[p15l1108t1449r1163b1493],
16	.	.	O	.	_	0	SENT_407	[p15l1108t1449r1163b1493],

1	Randomized	NNP	O	Randomized	_	0	SENT_408	[p15l1187t1449r1522b1500],
2	,	,	O	,	_	0	SENT_408	[p15l1187t1449r1522b1500],
3	multinational	JJ	O	multinational	appos	1	SENT_408	[p15l1545t1449r1909b1500],
4	,	,	O	,	_	0	SENT_408	[p15l1545t1449r1909b1500],
5	phase	NN	O	phase	nn	7	SENT_408	[p15l1933t1449r2080b1504],
6	III	CD	NUMBER	iii	num	7	SENT_408	[p15l2104t1452r2151b1493],
7	study	NN	O	study	appos	1	SENT_408	[p15l140t1516r281b1570],
8	of	IN	O	of	_	0	SENT_408	[p15l291t1516r345b1559],
9	docetaxel	NN	O	docetaxel	nn	12	SENT_408	[p15l351t1516r595b1559],
10	plus	CC	O	plus	_	0	SENT_408	[p15l608t1516r713b1570],
11	platinum	NN	O	platinum	nn	12	SENT_408	[p15l726t1516r961b1570],
12	combinations	NNS	O	combination	prep_of	7	SENT_408	[p15l973t1516r1323b1559],
13	versus	CC	O	versus	prep	12	SENT_408	[p15l1334t1528r1498b1559],
14	vinorelbine	NN	O	vinorelbine	dep	13	SENT_408	[p15l1509t1516r1803b1559],
15	plus	CC	O	plus	_	0	SENT_408	[p15l1816t1516r1921b1570],
16	cisplatin	NN	O	cisplatin	appos	1	SENT_408	[p15l1934t1516r2152b1570],
17	for	IN	O	for	_	0	SENT_408	[p15l139t1581r211b1625],
18	advanced	JJ	O	advanced	amod	20	SENT_408	[p15l225t1581r468b1625],
19	non	JJ	O	non	amod	20	SENT_408	[p15l484t1581r858b1625],
20	—	NN	O	—	prep_for	16	SENT_408	[p15l484t1581r858b1625],
21	small-cell	NN	O	small-cell	nn	23	SENT_408	[p15l484t1581r858b1625],
22	lung	NN	O	lung	nn	23	SENT_408	[p15l874t1581r987b1636],
23	cancer	NN	O	cancer	dep	20	SENT_408	[p15l1002t1594r1183b1625],
24	:	:	O	:	_	0	SENT_408	[p15l1002t1594r1183b1625],
25	the	DT	O	the	det	29	SENT_408	[p15l1203t1581r1284b1625],
26	TAX	NN	O	tax	nn	29	SENT_408	[p15l1298t1583r1403b1625],
27	326	CD	NUMBER	326	num	29	SENT_408	[p15l1416t1584r1511b1625],
28	study	NN	O	study	nn	29	SENT_408	[p15l1527t1581r1669b1636],
29	group	NN	O	group	dep	23	SENT_408	[p15l1682t1584r1875b1636],
30	.	.	O	.	_	0	SENT_408	[p15l1682t1584r1875b1636],
31	]	SYM	O	]	dep	16	SENT_408	[p15l1682t1584r1875b1636],

1	Clin	NNP	O	Clin	nn	2	SENT_409	[p15l1891t1581r1989b1625],
2	Oncol	NNP	O	Oncol	_	0	SENT_409	[p15l2005t1581r2151b1625],
3	2003	CD	DATE	2003	num	2	SENT_409	[p15l139t1650r606b1698],
4	;	:	O	;	_	0	SENT_409	[p15l139t1650r606b1698],
5	21:3016	CD	NUMBER	21:3016	number	6	SENT_409	[p15l139t1650r606b1698],
6	—	CD	NUMBER	—	dep	2	SENT_409	[p15l139t1650r606b1698],
7	24	CD	NUMBER	24	dep	6	SENT_409	[p15l139t1650r606b1698],
8	.	.	O	.	_	0	SENT_409	[p15l139t1650r606b1698],

1	[	NN	O	[	_	0	SENT_410	[p15l40t1714r104b1769],
2	5	CD	NUMBER	5	num	1	SENT_410	[p15l40t1714r104b1769],
3	]	CD	NUMBER	]	num	5	SENT_410	[p15l40t1714r104b1769],
4	Fukuoka	NNP	LOCATION	Fukuoka	nn	5	SENT_410	[p15l139t1714r356b1758],
5	M	NN	O	m	dep	1	SENT_410	[p15l375t1717r437b1764],
6	,	,	O	,	_	0	SENT_410	[p15l375t1717r437b1764],
7	Yano	NNP	PERSON	Yano	nn	8	SENT_410	[p15l455t1717r579b1758],
8	S	NNP	O	S	appos	5	SENT_410	[p15l600t1716r638b1764],
9	,	,	O	,	_	0	SENT_410	[p15l600t1716r638b1764],
10	Giaccone	NNP	PERSON	Giaccone	nn	11	SENT_410	[p15l659t1715r891b1758],
11	G	NNP	O	G	appos	5	SENT_410	[p15l911t1716r960b1764],
12	,	,	O	,	_	0	SENT_410	[p15l911t1716r960b1764],
13	et	FW	O	et	nn	14	SENT_410	[p15l980t1721r1028b1758],
14	al.	FW	O	al.	appos	5	SENT_410	[p15l1047t1714r1101b1758],
15	.	.	O	.	_	0	SENT_410	[p15l1047t1714r1101b1758],

1	Multi	JJ	O	multi	amod	2	SENT_411	[p15l1122t1714r1603b1758],
2	—	NN	O	—	nsubj	12	SENT_411	[p15l1122t1714r1603b1758],
3	institutional	JJ	O	institutional	amod	5	SENT_411	[p15l1122t1714r1603b1758],
4	randomized	JJ	O	randomized	amod	5	SENT_411	[p15l1623t1714r1932b1758],
5	phase	NN	O	phase	dep	2	SENT_411	[p15l1952t1714r2100b1769],
6	II	CD	NUMBER	ii	num	7	SENT_411	[p15l2121t1717r2151b1757],
7	trial	NN	O	trial	dep	2	SENT_411	[p15l138t1780r242b1823],
8	of	IN	O	of	_	0	SENT_411	[p15l262t1779r315b1823],
9	Geﬁtinib	NNP	O	Geﬁtinib	prep_of	7	SENT_411	[p15l329t1779r552b1823],
10	for	IN	O	for	prep	9	SENT_411	[p15l572t1779r643b1823],
11	previously	RB	DATE	previously	pcomp	10	SENT_411	[p15l661t1780r930b1834],
12	treated	VBN	O	treat	_	0	SENT_411	[p15l948t1780r1131b1823],
13	patients	NNS	O	patient	dobj	12	SENT_411	[p15l1151t1780r1358b1834],
14	with	IN	O	with	_	0	SENT_411	[p15l1377t1780r1495b1823],
15	advanced	JJ	O	advanced	amod	18	SENT_411	[p15l1514t1780r1757b1823],
16	non-small-cell	JJ	O	non-small-cell	amod	18	SENT_411	[p15l1778t1780r2151b1823],
17	lung	NN	O	lung	nn	18	SENT_411	[p15l139t1846r252b1900],
18	cancer	NN	O	cancer	prep_with	12	SENT_411	[p15l269t1849r478b1900],
19	.	.	O	.	_	0	SENT_411	[p15l269t1849r478b1900],

1	J	NNP	O	J	nn	3	SENT_412	[p15l269t1849r478b1900],
2	Clin	NNP	O	Clin	nn	3	SENT_412	[p15l496t1846r594b1890],
3	Oncol	NNP	O	Oncol	_	0	SENT_412	[p15l612t1846r758b1890],
4	2003	CD	DATE	2003	num	3	SENT_412	[p15l777t1848r1248b1896],
5	;	:	O	;	_	0	SENT_412	[p15l777t1848r1248b1896],
6	21:2237	CD	NUMBER	21:2237	number	7	SENT_412	[p15l777t1848r1248b1896],
7	—	CD	NUMBER	—	dep	3	SENT_412	[p15l777t1848r1248b1896],
8	46	CD	NUMBER	46	dep	7	SENT_412	[p15l777t1848r1248b1896],
9	.	.	O	.	_	0	SENT_412	[p15l777t1848r1248b1896],

1	[	NN	O	[	nn	3	SENT_413	[p15l40t1911r104b1966],
2	6	CD	NUMBER	6	num	3	SENT_413	[p15l40t1911r104b1966],
3	]	NN	O	]	_	0	SENT_413	[p15l40t1911r104b1966],
4	Kris	NNP	PERSON	Kris	nn	5	SENT_413	[p15l139t1912r236b1955],
5	MG	NN	PERSON	mg	dep	3	SENT_413	[p15l261t1914r362b1962],
6	,	,	O	,	_	0	SENT_413	[p15l261t1914r362b1962],
7	Natale	NNP	ORGANIZATION	Natale	nn	8	SENT_413	[p15l387t1912r549b1955],
8	RB	NN	ORGANIZATION	rb	appos	5	SENT_413	[p15l574t1914r651b1962],
9	,	,	O	,	_	0	SENT_413	[p15l574t1914r651b1962],
10	Herbst	NNP	ORGANIZATION	Herbst	nn	11	SENT_413	[p15l676t1911r847b1955],
11	RS	NN	ORGANIZATION	r	appos	5	SENT_413	[p15l870t1914r943b1962],
12	,	,	O	,	_	0	SENT_413	[p15l870t1914r943b1962],
13	et	FW	O	et	nn	14	SENT_413	[p15l967t1918r1015b1955],
14	al.	FW	O	al.	appos	5	SENT_413	[p15l1037t1911r1092b1955],
15	.	.	O	.	_	0	SENT_413	[p15l1037t1911r1092b1955],

1	Efﬁcacy	NN	O	efﬁcacy	_	0	SENT_414	[p15l1117t1911r1315b1966],
2	of	IN	O	of	_	0	SENT_414	[p15l1338t1911r1391b1955],
3	Geﬁtinib	NNP	LOCATION	Geﬁtinib	prep_of	1	SENT_414	[p15l1409t1911r1644b1962],
4	,	,	O	,	_	0	SENT_414	[p15l1409t1911r1644b1962],
5	an	DT	O	a	det	6	SENT_414	[p15l1669t1924r1729b1955],
6	inhibitor	NN	O	inhibitor	appos	3	SENT_414	[p15l1753t1911r1978b1955],
7	of	IN	O	of	_	0	SENT_414	[p15l2000t1911r2053b1955],
8	the	DT	O	the	det	14	SENT_414	[p15l2070t1911r2151b1955],
9	epidermal	JJ	O	epidermal	amod	14	SENT_414	[p15l139t1978r400b2032],
10	growth	NN	O	growth	nn	14	SENT_414	[p15l412t1978r598b2032],
11	factor	NN	O	factor	nn	14	SENT_414	[p15l610t1978r758b2021],
12	receptor	NN	O	receptor	nn	14	SENT_414	[p15l769t1984r984b2032],
13	tyrosine	NN	O	tyrosine	nn	14	SENT_414	[p15l995t1979r1204b2032],
14	kinase	NN	O	kinase	prep_of	6	SENT_414	[p15l1217t1978r1392b2028],
15	,	,	O	,	_	0	SENT_414	[p15l1217t1978r1392b2028],
16	in	IN	O	in	_	0	SENT_414	[p15l1406t1979r1453b2021],
17	symptomatic	JJ	O	symptomatic	amod	18	SENT_414	[p15l1466t1979r1803b2032],
18	patients	NNS	O	patient	prep_in	3	SENT_414	[p15l1815t1979r2021b2032],
19	with	IN	O	with	_	0	SENT_414	[p15l2033t1978r2152b2021],
20	non	JJ	O	non	amod	25	SENT_414	[p15l139t2044r399b2088],
21	—	JJ	O	—	amod	25	SENT_414	[p15l139t2044r399b2088],
22	small	JJ	O	small	amod	25	SENT_414	[p15l139t2044r399b2088],
23	cell	NN	O	cell	nn	25	SENT_414	[p15l417t2044r504b2088],
24	lung	NN	O	lung	nn	25	SENT_414	[p15l523t2044r635b2099],
25	cancer	NN	O	cancer	prep_with	18	SENT_414	[p15l652t2057r834b2088],
26	:	:	O	:	_	0	SENT_414	[p15l652t2057r834b2088],
27	a	DT	O	a	det	29	SENT_414	[p15l856t2057r882b2088],
28	randomized	JJ	O	randomized	amod	29	SENT_414	[p15l900t2044r1209b2088],
29	trial	NN	O	trial	dep	1	SENT_414	[p15l1227t2044r1343b2088],
30	.	.	O	.	_	0	SENT_414	[p15l1227t2044r1343b2088],

1	JAMA	NNP	O	JAMA	_	0	SENT_415	[p15l1355t2046r1505b2099],
2	2003	CD	DATE	2003	num	1	SENT_415	[p15l1521t2046r2024b2094],
3	;	:	O	;	_	0	SENT_415	[p15l1521t2046r2024b2094],
4	290:2149	CD	NUMBER	290:2149	number	5	SENT_415	[p15l1521t2046r2024b2094],
5	—	CD	NUMBER	—	dep	1	SENT_415	[p15l1521t2046r2024b2094],
6	58	CD	NUMBER	58	dep	5	SENT_415	[p15l1521t2046r2024b2094],
7	.	.	O	.	_	0	SENT_415	[p15l1521t2046r2024b2094],

1	[	NN	O	[	nn	5	SENT_416	[p15l40t2109r104b2164],
2	7	CD	NUMBER	7	num	5	SENT_416	[p15l40t2109r104b2164],
3	]	CD	NUMBER	]	num	5	SENT_416	[p15l40t2109r104b2164],
4	Lee	NNP	O	Lee	nn	5	SENT_416	[p15l139t2112r222b2153],
5	DH	NNP	O	DH	_	0	SENT_416	[p15l251t2112r342b2160],
6	,	,	O	,	_	0	SENT_416	[p15l251t2112r342b2160],
7	Han	NNP	PERSON	Han	nn	8	SENT_416	[p15l371t2112r473b2153],
8	JY	NN	PERSON	jy	appos	5	SENT_416	[p15l494t2112r558b2164],
9	,	,	O	,	_	0	SENT_416	[p15l494t2112r558b2164],
10	Lee	NNP	PERSON	Lee	nn	11	SENT_416	[p15l587t2112r670b2153],
11	HG	NNP	O	HG	appos	5	SENT_416	[p15l699t2112r789b2160],
12	,	,	O	,	_	0	SENT_416	[p15l699t2112r789b2160],
13	et	FW	O	et	nn	14	SENT_416	[p15l818t2116r866b2153],
14	al.	FW	O	al.	appos	5	SENT_416	[p15l892t2110r947b2154],
15	.	.	O	.	_	0	SENT_416	[p15l892t2110r947b2154],

1	Geﬁtinib	NNP	PERSON	Geﬁtinib	_	0	SENT_417	[p15l976t2109r1199b2153],
2	as	IN	O	as	_	0	SENT_417	[p15l1227t2122r1277b2153],
3	a	DT	O	a	det	5	SENT_417	[p15l1306t2122r1332b2153],
4	ﬁrst-line	JJ	O	ﬁrst-line	amod	5	SENT_417	[p15l1360t2109r1581b2153],
5	therapy	NN	O	therapy	prep_as	1	SENT_417	[p15l1608t2110r1807b2164],
6	of	IN	O	of	_	0	SENT_417	[p15l1834t2109r1887b2153],
7	advanced	JJ	O	advanced	amod	10	SENT_417	[p15l1908t2110r2151b2153],
8	or	CC	O	or	_	0	SENT_417	[p15l139t2189r192b2220],
9	metastatic	JJ	O	metastatic	amod	10	SENT_417	[p15l213t2177r482b2220],
10	adenocarcinoma	NN	O	adenocarcinoma	prep_of	5	SENT_417	[p15l504t2176r930b2220],
11	of	IN	O	of	_	0	SENT_417	[p15l953t2176r1006b2220],
12	the	DT	O	the	det	13	SENT_417	[p15l1022t2176r1104b2220],
13	lung	NN	O	lung	prep_of	1	SENT_417	[p15l1127t2176r1240b2230],
14	in	IN	O	in	_	0	SENT_417	[p15l1262t2177r1310b2219],
15	never-smokers	NNS	O	never-smoker	prep_in	13	SENT_417	[p15l1332t2176r1725b2220],
16	.	.	O	.	_	0	SENT_417	[p15l1332t2176r1725b2220],

1	Clin	NNP	O	Clin	nn	3	SENT_418	[p15l1750t2176r1848b2220],
2	Cancer	NNP	O	Cancer	nn	3	SENT_418	[p15l1870t2178r2046b2220],
3	Res	NNP	O	Res	_	0	SENT_418	[p15l2067t2179r2151b2220],
4	2005	CD	DATE	2005	num	3	SENT_418	[p15l139t2244r571b2292],
5	;	:	O	;	_	0	SENT_418	[p15l139t2244r571b2292],
6	11:3032	CD	NUMBER	11:3032	num	7	SENT_418	[p15l139t2244r571b2292],
7	—	NN	O	—	dep	3	SENT_418	[p15l139t2244r571b2292],
8	7	CD	NUMBER	7	dep	7	SENT_418	[p15l139t2244r571b2292],
9	.	.	O	.	_	0	SENT_418	[p15l139t2244r571b2292],

1	[	NN	O	[	nn	4	SENT_419	[p15l40t2308r104b2362],
2	8	CD	NUMBER	8	num	4	SENT_419	[p15l40t2308r104b2362],
3	]	NN	O	]	nn	4	SENT_419	[p15l40t2308r104b2362],
4	van	NN	PERSON	van	_	0	SENT_419	[p15l137t2321r228b2352],
5	Puijenbroek	NN	PERSON	puijenbroek	nn	6	SENT_419	[p15l263t2308r571b2362],
6	R	NN	PERSON	r	dep	4	SENT_419	[p15l603t2311r647b2358],
7	,	,	O	,	_	0	SENT_419	[p15l603t2311r647b2358],
8	Bosquee	NN	LOCATION	bosquee	nn	9	SENT_419	[p15l682t2311r894b2362],
9	L	NN	LOCATION	l	appos	6	SENT_419	[p15l929t2311r966b2358],
10	,	,	O	,	_	0	SENT_419	[p15l929t2311r966b2358],
11	Meert	NNP	ORGANIZATION	Meert	nn	12	SENT_419	[p15l1001t2311r1155b2352],
12	AP	NNP	ORGANIZATION	AP	appos	6	SENT_419	[p15l1186t2310r1261b2358],
13	,	,	O	,	_	0	SENT_419	[p15l1186t2310r1261b2358],
14	et	FW	O	et	nn	15	SENT_419	[p15l1296t2314r1344b2352],
15	al.	FW	O	al.	appos	6	SENT_419	[p15l1376t2308r1432b2352],
16	.	.	O	.	_	0	SENT_419	[p15l1376t2308r1432b2352],

1	Geﬁtinib	JJ	O	geﬁtinib	amod	2	SENT_420	[p15l1466t2308r1690b2352],
2	monotherapy	NN	O	monotherapy	_	0	SENT_420	[p15l1724t2308r2072b2362],
3	in	IN	O	in	_	0	SENT_420	[p15l2105t2309r2152b2351],
4	advanced	JJ	O	advanced	amod	8	SENT_420	[p15l139t2373r382b2417],
5	nonsmall	JJ	O	nonsmall	amod	8	SENT_420	[p15l399t2373r636b2417],
6	cell	NN	O	cell	nn	8	SENT_420	[p15l653t2374r739b2417],
7	lung	NN	O	lung	nn	8	SENT_420	[p15l756t2373r869b2428],
8	cancer	NN	O	cancer	prep_in	2	SENT_420	[p15l885t2386r1066b2417],
9	:	:	O	:	_	0	SENT_420	[p15l885t2386r1066b2417],
10	a	DT	O	a	det	14	SENT_420	[p15l1087t2386r1113b2417],
11	large	JJ	O	large	amod	14	SENT_420	[p15l1129t2373r1254b2428],
12	Western	JJ	MISC	western	amod	14	SENT_420	[p15l1269t2376r1486b2417],
13	community	NN	O	community	nn	14	SENT_420	[p15l1502t2374r1801b2428],
14	implementation	NN	O	implementation	dep	2	SENT_420	[p15l1816t2373r2151b2428, p15l138t2441r239b2483],
15	study	NN	O	study	dep	14	SENT_420	[p15l258t2440r408b2494],
16	.	.	O	.	_	0	SENT_420	[p15l258t2440r408b2494],

1	Eur	NNP	MISC	Eur	nn	2	SENT_421	[p15l427t2443r514b2483],
2	Respir	NNP	MISC	Respir	_	0	SENT_421	[p15l530t2441r720b2494],
3	]	CD	NUMBER	]	num	4	SENT_421	[p15l530t2441r720b2494],
4	2007	CD	DATE	2007	dep	2	SENT_421	[p15l739t2442r1177b2490],
5	;	:	O	;	_	0	SENT_421	[p15l739t2442r1177b2490],
6	29:128	CD	NUMBER	29:128	number	7	SENT_421	[p15l739t2442r1177b2490],
7	—	CD	NUMBER	—	dep	2	SENT_421	[p15l739t2442r1177b2490],
8	33	CD	NUMBER	33	dep	7	SENT_421	[p15l739t2442r1177b2490],
9	.	.	O	.	_	0	SENT_421	[p15l739t2442r1177b2490],

1	[	NN	O	[	nn	4	SENT_422	[p15l40t2506r104b2561],
2	9	CD	NUMBER	9	num	4	SENT_422	[p15l40t2506r104b2561],
3	]	NN	O	]	nn	4	SENT_422	[p15l40t2506r104b2561],
4	Ando	NN	PERSON	ando	_	0	SENT_422	[p15l137t2506r272b2550],
5	M	NN	O	m	dep	4	SENT_422	[p15l294t2509r355b2556],
6	,	,	O	,	_	0	SENT_422	[p15l294t2509r355b2556],
7	Okamoto	NNP	PERSON	Okamoto	nn	8	SENT_422	[p15l377t2506r610b2550],
8	I	NNP	O	I	appos	5	SENT_422	[p15l631t2509r657b2556],
9	,	,	O	,	_	0	SENT_422	[p15l631t2509r657b2556],
10	Yamamoto	NNP	PERSON	Yamamoto	nn	11	SENT_422	[p15l677t2509r953b2550],
11	N	NNP	O	N	appos	5	SENT_422	[p15l975t2509r1024b2557],
12	,	,	O	,	_	0	SENT_422	[p15l975t2509r1024b2557],
13	et	FW	O	et	nn	14	SENT_422	[p15l1047t2513r1094b2550],
14	al.	FW	O	al.	appos	5	SENT_422	[p15l1114t2506r1169b2550],
15	.	.	O	.	_	0	SENT_422	[p15l1114t2506r1169b2550],

1	Predictive	JJ	O	predictive	amod	2	SENT_423	[p15l1191t2506r1445b2550],
2	factors	NNS	O	factor	_	0	SENT_423	[p15l1467t2506r1638b2550],
3	for	IN	O	for	advmod	18	SENT_423	[p15l1660t2506r1732b2550],
4	interstitial	JJ	O	interstitial	amod	6	SENT_423	[p15l1752t2506r2018b2550],
5	lung	NN	O	lung	nn	6	SENT_423	[p15l2040t2506r2153b2561],
6	disease	NN	O	disease	pobj	3	SENT_423	[p15l139t2572r337b2622],
7	,	,	O	,	_	0	SENT_423	[p15l139t2572r337b2622],
8	antitumor	NN	O	antitumor	nn	9	SENT_423	[p15l350t2572r613b2615],
9	response	NN	O	response	appos	6	SENT_423	[p15l623t2584r864b2626],
10	,	,	O	,	_	0	SENT_423	[p15l623t2584r864b2626],
11	and	CC	O	and	_	0	SENT_423	[p15l877t2572r969b2615],
12	survival	NN	O	survival	pobj	3	SENT_423	[p15l983t2572r1182b2615],
13	in	IN	O	in	_	0	SENT_423	[p15l1195t2572r1243b2615],
14	non-small-cell	JJ	O	non-small-cell	amod	17	SENT_423	[p15l1255t2572r1628b2615],
15	lung	NN	O	lung	nn	17	SENT_423	[p15l1641t2572r1754b2626],
16	cancer	NN	O	cancer	nn	17	SENT_423	[p15l1765t2584r1934b2615],
17	patients	NNS	O	patient	prep_in	12	SENT_423	[p15l1944t2572r2151b2626],
18	treated	VBN	O	treat	dep	2	SENT_423	[p15l138t2638r321b2682],
19	with	IN	O	with	_	0	SENT_423	[p15l338t2638r457b2682],
20	Geﬁtinib	NN	PERSON	geﬁtinib	prep_with	18	SENT_423	[p15l475t2638r743b2692],
21	.	.	O	.	_	0	SENT_423	[p15l475t2638r743b2692],
22	]	SYM	O	]	dep	2	SENT_423	[p15l475t2638r743b2692],

1	Clin	NNP	O	Clin	nn	2	SENT_424	[p15l761t2638r860b2682],
2	Oncol	NNP	O	Oncol	_	0	SENT_424	[p15l878t2638r1024b2682],
3	2006	CD	DATE	2006	num	2	SENT_424	[p15l1042t2640r1519b2688],
4	;	:	O	;	_	0	SENT_424	[p15l1042t2640r1519b2688],
5	24:2549	CD	NUMBER	24:2549	number	6	SENT_424	[p15l1042t2640r1519b2688],
6	—	CD	NUMBER	—	dep	2	SENT_424	[p15l1042t2640r1519b2688],
7	56	CD	NUMBER	56	dep	6	SENT_424	[p15l1042t2640r1519b2688],
8	.	.	O	.	_	0	SENT_424	[p15l1042t2640r1519b2688],

1	[	NN	O	[	nn	5	SENT_425	[p15l11t2703r104b2758],
2	10	CD	NUMBER	10	num	5	SENT_425	[p15l11t2703r104b2758],
3	]	CD	NUMBER	]	num	5	SENT_425	[p15l11t2703r104b2758],
4	Bonjour	NNP	O	Bonjour	nn	5	SENT_425	[p15l139t2704r344b2758],
5	JP	NNP	O	JP	_	0	SENT_425	[p15l367t2706r426b2758],
6	,	,	O	,	_	0	SENT_425	[p15l367t2706r426b2758],
7	Chevalley	NNP	ORGANIZATION	Chevalley	nn	8	SENT_425	[p15l458t2703r706b2758],
8	T	NN	ORGANIZATION	t	appos	5	SENT_425	[p15l733t2706r773b2754],
9	,	,	O	,	_	0	SENT_425	[p15l733t2706r773b2754],
10	Rizzoli	JJ	PERSON	rizzoli	amod	11	SENT_425	[p15l805t2704r974b2747],
11	R	NN	PERSON	r	appos	5	SENT_425	[p15l1007t2706r1050b2754],
12	,	,	O	,	_	0	SENT_425	[p15l1007t2706r1050b2754],
13	et	FW	O	et	nn	14	SENT_425	[p15l1082t2710r1130b2747],
14	al.	FW	O	al.	appos	5	SENT_425	[p15l1159t2703r1214b2747],
15	.	.	O	.	_	0	SENT_425	[p15l1159t2703r1214b2747],

1	Gene-environment	JJ	O	gene-environment	amod	2	SENT_426	[p15l1246t2704r1738b2747],
2	interactions	NNS	O	interaction	_	0	SENT_426	[p15l1768t2704r2072b2747],
3	in	IN	O	in	_	0	SENT_426	[p15l2105t2704r2152b2747],
4	the	DT	O	the	det	6	SENT_426	[p15l138t2770r220b2813],
5	skeletal	JJ	O	skeletal	amod	6	SENT_426	[p15l243t2770r437b2813],
6	response	NN	O	response	prep_in	2	SENT_426	[p15l460t2782r689b2824],
7	to	TO	O	to	_	0	SENT_426	[p15l710t2776r759b2813],
8	nutrition	NN	O	nutrition	prep_to	6	SENT_426	[p15l782t2771r1012b2813],
9	and	CC	O	and	_	0	SENT_426	[p15l1034t2770r1127b2813],
10	exercise	NN	O	exercise	prep_to	6	SENT_426	[p15l1150t2771r1355b2813],
11	during	IN	O	during	_	0	SENT_426	[p15l1378t2770r1548b2824],
12	growth	NN	O	growth	prep_during	2	SENT_426	[p15l1568t2770r1765b2824],
13	.	.	O	.	_	0	SENT_426	[p15l1568t2770r1765b2824],

1	Med	NNP	O	Med	nn	3	SENT_427	[p15l1789t2770r1901b2813],
2	Sport	NNP	O	Sport	nn	3	SENT_427	[p15l1924t2772r2061b2824],
3	Sci	NNP	O	Sci	_	0	SENT_427	[p15l2082t2770r2151b2813],
4	2007:51:64	CD	NUMBER	2007:51:64	num	3	SENT_427	[p15l139t2838r545b2885],
5	—	CD	NUMBER	—	number	6	SENT_427	[p15l139t2838r545b2885],
6	80	CD	NUMBER	80	num	3	SENT_427	[p15l139t2838r545b2885],
7	.	.	O	.	_	0	SENT_427	[p15l139t2838r545b2885],

1	[	NN	O	[	nn	4	SENT_428	[p15l13t2902r104b2956],
2	11	CD	NUMBER	11	num	4	SENT_428	[p15l13t2902r104b2956],
3	]	NN	O	]	nn	4	SENT_428	[p15l13t2902r104b2956],
4	Saposnik	NN	O	saposnik	_	0	SENT_428	[p15l139t2902r369b2956],
5	B	NN	O	b	dep	4	SENT_428	[p15l389t2905r431b2952],
6	,	,	O	,	_	0	SENT_428	[p15l389t2905r431b2952],
7	Reny	NNP	PERSON	Reny	nn	8	SENT_428	[p15l453t2905r577b2956],
8	JL	NNP	PERSON	JL	appos	5	SENT_428	[p15l590t2905r651b2956],
9	,	,	O	,	_	0	SENT_428	[p15l590t2905r651b2956],
10	Gaussem	NNP	O	Gaussem	nn	11	SENT_428	[p15l672t2904r904b2946],
11	P	NN	O	p	appos	5	SENT_428	[p15l925t2905r960b2952],
12	,	,	O	,	_	0	SENT_428	[p15l925t2905r960b2952],
13	et	FW	O	et	nn	14	SENT_428	[p15l981t2908r1029b2946],
14	al.	FW	O	al.	appos	5	SENT_428	[p15l1049t2902r1103b2946],
15	.	.	O	.	_	0	SENT_428	[p15l1049t2902r1103b2946],

1	A	DT	O	a	det	2	SENT_429	[p15l1123t2904r1160b2945],
2	haplotype	NN	O	haplotype	nsubjpass	8	SENT_429	[p15l1179t2902r1436b2956],
3	of	IN	O	of	_	0	SENT_429	[p15l1457t2902r1511b2946],
4	the	DT	O	the	det	6	SENT_429	[p15l1524t2902r1606b2946],
5	EPCR	NN	O	epcr	nn	6	SENT_429	[p15l1627t2904r1758b2946],
6	gene	NN	O	gene	prep_of	2	SENT_429	[p15l1776t2915r1896b2956],
7	is	VBZ	O	be	auxpass	8	SENT_429	[p15l1917t2903r1955b2946],
8	associated	VBN	O	associate	_	0	SENT_429	[p15l1976t2903r2151b2946, p15l138t2967r248b3011],
9	with	IN	O	with	_	0	SENT_429	[p15l270t2967r388b3011],
10	increased	VBN	O	increase	amod	12	SENT_429	[p15l411t2967r655b3011],
11	plasma	NN	O	plasma	nn	12	SENT_429	[p15l679t2967r862b3022],
12	levels	NNS	O	level	prep_with	8	SENT_429	[p15l885t2967r1028b3011],
13	of	IN	O	of	_	0	SENT_429	[p15l1051t2967r1105b3011],
14	sEPCR	NN	O	sepcr	prep_of	12	SENT_429	[p15l1122t2970r1277b3011],
15	and	CC	O	and	_	0	SENT_429	[p15l1298t2967r1391b3011],
16	is	VBZ	O	be	cop	20	SENT_429	[p15l1414t2968r1451b3011],
17	a	DT	O	a	det	20	SENT_429	[p15l1475t2980r1501b3011],
18	candidate	NN	O	candidate	nn	20	SENT_429	[p15l1523t2967r1773b3011],
19	risk	NN	O	risk	nn	20	SENT_429	[p15l1797t2968r1891b3011],
20	factor	NN	O	factor	conj_and	8	SENT_429	[p15l1912t2967r2060b3011],
21	for	IN	O	for	_	0	SENT_429	[p15l2082t2967r2153b3011],
22	thrombosis	NN	O	thrombosis	prep_for	20	SENT_429	[p15l138t3034r442b3078],
23	.	.	O	.	_	0	SENT_429	[p15l138t3034r442b3078],

1	Blood	NN	O	blood	_	0	SENT_430	[p15l461t3034r605b3077],
2	2004	CD	DATE	2004	num	1	SENT_430	[p15l623t3036r1084b3084],
3	;	:	O	;	_	0	SENT_430	[p15l623t3036r1084b3084],
4	103:1311	CD	NUMBER	103:1311	number	5	SENT_430	[p15l623t3036r1084b3084],
5	—	CD	NUMBER	—	dep	1	SENT_430	[p15l623t3036r1084b3084],
6	8	CD	NUMBER	8	dep	5	SENT_430	[p15l623t3036r1084b3084],
7	.	.	O	.	_	0	SENT_430	[p15l623t3036r1084b3084],

1	[	NN	O	[	_	0	SENT_431	[p15l10t3100r104b3155],
2	12	CD	NUMBER	12	num	1	SENT_431	[p15l10t3100r104b3155],
3	]	CD	NUMBER	]	num	5	SENT_431	[p15l10t3100r104b3155],
4	Walgren	NNP	O	Walgren	nn	5	SENT_431	[p15l136t3100r354b3155],
5	RA	NN	O	ra	dep	1	SENT_431	[p15l369t3102r450b3151],
6	,	,	O	,	_	0	SENT_431	[p15l369t3102r450b3151],
7	Meucci	NNP	PERSON	Meucci	nn	8	SENT_431	[p15l466t3101r649b3144],
8	MA	NNP	O	MA	appos	5	SENT_431	[p15l664t3102r764b3151],
9	,	,	O	,	_	0	SENT_431	[p15l664t3102r764b3151],
10	McLeod	NNP	PERSON	McLeod	nn	11	SENT_431	[p15l779t3100r978b3144],
11	HL	NNS	O	hl	appos	5	SENT_431	[p15l993t3103r1072b3144],
12	.	.	O	.	_	0	SENT_431	[p15l993t3103r1072b3144],

1	Pharmacogenomic	JJ	MISC	pharmacogenomic	amod	3	SENT_432	[p15l1088t3100r1566b3155],
2	discovery	NN	O	discovery	nn	3	SENT_432	[p15l1580t3100r1826b3155],
3	approaches	NNS	O	approach	_	0	SENT_432	[p15l1839t3100r2147b3155],
4	:	:	O	:	_	0	SENT_432	[p15l1839t3100r2147b3155],

1	will	MD	O	will	aux	5	SENT_433	[p15l137t3166r233b3209],
2	the	DT	O	the	det	4	SENT_433	[p15l251t3166r333b3209],
3	real	JJ	O	real	amod	4	SENT_433	[p15l352t3166r445b3209],
4	genes	NNS	O	gene	nsubj	5	SENT_433	[p15l463t3178r608b3220],
5	please	VB	O	please	_	0	SENT_433	[p15l627t3166r787b3220],
6	stand	VB	O	stand	ccomp	5	SENT_433	[p15l806t3166r944b3209],
7	up	RP	O	up	prep	6	SENT_433	[p15l963t3168r1089b3220],
8	?	.	O	?	_	0	SENT_433	[p15l963t3168r1089b3220],
9	]	SYM	O	]	dep	5	SENT_433	[p15l963t3168r1089b3220],

1	Clin	NNP	O	Clin	nn	2	SENT_434	[p15l1107t3166r1205b3209],
2	Oncol	NNP	O	Oncol	_	0	SENT_434	[p15l1224t3166r1369b3209],
3	2005	CD	DATE	2005	num	2	SENT_434	[p15l1388t3168r1830b3216],
4	;	:	O	;	_	0	SENT_434	[p15l1388t3168r1830b3216],
5	23:7342	CD	NUMBER	23:7342	number	6	SENT_434	[p15l1388t3168r1830b3216],
6	—	CD	NUMBER	—	dep	2	SENT_434	[p15l1388t3168r1830b3216],
7	9	CD	NUMBER	9	dep	6	SENT_434	[p15l1388t3168r1830b3216],
8	.	.	O	.	_	0	SENT_434	[p15l1388t3168r1830b3216],

1	[	NN	O	[	_	0	SENT_435	[p15l10t3232r104b3286],
2	13	CD	NUMBER	13	num	6	SENT_435	[p15l10t3232r104b3286],
3	]	NNP	O	]	nn	6	SENT_435	[p15l10t3232r104b3286],
4	Lynch	NNP	PERSON	Lynch	nn	6	SENT_435	[p15l139t3232r287b3286],
5	T	NN	O	t	nn	6	SENT_435	[p15l313t3235r374b3286],
6	]	NN	O	]	dep	1	SENT_435	[p15l313t3235r374b3286],
7	,	,	O	,	_	0	SENT_435	[p15l313t3235r374b3286],
8	Bell	NNP	ORGANIZATION	Bell	nn	9	SENT_435	[p15l404t3232r497b3276],
9	DW	NNP	ORGANIZATION	DW	appos	6	SENT_435	[p15l526t3235r629b3282],
10	,	,	O	,	_	0	SENT_435	[p15l526t3235r629b3282],
11	Sordella	NNP	PERSON	Sordella	nn	12	SENT_435	[p15l659t3232r866b3276],
12	R	NNP	PERSON	R	appos	6	SENT_435	[p15l894t3235r937b3282],
13	,	,	O	,	_	0	SENT_435	[p15l894t3235r937b3282],
14	et	FW	O	et	nn	15	SENT_435	[p15l967t3238r1014b3276],
15	al.	FW	O	al.	appos	6	SENT_435	[p15l1042t3232r1097b3276],
16	.	.	O	.	_	0	SENT_435	[p15l1042t3232r1097b3276],

1	Activating	VBG	O	activate	amod	2	SENT_436	[p15l1124t3233r1386b3286],
2	mutations	NNS	O	mutation	_	0	SENT_436	[p15l1413t3233r1674b3276],
3	in	IN	O	in	_	0	SENT_436	[p15l1704t3233r1752b3275],
4	the	DT	O	the	det	7	SENT_436	[p15l1779t3232r1861b3276],
5	epidermal	JJ	O	epidermal	amod	7	SENT_436	[p15l1890t3232r2151b3286],
6	growth	NN	O	growth	nn	7	SENT_436	[p15l138t3297r323b3352],
7	factor	NN	O	factor	prep_in	2	SENT_436	[p15l335t3297r484b3341],
8	receptor	NN	O	receptor	nn	10	SENT_436	[p15l495t3304r710b3352],
9	underlying	VBG	O	underlie	amod	10	SENT_436	[p15l720t3297r1001b3352],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_436	[p15l1013t3298r1400b3352],
11	of	IN	O	of	_	0	SENT_436	[p15l1414t3297r1467b3341],
12	non-small-cell	JJ	O	non-small-cell	amod	14	SENT_436	[p15l1474t3297r1847b3341],
13	lung	NN	O	lung	nn	14	SENT_436	[p15l1861t3298r1973b3352],
14	cancer	NN	O	cancer	prep_of	10	SENT_436	[p15l1985t3310r2153b3341],
15	to	TO	O	to	_	0	SENT_436	[p15l138t3370r187b3408],
16	Geﬁtinib	NNP	LOCATION	Geﬁtinib	prep_to	14	SENT_436	[p15l205t3364r440b3408],
17	.	.	O	.	_	0	SENT_436	[p15l205t3364r440b3408],

1	N	NN	O	n	nn	3	SENT_437	[p15l460t3367r497b3407],
2	Engl	NNP	O	Engl	nn	3	SENT_437	[p15l515t3364r657b3418],
3	]	NNP	O	]	nsubj	4	SENT_437	[p15l515t3364r657b3418],
4	Med	VBD	O	med	_	0	SENT_437	[p15l675t3364r787b3408],
5	2004	CD	DATE	2004	dobj	4	SENT_437	[p15l806t3366r1309b3414],
6	;	:	O	;	_	0	SENT_437	[p15l806t3366r1309b3414],
7	350:2129	CD	NUMBER	350:2129	number	8	SENT_437	[p15l806t3366r1309b3414],
8	—	CD	NUMBER	—	dep	5	SENT_437	[p15l806t3366r1309b3414],
9	39	CD	NUMBER	39	dep	8	SENT_437	[p15l806t3366r1309b3414],
10	.	.	O	.	_	0	SENT_437	[p15l806t3366r1309b3414],

1	[	RB	O	[	advmod	6	SENT_438	[p15l11t3429r104b3484],
2	14	CD	NUMBER	14	number	3	SENT_438	[p15l11t3429r104b3484],
3	]	CD	NUMBER	]	num	6	SENT_438	[p15l11t3429r104b3484],
4	Paez	NNP	O	Paez	nn	6	SENT_438	[p15l139t3432r253b3473],
5	]	CD	NUMBER	]	num	6	SENT_438	[p15l263t3432r494b3484],
6	G	NN	O	g	_	0	SENT_438	[p15l263t3432r494b3484],
7	,	,	O	,	_	0	SENT_438	[p15l263t3432r494b3484],
8	]	CD	NUMBER	]	num	10	SENT_438	[p15l263t3432r494b3484],
9	anne	NN	O	anne	nn	10	SENT_438	[p15l263t3432r494b3484],
10	PA	NN	ORGANIZATION	pa	appos	6	SENT_438	[p15l511t3431r586b3480],
11	,	,	O	,	_	0	SENT_438	[p15l511t3431r586b3480],
12	Lee	NNP	PERSON	Lee	nn	14	SENT_438	[p15l604t3432r687b3473],
13	]	CD	NUMBER	]	num	14	SENT_438	[p15l697t3432r764b3484],
14	C	NN	O	c	appos	10	SENT_438	[p15l697t3432r764b3484],
15	,	,	O	,	_	0	SENT_438	[p15l697t3432r764b3484],
16	et	FW	O	et	nn	17	SENT_438	[p15l781t3436r829b3473],
17	al.	FW	O	al.	appos	10	SENT_438	[p15l844t3429r899b3473],
18	.	.	O	.	_	0	SENT_438	[p15l844t3429r899b3473],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_439	[p15l916t3432r1050b3473],
2	mutations	NNS	O	mutation	_	0	SENT_439	[p15l1064t3430r1325b3473],
3	in	IN	O	in	_	0	SENT_439	[p15l1343t3430r1390b3473],
4	lung	NN	O	lung	nn	5	SENT_439	[p15l1407t3430r1520b3484],
5	cancer	NN	O	cancer	prep_in	2	SENT_439	[p15l1535t3442r1716b3473],
6	:	:	O	:	_	0	SENT_439	[p15l1535t3442r1716b3473],
7	correlation	NN	O	correlation	dep	2	SENT_439	[p15l1737t3429r2019b3473],
8	with	IN	O	with	_	0	SENT_439	[p15l2033t3430r2152b3473],
9	clinical	JJ	O	clinical	amod	10	SENT_439	[p15l139t3496r320b3539],
10	response	NN	O	response	prep_with	7	SENT_439	[p15l338t3508r566b3550],
11	to	TO	O	to	_	0	SENT_439	[p15l584t3502r633b3539],
12	Geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_439	[p15l652t3496r874b3539],
13	therapy	NN	O	therapy	prep_to	10	SENT_439	[p15l892t3496r1099b3550],
14	.	.	O	.	_	0	SENT_439	[p15l892t3496r1099b3550],

1	Science	NNP	O	Science	_	0	SENT_440	[p15l1118t3497r1308b3539],
2	2004	CD	DATE	2004	num	1	SENT_440	[p15l1326t3498r1866b3546],
3	;	:	O	;	_	0	SENT_440	[p15l1326t3498r1866b3546],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_440	[p15l1326t3498r1866b3546],
5	—	CD	NUMBER	—	dep	1	SENT_440	[p15l1326t3498r1866b3546],
6	500	CD	NUMBER	500	dep	5	SENT_440	[p15l1326t3498r1866b3546],
7	.	.	O	.	_	0	SENT_440	[p15l1326t3498r1866b3546],

1	[	RB	O	[	dep	5	SENT_441	[p15l11t3562r104b3617],
2	15	CD	NUMBER	15	num	5	SENT_441	[p15l11t3562r104b3617],
3	]	CD	NUMBER	]	num	5	SENT_441	[p15l11t3562r104b3617],
4	Han	NNP	O	Han	nn	5	SENT_441	[p15l139t3565r241b3606],
5	SW	NNP	O	SW	_	0	SENT_441	[p15l254t3564r348b3612],
6	,	,	O	,	_	0	SENT_441	[p15l254t3564r348b3612],
7	Kim	NNP	PERSON	Kim	nn	8	SENT_441	[p15l362t3563r465b3605],
8	TY	NNP	PERSON	TY	appos	5	SENT_441	[p15l475t3565r551b3612],
9	,	,	O	,	_	0	SENT_441	[p15l475t3565r551b3612],
10	Hwang	NNP	PERSON	Hwang	nn	11	SENT_441	[p15l565t3565r746b3617],
11	PG	NNP	O	PG	appos	5	SENT_441	[p15l758t3564r838b3612],
12	,	,	O	,	_	0	SENT_441	[p15l758t3564r838b3612],
13	et	FW	O	et	nn	14	SENT_441	[p15l852t3569r900b3606],
14	al.	FW	O	al.	appos	11	SENT_441	[p15l912t3562r966b3606],
15	.	.	O	.	_	0	SENT_441	[p15l912t3562r966b3606],

1	Predictive	JJ	O	predictive	amod	4	SENT_442	[p15l981t3562r1235b3606],
2	and	CC	O	and	_	0	SENT_442	[p15l1248t3562r1342b3606],
3	prognostic	JJ	O	prognostic	conj_and	1	SENT_442	[p15l1356t3563r1627b3617],
4	impact	NN	O	impact	nsubj	16	SENT_442	[p15l1640t3563r1817b3617],
5	of	IN	O	of	_	0	SENT_442	[p15l1829t3562r1883b3606],
6	epidermal	JJ	O	epidermal	amod	10	SENT_442	[p15l1890t3562r2151b3617],
7	growth	NN	O	growth	nn	10	SENT_442	[p15l138t3628r323b3682],
8	factor	NN	O	factor	nn	10	SENT_442	[p15l338t3627r487b3671],
9	receptor	NN	O	receptor	nn	10	SENT_442	[p15l501t3634r716b3682],
10	mutation	NN	O	mutation	prep_of	4	SENT_442	[p15l730t3628r967b3671],
11	in	IN	O	in	_	0	SENT_442	[p15l983t3628r1030b3671],
12	non-small-cell	JJ	O	non-small-cell	amod	15	SENT_442	[p15l1046t3628r1419b3671],
13	lung	NN	O	lung	nn	15	SENT_442	[p15l1436t3628r1548b3682],
14	cancer	NN	O	cancer	nn	15	SENT_442	[p15l1563t3640r1731b3671],
15	patients	NNS	O	patient	prep_in	10	SENT_442	[p15l1746t3628r1952b3682],
16	treated	VBN	O	treat	_	0	SENT_442	[p15l1968t3628r2151b3671],
17	with	IN	O	with	_	0	SENT_442	[p15l137t3694r256b3738],
18	Geﬁtinib	JJ	O	geﬁtinib	amod	21	SENT_442	[p15l274t3694r541b3748],
19	]	NN	O	]	nn	21	SENT_442	[p15l274t3694r541b3748],
20	Clin	NN	O	clin	nn	21	SENT_442	[p15l560t3694r658b3738],
21	Oncol	NN	O	oncol	prep_with	16	SENT_442	[p15l676t3694r823b3738],
22	2005	CD	DATE	2005	dep	21	SENT_442	[p15l841t3696r1343b3744],
23	;	:	O	;	_	0	SENT_442	[p15l841t3696r1343b3744],
24	23:2493	CD	NUMBER	23:2493	num	25	SENT_442	[p15l841t3696r1343b3744],
25	—	NN	O	—	dep	21	SENT_442	[p15l841t3696r1343b3744],
26	501	CD	NUMBER	501	advmod	16	SENT_442	[p15l841t3696r1343b3744],
27	.	.	O	.	_	0	SENT_442	[p15l841t3696r1343b3744],

1	[	RB	O	[	dep	5	SENT_443	[p15l11t3759r104b3814],
2	16	CD	NUMBER	16	num	5	SENT_443	[p15l11t3759r104b3814],
3	]	CD	NUMBER	]	num	5	SENT_443	[p15l11t3759r104b3814],
4	Bell	NNP	ORGANIZATION	Bell	nn	5	SENT_443	[p15l139t3759r232b3803],
5	DW	NNP	ORGANIZATION	DW	_	0	SENT_443	[p15l252t3762r355b3810],
6	,	,	O	,	_	0	SENT_443	[p15l252t3762r355b3810],
7	Lynch	NNP	PERSON	Lynch	nn	9	SENT_443	[p15l376t3759r525b3814],
8	T	NN	O	t	nn	9	SENT_443	[p15l542t3762r602b3814],
9	]	NN	O	]	appos	5	SENT_443	[p15l542t3762r602b3814],
10	,	,	O	,	_	0	SENT_443	[p15l542t3762r602b3814],
11	Haserlat	NNP	ORGANIZATION	Haserlat	nn	12	SENT_443	[p15l623t3759r837b3803],
12	SM	NNP	ORGANIZATION	SM	appos	5	SENT_443	[p15l855t3762r946b3810],
13	,	,	O	,	_	0	SENT_443	[p15l855t3762r946b3810],
14	et	FW	O	et	nn	15	SENT_443	[p15l967t3766r1014b3803],
15	al.	FW	O	al.	appos	12	SENT_443	[p15l1033t3759r1088b3803],
16	.	.	O	.	_	0	SENT_443	[p15l1033t3759r1088b3803],

1	Epidermal	JJ	O	epidermal	amod	3	SENT_444	[p15l1109t3759r1372b3814],
2	growth	NN	O	growth	nn	3	SENT_444	[p15l1391t3759r1577b3814],
3	factor	NN	O	factor	_	0	SENT_444	[p15l1596t3759r1744b3803],
4	receptor	NN	O	receptor	nn	5	SENT_444	[p15l1762t3766r1977b3814],
5	mutations	NNS	O	mutation	dep	3	SENT_444	[p15l1996t3766r2151b3803, p16l138t14r264b56],

1	and	CC	O	and	cc	2	SENT_445	[p16l281t13r374b56],
2	gene	NN	O	gene	_	0	SENT_445	[p16l391t25r511b67],
3	ampliﬁcation	NN	O	ampliﬁcation	dep	2	SENT_445	[p16l528t13r870b67],
4	in	IN	O	in	prep	3	SENT_445	[p16l887t14r934b56],
5	non-small-cell	JJ	O	non-small-cell	amod	7	SENT_445	[p16l951t13r1325b56],
6	lung	NN	O	lung	nn	7	SENT_445	[p16l1342t13r1455b67],
7	cancer	NN	O	cancer	dep	4	SENT_445	[p16l1471t25r1653b57],
8	:	:	O	:	_	0	SENT_445	[p16l1471t25r1653b57],
9	molecular	JJ	O	molecular	amod	10	SENT_445	[p16l1674t13r1933b56],
10	analysis	NN	O	analysis	dep	7	SENT_445	[p16l1948t13r2151b67],
11	of	IN	O	of	_	0	SENT_445	[p16l139t79r192b123],
12	the	DT	O	the	det	15	SENT_445	[p16l203t79r284b123],
13	IDEAL/INTACT	NNP	MISC	IDEAL/INTACT	nn	15	SENT_445	[p16l303t79r666b134],
14	Geﬁtinib	NNP	MISC	Geﬁtinib	nn	15	SENT_445	[p16l682t79r905b123],
15	trials	NNS	O	trial	prep_of	10	SENT_445	[p16l923t79r1097b134],
16	.	.	O	.	_	0	SENT_445	[p16l923t79r1097b134],
17	]	SYM	O	]	dep	3	SENT_445	[p16l923t79r1097b134],

1	Clin	NNP	O	Clin	nn	2	SENT_446	[p16l1115t79r1214b123],
2	Oncol	NNP	O	Oncol	_	0	SENT_446	[p16l1232t79r1378b123],
3	2005	CD	DATE	2005	num	2	SENT_446	[p16l1396t81r1872b129],
4	;	:	O	;	_	0	SENT_446	[p16l1396t81r1872b129],
5	23:8081	CD	NUMBER	23:8081	number	6	SENT_446	[p16l1396t81r1872b129],
6	—	CD	NUMBER	—	dep	2	SENT_446	[p16l1396t81r1872b129],
7	92	CD	NUMBER	92	dep	6	SENT_446	[p16l1396t81r1872b129],
8	.	.	O	.	_	0	SENT_446	[p16l1396t81r1872b129],

1	[	NN	O	[	nn	5	SENT_447	[p16l12t144r104b199],
2	17	CD	NUMBER	17	num	5	SENT_447	[p16l12t144r104b199],
3	]	CD	NUMBER	]	num	5	SENT_447	[p16l12t144r104b199],
4	Sharma	NNP	ORGANIZATION	Sharma	nn	5	SENT_447	[p16l139t145r333b188],
5	SV	NNP	ORGANIZATION	SV	_	0	SENT_447	[p16l349t147r424b195],
6	,	,	O	,	_	0	SENT_447	[p16l349t147r424b195],
7	Bell	NNP	ORGANIZATION	Bell	nn	8	SENT_447	[p16l441t145r534b188],
8	DW	NNP	ORGANIZATION	DW	appos	5	SENT_447	[p16l551t147r654b195],
9	,	,	O	,	_	0	SENT_447	[p16l551t147r654b195],
10	Settleman	NNP	O	Settleman	appos	5	SENT_447	[p16l671t145r972b199],
11	]	CD	NUMBER	]	num	10	SENT_447	[p16l671t145r972b199],
12	,	,	O	,	_	0	SENT_447	[p16l671t145r972b199],
13	et	FW	O	et	nn	14	SENT_447	[p16l989t151r1037b188],
14	al.	FW	O	al.	appos	5	SENT_447	[p16l1052t145r1106b189],
15	.	.	O	.	_	0	SENT_447	[p16l1052t145r1106b189],

1	Epidermal	JJ	O	epidermal	amod	3	SENT_448	[p16l1124t145r1387b199],
2	growth	NN	O	growth	nn	3	SENT_448	[p16l1402t145r1588b199],
3	factor	NN	O	factor	_	0	SENT_448	[p16l1603t144r1752b188],
4	receptor	NN	O	receptor	nn	5	SENT_448	[p16l1766t151r1981b199],
5	mutations	NNS	O	mutation	dep	3	SENT_448	[p16l1996t151r2151b188, p16l138t212r264b255],

1	in	IN	O	in	_	0	SENT_449	[p16l283t212r330b254],
2	lung	NN	O	lung	nn	3	SENT_449	[p16l348t211r461b265],
3	cancer	NN	O	cancer	pobj	1	SENT_449	[p16l478t224r654b255],
4	.	.	O	.	_	0	SENT_449	[p16l478t224r654b255],

1	Nat	NNP	O	Nat	nn	3	SENT_450	[p16l673t214r761b255],
2	Rev	NN	O	rev	nn	3	SENT_450	[p16l778t214r869b255],
3	Cancer	NN	O	cancer	_	0	SENT_450	[p16l886t213r1061b255],
4	2007	CD	DATE	2007	dep	3	SENT_450	[p16l1077t213r1474b261],
5	;	:	O	;	_	0	SENT_450	[p16l1077t213r1474b261],
6	7:169	CD	NUMBER	7:169	number	7	SENT_450	[p16l1077t213r1474b261],
7	—	CD	NUMBER	—	dep	3	SENT_450	[p16l1077t213r1474b261],
8	81	CD	NUMBER	81	dep	7	SENT_450	[p16l1077t213r1474b261],
9	.	.	O	.	_	0	SENT_450	[p16l1077t213r1474b261],

1	[	NN	O	[	nn	5	SENT_451	[p16l11t276r104b331],
2	18	CD	NUMBER	18	num	5	SENT_451	[p16l11t276r104b331],
3	]	CD	NUMBER	]	num	5	SENT_451	[p16l11t276r104b331],
4	Amador	NNP	ORGANIZATION	Amador	nn	5	SENT_451	[p16l136t277r344b320],
5	ML	NNP	ORGANIZATION	ML	_	0	SENT_451	[p16l357t279r445b327],
6	,	,	O	,	_	0	SENT_451	[p16l357t279r445b327],
7	Oppenheimer	NNP	ORGANIZATION	Oppenheimer	nn	8	SENT_451	[p16l460t277r816b331],
8	D	NNP	ORGANIZATION	D	appos	5	SENT_451	[p16l828t279r877b327],
9	,	,	O	,	_	0	SENT_451	[p16l828t279r877b327],
10	Perea	NNP	PERSON	Perea	nn	11	SENT_451	[p16l891t279r1030b320],
11	S	NNP	O	S	appos	5	SENT_451	[p16l1043t279r1081b327],
12	,	,	O	,	_	0	SENT_451	[p16l1043t279r1081b327],
13	et	FW	O	et	nn	14	SENT_451	[p16l1095t283r1143b320],
14	al.	FW	O	al.	appos	5	SENT_451	[p16l1155t277r1210b321],
15	.	.	O	.	_	0	SENT_451	[p16l1155t277r1210b321],

1	An	DT	O	a	det	8	SENT_452	[p16l1222t279r1292b320],
2	epidermal	JJ	O	epidermal	amod	8	SENT_452	[p16l1305t277r1567b331],
3	growth	NN	O	growth	nn	8	SENT_452	[p16l1579t277r1765b331],
4	factor	NN	O	factor	nn	8	SENT_452	[p16l1778t276r1926b320],
5	receptor	NN	O	receptor	nn	8	SENT_452	[p16l1938t283r2153b331],
6	intron	NN	O	intron	nn	8	SENT_452	[p16l139t344r296b387],
7	1	CD	NUMBER	1	num	8	SENT_452	[p16l313t345r333b386],
8	polymorphism	NN	O	polymorphism	nsubj	9	SENT_452	[p16l354t343r734b397],
9	mediates	VBZ	O	mediate	_	0	SENT_452	[p16l748t343r981b387],
10	response	NN	O	response	dobj	9	SENT_452	[p16l996t356r1224b397],
11	to	TO	O	to	_	0	SENT_452	[p16l1239t349r1287b387],
12	epidermal	JJ	O	epidermal	amod	16	SENT_452	[p16l1302t343r1564b397],
13	growth	NN	O	growth	nn	16	SENT_452	[p16l1577t343r1763b397],
14	factor	NN	O	factor	nn	16	SENT_452	[p16l1777t343r1925b387],
15	receptor	NN	O	receptor	nn	16	SENT_452	[p16l1938t349r2153b397],
16	inhibitors	NNS	O	inhibitor	prep_to	9	SENT_452	[p16l139t408r400b452],
17	.	.	O	.	_	0	SENT_452	[p16l139t408r400b452],

1	Cancer	NNP	O	Cancer	nn	2	SENT_453	[p16l419t411r595b452],
2	Res	NNP	O	Res	_	0	SENT_453	[p16l611t411r695b452],
3	2004	CD	DATE	2004	num	2	SENT_453	[p16l713t411r1185b459],
4	;	:	O	;	_	0	SENT_453	[p16l713t411r1185b459],
5	64:9139	CD	NUMBER	64:9139	number	6	SENT_453	[p16l713t411r1185b459],
6	—	CD	NUMBER	—	dep	2	SENT_453	[p16l713t411r1185b459],
7	43	CD	NUMBER	43	dep	6	SENT_453	[p16l713t411r1185b459],
8	.	.	O	.	_	0	SENT_453	[p16l713t411r1185b459],

1	[	NN	O	[	_	0	SENT_454	[p16l11t475r104b529],
2	19	CD	NUMBER	19	num	13	SENT_454	[p16l11t475r104b529],
3	]	CD	NUMBER	]	num	13	SENT_454	[p16l11t475r104b529],
4	Perea	NNP	PERSON	Perea	nn	13	SENT_454	[p16l139t478r277b518],
5	S	NN	O	s	nn	13	SENT_454	[p16l295t477r334b525],
6	,	,	O	,	_	0	SENT_454	[p16l295t477r334b525],
7	Oppenheimer	NNP	ORGANIZATION	Oppenheimer	dep	13	SENT_454	[p16l353t475r709b529],
8	D	NNP	ORGANIZATION	D	nn	13	SENT_454	[p16l726t478r775b525],
9	,	,	O	,	_	0	SENT_454	[p16l726t478r775b525],
10	Amador	NNP	PERSON	Amador	appos	13	SENT_454	[p16l792t475r1000b518],
11	M.	NNP	PERSON	M.	nn	13	SENT_454	[p16l1016t478r1078b519],
12	Genotypic	NNP	PERSON	Genotypic	nn	13	SENT_454	[p16l1097t476r1358b529],
13	bases	NNS	O	basis	dep	1	SENT_454	[p16l1375t475r1514b518],
14	of	IN	O	of	_	0	SENT_454	[p16l1533t475r1586b518],
15	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_454	[p16l1598t477r1732b518],
16	inhibitors	NNS	O	inhibitor	prep_of	13	SENT_454	[p16l1748t475r1996b518],
17	pharmacological	JJ	O	pharmacological	dep	1	SENT_454	[p16l2015t475r2151b529, p16l139t541r445b596],

1	actions	NNS	O	action	_	0	SENT_455	[p16l463t542r658b585],
2	.	.	O	.	_	0	SENT_455	[p16l463t542r658b585],

1	Proc	NNP	O	Proc	nn	5	SENT_456	[p16l677t544r787b585],
2	Am	NNP	O	Am	nn	5	SENT_456	[p16l802t543r891b584],
3	Soc	NNP	O	Soc	nn	5	SENT_456	[p16l909t543r994b585],
4	Clin	NNP	O	Clin	nn	5	SENT_456	[p16l1012t541r1110b585],
5	Oncol	NNP	O	Oncol	_	0	SENT_456	[p16l1128t541r1274b585],
6	2004	CD	DATE	2004	num	5	SENT_456	[p16l1293t541r1846b595],
7	;	:	O	;	_	0	SENT_456	[p16l1293t541r1846b595],
8	23	CD	NUMBER	23	num	9	SENT_456	[p16l1293t541r1846b595],
9	(	NN	O	(	dep	5	SENT_456	[p16l1293t541r1846b595],
10	196	CD	NUMBER	196	num	11	SENT_456	[p16l1293t541r1846b595],
11	)	NN	O	)	dep	9	SENT_456	[p16l1293t541r1846b595],
12	:	:	O	:	_	0	SENT_456	[p16l1293t541r1846b595],
13	A3005	NN	O	a3005	dep	9	SENT_456	[p16l1293t541r1846b595],
14	.	.	O	.	_	0	SENT_456	[p16l1293t541r1846b595],

1	[	RB	O	[	advmod	2	SENT_457	[p16l7t606r104b661],
2	20	CD	NUMBER	20	_	0	SENT_457	[p16l7t606r104b661],
3	]	CD	NUMBER	]	num	5	SENT_457	[p16l7t606r104b661],
4	Brandt	NNP	PERSON	Brandt	nn	5	SENT_457	[p16l139t607r311b650],
5	B	NN	O	b	dep	2	SENT_457	[p16l329t609r372b657],
6	,	,	O	,	_	0	SENT_457	[p16l329t609r372b657],
7	Meyer	NNP	PERSON	Meyer	appos	5	SENT_457	[p16l393t607r839b661],
8	.	.	O	.	_	0	SENT_457	[p16l393t607r839b661],

1	—	NN	O	—	_	0	SENT_458	[p16l393t607r839b661],
2	.	.	O	.	_	0	SENT_458	[p16l393t607r839b661],

1	Staeckling	VBG	O	staeckle	_	0	SENT_459	[p16l393t607r839b661],
2	S	NN	O	s	dobj	1	SENT_459	[p16l857t609r895b657],
3	,	,	O	,	_	0	SENT_459	[p16l857t609r895b657],
4	Schmidt	NNP	PERSON	Schmidt	nn	5	SENT_459	[p16l916t607r1128b650],
5	H	NNP	O	H	appos	2	SENT_459	[p16l1147t609r1197b657],
6	,	,	O	,	_	0	SENT_459	[p16l1147t609r1197b657],
7	et	FW	O	et	nn	8	SENT_459	[p16l1217t613r1265b650],
8	al.	FW	O	al.	appos	5	SENT_459	[p16l1283t607r1338b651],
9	.	.	O	.	_	0	SENT_459	[p16l1283t607r1338b651],

1	Mechanisms	NNS	O	mechanism	_	0	SENT_460	[p16l1359t607r1681b650],
2	of	IN	O	of	_	0	SENT_460	[p16l1701t607r1754b650],
3	egfr	NN	O	egfr	nn	6	SENT_460	[p16l1768t606r1868b661],
4	gene	NN	O	gene	nn	6	SENT_460	[p16l1885t619r2005b661],
5	transcription	NN	O	transcription	nn	6	SENT_460	[p16l2025t613r2151b650, p16l139t674r365b727],
6	modulation	NN	O	modulation	prep_of	1	SENT_460	[p16l390t673r704b717],
7	:	:	O	:	_	0	SENT_460	[p16l390t673r704b717],
8	relationship	NN	O	relationship	dep	1	SENT_460	[p16l733t673r1041b727],
9	to	TO	O	to	dep	8	SENT_460	[p16l1065t679r1114b717],
10	cancer	NN	O	cancer	nn	11	SENT_460	[p16l1139t686r1308b717],
11	risk	NN	O	risk	dep	8	SENT_460	[p16l1331t673r1425b717],
12	and	CC	O	and	_	0	SENT_460	[p16l1448t673r1541b717],
13	therapy	NN	O	therapy	nn	14	SENT_460	[p16l1565t673r1764b727],
14	response	NN	O	response	conj_and	11	SENT_460	[p16l1787t686r2028b727],
15	.	.	O	.	_	0	SENT_460	[p16l1787t686r2028b727],

1	Clin	NNP	O	Clin	nn	3	SENT_461	[p16l2053t673r2152b717],
2	Cancer	NNP	O	Cancer	nn	3	SENT_461	[p16l139t741r314b782],
3	Res	NNP	O	Res	_	0	SENT_461	[p16l330t741r414b782],
4	2006	CD	DATE	2006	num	3	SENT_461	[p16l433t741r906b789],
5	;	:	O	;	_	0	SENT_461	[p16l433t741r906b789],
6	12:7252	CD	NUMBER	12:7252	number	7	SENT_461	[p16l433t741r906b789],
7	—	CD	NUMBER	—	dep	3	SENT_461	[p16l433t741r906b789],
8	60	CD	NUMBER	60	dep	7	SENT_461	[p16l433t741r906b789],
9	.	.	O	.	_	0	SENT_461	[p16l433t741r906b789],

1	[	NN	O	[	_	0	SENT_462	[p16l9t805r104b859],
2	21	CD	NUMBER	21	number	3	SENT_462	[p16l9t805r104b859],
3	]	CD	NUMBER	]	dep	1	SENT_462	[p16l9t805r104b859],
4	Chrysogelos	NNP	O	Chrysogelos	nn	5	SENT_462	[p16l139t805r447b859],
5	SA	NNP	O	SA	dep	3	SENT_462	[p16l478t807r554b849],
6	.	.	O	.	_	0	SENT_462	[p16l478t807r554b849],

1	Chromatin	NN	O	chromatin	nn	2	SENT_463	[p16l585t805r858b848],
2	structure	NN	O	structure	nsubj	7	SENT_463	[p16l889t811r1121b848],
3	of	IN	O	of	_	0	SENT_463	[p16l1152t805r1205b848],
4	the	DT	O	the	det	6	SENT_463	[p16l1228t805r1310b848],
5	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_463	[p16l1340t807r1474b848],
6	gene	NN	O	gene	prep_of	2	SENT_463	[p16l1501t817r1621b859],
7	suggests	VBZ	O	suggest	_	0	SENT_463	[p16l1652t811r1868b859],
8	a	DT	O	a	det	9	SENT_463	[p16l1898t817r1924b848],
9	role	NN	O	role	dobj	7	SENT_463	[p16l1954t805r2051b848],
10	for	IN	O	for	_	0	SENT_463	[p16l2082t805r2153b848],
11	intron	NN	O	intron	nn	13	SENT_463	[p16l139t872r296b915],
12	1	CD	NUMBER	1	num	13	SENT_463	[p16l323t874r342b914],
13	sequences	NNS	O	sequence	prep_for	9	SENT_463	[p16l373t884r635b926],
14	in	IN	O	in	_	0	SENT_463	[p16l660t872r708b914],
15	its	PRP$	O	its	poss	16	SENT_463	[p16l732t872r790b915],
16	regulation	NN	O	regulation	prep_in	7	SENT_463	[p16l815t871r1079b926],
17	in	IN	O	in	_	0	SENT_463	[p16l1103t872r1150b914],
18	breast	NN	O	breast	nn	20	SENT_463	[p16l1173t871r1331b915],
19	cancer	NN	O	cancer	nn	20	SENT_463	[p16l1355t884r1523b915],
20	cells	NNS	O	cell	prep_in	16	SENT_463	[p16l1545t871r1670b915],
21	.	.	O	.	_	0	SENT_463	[p16l1545t871r1670b915],

1	Nucleic	JJ	O	nucleic	amod	2	SENT_464	[p16l1695t871r1884b915],
2	Acids	NNS	O	acid	_	0	SENT_464	[p16l1905t871r2042b915],
3	Res	NNP	O	Res	dep	2	SENT_464	[p16l2067t874r2151b915],
4	1993	CD	DATE	1993	num	3	SENT_464	[p16l141t939r259b980],
5	;	:	O	;	_	0	SENT_464	[p16l270t939r338b987],
6	21	CD	NUMBER	21	number	7	SENT_464	[p16l270t939r338b987],
7	:5736	CD	NUMBER	:5736	dep	2	SENT_464	[p16l353t939r595b981],
8	—	NN	O	—	dep	7	SENT_464	[p16l353t939r595b981],
9	41	CD	NUMBER	41	num	8	SENT_464	[p16l353t939r595b981],
10	.	.	O	.	_	0	SENT_464	[p16l353t939r595b981],

1	[	NN	O	[	_	0	SENT_465	[p16l7t1003r104b1057],
2	22	CD	NUMBER	22	num	1	SENT_465	[p16l7t1003r104b1057],
3	]	CD	NUMBER	]	num	5	SENT_465	[p16l7t1003r104b1057],
4	Etienne-Grimaldi	NN	O	etienne-grimaldus	nn	5	SENT_465	[p16l139t1003r584b1047],
5	MC	NNP	O	MC	dep	1	SENT_465	[p16l610t1005r704b1053],
6	,	,	O	,	_	0	SENT_465	[p16l610t1005r704b1053],
7	Pereira	NNP	PERSON	Pereira	nn	8	SENT_465	[p16l730t1004r908b1047],
8	S	NNP	PERSON	S	appos	5	SENT_465	[p16l932t1005r970b1053],
9	,	,	O	,	_	0	SENT_465	[p16l932t1005r970b1053],
10	Magne	NNP	PERSON	Magne	nn	11	SENT_465	[p16l995t1006r1168b1057],
11	N	NNP	PERSON	N	appos	5	SENT_465	[p16l1193t1006r1242b1053],
12	,	,	O	,	_	0	SENT_465	[p16l1193t1006r1242b1053],
13	et	FW	O	et	nn	14	SENT_465	[p16l1268t1009r1315b1047],
14	al.	FW	O	al.	appos	5	SENT_465	[p16l1338t1003r1393b1047],
15	.	.	O	.	_	0	SENT_465	[p16l1338t1003r1393b1047],

1	Analysis	NN	O	analysis	_	0	SENT_466	[p16l1416t1003r1628b1057],
2	of	IN	O	of	_	0	SENT_466	[p16l1653t1003r1707b1047],
3	the	DT	O	the	det	6	SENT_466	[p16l1724t1003r1805b1047],
4	dinucleotide	NN	O	dinucleotide	nn	6	SENT_466	[p16l1830t1003r2151b1047],
5	repeat	NN	O	repeat	nn	6	SENT_466	[p16l139t1075r302b1123],
6	polymorphism	NN	O	polymorphism	prep_of	1	SENT_466	[p16l321t1069r700b1123],
7	in	IN	O	in	_	0	SENT_466	[p16l720t1069r767b1112],
8	the	DT	O	the	det	16	SENT_466	[p16l786t1069r868b1112],
9	epidermal	JJ	O	epidermal	amod	16	SENT_466	[p16l887t1069r1148b1123],
10	growth	NN	O	growth	nn	16	SENT_466	[p16l1168t1069r1353b1123],
11	factor	NN	O	factor	nn	16	SENT_466	[p16l1373t1068r1521b1112],
12	receptor	NN	O	receptor	nn	16	SENT_466	[p16l1539t1075r1754b1123],
13	(	CD	NUMBER	(	num	16	SENT_466	[p16l1772t1069r1945b1123],
14	EGFR	NN	O	egfr	nn	16	SENT_466	[p16l1772t1069r1945b1123],
15	)	NN	O	)	nn	16	SENT_466	[p16l1772t1069r1945b1123],
16	gene	NN	O	gene	prep_in	1	SENT_466	[p16l1964t1081r2084b1123],
17	in	IN	O	in	_	0	SENT_466	[p16l2105t1069r2152b1112],
18	head	NN	O	head	nn	22	SENT_466	[p16l139t1135r261b1179],
19	and	CC	O	and	_	0	SENT_466	[p16l279t1135r372b1179],
20	neck	NN	O	neck	nn	22	SENT_466	[p16l391t1135r511b1179],
21	cancer	NN	O	cancer	nn	22	SENT_466	[p16l527t1148r695b1179],
22	patients	NNS	O	patient	prep_in	16	SENT_466	[p16l712t1136r931b1189],
23	.	.	O	.	_	0	SENT_466	[p16l712t1136r931b1189],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_467	[p16l948t1137r1053b1178],
2	Oncol	NNP	O	Oncol	_	0	SENT_467	[p16l1070t1135r1217b1179],
3	2005	CD	DATE	2005	num	2	SENT_467	[p16l1235t1137r1666b1185],
4	;	:	O	;	_	0	SENT_467	[p16l1235t1137r1666b1185],
5	16:934	CD	NUMBER	16:934	number	6	SENT_467	[p16l1235t1137r1666b1185],
6	—	CD	NUMBER	—	dep	2	SENT_467	[p16l1235t1137r1666b1185],
7	41	CD	NUMBER	41	dep	6	SENT_467	[p16l1235t1137r1666b1185],
8	.	.	O	.	_	0	SENT_467	[p16l1235t1137r1666b1185],

1	[	NN	O	[	nn	5	SENT_468	[p16l7t1200r104b1255],
2	23	CD	NUMBER	23	num	5	SENT_468	[p16l7t1200r104b1255],
3	]	CD	NUMBER	]	num	5	SENT_468	[p16l7t1200r104b1255],
4	Han	NNP	O	Han	nn	5	SENT_468	[p16l139t1203r241b1244],
5	SW	NNP	O	SW	_	0	SENT_468	[p16l257t1203r351b1251],
6	,	,	O	,	_	0	SENT_468	[p16l257t1203r351b1251],
7	Kim	NNP	PERSON	Kim	nn	8	SENT_468	[p16l368t1201r470b1244],
8	TY	NNP	PERSON	TY	appos	5	SENT_468	[p16l483t1203r559b1251],
9	,	,	O	,	_	0	SENT_468	[p16l483t1203r559b1251],
10	Lee	NNP	PERSON	Lee	nn	11	SENT_468	[p16l576t1203r659b1244],
11	KW	NNP	O	KW	appos	5	SENT_468	[p16l675t1203r776b1251],
12	,	,	O	,	_	0	SENT_468	[p16l675t1203r776b1251],
13	et	FW	O	et	nn	14	SENT_468	[p16l793t1207r840b1244],
14	al.	FW	O	al.	appos	5	SENT_468	[p16l855t1200r910b1244],
15	.	.	O	.	_	0	SENT_468	[p16l855t1200r910b1244],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_469	[p16l927t1203r1060b1244],
2	mutation	NN	O	mutation	dep	1	SENT_469	[p16l1074t1201r1311b1244],
3	and	CC	O	and	_	0	SENT_469	[p16l1327t1200r1420b1244],
4	intron	NN	O	intron	dep	1	SENT_469	[p16l1436t1201r1593b1244],
5	1	CD	NUMBER	1	num	8	SENT_469	[p16l1612t1203r1631b1244],
6	CA	NNP	O	CA	nn	8	SENT_469	[p16l1654t1202r1723b1244],
7	repeat	NN	O	repeat	nn	8	SENT_469	[p16l1737t1207r1900b1255],
8	polymorphism	NN	O	polymorphism	dep	2	SENT_469	[p16l1915t1200r2151b1255, p16l139t1267r298b1321],
9	as	IN	O	as	prep	8	SENT_469	[p16l314t1279r364b1310],
10	predictive	JJ	O	predictive	amod	11	SENT_469	[p16l382t1267r639b1321],
11	markers	NNS	O	marker	dep	21	SENT_469	[p16l657t1267r865b1310],
12	of	IN	O	of	_	0	SENT_469	[p16l883t1267r936b1310],
13	Geﬁtinib	NN	O	geﬁtinib	nn	14	SENT_469	[p16l947t1267r1170b1310],
14	responsiveness	NN	O	responsiveness	prep_of	11	SENT_469	[p16l1188t1268r1575b1321],
15	in	IN	O	in	_	0	SENT_469	[p16l1594t1268r1641b1310],
16	non	JJ	O	non	amod	19	SENT_469	[p16l1658t1267r1918b1310],
17	—	JJ	O	—	amod	19	SENT_469	[p16l1658t1267r1918b1310],
18	small	JJ	O	small	amod	19	SENT_469	[p16l1658t1267r1918b1310],
19	cell	NN	O	cell	prep_in	14	SENT_469	[p16l1936t1267r2022b1310],
20	lung	NN	O	lung	nn	21	SENT_469	[p16l2040t1267r2153b1321],
21	cancer	NN	O	cancer	dep	9	SENT_469	[p16l139t1346r307b1377],
22	(	CD	NUMBER	(	num	24	SENT_469	[p16l323t1333r574b1388],
23	NSCLC	NN	O	nsclc	nn	24	SENT_469	[p16l323t1333r574b1388],
24	)	NN	O	)	dep	21	SENT_469	[p16l323t1333r574b1388],
25	.	.	O	.	_	0	SENT_469	[p16l323t1333r574b1388],
26	]	SYM	O	]	dep	8	SENT_469	[p16l323t1333r574b1388],

1	Clin	NNP	O	Clin	nn	3	SENT_470	[p16l593t1333r691b1377],
2	Oncol	NNP	O	Oncol	nn	3	SENT_470	[p16l709t1333r856b1377],
3	ASCO	NNP	ORGANIZATION	ASCO	_	0	SENT_470	[p16l872t1335r1010b1377],
4	Annual	JJ	SET	annual	amod	3	SENT_470	[p16l1027t1333r1211b1377],
5	Meeting	VBG	O	meet	partmod	3	SENT_470	[p16l1230t1334r1442b1388],
6	Proceedings	NNP	O	Proceedings	nn	9	SENT_470	[p16l1459t1333r1768b1388],
7	(	CD	NUMBER	(	num	9	SENT_470	[p16l1787t1333r2153b1388],
8	Post-Meeting	NNP	O	Post-Meeting	nn	9	SENT_470	[p16l1787t1333r2153b1388],
9	Edition	NNP	O	Edition	dobj	5	SENT_470	[p16l139t1399r342b1453],
10	)	CD	NUMBER	)	num	11	SENT_470	[p16l139t1399r342b1453],
11	2006	CD	DATE	2006	dep	9	SENT_470	[p16l360t1399r899b1453],
12	;	:	O	;	_	0	SENT_470	[p16l360t1399r899b1453],
13	24	CD	NUMBER	24	number	14	SENT_470	[p16l360t1399r899b1453],
14	(	CD	NUMBER	(	dep	9	SENT_470	[p16l360t1399r899b1453],
15	18S	NN	O	18	nn	16	SENT_470	[p16l360t1399r899b1453],
16	)	NN	O	)	dep	14	SENT_470	[p16l360t1399r899b1453],
17	:	:	O	:	_	0	SENT_470	[p16l360t1399r899b1453],
18	A7173	NN	O	a7173	dep	9	SENT_470	[p16l360t1399r899b1453],
19	.	.	O	.	_	0	SENT_470	[p16l360t1399r899b1453],

1	[	NN	O	[	nn	5	SENT_471	[p16l8t1465r104b1519],
2	24	CD	NUMBER	24	num	5	SENT_471	[p16l8t1465r104b1519],
3	]	CD	NUMBER	]	num	5	SENT_471	[p16l8t1465r104b1519],
4	Liu	NNP	O	Liu	nn	5	SENT_471	[p16l139t1466r214b1509],
5	W	NNP	O	W	_	0	SENT_471	[p16l228t1468r295b1515],
6	,	,	O	,	_	0	SENT_471	[p16l228t1468r295b1515],
7	Innocenti	NNP	PERSON	Innocenti	nn	8	SENT_471	[p16l313t1466r555b1509],
8	F	NN	O	f	appos	5	SENT_471	[p16l573t1468r607b1515],
9	,	,	O	,	_	0	SENT_471	[p16l573t1468r607b1515],
10	Wu	NNP	O	Wu	nn	11	SENT_471	[p16l622t1468r712b1509],
11	MH	NNP	O	MH	appos	5	SENT_471	[p16l729t1468r832b1515],
12	,	,	O	,	_	0	SENT_471	[p16l729t1468r832b1515],
13	et	FW	O	et	nn	14	SENT_471	[p16l850t1471r898b1509],
14	al.	FW	O	al.	appos	5	SENT_471	[p16l913t1465r968b1509],
15	.	.	O	.	_	0	SENT_471	[p16l913t1465r968b1509],

1	A	DT	O	a	det	4	SENT_472	[p16l983t1467r1021b1508],
2	functional	JJ	O	functional	amod	4	SENT_472	[p16l1036t1465r1296b1509],
3	common	JJ	O	common	amod	4	SENT_472	[p16l1313t1478r1540b1509],
4	polymorphism	NN	O	polymorphism	_	0	SENT_472	[p16l1556t1465r1936b1519],
5	in	IN	O	in	_	0	SENT_472	[p16l1953t1466r2001b1508],
6	a	DT	O	a	det	9	SENT_472	[p16l2017t1478r2043b1509],
7	Sp1	NN	O	sp1	nn	9	SENT_472	[p16l2059t1467r2145b1519],
8	recognition	NN	O	recognition	nn	9	SENT_472	[p16l139t1531r433b1585],
9	site	NN	O	site	prep_in	4	SENT_472	[p16l448t1531r535b1574],
10	of	IN	O	of	_	0	SENT_472	[p16l551t1530r604b1574],
11	the	DT	O	the	det	17	SENT_472	[p16l613t1531r694b1574],
12	epidermal	JJ	O	epidermal	amod	17	SENT_472	[p16l710t1530r971b1585],
13	growth	NN	O	growth	nn	17	SENT_472	[p16l985t1530r1171b1585],
14	factor	NN	O	factor	nn	17	SENT_472	[p16l1186t1530r1334b1574],
15	receptor	NN	O	receptor	nn	17	SENT_472	[p16l1347t1537r1563b1585],
16	gene	NN	O	gene	nn	17	SENT_472	[p16l1575t1543r1696b1585],
17	promoter	NN	O	promoter	prep_of	4	SENT_472	[p16l1711t1537r1962b1585],
18	.	.	O	.	_	0	SENT_472	[p16l1711t1537r1962b1585],

1	Cancer	NNP	O	Cancer	nn	2	SENT_473	[p16l1978t1533r2153b1574],
2	Res	NNP	O	Res	_	0	SENT_473	[p16l139t1600r223b1640],
3	2005	CD	DATE	2005	num	2	SENT_473	[p16l241t1599r652b1647],
4	;	:	O	;	_	0	SENT_473	[p16l241t1599r652b1647],
5	65:46	CD	NUMBER	65:46	number	6	SENT_473	[p16l241t1599r652b1647],
6	—	CD	NUMBER	—	dep	2	SENT_473	[p16l241t1599r652b1647],
7	53	CD	NUMBER	53	dep	6	SENT_473	[p16l241t1599r652b1647],
8	.	.	O	.	_	0	SENT_473	[p16l241t1599r652b1647],

1	[	NN	O	[	_	0	SENT_474	[p16l7t1663r104b1718],
2	25	CD	NUMBER	25	num	1	SENT_474	[p16l7t1663r104b1718],
3	]	CD	NUMBER	]	num	5	SENT_474	[p16l7t1663r104b1718],
4	Rudin	NNP	PERSON	Rudin	nn	5	SENT_474	[p16l139t1663r288b1707],
5	CM	NN	O	cm	dep	1	SENT_474	[p16l304t1665r399b1714],
6	,	,	O	,	_	0	SENT_474	[p16l304t1665r399b1714],
7	Liu	NNP	PERSON	Liu	nn	8	SENT_474	[p16l417t1664r492b1707],
8	W	NNP	PERSON	W	appos	5	SENT_474	[p16l506t1666r573b1713],
9	,	,	O	,	_	0	SENT_474	[p16l506t1666r573b1713],
10	Desai	NNP	PERSON	Desai	nn	11	SENT_474	[p16l590t1664r728b1707],
11	A	NNP	O	A	appos	5	SENT_474	[p16l742t1665r791b1714],
12	,	,	O	,	_	0	SENT_474	[p16l742t1665r791b1714],
13	et	FW	O	et	nn	14	SENT_474	[p16l809t1670r856b1707],
14	al.	FW	O	al.	appos	5	SENT_474	[p16l872t1663r926b1707],
15	.	.	O	.	_	0	SENT_474	[p16l872t1663r926b1707],

1	Pharmacogenomic	JJ	PERSON	pharmacogenomic	_	0	SENT_475	[p16l944t1663r1422b1718],
2	and	CC	O	and	_	0	SENT_475	[p16l1438t1663r1531b1707],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_475	[p16l1548t1663r1983b1718],
4	determinants	NNS	O	determinant	conj_and	1	SENT_475	[p16l1999t1663r2151b1707, p16l139t1729r347b1772],

1	of	IN	O	of	_	0	SENT_476	[p16l366t1728r420b1772],
2	erlotinib	NN	O	erlotinib	nn	3	SENT_476	[p16l431t1729r650b1772],
3	toxicity	NN	O	toxicity	pobj	1	SENT_476	[p16l667t1729r902b1783],
4	.	.	O	.	_	0	SENT_476	[p16l667t1729r902b1783],
5	]	SYM	O	]	dep	1	SENT_476	[p16l667t1729r902b1783],

1	Clin	NNP	O	Clin	nn	2	SENT_477	[p16l920t1729r1018b1772],
2	Oncol	NNP	O	Oncol	_	0	SENT_477	[p16l1036t1729r1182b1772],
3	2008	CD	DATE	2008	num	2	SENT_477	[p16l1201t1731r1654b1779],
4	;	:	O	;	_	0	SENT_477	[p16l1201t1731r1654b1779],
5	26:1119	CD	NUMBER	26:1119	number	6	SENT_477	[p16l1201t1731r1654b1779],
6	—	CD	NUMBER	—	dep	2	SENT_477	[p16l1201t1731r1654b1779],
7	27	CD	NUMBER	27	dep	6	SENT_477	[p16l1201t1731r1654b1779],
8	.	.	O	.	_	0	SENT_477	[p16l1201t1731r1654b1779],

1	[	NN	O	[	nn	5	SENT_478	[p16l7t1795r104b1850],
2	26	CD	NUMBER	26	num	5	SENT_478	[p16l7t1795r104b1850],
3	]	CD	NUMBER	]	num	5	SENT_478	[p16l7t1795r104b1850],
4	Liu	NNP	O	Liu	nn	5	SENT_478	[p16l139t1796r214b1839],
5	G	NNP	O	G	_	0	SENT_478	[p16l239t1797r288b1845],
6	,	,	O	,	_	0	SENT_478	[p16l239t1797r288b1845],
7	Gurubhagavatula	NNP	LOCATION	Gurubhagavatula	nn	8	SENT_478	[p16l314t1795r756b1850],
8	S	NNP	LOCATION	S	appos	5	SENT_478	[p16l781t1797r819b1845],
9	,	,	O	,	_	0	SENT_478	[p16l781t1797r819b1845],
10	Zhou	NNP	PERSON	Zhou	nn	11	SENT_478	[p16l845t1795r974b1839],
11	W	NNP	PERSON	W	appos	5	SENT_478	[p16l997t1798r1064b1845],
12	,	,	O	,	_	0	SENT_478	[p16l997t1798r1064b1845],
13	et	FW	O	et	nn	14	SENT_478	[p16l1090t1802r1138b1839],
14	al.	FW	O	al.	appos	5	SENT_478	[p16l1162t1795r1217b1839],
15	.	.	O	.	_	0	SENT_478	[p16l1162t1795r1217b1839],

1	Epidermal	JJ	O	epidermal	amod	4	SENT_479	[p16l1244t1795r1507b1850],
2	growth	NN	O	growth	nn	4	SENT_479	[p16l1532t1795r1717b1850],
3	factor	NN	O	factor	nn	4	SENT_479	[p16l1743t1795r1891b1839],
4	polymorphisms	NNS	O	polymorphism	nsubj	13	SENT_479	[p16l1915t1795r2151b1850, p16l139t1861r322b1915],
5	and	CC	O	and	_	0	SENT_479	[p16l346t1861r439b1904],
6	clinical	JJ	O	clinical	amod	7	SENT_479	[p16l463t1861r644b1904],
7	outcomes	NNS	O	outcome	nsubj	13	SENT_479	[p16l669t1867r918b1904],
8	in	IN	O	in	_	0	SENT_479	[p16l942t1861r990b1904],
9	non-small-cell	JJ	O	non-small-cell	amod	12	SENT_479	[p16l1014t1861r1387b1904],
10	lung	NN	O	lung	nn	12	SENT_479	[p16l1411t1861r1524b1915],
11	cancer	NN	O	cancer	nn	12	SENT_479	[p16l1547t1873r1715b1904],
12	patients	NNS	O	patient	prep_in	7	SENT_479	[p16l1737t1861r1944b1915],
13	treated	VBN	O	treat	_	0	SENT_479	[p16l1968t1861r2151b1904],
14	with	IN	O	with	_	0	SENT_479	[p16l137t1927r256b1971],
15	geﬁtinib	NN	O	geﬁtinib	prep_with	13	SENT_479	[p16l273t1927r499b1981],
16	.	.	O	.	_	0	SENT_479	[p16l273t1927r499b1981],

1	Pharmacogenomics	NNS	MISC	pharmacogenomic	nsubj	2	SENT_480	[p16l518t1927r1053b1981],
2	]	VBP	O	]	_	0	SENT_480	[p16l518t1927r1053b1981],
3	2008	CD	DATE	2008	dobj	2	SENT_480	[p16l1071t1929r1479b1977],
4	;	:	O	;	_	0	SENT_480	[p16l1071t1929r1479b1977],
5	8:129	CD	NUMBER	8:129	number	6	SENT_480	[p16l1071t1929r1479b1977],
6	—	CD	NUMBER	—	dep	3	SENT_480	[p16l1071t1929r1479b1977],
7	38	CD	NUMBER	38	dep	6	SENT_480	[p16l1071t1929r1479b1977],
8	.	.	O	.	_	0	SENT_480	[p16l1071t1929r1479b1977],

1	[	NN	O	[	nn	5	SENT_481	[p16l9t1992r104b2047],
2	27	CD	NUMBER	27	num	5	SENT_481	[p16l9t1992r104b2047],
3	]	CD	NUMBER	]	num	5	SENT_481	[p16l9t1992r104b2047],
4	Gregorc	NNP	MISC	Gregorc	nn	5	SENT_481	[p16l139t1995r339b2047],
5	V	NNP	O	V	_	0	SENT_481	[p16l353t1995r401b2043],
6	,	,	O	,	_	0	SENT_481	[p16l353t1995r401b2043],
7	Hidalgo	NNP	PERSON	Hidalgo	nn	8	SENT_481	[p16l419t1992r616b2047],
8	M	NNP	O	M	appos	5	SENT_481	[p16l634t1995r695b2043],
9	,	,	O	,	_	0	SENT_481	[p16l634t1995r695b2043],
10	Spreaﬁco	NNP	O	Spreaﬁco	nn	11	SENT_481	[p16l713t1992r948b2047],
11	A	NNP	O	A	appos	5	SENT_481	[p16l963t1994r1012b2043],
12	,	,	O	,	_	0	SENT_481	[p16l963t1994r1012b2043],
13	et	FW	O	et	nn	14	SENT_481	[p16l1030t1999r1078b2036],
14	al.	FW	O	al.	appos	5	SENT_481	[p16l1094t1992r1149b2036],
15	.	.	O	.	_	0	SENT_481	[p16l1094t1992r1149b2036],

1	Germline	NN	O	germline	nn	2	SENT_482	[p16l1167t1992r1405b2036],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_482	[p16l1423t1992r1827b2047],
3	in	IN	O	in	_	0	SENT_482	[p16l1846t1993r1893b2036],
4	EGFR	NN	O	egfr	prep_in	2	SENT_482	[p16l1910t1995r2044b2036],
5	and	CC	O	and	_	0	SENT_482	[p16l2058t1992r2151b2036],
6	survival	NN	O	survival	prep_in	2	SENT_482	[p16l139t2059r339b2102],
7	in	IN	O	in	_	0	SENT_482	[p16l361t2060r408b2102],
8	patients	NNS	O	patient	prep_in	2	SENT_482	[p16l430t2060r637b2113],
9	with	IN	O	with	_	0	SENT_482	[p16l658t2059r777b2102],
10	lung	NN	O	lung	nn	11	SENT_482	[p16l798t2059r911b2113],
11	cancer	NN	O	cancer	prep_with	8	SENT_482	[p16l931t2071r1100b2102],
12	receiving	VBG	O	receive	partmod	2	SENT_482	[p16l1120t2060r1354b2113],
13	geﬁtinib	NN	O	geﬁtinib	dobj	12	SENT_482	[p16l1374t2059r1600b2113],
14	.	.	O	.	_	0	SENT_482	[p16l1374t2059r1600b2113],

1	Clin	NNP	O	Clin	nn	3	SENT_483	[p16l1623t2059r1721b2102],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_483	[p16l1743t2059r2015b2102],
3	Ther	NNP	O	Ther	_	0	SENT_483	[p16l2034t2059r2153b2102],
4	2008	CD	DATE	2008	num	3	SENT_483	[p16l138t2127r578b2175],
5	;	:	O	;	_	0	SENT_483	[p16l138t2127r578b2175],
6	83:477	CD	NUMBER	83:477	number	7	SENT_483	[p16l138t2127r578b2175],
7	—	CD	NUMBER	—	dep	3	SENT_483	[p16l138t2127r578b2175],
8	84	CD	NUMBER	84	dep	7	SENT_483	[p16l138t2127r578b2175],
9	.	.	O	.	_	0	SENT_483	[p16l138t2127r578b2175],

1	[	NN	O	[	_	0	SENT_484	[p16l7t2190r104b2245],
2	28	CD	NUMBER	28	num	1	SENT_484	[p16l7t2190r104b2245],
3	]	CD	NUMBER	]	num	5	SENT_484	[p16l7t2190r104b2245],
4	Nomura	NNP	O	Nomura	nn	5	SENT_484	[p16l139t2193r346b2234],
5	M	NN	O	m	dep	1	SENT_484	[p16l370t2193r431b2241],
6	,	,	O	,	_	0	SENT_484	[p16l370t2193r431b2241],
7	Shigematsu	NN	PERSON	shigematsu	nn	8	SENT_484	[p16l455t2191r754b2245],
8	H	NN	PERSON	h	appos	5	SENT_484	[p16l778t2193r828b2241],
9	,	,	O	,	_	0	SENT_484	[p16l778t2193r828b2241],
10	Li	NNP	PERSON	Li	nn	11	SENT_484	[p16l853t2191r893b2234],
11	L	NNP	PERSON	L	appos	5	SENT_484	[p16l918t2193r954b2241],
12	,	,	O	,	_	0	SENT_484	[p16l918t2193r954b2241],
13	et	FW	O	et	nn	14	SENT_484	[p16l979t2197r1026b2234],
14	al.	FW	O	al.	appos	5	SENT_484	[p16l1049t2191r1103b2235],
15	.	.	O	.	_	0	SENT_484	[p16l1049t2191r1103b2235],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_485	[p16l1128t2191r1543b2245],
2	,	,	O	,	_	0	SENT_485	[p16l1128t2191r1543b2245],
3	mutations	NNS	O	mutation	conj_and	1	SENT_485	[p16l1567t2191r1842b2241],
4	,	,	O	,	_	0	SENT_485	[p16l1567t2191r1842b2241],
5	and	CC	O	and	_	0	SENT_485	[p16l1866t2191r1959b2234],
6	ampliﬁcation	NN	O	ampliﬁcation	conj_and	1	SENT_485	[p16l1983t2191r2151b2245, p16l139t2257r331b2301],
7	of	IN	O	of	_	0	SENT_485	[p16l356t2257r409b2301],
8	the	DT	O	the	det	10	SENT_485	[p16l427t2257r508b2301],
9	EGFR	NN	ORGANIZATION	egfr	nn	10	SENT_485	[p16l534t2259r667b2301],
10	gene	NN	O	gene	prep_of	6	SENT_485	[p16l689t2270r809b2311],
11	in	IN	O	in	_	0	SENT_485	[p16l835t2258r882b2300],
12	non	JJ	O	non	amod	17	SENT_485	[p16l907t2257r1167b2301],
13	—	JJ	O	—	amod	17	SENT_485	[p16l907t2257r1167b2301],
14	small	JJ	O	small	amod	17	SENT_485	[p16l907t2257r1167b2301],
15	cell	NN	O	cell	nn	17	SENT_485	[p16l1192t2257r1279b2301],
16	lung	NN	O	lung	nn	17	SENT_485	[p16l1304t2257r1417b2311],
17	cancers	NNS	O	cancer	prep_in	10	SENT_485	[p16l1441t2270r1645b2301],
18	.	.	O	.	_	0	SENT_485	[p16l1441t2270r1645b2301],

1	PLoS	NNP	O	PLoS	nn	2	SENT_486	[p16l1671t2259r1788b2301],
2	Med	NNP	O	Med	_	0	SENT_486	[p16l1814t2257r1926b2301],
3	2007	CD	DATE	2007	num	2	SENT_486	[p16l1951t2259r2147b2307],
4	;	:	O	;	_	0	SENT_486	[p16l1951t2259r2147b2307],
5	4	CD	NUMBER	4	num	7	SENT_486	[p16l1951t2259r2147b2307],
6	:	:	O	:	_	0	SENT_486	[p16l1951t2259r2147b2307],
7	e125	CD	NUMBER	e125	dep	2	SENT_486	[p16l139t2326r272b2368],
8	.	.	O	.	_	0	SENT_486	[p16l139t2326r272b2368],

1	[	NN	O	[	_	0	SENT_487	[p16l7t2390r104b2444],
2	29	CD	NUMBER	29	num	1	SENT_487	[p16l7t2390r104b2444],
3	]	CD	NUMBER	]	num	5	SENT_487	[p16l7t2390r104b2444],
4	Therasse	NN	O	therasse	nn	5	SENT_487	[p16l136t2390r362b2433],
5	P	NN	O	p	dep	1	SENT_487	[p16l388t2393r423b2440],
6	,	,	O	,	_	0	SENT_487	[p16l388t2393r423b2440],
7	Arbuck	NNP	ORGANIZATION	Arbuck	nn	8	SENT_487	[p16l447t2390r631b2433],
8	SG	NNP	ORGANIZATION	SG	appos	5	SENT_487	[p16l656t2392r733b2440],
9	,	,	O	,	_	0	SENT_487	[p16l656t2392r733b2440],
10	Eisenhauer	NNP	PERSON	Eisenhauer	nn	11	SENT_487	[p16l760t2390r1046b2433],
11	EA	NN	PERSON	ea	appos	5	SENT_487	[p16l1069t2392r1148b2440],
12	,	,	O	,	_	0	SENT_487	[p16l1069t2392r1148b2440],
13	et	FW	O	et	nn	14	SENT_487	[p16l1174t2396r1222b2433],
14	al.	FW	O	al.	appos	5	SENT_487	[p16l1246t2390r1301b2434],
15	.	.	O	.	_	0	SENT_487	[p16l1246t2390r1301b2434],

1	New	NNP	O	New	nn	2	SENT_488	[p16l1327t2392r1443b2433],
2	guidelines	NNS	O	guideline	nsubj	4	SENT_488	[p16l1466t2390r1730b2444],
3	to	TO	O	to	aux	4	SENT_488	[p16l1756t2396r1805b2433],
4	evaluate	VB	O	evaluate	_	0	SENT_488	[p16l1830t2390r2045b2433],
5	the	DT	O	the	det	6	SENT_488	[p16l2070t2390r2151b2433],
6	response	NN	O	response	dobj	4	SENT_488	[p16l139t2469r367b2511],
7	to	TO	O	to	_	0	SENT_488	[p16l385t2463r433b2500],
8	treatment	NN	O	treatment	prep_to	4	SENT_488	[p16l451t2463r710b2500],
9	in	IN	O	in	prep	4	SENT_488	[p16l727t2457r775b2499],
10	solid	JJ	O	solid	amod	11	SENT_488	[p16l793t2456r913b2500],
11	tumors	NNS	O	tumor	dep	9	SENT_488	[p16l931t2459r1161b2511],
12	.	.	O	.	_	0	SENT_488	[p16l931t2459r1161b2511],
13	]	SYM	O	]	dep	4	SENT_488	[p16l931t2459r1161b2511],

1	Natl	NNP	O	Natl	nn	3	SENT_489	[p16l1179t2456r1282b2500],
2	Cancer	NNP	O	Cancer	nn	3	SENT_489	[p16l1301t2458r1476b2500],
3	Inst	NNP	O	Inst	_	0	SENT_489	[p16l1493t2459r1587b2500],
4	2000	CD	DATE	2000	num	3	SENT_489	[p16l1604t2458r2045b2506],
5	;	:	O	;	_	0	SENT_489	[p16l1604t2458r2045b2506],
6	92:205	CD	NUMBER	92:205	number	7	SENT_489	[p16l1604t2458r2045b2506],
7	—	CD	NUMBER	—	dep	3	SENT_489	[p16l1604t2458r2045b2506],
8	16	CD	NUMBER	16	dep	7	SENT_489	[p16l1604t2458r2045b2506],
9	.	.	O	.	_	0	SENT_489	[p16l1604t2458r2045b2506],

1	[	RB	O	[	advmod	2	SENT_490	[p16l7t2522r104b2576],
2	30	CD	NUMBER	30	_	0	SENT_490	[p16l7t2522r104b2576],
3	]	CD	NUMBER	]	dep	2	SENT_490	[p16l7t2522r104b2576],
4	Stram	NNP	PERSON	Stram	nn	5	SENT_490	[p16l139t2524r289b2565],
5	DO	NNP	O	DO	dep	3	SENT_490	[p16l314t2524r404b2566],
6	.	.	O	.	_	0	SENT_490	[p16l314t2524r404b2566],

1	Software	NNP	O	Software	_	0	SENT_491	[p16l430t2522r657b2565],
2	for	IN	O	for	_	0	SENT_491	[p16l683t2522r755b2565],
3	tag	NN	O	tag	prep_for	1	SENT_491	[p16l778t2528r857b2576],
4	single	JJ	O	single	amod	7	SENT_491	[p16l882t2522r1031b2576],
5	nucleotide	NN	O	nucleotide	nn	7	SENT_491	[p16l1058t2522r1327b2565],
6	polymorphism	NN	O	polymorphism	nn	7	SENT_491	[p16l1354t2522r1733b2576],
7	selection	NN	O	selection	dep	3	SENT_491	[p16l1759t2522r2000b2566],
8	.	.	O	.	_	0	SENT_491	[p16l1759t2522r2000b2566],

1	Hum	NNP	O	Hum	_	0	SENT_492	[p16l2027t2524r2152b2565],

1	Genomics	NNS	O	genomic	_	0	SENT_493	[p16l139t2589r392b2632],
2	2005	CD	DATE	2005	num	1	SENT_493	[p16l410t2590r809b2638],
3	;	:	O	;	_	0	SENT_493	[p16l410t2590r809b2638],
4	2:144	CD	NUMBER	2:144	number	5	SENT_493	[p16l410t2590r809b2638],
5	—	CD	NUMBER	—	dep	1	SENT_493	[p16l410t2590r809b2638],
6	51	CD	NUMBER	51	dep	5	SENT_493	[p16l410t2590r809b2638],
7	.	.	O	.	_	0	SENT_493	[p16l410t2590r809b2638],

1	[	NN	O	[	nn	5	SENT_494	[p16l10t2653r104b2708],
2	31	CD	NUMBER	31	num	5	SENT_494	[p16l10t2653r104b2708],
3	]	CD	NUMBER	]	num	5	SENT_494	[p16l10t2653r104b2708],
4	Sauna	NNP	O	Sauna	nn	5	SENT_494	[p16l139t2656r291b2697],
5	ZE	NNP	O	ZE	_	0	SENT_494	[p16l309t2656r383b2704],
6	,	,	O	,	_	0	SENT_494	[p16l309t2656r383b2704],
7	Kimchi-Sarfaty	NNP	O	Kimchi-Sarfaty	nn	8	SENT_494	[p16l404t2653r790b2708],
8	C	NNP	O	C	appos	5	SENT_494	[p16l808t2656r850b2704],
9	,	,	O	,	_	0	SENT_494	[p16l808t2656r850b2704],
10	Ambudkar	NNP	O	Ambudkar	nn	11	SENT_494	[p16l869t2654r1143b2697],
11	SV	NNP	O	SV	appos	5	SENT_494	[p16l1160t2656r1236b2704],
12	,	,	O	,	_	0	SENT_494	[p16l1160t2656r1236b2704],
13	et	FW	O	et	nn	14	SENT_494	[p16l1256t2660r1304b2697],
14	al.	FW	O	al.	appos	5	SENT_494	[p16l1322t2654r1377b2698],
15	.	.	O	.	_	0	SENT_494	[p16l1322t2654r1377b2698],

1	Silent	JJ	O	silent	amod	2	SENT_495	[p16l1398t2654r1543b2697],
2	polymorphisms	NNS	O	polymorphism	nsubj	3	SENT_495	[p16l1562t2654r1966b2708],
3	speak	VBP	O	speak	_	0	SENT_495	[p16l1987t2654r2147b2708],
4	:	:	O	:	_	0	SENT_495	[p16l1987t2654r2147b2708],
5	how	WRB	O	how	advmod	7	SENT_495	[p16l139t2720r250b2764],
6	they	PRP	O	they	nsubj	7	SENT_495	[p16l271t2720r385b2774],
7	affect	VBP	O	affect	ccomp	3	SENT_495	[p16l406t2720r549b2764],
8	pharmacogenomics	NNS	O	pharmacogenomic	dobj	7	SENT_495	[p16l571t2720r1075b2774],
9	and	CC	O	and	_	0	SENT_495	[p16l1099t2720r1191b2764],
10	the	DT	O	the	det	11	SENT_495	[p16l1214t2720r1296b2764],
11	treatment	NN	O	treatment	conj_and	8	SENT_495	[p16l1319t2726r1578b2764],
12	of	IN	O	of	_	0	SENT_495	[p16l1600t2720r1653b2764],
13	cancer	NN	O	cancer	prep_of	11	SENT_495	[p16l1670t2733r1846b2764],
14	.	.	O	.	_	0	SENT_495	[p16l1670t2733r1846b2764],

1	Cancer	NN	O	cancer	_	0	SENT_496	[p16l1870t2722r2045b2764],
2	Res	NNP	O	Res	dep	1	SENT_496	[p16l2067t2723r2151b2764],
3	2007	CD	DATE	2007	num	2	SENT_496	[p16l138t2788r606b2836],
4	;	:	O	;	_	0	SENT_496	[p16l138t2788r606b2836],
5	67:9609	CD	NUMBER	67:9609	number	6	SENT_496	[p16l138t2788r606b2836],
6	—	CD	NUMBER	—	dep	1	SENT_496	[p16l138t2788r606b2836],
7	12	CD	NUMBER	12	dep	6	SENT_496	[p16l138t2788r606b2836],
8	.	.	O	.	_	0	SENT_496	[p16l138t2788r606b2836],

1	[	NN	O	[	_	0	SENT_497	[p16l7t2852r104b2906],
2	32	CD	NUMBER	32	number	3	SENT_497	[p16l7t2852r104b2906],
3	]	CD	NUMBER	]	dep	1	SENT_497	[p16l7t2852r104b2906],
4	Kimchi	NNP	O	Kimchi	dep	3	SENT_497	[p16l139t2852r525b2906],
5	.	.	O	.	_	0	SENT_497	[p16l139t2852r525b2906],

1	—	NN	O	—	_	0	SENT_498	[p16l139t2852r525b2906],
2	.	.	O	.	_	0	SENT_498	[p16l139t2852r525b2906],

1	Sarfaty	NNP	PERSON	Sarfaty	nn	2	SENT_499	[p16l139t2852r525b2906],
2	C	NNP	O	C	_	0	SENT_499	[p16l542t2854r584b2902],
3	,	,	O	,	_	0	SENT_499	[p16l542t2854r584b2902],
4	Oh	UH	O	oh	dep	6	SENT_499	[p16l603t2852r674b2895],
5	]	CD	NUMBER	]	num	6	SENT_499	[p16l685t2855r771b2906],
6	M	NN	O	m	rcmod	2	SENT_499	[p16l685t2855r771b2906],
7	,	,	O	,	_	0	SENT_499	[p16l685t2855r771b2906],
8	Kim	NNP	PERSON	Kim	nn	9	SENT_499	[p16l790t2853r892b2895],
9	I-W	NNP	O	I-W	appos	2	SENT_499	[p16l910t2855r1013b2902],
10	,	,	O	,	_	0	SENT_499	[p16l910t2855r1013b2902],
11	et	FW	O	et	nn	12	SENT_499	[p16l1032t2858r1080b2895],
12	al.	FW	O	al.	appos	9	SENT_499	[p16l1096t2852r1151b2896],
13	.	.	O	.	_	0	SENT_499	[p16l1096t2852r1151b2896],

1	A	DT	O	a	det	2	SENT_500	[p16l1168t2854r1205b2895],
2	“	NN	O	“	_	0	SENT_500	[p16l1222t2852r1413b2895],
3	Silent	JJ	O	silent	amod	5	SENT_500	[p16l1222t2852r1413b2895],
4	”	NN	O	”	nn	5	SENT_500	[p16l1222t2852r1413b2895],
5	polymorphism	NN	O	polymorphism	dep	2	SENT_500	[p16l1432t2852r1812b2906],
6	in	IN	O	in	_	0	SENT_500	[p16l1830t2853r1878b2895],
7	the	DT	O	the	det	8	SENT_500	[p16l1895t2852r1976b2895],
8	MDR1	NN	O	mdr1	prep_in	5	SENT_500	[p16l1995t2854r2145b2895],

1	gene	NN	O	gene	nn	2	SENT_501	[p16l138t2931r258b2973],
2	changes	NNS	O	change	_	0	SENT_501	[p16l276t2918r481b2973],
3	substrate	JJ	O	substrate	amod	4	SENT_501	[p16l500t2918r735b2962],
4	speciﬁcity	NN	O	speciﬁcity	dep	2	SENT_501	[p16l754t2918r1024b2973],
5	.	.	O	.	_	0	SENT_501	[p16l754t2918r1024b2973],

1	Science	NNP	O	Science	_	0	SENT_502	[p16l1043t2919r1233b2962],
2	2007	CD	DATE	2007	num	1	SENT_502	[p16l1251t2920r1687b2968],
3	;	:	O	;	_	0	SENT_502	[p16l1251t2920r1687b2968],
4	315:525	CD	NUMBER	315:525	number	5	SENT_502	[p16l1251t2920r1687b2968],
5	—	CD	NUMBER	—	dep	1	SENT_502	[p16l1251t2920r1687b2968],
6	8	CD	NUMBER	8	dep	5	SENT_502	[p16l1251t2920r1687b2968],
7	.	.	O	.	_	0	SENT_502	[p16l1251t2920r1687b2968],

1	[	NN	O	[	nn	5	SENT_503	[p16l8t2983r104b3038],
2	33	CD	NUMBER	33	num	5	SENT_503	[p16l8t2983r104b3038],
3	]	CD	NUMBER	]	num	5	SENT_503	[p16l8t2983r104b3038],
4	Nackley	NNP	ORGANIZATION	Nackley	nn	5	SENT_503	[p16l139t2984r341b3038],
5	AG	NNP	ORGANIZATION	AG	_	0	SENT_503	[p16l393t2986r479b3034],
6	,	,	O	,	_	0	SENT_503	[p16l393t2986r479b3034],
7	Shabalina	NNP	ORGANIZATION	Shabalina	nn	8	SENT_503	[p16l536t2984r784b3027],
8	SA	NNP	ORGANIZATION	SA	appos	5	SENT_503	[p16l840t2986r916b3034],
9	,	,	O	,	_	0	SENT_503	[p16l840t2986r916b3034],
10	Tchivileva	NNP	O	Tchivileva	nn	11	SENT_503	[p16l970t2984r1226b3027],
11	IE	NN	O	ie	appos	5	SENT_503	[p16l1281t2986r1339b3034],
12	,	,	O	,	_	0	SENT_503	[p16l1281t2986r1339b3034],
13	et	FW	O	et	nn	14	SENT_503	[p16l1395t2990r1443b3027],
14	al.	FW	O	al.	appos	5	SENT_503	[p16l1497t2984r1552b3028],
15	.	.	O	.	_	0	SENT_503	[p16l1497t2984r1552b3028],

1	Human	JJ	O	human	amod	3	SENT_504	[p16l1609t2986r1797b3027],
2	catecholOmethyltransferase	NN	O	catecholomethyltransferase	nn	3	SENT_504	[p16l1852t2984r2151b3027, p16l139t3050r604b3104],
3	haplotypes	NNS	O	haplotype	nsubj	4	SENT_504	[p16l625t3050r906b3104],
4	modulate	VBP	O	modulate	_	0	SENT_504	[p16l928t3050r1172b3094],
5	protein	NN	O	protein	nn	6	SENT_504	[p16l1193t3051r1378b3104],
6	expression	NN	O	expression	dobj	4	SENT_504	[p16l1398t3051r1674b3104],
7	by	IN	O	by	_	0	SENT_504	[p16l1693t3050r1754b3104],
8	altering	VBG	O	alter	prepc_by	4	SENT_504	[p16l1773t3050r1972b3104],
9	mRNA	NN	O	mrna	nn	11	SENT_504	[p16l1991t3052r2153b3093],
10	secondary	JJ	O	secondary	amod	11	SENT_504	[p16l139t3115r402b3170],
11	structure	NN	O	structure	dobj	8	SENT_504	[p16l419t3122r665b3159],
12	.	.	O	.	_	0	SENT_504	[p16l419t3122r665b3159],

1	Science	NNP	O	Science	_	0	SENT_505	[p16l683t3116r874b3159],
2	2006	CD	DATE	2006	num	1	SENT_505	[p16l892t3118r1358b3166],
3	;	:	O	;	_	0	SENT_505	[p16l892t3118r1358b3166],
4	314:1930	CD	NUMBER	314:1930	number	5	SENT_505	[p16l892t3118r1358b3166],
5	—	CD	NUMBER	—	dep	1	SENT_505	[p16l892t3118r1358b3166],
6	3	CD	NUMBER	3	dep	5	SENT_505	[p16l892t3118r1358b3166],
7	.	.	O	.	_	0	SENT_505	[p16l892t3118r1358b3166],

1	[	NN	O	[	_	0	SENT_506	[p16l7t3182r104b3236],
2	34	CD	NUMBER	34	num	1	SENT_506	[p16l7t3182r104b3236],
3	]	CD	NUMBER	]	num	5	SENT_506	[p16l7t3182r104b3236],
4	Capon	NNP	MISC	Capon	nn	5	SENT_506	[p16l139t3184r299b3236],
5	F	NN	MISC	f	dep	1	SENT_506	[p16l316t3185r350b3232],
6	,	,	O	,	_	0	SENT_506	[p16l316t3185r350b3232],
7	Allen	NNP	PERSON	Allen	nn	8	SENT_506	[p16l366t3182r500b3225],
8	MH	NNP	O	MH	appos	5	SENT_506	[p16l517t3185r620b3232],
9	,	,	O	,	_	0	SENT_506	[p16l517t3185r620b3232],
10	Ameen	NNP	PERSON	Ameen	nn	11	SENT_506	[p16l637t3184r819b3225],
11	M	NNP	O	M	appos	5	SENT_506	[p16l836t3185r897b3232],
12	,	,	O	,	_	0	SENT_506	[p16l836t3185r897b3232],
13	et	FW	O	et	nn	14	SENT_506	[p16l916t3188r963b3225],
14	al.	FW	O	al.	appos	5	SENT_506	[p16l979t3182r1035b3226],
15	.	.	O	.	_	0	SENT_506	[p16l979t3182r1035b3226],

1	A	DT	O	a	det	3	SENT_507	[p16l1051t3184r1088b3225],
2	synonymous	JJ	O	synonymous	amod	3	SENT_507	[p16l1105t3194r1429b3236],
3	SNP	NN	O	snp	nsubj	14	SENT_507	[p16l1447t3184r1548b3225],
4	of	IN	O	of	_	0	SENT_507	[p16l1564t3182r1618b3225],
5	the	DT	O	the	det	7	SENT_507	[p16l1628t3182r1710b3225],
6	corneodesmosin	NN	O	corneodesmosin	nn	7	SENT_507	[p16l1727t3182r2152b3225],
7	gene	NN	O	gene	prep_of	3	SENT_507	[p16l138t3260r258b3302],
8	leads	VBZ	O	lead	_	0	SENT_507	[p16l287t3247r417b3291],
9	to	TO	O	to	_	0	SENT_507	[p16l445t3254r494b3291],
10	increased	VBN	O	increase	amod	12	SENT_507	[p16l523t3247r767b3291],
11	mRNA	NN	O	mrna	nn	12	SENT_507	[p16l796t3249r959b3291],
12	stability	NN	O	stability	prep_to	8	SENT_507	[p16l985t3247r1193b3302],
13	and	CC	O	and	_	0	SENT_507	[p16l1220t3247r1313b3291],
14	demonstrates	VBZ	O	demonstrate	conj_and	8	SENT_507	[p16l1341t3247r1692b3291],
15	association	NN	O	association	dobj	14	SENT_507	[p16l1720t3248r2007b3291],
16	with	IN	O	with	_	0	SENT_507	[p16l2033t3247r2152b3291],
17	psoriasis	NN	O	psoriasis	prep_with	14	SENT_507	[p16l139t3315r362b3368],
18	across	IN	O	across	_	0	SENT_507	[p16l380t3326r537b3357],
19	diverse	JJ	O	diverse	amod	21	SENT_507	[p16l556t3314r739b3357],
20	ethnic	JJ	O	ethnic	amod	21	SENT_507	[p16l758t3314r917b3357],
21	groups	NNS	O	group	prep_across	17	SENT_507	[p16l934t3326r1122b3368],
22	.	.	O	.	_	0	SENT_507	[p16l934t3326r1122b3368],

1	Hum	NNP	O	Hum	nn	3	SENT_508	[p16l1141t3317r1265b3357],
2	Mol	NNP	O	Mol	nn	3	SENT_508	[p16l1283t3314r1380b3357],
3	Genet	NNP	O	Genet	_	0	SENT_508	[p16l1399t3316r1550b3357],
4	2004	CD	DATE	2004	num	3	SENT_508	[p16l1567t3316r2006b3364],
5	;	:	O	;	_	0	SENT_508	[p16l1567t3316r2006b3364],
6	13:2361	CD	NUMBER	13:2361	number	7	SENT_508	[p16l1567t3316r2006b3364],
7	—	CD	NUMBER	—	dep	3	SENT_508	[p16l1567t3316r2006b3364],
8	8	CD	NUMBER	8	dep	7	SENT_508	[p16l1567t3316r2006b3364],
9	.	.	O	.	_	0	SENT_508	[p16l1567t3316r2006b3364],

1	[	NN	O	[	_	0	SENT_509	[p16l8t3380r104b3435],
2	35	CD	NUMBER	35	num	1	SENT_509	[p16l8t3380r104b3435],
3	]	CD	NUMBER	]	num	5	SENT_509	[p16l8t3380r104b3435],
4	Nielsen	NNP	ORGANIZATION	Nielsen	nn	5	SENT_509	[p16l139t3380r330b3424],
5	KB	NN	ORGANIZATION	kb	dep	1	SENT_509	[p16l349t3383r428b3430],
6	,	,	O	,	_	0	SENT_509	[p16l349t3383r428b3430],
7	Sorensen	NNP	PERSON	Sorensen	nn	8	SENT_509	[p16l449t3382r683b3424],
8	S	NNP	O	S	appos	5	SENT_509	[p16l703t3382r741b3430],
9	,	,	O	,	_	0	SENT_509	[p16l703t3382r741b3430],
10	Cartegni	NNP	PERSON	Cartegni	nn	11	SENT_509	[p16l761t3381r975b3435],
11	L	NNP	PERSON	L	appos	5	SENT_509	[p16l996t3383r1032b3430],
12	,	,	O	,	_	0	SENT_509	[p16l996t3383r1032b3430],
13	et	FW	O	et	nn	14	SENT_509	[p16l1053t3387r1100b3424],
14	al.	FW	O	al.	appos	5	SENT_509	[p16l1119t3380r1174b3424],
15	.	.	O	.	_	0	SENT_509	[p16l1119t3380r1174b3424],

1	Seemingly	RB	O	seemingly	advmod	2	SENT_510	[p16l1195t3380r1463b3435],
2	neutral	JJ	O	neutral	amod	4	SENT_510	[p16l1481t3380r1664b3424],
3	polymorphic	JJ	O	polymorphic	amod	4	SENT_510	[p16l1685t3380r2014b3435],
4	variants	NNS	O	variant	nsubj	6	SENT_510	[p16l2032t3381r2151b3424, p16l138t3452r244b3489],
5	may	MD	O	may	aux	6	SENT_510	[p16l267t3458r376b3500],
6	confer	VB	O	confer	_	0	SENT_510	[p16l396t3445r559b3489],
7	immunity	NN	O	immunity	dobj	6	SENT_510	[p16l579t3446r835b3500],
8	to	TO	O	to	_	0	SENT_510	[p16l855t3452r904b3489],
9	splicing-inactivating	JJ	O	splicing-inactivating	amod	10	SENT_510	[p16l926t3446r1454b3500],
10	mutations	NNS	O	mutation	prep_to	6	SENT_510	[p16l1475t3446r1753b3490],
11	:	:	O	:	_	0	SENT_510	[p16l1475t3446r1753b3490],
12	a	DT	O	a	det	14	SENT_510	[p16l1778t3458r1804b3489],
13	synonymous	JJ	O	synonymous	amod	14	SENT_510	[p16l1826t3458r2151b3500],
14	SNP	NN	O	snp	nsubj	20	SENT_510	[p16l139t3514r239b3556],
15	in	IN	O	in	_	0	SENT_510	[p16l252t3513r300b3555],
16	exon	NN	O	exon	prep_in	14	SENT_510	[p16l314t3525r435b3556],
17	5	CD	NUMBER	5	num	16	SENT_510	[p16l449t3515r476b3556],
18	of	IN	O	of	_	0	SENT_510	[p16l492t3512r545b3556],
19	MCAD	NNP	ORGANIZATION	MCAD	prep_of	16	SENT_510	[p16l553t3514r713b3556],
20	protects	VBZ	O	protect	parataxis	6	SENT_510	[p16l728t3518r934b3566],
21	from	IN	O	from	_	0	SENT_510	[p16l949t3512r1071b3556],
22	deleterious	JJ	O	deleterious	amod	23	SENT_510	[p16l1085t3512r1372b3556],
23	mutations	NNS	O	mutation	prep_from	20	SENT_510	[p16l1387t3513r1648b3556],
24	in	IN	O	in	_	0	SENT_510	[p16l1664t3513r1711b3555],
25	a	DT	O	a	det	29	SENT_510	[p16l1725t3525r1751b3556],
26	ﬂanking	JJ	O	ﬂanking	amod	29	SENT_510	[p16l1765t3512r1974b3566],
27	exonic	JJ	O	exonic	amod	29	SENT_510	[p16l1987t3513r2152b3556],
28	splicing	NN	O	splicing	nn	29	SENT_510	[p16l139t3577r338b3632],
29	enhancer	NN	O	enhancer	prep_in	23	SENT_510	[p16l355t3577r602b3621],
30	.	.	O	.	_	0	SENT_510	[p16l355t3577r602b3621],

1	Am	VBP	O	be	dep	4	SENT_511	[p16l619t3579r738b3632],
2	]	CD	NUMBER	]	num	4	SENT_511	[p16l619t3579r738b3632],
3	Hum	NNP	O	Hum	nn	4	SENT_511	[p16l757t3580r881b3621],
4	Genet	NNP	O	Genet	_	0	SENT_511	[p16l899t3580r1051b3621],
5	2007	CD	DATE	2007	num	4	SENT_511	[p16l1067t3580r1502b3628],
6	;	:	O	;	_	0	SENT_511	[p16l1067t3580r1502b3628],
7	80:416	CD	NUMBER	80:416	dep	4	SENT_511	[p16l1067t3580r1502b3628],
8	—	CD	NUMBER	—	num	9	SENT_511	[p16l1067t3580r1502b3628],
9	32	CD	NUMBER	32	dep	7	SENT_511	[p16l1067t3580r1502b3628],
10	.	.	O	.	_	0	SENT_511	[p16l1067t3580r1502b3628],

1	[	NN	O	[	nn	4	SENT_512	[p16l7t3644r104b3698],
2	36	CD	NUMBER	36	num	4	SENT_512	[p16l7t3644r104b3698],
3	]	NN	O	]	nn	4	SENT_512	[p16l7t3644r104b3698],
4	Moriai	NN	ORGANIZATION	moriaus	_	0	SENT_512	[p16l139t3645r305b3687],
5	T	NN	ORGANIZATION	t	dep	4	SENT_512	[p16l323t3647r362b3694],
6	,	,	O	,	_	0	SENT_512	[p16l323t3647r362b3694],
7	Kobrin	NNP	PERSON	Kobrin	nn	8	SENT_512	[p16l382t3644r552b3687],
8	MS	NN	O	m	appos	5	SENT_512	[p16l571t3646r662b3694],
9	,	,	O	,	_	0	SENT_512	[p16l571t3646r662b3694],
10	Hope	NNP	O	Hope	nn	11	SENT_512	[p16l682t3646r815b3698],
11	C	NNP	O	C	appos	5	SENT_512	[p16l835t3646r877b3694],
12	,	,	O	,	_	0	SENT_512	[p16l835t3646r877b3694],
13	et	FW	O	et	nn	14	SENT_512	[p16l897t3650r945b3687],
14	al.	FW	O	al.	appos	5	SENT_512	[p16l962t3644r1017b3688],
15	.	.	O	.	_	0	SENT_512	[p16l962t3644r1017b3688],

1	A	DT	O	a	det	6	SENT_513	[p16l1035t3646r1072b3687],
2	variant	JJ	O	variant	amod	6	SENT_513	[p16l1088t3645r1271b3687],
3	epidermal	JJ	O	epidermal	amod	6	SENT_513	[p16l1288t3644r1550b3698],
4	growth	NN	O	growth	nn	6	SENT_513	[p16l1568t3644r1754b3698],
5	factor	NN	O	factor	nn	6	SENT_513	[p16l1773t3644r1921b3687],
6	receptor	NN	O	receptor	nsubj	7	SENT_513	[p16l1938t3650r2153b3698],
7	exhibits	VBZ	O	exhibit	_	0	SENT_513	[p16l139t3710r341b3754],
8	altered	JJ	O	altered	amod	9	SENT_513	[p16l361t3710r539b3754],
9	type	NN	O	type	dobj	7	SENT_513	[p16l558t3717r670b3765],
10	transforming	VBG	O	transform	partmod	9	SENT_513	[p16l689t3710r1027b3765],
11	growth	NN	O	growth	nn	13	SENT_513	[p16l1044t3710r1229b3765],
12	factor	NN	O	factor	nn	13	SENT_513	[p16l1248t3710r1396b3754],
13	binding	NN	O	binding	dobj	10	SENT_513	[p16l1413t3710r1610b3765],
14	and	CC	O	and	_	0	SENT_513	[p16l1628t3710r1721b3754],
15	transmembrane	NN	O	transmembrane	nn	16	SENT_513	[p16l1740t3710r2151b3754],
16	signalling	NN	O	signalling	conj_and	13	SENT_513	[p16l139t3776r399b3830],
17	.	.	O	.	_	0	SENT_513	[p16l139t3776r399b3830],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_514	[p16l418t3778r528b3819],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_514	[p16l546t3776r649b3819],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_514	[p16l666t3776r790b3819],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_514	[p16l808t3776r878b3819],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_514	[p16l896t3778r1001b3819],
6	1994	CD	DATE	1994	num	5	SENT_514	[p16l1020t3778r1218b3826],
7	;	:	O	;	_	0	SENT_514	[p16l1020t3778r1218b3826],
8	91 210217	CD	NUMBER	91 210217	number	9	SENT_514	[p16l1232t3778r1500b3820],[p16l1020t3778r1218b3826],
9	-21	CD	NUMBER	-21	dep	5	SENT_514	[p16l1232t3778r1500b3820],
10	.	.	O	.	_	0	SENT_514	[p16l1232t3778r1500b3820],

1	[	NN	O	[	nn	5	SENT_515	[p17l9t17r104b71],
2	37	CD	NUMBER	37	num	5	SENT_515	[p17l9t17r104b71],
3	]	CD	NUMBER	]	num	5	SENT_515	[p17l9t17r104b71],
4	Liu	NNP	O	Liu	nn	5	SENT_515	[p17l139t18r214b61],
5	W	NNP	O	W	_	0	SENT_515	[p17l226t20r292b67],
6	,	,	O	,	_	0	SENT_515	[p17l226t20r292b67],
7	Wu	NNP	O	Wu	nn	8	SENT_515	[p17l305t20r395b61],
8	X	NNP	O	X	appos	5	SENT_515	[p17l407t20r455b67],
9	,	,	O	,	_	0	SENT_515	[p17l407t20r455b67],
10	Zhang	NNP	PERSON	Zhang	nn	11	SENT_515	[p17l469t17r627b71],
11	W	NNP	PERSON	W	appos	5	SENT_515	[p17l638t20r704b67],
12	,	,	O	,	_	0	SENT_515	[p17l638t20r704b67],
13	et	FW	O	et	nn	14	SENT_515	[p17l719t23r767b61],
14	al.	FW	O	al.	appos	5	SENT_515	[p17l779t17r835b61],
15	.	.	O	.	_	0	SENT_515	[p17l779t17r835b61],

1	Relationship	NN	O	relationship	_	0	SENT_516	[p17l849t17r1170b71],
2	of	IN	O	of	_	0	SENT_516	[p17l1184t17r1237b61],
3	EGFR	NN	O	egfr	nn	4	SENT_516	[p17l1245t19r1379b61],
4	mutations	NNS	O	mutation	prep_of	1	SENT_516	[p17l1391t18r1665b67],
5	,	,	O	,	_	0	SENT_516	[p17l1391t18r1665b67],
6	expression	NN	O	expression	prep_of	1	SENT_516	[p17l1680t18r1968b71],
7	,	,	O	,	_	0	SENT_516	[p17l1680t18r1968b71],
8	ampliﬁcation	NN	O	ampliﬁcation	conj_and	4	SENT_516	[p17l1983t17r2151b71, p17l139t82r343b133],
9	,	,	O	,	_	0	SENT_516	[p17l1983t17r2151b71, p17l139t82r343b133],
10	and	CC	O	and	_	0	SENT_516	[p17l361t82r454b126],
11	polymorphisms	NNS	O	polymorphism	conj_and	4	SENT_516	[p17l473t83r876b137],
12	to	TO	O	to	_	0	SENT_516	[p17l894t89r943b126],
13	epidermal	JJ	O	epidermal	amod	17	SENT_516	[p17l961t82r1222b137],
14	growth	NN	O	growth	nn	17	SENT_516	[p17l1239t82r1425b137],
15	factor	NN	O	factor	nn	17	SENT_516	[p17l1443t82r1590b126],
16	receptor	NN	O	receptor	nn	17	SENT_516	[p17l1606t89r1822b137],
17	inhibitors	NNS	O	inhibitor	prep_to	1	SENT_516	[p17l1838t82r2086b126],
18	in	IN	O	in	_	0	SENT_516	[p17l2105t83r2152b126],
19	the	DT	O	the	det	22	SENT_516	[p17l138t149r219b192],
20	NCI6O	NN	O	nci6o	nn	22	SENT_516	[p17l238t151r392b192],
21	cell	NN	O	cell	nn	22	SENT_516	[p17l410t149r496b192],
22	lines	NNS	O	line	prep_in	17	SENT_516	[p17l515t149r647b193],
23	.	.	O	.	_	0	SENT_516	[p17l515t149r647b193],

1	Clin	NNP	O	Clin	nn	3	SENT_517	[p17l665t149r764b192],
2	Cancer	NNP	O	Cancer	nn	3	SENT_517	[p17l782t151r957b192],
3	Res	NNP	O	Res	_	0	SENT_517	[p17l973t152r1057b192],
4	2007	CD	DATE	2007	num	3	SENT_517	[p17l1076t151r1546b199],
5	;	:	O	;	_	0	SENT_517	[p17l1076t151r1546b199],
6	13:6788	CD	NUMBER	13:6788	number	7	SENT_517	[p17l1076t151r1546b199],
7	—	CD	NUMBER	—	dep	3	SENT_517	[p17l1076t151r1546b199],
8	95	CD	NUMBER	95	dep	7	SENT_517	[p17l1076t151r1546b199],
9	.	.	O	.	_	0	SENT_517	[p17l1076t151r1546b199],

1	[	NN	O	[	_	0	SENT_518	[p17l7t214r104b269],
2	38	CD	NUMBER	38	num	1	SENT_518	[p17l7t214r104b269],
3	]	CD	NUMBER	]	num	5	SENT_518	[p17l7t214r104b269],
4	Nie	NN	O	nie	nn	5	SENT_518	[p17l139t215r223b258],
5	Q	NNP	O	Q	dep	1	SENT_518	[p17l246t217r295b267],
6	,	,	O	,	_	0	SENT_518	[p17l246t217r295b267],
7	Wang	NNP	PERSON	Wang	nn	8	SENT_518	[p17l316t217r466b269],
8	Z	NNP	PERSON	Z	appos	5	SENT_518	[p17l486t217r528b265],
9	,	,	O	,	_	0	SENT_518	[p17l486t217r528b265],
10	Zhang	NNP	O	Zhang	nn	11	SENT_518	[p17l550t214r709b269],
11	GC	NN	O	gc	appos	5	SENT_518	[p17l730t217r813b265],
12	,	,	O	,	_	0	SENT_518	[p17l730t217r813b265],
13	et	FW	O	et	nn	14	SENT_518	[p17l836t221r884b258],
14	al.	FW	O	al.	appos	5	SENT_518	[p17l905t215r960b258],
15	.	.	O	.	_	0	SENT_518	[p17l905t215r960b258],

1	The	DT	O	the	det	5	SENT_519	[p17l981t214r1075b258],
2	epidermal	JJ	O	epidermal	dep	3	SENT_519	[p17l1098t214r1359b269],
3	growth	NN	O	growth	amod	5	SENT_519	[p17l1381t214r1567b269],
4	factor	NN	O	factor	nn	5	SENT_519	[p17l1589t214r1737b258],
5	receptor	NN	O	receptor	ccomp	18	SENT_519	[p17l1759t221r1974b269],
6	intron	NN	O	intron	nn	10	SENT_519	[p17l1995t215r2152b258],
7	1	CD	NUMBER	1	num	10	SENT_519	[p17l141t283r161b324],
8	(	CD	NUMBER	(	num	10	SENT_519	[p17l199t281r330b335],
9	CA	NNP	O	CA	nn	10	SENT_519	[p17l199t281r330b335],
10	)	NNP	O	)	dep	5	SENT_519	[p17l199t281r330b335],
11	,	,	O	,	_	0	SENT_519	[p17l199t281r330b335],
12	,	,	O	,	_	0	SENT_519	[p17l199t281r330b335],
13	microsatellite	NN	O	microsatellite	nn	14	SENT_519	[p17l366t281r718b324],
14	polymorphism	NN	O	polymorphism	nsubj	18	SENT_519	[p17l751t281r1130b335],
15	is	VBZ	O	be	cop	18	SENT_519	[p17l1161t282r1198b324],
16	a	DT	O	a	det	18	SENT_519	[p17l1231t293r1256b324],
17	potential	JJ	O	potential	amod	18	SENT_519	[p17l1288t281r1517b335],
18	predictor	NN	O	predictor	_	0	SENT_519	[p17l1549t281r1786b335],
19	of	IN	O	of	_	0	SENT_519	[p17l1816t281r1869b324],
20	treatment	NN	O	treatment	nn	21	SENT_519	[p17l1894t287r2153b324],
21	outcome	NN	O	outcome	prep_of	18	SENT_519	[p17l139t354r363b391],
22	in	IN	O	in	_	0	SENT_519	[p17l387t348r435b390],
23	patients	NNS	O	patient	prep_in	21	SENT_519	[p17l458t348r664b402],
24	with	IN	O	with	_	0	SENT_519	[p17l687t347r806b391],
25	advanced	JJ	O	advanced	amod	27	SENT_519	[p17l829t347r1072b391],
26	lung	NN	O	lung	nn	27	SENT_519	[p17l1097t347r1209b402],
27	cancer	NN	O	cancer	prep_with	23	SENT_519	[p17l1232t360r1400b391],
28	treated	VBN	O	treat	partmod	27	SENT_519	[p17l1421t347r1605b391],
29	with	IN	O	with	_	0	SENT_519	[p17l1627t347r1746b391],
30	Geﬁtinib	NN	O	geﬁtinib	prep_with	28	SENT_519	[p17l1769t347r2005b391],
31	.	.	O	.	_	0	SENT_519	[p17l1769t347r2005b391],

1	Eur	NNP	MISC	Eur	nn	3	SENT_520	[p17l2029t350r2151b402],
2	]	NNP	O	]	nn	3	SENT_520	[p17l2029t350r2151b402],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_520	[p17l139t413r410b456],
4	2007	CD	DATE	2007	num	3	SENT_520	[p17l429t415r890b463],
5	;	:	O	;	_	0	SENT_520	[p17l429t415r890b463],
6	570:175	CD	NUMBER	570:175	number	7	SENT_520	[p17l429t415r890b463],
7	—	CD	NUMBER	—	dep	3	SENT_520	[p17l429t415r890b463],
8	81	CD	NUMBER	81	dep	7	SENT_520	[p17l429t415r890b463],
9	.	.	O	.	_	0	SENT_520	[p17l429t415r890b463],

1	[	NN	O	[	nn	5	SENT_521	[p17l7t479r104b533],
2	39	CD	NUMBER	39	num	5	SENT_521	[p17l7t479r104b533],
3	]	CD	NUMBER	]	num	5	SENT_521	[p17l7t479r104b533],
4	Liu	NNP	O	Liu	nn	5	SENT_521	[p17l139t480r214b523],
5	W	NNP	O	W	_	0	SENT_521	[p17l248t482r315b529],
6	,	,	O	,	_	0	SENT_521	[p17l248t482r315b529],
7	Montenegro	NNP	LOCATION	Montenegro	nn	8	SENT_521	[p17l353t482r666b533],
8	RC	NNP	O	RC	appos	5	SENT_521	[p17l704t481r780b529],
9	,	,	O	,	_	0	SENT_521	[p17l704t481r780b529],
10	Zhang	NNP	PERSON	Zhang	nn	11	SENT_521	[p17l816t479r975b533],
11	W	NNP	PERSON	W	appos	5	SENT_521	[p17l1009t482r1075b529],
12	,	,	O	,	_	0	SENT_521	[p17l1009t482r1075b529],
13	et	FW	O	et	nn	14	SENT_521	[p17l1112t485r1160b523],
14	al.	FW	O	al.	appos	5	SENT_521	[p17l1195t479r1251b523],
15	.	.	O	.	_	0	SENT_521	[p17l1195t479r1251b523],

1	Response	NN	O	response	nsubj	15	SENT_522	[p17l1288t482r1528b533],
2	to	TO	O	to	_	0	SENT_522	[p17l1564t485r1613b523],
3	EGFR	NN	O	egfr	nn	4	SENT_522	[p17l1650t481r1784b523],
4	inhibitors	NNS	O	inhibitor	prep_to	1	SENT_522	[p17l1819t479r2066b523],
5	in	IN	O	in	_	0	SENT_522	[p17l2105t480r2152b522],
6	ﬁbroblast	NN	O	ﬁbroblast	nn	8	SENT_522	[p17l139t544r383b588],
7	cell	NN	O	cell	nn	8	SENT_522	[p17l407t544r493b588],
8	lines	NNS	O	line	prep_in	4	SENT_522	[p17l519t544r637b588],
9	and	CC	O	and	_	0	SENT_522	[p17l663t544r756b588],
10	its	PRP$	O	its	poss	11	SENT_522	[p17l781t545r839b588],
11	association	NN	O	association	conj_and	4	SENT_522	[p17l865t545r1151b588],
12	with	IN	O	with	_	0	SENT_522	[p17l1174t544r1293b588],
13	germline	NN	O	germline	nn	14	SENT_522	[p17l1317t544r1546b599],
14	polymorphisms	NNS	O	polymorphism	prep_with	11	SENT_522	[p17l1572t544r2028b599],
15	]	VBP	O	]	_	0	SENT_522	[p17l1572t544r2028b599],
16	Clin	NNP	O	Clin	nn	18	SENT_522	[p17l2053t544r2152b588],
17	Oncol	NNP	O	Oncol	nn	18	SENT_522	[p17l139t611r285b654],
18	ASCO	NNP	ORGANIZATION	ASCO	nsubj	20	SENT_522	[p17l296t613r435b654],
19	Annual	JJ	SET	annual	dep	20	SENT_522	[p17l446t611r630b654],
20	Meeting	VBG	O	meet	xcomp	15	SENT_522	[p17l643t612r855b665],
21	Proceedings	NNP	O	Proceedings	nn	23	SENT_522	[p17l867t611r1177b665],
22	(	NNP	O	(	nn	23	SENT_522	[p17l1190t611r1556b665],
23	Post	NNP	O	Post	dobj	20	SENT_522	[p17l1190t611r1556b665],
24	.	.	O	.	_	0	SENT_522	[p17l1190t611r1556b665],

1	—	NN	O	—	_	0	SENT_523	[p17l1190t611r1556b665],
2	.	.	O	.	_	0	SENT_523	[p17l1190t611r1556b665],

1	Meeting	VBG	O	meet	_	0	SENT_524	[p17l1190t611r1556b665],
2	Edition	NNP	O	Edition	dobj	1	SENT_524	[p17l1568t611r1771b665],
3	)	CD	NUMBER	)	num	2	SENT_524	[p17l1568t611r1771b665],
4	2006	CD	DATE	2006	dep	2	SENT_524	[p17l1784t611r2147b665],
5	;	:	O	;	_	0	SENT_524	[p17l1784t611r2147b665],
6	24	CD	NUMBER	24	number	7	SENT_524	[p17l1784t611r2147b665],
7	(	CD	NUMBER	(	dep	2	SENT_524	[p17l1784t611r2147b665],
8	18S	NN	O	18	nn	9	SENT_524	[p17l1784t611r2147b665],
9	)	NN	O	)	dep	7	SENT_524	[p17l1784t611r2147b665],
10	:	:	O	:	_	0	SENT_524	[p17l1784t611r2147b665],
11	A13167	NN	O	a13167	dep	2	SENT_524	[p17l136t680r332b722],
12	.	.	O	.	_	0	SENT_524	[p17l136t680r332b722],

1	[	RB	O	[	advmod	2	SENT_525	[p17l7t743r104b798],
2	40	CD	NUMBER	40	_	0	SENT_525	[p17l7t743r104b798],
3	]	CD	NUMBER	]	num	5	SENT_525	[p17l7t743r104b798],
4	Dubey	NNP	PERSON	Dubey	nn	5	SENT_525	[p17l139t744r304b798],
5	S	NN	O	s	dep	2	SENT_525	[p17l332t746r370b794],
6	,	,	O	,	_	0	SENT_525	[p17l332t746r370b794],
7	Stephenson	NNP	PERSON	Stephenson	nn	8	SENT_525	[p17l401t744r699b798],
8	P	NN	O	p	appos	5	SENT_525	[p17l729t746r764b794],
9	,	,	O	,	_	0	SENT_525	[p17l729t746r764b794],
10	Levy	NNP	ORGANIZATION	Levy	nn	11	SENT_525	[p17l795t746r911b798],
11	DE	NN	ORGANIZATION	de	appos	5	SENT_525	[p17l939t746r1020b794],
12	,	,	O	,	_	0	SENT_525	[p17l939t746r1020b794],
13	et	FW	O	et	nn	14	SENT_525	[p17l1050t750r1098b787],
14	al.	FW	O	al.	appos	5	SENT_525	[p17l1126t744r1181b788],
15	.	.	O	.	_	0	SENT_525	[p17l1126t744r1181b788],

1	EGFR	NN	O	egfr	nn	4	SENT_526	[p17l1211t746r1345b787],
2	dinucleotide	NN	O	dinucleotide	nn	4	SENT_526	[p17l1372t744r1693b787],
3	repeat	NN	O	repeat	nn	4	SENT_526	[p17l1723t750r1886b798],
4	polymorphism	NN	O	polymorphism	_	0	SENT_526	[p17l1915t744r2151b798, p17l139t810r298b864],
5	as	IN	O	as	_	0	SENT_526	[p17l319t823r369b854],
6	a	DT	O	a	det	8	SENT_526	[p17l391t823r417b854],
7	prognostic	JJ	O	prognostic	amod	8	SENT_526	[p17l439t811r710b864],
8	indicator	NN	O	indicator	prep_as	4	SENT_526	[p17l732t810r963b854],
9	in	IN	O	in	_	0	SENT_526	[p17l983t811r1031b853],
10	non-small	JJ	O	non-small	amod	13	SENT_526	[p17l1052t810r1312b854],
11	cell	NN	O	cell	nn	13	SENT_526	[p17l1334t810r1420b854],
12	lung	NN	O	lung	nn	13	SENT_526	[p17l1443t810r1556b864],
13	cancer	NN	O	cancer	prep_in	4	SENT_526	[p17l1576t823r1752b854],
14	.	.	O	.	_	0	SENT_526	[p17l1576t823r1752b854],

1	J	NNP	O	J	nn	3	SENT_527	[p17l1768t813r1789b864],
2	Thorac	NNP	O	Thorac	nn	3	SENT_527	[p17l1808t810r1983b854],
3	Oncol	NNP	O	Oncol	_	0	SENT_527	[p17l2005t810r2151b854],
4	2006	CD	DATE	2006	num	3	SENT_527	[p17l138t878r547b925],
5	;	:	O	;	_	0	SENT_527	[p17l138t878r547b925],
6	1:406	CD	NUMBER	1:406	number	7	SENT_527	[p17l138t878r547b925],
7	—	CD	NUMBER	—	dep	3	SENT_527	[p17l138t878r547b925],
8	12	CD	NUMBER	12	dep	7	SENT_527	[p17l138t878r547b925],
9	.	.	O	.	_	0	SENT_527	[p17l138t878r547b925],

